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Abstract 
 
Intense excitement and optimism surrounds the rapidly-expanding field of stem cell 
research, owing to their high capacity for self-renewal and intrinsic ability to 
differentiate into mature cell lineages. Although it may be envisioned that embryonic 
stem cells will be of significantly greater therapeutic value than their adult stem cell 
counterparts, the use of embryonic stem cells is fraught with both technical and ethical 
challenges and, as such, significant impetus has been placed on adult stem cell-based 
research. In particular, mesenchymal stem cells (MSCs) present as exciting candidates 
for potential use in cellular therapies and tissue engineering strategies. 
 
MSCs are defined at the functional level in terms of their ability to differentiate into 
mesodermal derivatives such as bone and fat. However, this functional definition is 
evolving, and there is considerable evidence to suggest that MSCs have a key role 
within their niche involving the release and/or uptake of soluble factors and cytokines, 
significantly influencing the behaviour of other cell types within the niche. Both facets 
of MSC behaviour are valuable from a clinical perspective, and have been examined in 
the present thesis. 
 
The most obvious and realistically-achievable clinical application of MSCs at present 
is in the treatment of osseous and adipose tissue defects. However, before the use of 
MSCs in the clinic becomes more commonplace, it is crucial to gain a more 
comprehensive understanding of the complex molecular and cellular mechanism(s) by 
which MSCs commit to a given fate and undergo differentiation to produce mature, 
fully-functional derivatives. Much of our present knowledge is derived from studies 
performed on the highly unnatural, 2D environment of tissue culture plastic. The 
present study assessed the behaviour of MSCs cultured on Alvetex
TM
, a novel, 3D 
scaffold manufactured by ReInnervate, with particular emphasis on the ability of 
MSCs to undergo osteogenic and adipogenic differentiation. Results obtained suggest 
that Alvetex
TM
 may provide a more realistic and physiologically-relevant system in 
which to study osteogenesis and adipogenesis, in a manner more pertinent to that 
which occurs in vivo. 
 
  
Furthermore, the ability of MSCs to influence the behaviour of other cell types via the 
release of trophic factors and cytokines was examined, with particular emphasis on the 
nervous system. An in vitro conditioned media model was developed in order to 
investigate the influence(s) of MSC-derived soluble factors/cytokines on neural 
development and plasticity, using the adult rat hippocampal progenitor cell (AHPC) 
line as a model system. Results obtained suggest that, under defined conditions, MSCs 
secreted a complement of soluble factors/cytokines that induce AHPCs to commit to 
and undergo astrogenesis. This effect was characterised at both the cellular and 
molecular level. The specific complement of bioactive factors secreted by MSCs has 
been investigated using a combination of targeted transcriptional profiling and shotgun 
proteomics, and several putative candidate factors have been identified for further 
investigation.
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1.1 Introduction 
 
Intense excitement and optimism surrounds the rapidly-expanding field of stem cell 
research where it is envisioned that these primitive cells hold the potential to 
revolutionise modern medical approaches against a wide range of clinically-important 
disorders, principally via cellular-based regenerative therapies and tissue engineering 
strategies (Bianco and Robey, 2001; Giannoudis and Pountos, 2005; Martino and 
Pluchino, 2006). The potential role of stem cells in modern medicine has garnered 
much media interest to date and it is anticipated that this interest will only serve to 
intensify in the future.  
 
One aspect of stem cell behaviour that is overlooked by the media, however, is the 
somewhat paradoxical role played by stem cells in disease aetiology. Although the 
obvious therapeutic potential of stem cells in the clinic cannot be questioned, it is has 
been demonstrated in several systems that stem cells present as the main targets for 
neoplastic transformation in oncology, where their persistence throughout the lifespan 
of the organism means they exist long enough to accumulate the numerous genetic 
alterations required for transformation, in keeping with Knudson’s ‘multi-hit’ 
hypothesis (Knudson et al., 1973; Bonnet and Dick, 1997). Additionally, the 
maintenance of stem cell populations within tumours has been demonstrated in 
numerous systems, where it proposed that such ‘cancer stem cells’ have the potential 
to give rise to new tumours (Reya et al., 2001; Al-Hajj et al., 2003; Collins et al., 
2005; Florek et al., 2005; Kim et al., 2005; Singh et al., 2003).  
 
From an academic perspective, stem cells are also invaluable models in developmental 
biology and it is envisioned that a greater understanding of the complex cellular and 
molecular mechanisms by which stem cells commit to and undergo differentiation will 
reveal new facets in how development proceeds from embryo to organism (Rohwedel 
et al., 2001; Rodda et al., 2002). 
 
Stem cell research therefore has many different facets and potential applications in 
both the laboratory and the clinic; however, our current understanding of stem cell 
behaviour is too basic at present in order to recognise their true potential. 
Consequently, translation of stem cells from the laboratory bench to the clinic has been 
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slow and somewhat disappointing, despite continued claims from the media that stem 
cell breakthroughs are imminent. Improved knowledge regarding the 
behaviour/function of stem cells and how such behaviour can be 
controlled/manipulated appropriately is the first major step towards achieving this 
goal. 
 
1.2 Basic principles in stem cell biology 
 
1.2.1  Stem cell definition, sources and potency 
Stem cells are characterised at the functional level in terms of their high capacity for 
self-renewal and intrinsic ability to differentiate into mature cell lineages (Weissman, 
2000). ‘Embryonic stem (ES) cells’ are derived from the inner cell mass of the 
blastocyst, a structure formed during the early stages of embryogenesis in mammals, 
and demonstrate the potential to differentiate into all the specialised tissues of an 
organism. This potential for human ES cells was initially demonstrated both in vitro 
and in vivo by Thomson and colleagues (1998). ‘Adult stem cells’, conversely, are 
found in the vast majority of adult tissues, albeit in relatively small numbers 
(approximately 1-2%), where they contribute to tissue repair and general cell turnover 
(Presnell et al., 2002). The capacity for self-renewal extends throughout the adult life 
of an organism, permitting tissue repair and regeneration from damage encountered 
throughout the lifespan of an organism (Preston et al., 2003). Despite this high 
capacity for self-renewal, stem cells generally exist in a non-dividing, quiescent state 
in vivo. This serves to protect the stem cell from accumulative DNA replication errors, 
which would be deleterious to the survival of an organism. Previously, the majority of 
adult stem cell research has focussed on tissues characterised by a rapid cell turnover, 
such as the skin, gut and haematopoietic systems; however, there has since been a shift 
in interest to include tissues characterised by a much slower cell turnover rate, 
including the prostate (Hall and Watt, 1989; Isaacs and Coffey, 1989). 
 
Although stem cells can be classified at the broadest level as either ‘embryonic’ or 
‘adult’, they can be further classified according to their differentiative potential 
(potency). 
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 Totipotency (omnipotency) 
Describes the ability of a stem cell to differentiate into specialised cell 
types representative of all three germ layers and form extraembryonic 
tissue such as the trophoblast of the placenta (Thomson et al., 1998). 
By definition, totipotent (omnipotent) stem cells are the only cell type with 
the potential to generate a new, viable organism; as such, use of this term is 
usually restricted to description of the zygote and cells produced by the first 
few zygotic divisions (Mitalipov and Wolf, 2009). 
 
 Pluripotency 
Describes the ability of a stem cell to differentiate into specialised cell 
types representative of all three germ layers but not extraembryonic tissue; 
as such, pluripotent stem cells do not have the potential to generate a new, 
viable organism and use of this term is usually restricted to description of 
ES cells derived from the inner cell mass of the blastocyst (Ulloa-Montoya 
et al., 2005).  
 
 Multipotency 
Describes the ability of a stem cell to differentiate into a range of closely-
related specialised cell types appropriate to their physiological location. 
This term can be used in the description of most adult stem cell types, 
including mesenchymal and haematopoietic stem cells. 
 
 Unipotency 
Describes the ability of a stem cell to differentiate into one specialised cell 
type e.g. spermatogonodal cells. 
 
1.2.2 Embryonic stem cells versus adult stem cells 
The obvious differences between pluripotent embryonic stem cells and multipotent, 
lineage-restricted adult stem cells reflects the different functions of the two cell types 
in development. Embryonic stem cells contribute to the formation of all the specialised 
tissue that will eventually give rise to a new organism, whereas adult stem cells are 
predominantly involved in tissue maintenance and general cell turnover; as such, the 
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differentiative potential of adult stem cells is more restricted in keeping with this 
function. 
 
From a clinical perspective, it may therefore be envisioned that embryonic stem cells 
will be of significantly greater therapeutic value than their adult counterparts, owing to 
their potential to generate all specialised tissues found throughout organisms, including 
germ cells as well as somatic cells. However, the use of embryonic stem cells in both 
an academic and clinical environment is fraught with both technical and ethical 
challenges. These will be considered very briefly below. 
 
1.2.2.1  Source of material 
This is perhaps the most ethically-controversial aspect of embryonic stem cell biology. 
Thomson and colleagues isolated human embryonic stem cells from ‘spare’ embryos 
that had been donated from couples undergoing in vitro fertilisation (IVF). Similarly, 
Zhang and colleagues isolated human embryonic stem cells from arrested embryos 
produced during IVF treatment (Thomson et al., 1998; Zhang et al., 2006). At present, 
public opinion is largely divided over the ethical issues concerning the derivation of 
stem cells from human embryos. Conversely, adult stem cells can be easily and 
routinely isolated from a wide variety of readily-accessible sources, including bone 
marrow, adipose tissue, adult blood, umbilical cord blood, amniotic fluid, tendon and 
ligaments, chorionic villi of the placenta, synovial membranes and deciduous teeth, 
amongst many others (Kuznetsov et al., 2001, Rosada et al., 2003, Vandenabeele et al., 
2003, Miura et al., 2003, Gronthos et al., 2001, Igura et al., 2004, Tsai et al., 2004, 
Anker et al., 2003, Salingcarnboriboon et al., 2003, Seo et al., 2004). As such, the use 
of adult stem cells both in the laboratory and the clinic is more ethically-acceptable at 
present. 
 
1.2.2.2  Technical challenges of in vitro research 
Culturing human ES cells in the laboratory is technically challenging for several 
reasons. 
 
 Isolation of cells from the inner cell mass is technically challenging due to 
the presence of a protective layer of tissue surrounding the blastocyst 
known as the trophoectoderm (Stojkovic et al., 2004). 
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 Requires a feeder layer of mitotically-inactive mouse embryonic 
fibroblasts, though leukaemia inhibitory factor (LIF) can be used for mouse 
ES cells (Evans and Kaufman, 1981). 
 
 Difficult to maintain embryonic stem cells in an undifferentiated state as 
they are highly prone to spontaneous differentiation. 
 
 
1.2.2.3  Teratoma formation 
Direct systemic administration of undifferentiated embryonic stem cells leads to 
teratoma formation in the host organism (Thomson et al., 1998). 
 
The numerous ethical and technical disadvantages/limitations of embryonic stem cell 
behaviour have resulted in increased interest in adult stem cell biology, as such cells 
present as promising alternatives for potential therapeutic applications in the clinic. 
 
1.2.3 Stem cells undergo asymmetric division to produce two phenotypically-
distinct daughter cells  
Since stem cells only account for approximately 1-2% of total cellular content of adult 
tissues, a number of interesting issues are raised: 
 
a) How can such a small proportion of stem cells (1-2%) contribute to total 
tissue turnover and repair throughout the lifespan of an organism? 
 
b) How are stem cell populations maintained throughout the lifespan of an 
organism and how do they avoid depletion? 
 
Although there are currently no satisfactory explanations to account for these 
phenomena, one facet of stem cell biology which could potentially account for these 
observations is the ability of stem cells to undergo asymmetric division, as 
demonstrated in Figure 1.1. It is widely accepted that stem cells are able to undergo 
asymmetric division to produce two phenotypically-distinct daughter cells – one 
corresponding to a quiescent, immature stem cell (self-renewal) and the other 
corresponding to highly-proliferative, lineage-restricted progenitor cell (transit-
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amplifying progenitor). Following a limited number of replications, transit-amplifying 
progenitors will exit the cell cycle and undergo terminal differentiation, thus 
contributing to tissue maintenance/repair whilst maintaining the stem cell population 
(Hall and Watt, 1989; Preston et al., 2003). 
 
 
 
 
Figure 1.1. Stem cells undergo asymmetrical division to produce two 
phenotypically-distinct daughter cells. Under normal physiological conditions it is 
hypothesised that stem cells undergo asymmetrical division to produce two 
phenotypically-distinct daughter cells, one of which corresponds to an identical stem 
cell (self-renewal) and the other of which corresponds to a rapidly-cycling, lineage-
restricted transit-amplifying progenitor. The proliferative potential of transit-
amplifying progenitors is limited and, following a limited number of replications, these 
cells exit the cell cycle and undergo terminal differentiation. (Adapted from Preston et 
al., 2003). 
 
As demonstrated in Figure 1.1, the relationship between stem cell, transit-amplifying 
progenitor and terminally-differentiated cell can be considered a hierarchical 
organisation; however, this is likely to represent an oversimplification of the biological 
situation. For example, it is highly probable that there are numerous intermediate 
stages in the transition from stem cell to terminally differentiated cell. Similarly, it is 
not known with any certainty whether stem cell division is always asymmetrical or 
whether the reported equality in the proportion of stem and transit-amplifying 
progenitors is a consequence of an overall net effect encompassing both symmetrical 
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and asymmetrical divisions (Hall and Watt, 1989). Distinction between symmetrical 
and asymmetrical division at the molecular level has been achieved by analysis of the 
composition of cell membrane proteins between daughter cells (Beckmann et al., 
2007). Regardless, the hierarchy highlighted in Figure 1 must be stringently regulated 
in order to maintain correctly-balanced tissue turnover. 
 
1.2.4 Stem cell niche 
The concept of the ‘stem cell niche’ was first proposed by Schofield over 30 years ago 
to describe the specialised microenvironment in which a stem cell resides in vivo 
(Schofield, 1978). At the physiological level, the stem cell niche consists of cellular 
and extracellular matrix components which form a functioning unit of tissue. At a 
more molecular level, however, the stem cell niche can be considered a dynamic entity 
in which complex interactions occur between stem cells and neighbouring cells, 
typically involving direct cell-cell interactions and/or the release of diffusible soluble 
factors/cytokines (produced by identical cells (autocrine) or different cells (paracrine) 
within the niche), extracellular matrix, oxygen tension and pH, amongst many other 
crucial parameters (Preston, 2003; Fuchs et al., 2004; Scadden, 2006). The complex 
and highly dynamic relationship between the stem cell and various components of its 
surrounding microenvironment play a crucial role in regulation of stem cell behaviour, 
with niche-specific signals serving to maintain the stem cell in its quiescent state until 
appropriate, at which point niche-specific signals can be modified accordingly to 
induce an appropriate response in the stem cell e.g. proliferation, migration and/or 
differentiation (Fuchs et al., 2004; Scadden, 2006). 
 
The concept of the stem cell niche and its importance in maintenance/regulation of 
stem cell behaviour/function has remained a largely theoretical concept following its 
original postulation by Schofield in 1978. However, it is now widely accepted that the 
influence of niche-specific signals on stem cell behaviour/function are equally as 
important as the intrinsic properties of the stem cells themselves; indeed, Scadden 
(2006) states, ‘The niche is as critical as stem-cell-autonomous functions in shaping 
our understanding of basic stem-cell biology, and how it contributes to health and 
disease’. Evidence in support of niche-specific signals governing stem cell 
behaviour/function is perhaps best demonstrated by one study in which germ line cells 
were transplanted into male mice lacking a stable germ line stem cell population 
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(Wang and Zhao, 1999). Following transplantation, it was observed that the majority 
of transplanted cells occupied the empty niches along the basal layer of the testes and 
underwent differentiation into mature sperm, restoring fertility in the recipient. As 
such, there is rejuvenated interest in the stem cell niche, its various components, and 
how these interplay to shape stem cell behaviour/function in vivo. 
 
Stem cell niches have since been described in considerable detail for numerous stem 
cell populations in vivo; however, it is perhaps the niches contained with epithelial 
tissues such as skin and the intestinal crypt that have been characterised the most 
extensively (Figure 1.2). 
 
 
 
Figure 1.2. Organisation of the highly-characterised stem cell niches within the 
skin epidermis (A) and intestinal crypt (B). A: The putative stem cell population 
within the skin epidermis is housed in the basal layer. During differentiation, stem 
cells migrate from the basal layer in an upward direction towards the upper layers of 
the epidermis. B: The intestinal crypt demonstrates a similar organisation, wherein the 
putative stem cell population is housed deep within the crypt and undergoes migration 
in an upward direction towards the villi during differentiation. (Adapted from Hall and 
Watt, 1989). 
 
Cells within the skin epidermis are arranged within multiple layers, as demonstrated in 
Figure 1.2A, with the putative stem cell population being housed within the basal layer 
(Hall and Watt, 1989). During differentiation, stem cells undergo migration from the 
basal layer in an upward direction through the various other layers of the niche, such 
that terminally-differentiated cells exist as a squame at the uppermost region of the 
epidermis (Withers, 1967, Potten and Hendry, 1973). A similar phenomenon has been 
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described in other epithelial-lined tissues such as prostate (Isaacs and Coffey, 1989). 
Confinement of the stem cell population to the basal layer in the skin epidermis was 
demonstrated following radiological damage to the mouse epidermis and subsequent 
cell cycle analysis. Cell proliferation could only be detected within the basal layer, and 
within a small subpopulation at that, accounting for approximately 10% of total 
cellular content of the basal layer (Withers, 1967).  
 
A second example of a highly-characterised stem cell niche is provided by the 
intestinal crypt (Hall and Watt, 1989). The gross morphology of the small intestine is 
such that its epithelial layer is organised into crypts and villi, as demonstrated in 
Figure 1.2B, with the putative stem cell population being housed deep within the 
crypts (Hall and Watt, 1989; Potten et al., 1987). As described for the skin epidermis, 
stem cells in the intestinal crypt undergo migration in an upward direction during 
differentiation, replacing those terminally-differentiated cells that are continually shed 
from the tips of villi (Potten et al., 1987). It was originally estimated that the number 
of stem cells contained with each crypt averaged between 4 and 16; however, further 
studies have since proven that crypts are derived and maintained by a single stem cell 
(Potten et al., 1987; Potten and Loeffler, 1987; Griffiths et al., 1988; Schmidt et al., 
1988).  
 
Although the structural organisation of the stem cell niches in the skin epidermis and 
intestinal crypt have been extensively characterised, a more comprehensive 
understanding of the effects of niche-specific signals and how they combine to 
modulate stem cell behaviour/function is desirable (Coffey et al., 1987; Akhurst et al., 
1988; Barnard et al., 1989). Such signals may include growth factors released by 
underlying stromal cells and other cell types within the niche. 
 
1.3 Mesenchymal stem cells (MSCs) 
 
1.3.1 Overview of MSC biology 
Mesenchymal stem cells (MSCs) are exciting candidates for use in cellular therapies 
and tissue engineering strategies. They are an adult stem cell population and derive 
their name from an intrinsic ability to differentiate into multiple cell lineages of 
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mesodermal origin such as bone, fat and cartilage (Pittenger et al., 1999). This is 
shown diagrammatically in Figure 1.3. Given these differentiative capabilities, MSCs 
can be described as multipotent, meaning they are able to differentiate into closely-
related cell types of the same germ layer. 
 
1.3.2 Historical perspective 
MSCs were first identified in 1976 in a fundamental work by Friedenstein 
(Friedenstein et al., 1976). At the time of this work, much research had been done and 
emphasis placed on haematopoietic cells present within the bone marrow. Friedenstein 
identified the presence of a second cell population within the bone marrow, distinct 
from the haematopoietic lineage, and these cells displayed two key properties: 1) 
colony-forming potential; and 2) ability to differentiate into bone and cartilage (both 
mesodermal tissues). Both the ability to form colonies (self-renew) and differentiate to 
produce progeny displaying a more mature phenotype confirmed that the cell 
population identified by Friedenstein were stem cell in nature. Morphologically, these 
cells appeared fusiform and fibroblastic, and as such were initially described as colony 
forming unit-fibroblasts (CFU-F). This original terminology proposed by Friedenstein 
has generally been replaced and nowadays these cells are typically referred to as 
mesenchymal stem cells, or marrow stromal cells. 
 
1.3.3 Sources of MSCs and their niche 
MSCs can be found ubiquitously throughout the body and are routinely isolated from 
sources such as bone marrow, adipose tissue, adult blood, umbilical cord blood, 
amniotic fluid, tendon and ligaments, chorionic villi of the placenta, synovial 
membranes, deciduous teeth and foetal liver, lung and spleen (Kuznetsov et al., 2001, 
Rosada et al., 2003, Vandenabeele et al., 2003, Miura et al., 2003, Gronthos et al., 
2001, Igura et al., 2004, Tsai et al., 2004, Anker et al., 2003, Salingcarnboriboon et al., 
2003, Seo et al., 2004). In fact, the distribution of MSCs throughout the body may be 
even more widespread, as alluded to in a recently published study by da Silva 
Meirelles and colleagues entitled ‘Mesenchymal stem cells reside in virtually all post-
natal organs and tissues’ (da Silva Meirelles et al., 2006). In this study, it was found 
that MSCs could be isolated and subsequently cultured in vitro from all of the organs 
and tissues examined in a murine system, including brain, spleen, liver, kidney, lung, 
muscle, thymus, pancreas and, of course, bone marrow. In doing so, the authors 
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convincingly showed that MSCs can be isolated from tissues arising from all three 
germ layers. Morphologically, MSCs isolated from the different tissues were very 
similar and marker expression profiles were indicative of an MSC population, although 
slight differences in marker expression profiles were observed between MSCs isolated 
from different sources. In terms of their capacity to differentiate into the mesodermal 
derivatives bone and fat, differences were more apparent between the cells depending 
on their site of origin, although all cells examined had the capabilities to undergo 
osteogenic and adipogenic differentiation (and hence may be correctly termed MSC). 
Such differences aside, the cells isolated from these various sources of tissue were 
similar enough in biological terms to suggest a close relationship between them.  
 
 
 
 
 
Figure 1.3. A schematic diagram showing the differentiative capabilities of MSCs. 
Following cell division, MSCs may form one of two different progeny: they may 
produce a daughter stem cell, in a process known as self-renewal, or may give rise to a 
progenitor cell that is more rapidly proliferating but more restricted in terms of its 
proliferative capacity and differentiative capabilities. MSCs have the capability to 
differentiate into a wide range of mesodermal cell types, including bone, fat, cartilage, 
connective tissue and muscle. 
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The ability to isolate and successfully propagate MSCs from such a wide range of 
tissues, both mesodermal and non-mesodermal in origin, raises the interesting issue of 
whether these tissues house a common MSC niche or whether MSCs are able to 
function in a manner that is independent of their environment, meaning that niche-
specific signals are not important determinants of their behaviour (Kolf et al., 2007). 
Da Silva Meirelles and colleagues shed further light on this subject, examining the 
isolation and  culture of MSCs from vascular tissue, both complex (aorta and vena 
cava) and simple (capillaries of the kidney glomerulus). The successful isolation and 
propagation of MSC populations from such sources is in keeping with previous reports 
claiming that MSCs may arise from perivascular cells (Farrington-Rock et al., 2004, 
Shi and Gronthos, 2003). These data therefore suggest that MSCs occupy a 
perivascular niche in vivo, which could also account for the widespread distribution of 
MSCs throughout the body (da Silva Meirelles et al., 2006). The perivascular niche of 
MSCs and its putative structure is shown diagrammatically in Figure 1.4. 
 
However, despite improved understanding of the structural organisation of the MSC 
perivascular niche, current knowledge pertaining to the complex and dynamic 
interactions occurring between MSCs and neighbouring cells/extracellular matrix 
within this niche is somewhat limited. In one study, Kaigler and colleagues (2005) 
examined the influence of endothelial cells on the osteogenic potential of MSCs, 
wherein they observed that endothelial cells could enhance the osteogenic 
differentiation of MSCs but only when in direct contact. This effect could not be 
reproduced following culture of MSCs with conditioned media or following culture of 
MSCs on extracellular matrix laid down by endothelial cells (Kaigler et al., 2005). 
Another important parameter to consider within the MSC niche is oxygen tension, as 
cells are exposed to much lower oxygen tensions in vivo compared to tensions 
encountered during routine in vitro culture. Indeed, culturing of cells under lowered 
oxygen tension in vitro has been demonstrated in numerous systems to significantly 
influence cellular behaviour (Csete, 2005; Sullivan et al., 2006). 
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Figure 1.4. The hypothesised perivascular niche of MSCs and its organisation. It 
is postulated that MSCs occupy a perivascular niche in vivo, which accounts for their 
widespread distribution throughout the body. MSCs interact with various components 
of this niche, including blood vessels (BV), differentiated cell types within the niche 
(DC1 and DC2), extracellular matrix (ECM) components and numerous diffusible 
soluble factors and cytokines, both self-derived (autocrine behaviour) and derived 
from other cell types (paracrine behaviour). (Reproduced from Kolf et al., 2007). 
 
 
1.3.4 Isolation of MSCs from bone marrow  
Despite the wide distribution of MSCs throughout the body, the bone marrow remains 
the most commonly used source for MSC isolation to date, even though MSCs 
represent only a tiny fraction of the total marrow population, around 0.01% (Pittenger 
et al., 1999). Commonly used sources of bone marrow for the isolation of MSCs 
include the iliac crest of the pelvis, femur, tibia and thoracic and lumbar spine 
(Pittenger et al., 1999, Digirolamo et al., 1999, Murphy et al., 2002, D'Ippolito et al., 
2002). The iliac crest of the pelvis is the most commonly used human source of MSCs, 
whereas the most predominant source in rodents are the longer bones (femurs and 
tibiae). 
 
A typical protocol for the isolation of MSCs from rodent femurs and tibiae is described 
below and shown in Figure 1.5. Firstly, the rodent must be euthanized and their femurs 
and tibiae extracted, cleaned of all connective tissue and placed in complete culture 
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medium (CCM) on ice. CCM typically consists of Dulbecco’s Modified Eagles 
Medium (DMEM) supplemented with 10% foetal calf serum (FCS), non-essential 
amino acids, L-glutamine, penicillin and streptomycin, although the exact components 
of CCM can vary somewhat between different laboratories. The ends of the bones 
must then be cut in order to expose the bone marrow, and the marrow aspirated with 
CCM by inserting a 21-gauge needle into the shaft of the bone and flushing with CCM. 
Bone marrow aspirates must then be plated into a tissue culture flask with more CCM 
and incubated, typically at 37
o
C and 5% CO2 in a humidified incubator. Aspirates must 
be left untouched for 48 hours to allow the stromal component of the marrow (MSCs) 
to adhere to the tissue culture plastic. The second cell population present within bone 
marrow – the haematopoietic population – should remain in suspension and not attach 
to the cellware. Adherence to tissue culture plastic is the major criterion to 
discriminate between and separate the haematopoietic and stromal components of the 
bone marrow. The resulting cultures of MSCs are therefore highly heterogeneous, 
consisting of a mixture of cells at various stages of development. Alternative isolation 
methods exploiting marker expression are currently being sought in order to isolate a 
more homogenous starting population of MSCs, however, adherence to tissue culture 
plastic remains the most highly used method to date. After 48 hours, non-adherent 
cells (haematopoietic cells) should be removed from the cultures and the adherent cells 
maintained in CCM. These cells are designated as passage 0 (P0). 
 
1.3.5 Cell-surface and intracellular markers indicative of a MSC phenotype 
Presently, there is no single definitive marker to define an MSC population. This is 
largely due to the heterogeneity observed within MSC cultures. MSCs are 
heterogeneous not only in terms of marker expression, but also cell size, morphology 
and potency. It is therefore necessary to build up an expression profile i.e. examine 
expression of a range of markers, none of which purely exclusive to MSCs, in order to 
determine the phenotype of the population. Positive markers include CD29, CD44, 
CD54, CD55, CD73 (SH3 and SH4), CD90 (Thy-1), CD105 (SH2, or endoglin), 
CD106 (vascular cell adhesion molecule, VCAM-1), CD117 and CD166, while 
negative markers include CD11b, CD14, CD31, CD33, CD34 and CD45 (Pittenger et 
al., 1999; Shyu et al., 2006). Negative markers are largely typical for the 
haematopoietic contingent within the bone marrow. In addition to these cell surface 
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antigens, MSCs also show expression of intracellular mesenchymal markers, including 
fibronectin, vimentin and α-smooth muscle actin (α-SMA) (Romanov et al., 2005). 
 
There are several examples in the literature where groups have attempted to exploit 
marker expression to produce a more homogeneous starting population of MSCs. By 
far, the most prominent method of MSC isolation exploits the property of plastic 
adherence, which assumes that the stromal population (MSC) of the bone marrow will 
adhere to tissue culture plastic, whereas the haematopoietic contingent (haematopoietic 
stem cells or HSCs) will not (Figure 5). Consequently, contaminating HSCs will be 
removed with continual media changes and passage, and what should remain in culture 
is a heterogeneous mixture of stromal cells at various stages of development. Efforts 
are currently underway to utilise cell surface markers to further purify specifically-
labelled MSCs from these heterogeneous pools, for example by fluorescence-activated 
cell sorting (FACS) (Alsalameh et al., 2004; Dennis et al., 2002). 
 
1.3.6 Differentiation of MSCs into mesodermal derivatives 
Analysis of marker expression is not the only factor to consider in confirming the 
isolation of a true MSC population. As the definition of a stem cell is a functional one, 
it is perhaps functional characterisation rather than simple marker analysis that is more 
compelling in proving the isolation of a true MSC population. MSCs have the potential 
to differentiate into a wide range of mesodermal cell types, including osteoblasts 
(bone), adipocytes (fat), chondrocytes (cartilage) and myoblasts (muscle) (Pittenger et 
al., 1999). Such differentiation can be easily achieved in vitro by addition of specific 
inducing factors to the cell’s culture medium. For osteogenic differentiation, MSCs 
must be treated with a cocktail of dexamethasone, ascorbic acid 2-phosphate and β-
glycerophosphate. Adipogenesis, on the other hand, is slightly more complex, 
requiring a cyclic treatment with dexamethasone, indomethacin, insulin and 3-
isobutyl-1-methylxanthine (IBMX) (induction medium) for three days, followed by 
treatment with insulin alone (maintenance medium) for two days. Although slight 
variations in the differentiation protocols are inevitable between different laboratories 
e.g. concentrations of differentiation factors, frequency of media changes etc., the 
inducing factors used are highly standardised.  
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Figure 1.5. Overview of the isolation of MSCs from bone marrow. Schematic 
representation of the isolation of MSCs from bone marrow in vitro. Briefly, bone 
marrow is aspirated and plated out into a tissue culture flask and cultured for 48 hours 
at 37
o
C and 5% CO2 to allow adherence of MSCs to tissue culture plastic. 
Haematopoietic components remain in suspension and do not adhere to tissue culture 
plastic. Following 48 hours, haematopoietic contaminants are removed by changing 
the culture media and PBS washes, resulting in a relatively pure MSC population. 
 
 
To assess the phenotype of MSCs induced to undergo osteogenic and adipogenic 
differentiation, a range of techniques must be employed.  These techniques are largely 
histological and require the cells to be stained with solutions that allow identification 
of various structures associated with either lineage. Demonstration of a mature 
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osteoblastic phenotype can be achieved using standard procedures involving staining 
for deposition of mineralised matrix using von Kossa and staining to visualise calcium 
and collagen deposition using Masson’s trichrome (Pittenger et al., 1999). Similarly, 
demonstration of a mature adipogenic phenotype can be achieved using standard 
procedures involving staining for the accumulation of intracellular lipid droplets within 
the cytoplasm of a cell using oil red O staining (Pittenger et al., 1999). In both 
instances, it is necessary to counterstain cells with haematoxylin, a basic dye that 
stains cell nuclei a blue-purple colour. Examples of von Kossa, Masson’s trichrome 
and oil red O staining are demonstrated in Chapter 3. 
 
1.3.7 Differentiation of MSCs into non-mesodermal derivatives 
Established dogma in stem cell biology has held that adult stem cells possess a more 
limited differentiation potential than their embryonic counterparts, being restricted to 
only form lineages specific to their tissue of origin. Consequently, the potency of 
MSCs was considered to be such that they could only form tissues of mesodermal 
origin. However, in recent years this paradigm has been challenged, with numerous 
reports of stem cells ‘crossing’ the germ layer boundary and forming tissues 
representative of a different lineage, a process termed ‘trans’-differentiation. The 
concept that adult stem cells may possess a far wider potential for differentiation than 
previously anticipated has led to much excitement with respect to their therapeutic 
application, since the use of adult stem cells is not met with the same criticism or 
ethical issues associated with the use of embryonic stem cells. Reports of ‘trans’-
differentiation are especially rife with regard to MSCs, with evidence of MSCs 
(mesodermal in origin) forming tissues of both endodermal and ectodermal origins 
(Krause et al., 2001; Petersen et al., 1999; Sanchez-Ramos et al., 2000; Sato et al., 
2005; Woodbury et al., 2002; Woodbury et al., 2000). If such reports hold true, then it 
is perhaps more accurate to describe MSCs as a pluripotent stem cell population as 
opposed to a multipotent one though this term should be used with caution. This 
chapter will focus particularly on the formation of neural-like cells from MSCs and 
address the issue of whether or not they represent an alternative source to neural stem 
cells for use in neurological therapies. 
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1.4 Potential therapeutic applications of MSCs 
 
1.4.1 MSCs demonstrate several properties which render them promising 
candidates for therapeutic application 
MSCs are promising candidates for clinical use in cellular therapies and tissue 
engineering strategies. Cellular therapies are medical processes that involve the 
administration of healthy, fully-functioning cells to replace dysfunctional cells that 
have been damaged or destroyed in disease. The principle of tissue engineering is 
largely the same, though the situation is somewhat more complex as it involves 
culturing cells on three-dimensional structures in vitro, rather than tissue culture 
plastic, in order to form functional units that more closely resemble the in vivo target 
tissue. Tissue engineering brings together expertise from a range of fields, including 
cell biology, biochemistry and polymer chemistry. A variety of different cell types 
may be used in cellular therapies and tissue engineering, including mature functional 
cells, genetically-modified cells or even cells from different species (xeno-
transplantation). However, the focus of this literature review will be the potential 
applications of stem cell-based therapies, in particular, MSC-based therapies. 
 
Although adult stem cells can be isolated from a variety of sources throughout the 
body, MSCs are perhaps the most promising for use as potential therapeutic agents. 
There are a number of reasons as to why this is the case: 
 
a) MSCs can be found and isolated from a wide range of autologous sources, 
(Kuznetsov et al., 2001, Rosada et al., 2003, Vandenabeele et al., 2003, 
Miura et al., 2003, Gronthos et al., 2001, Igura et al., 2004, Tsai et al., 
2004, in 't Anker et al., 2003, Salingcarnboriboon et al., 2003, Seo et al., 
2004). 
 
b) Many of these sources, particularly bone marrow and adipose tissue, are 
clinically accessible, meaning that MSCs can be easily isolated using 
robust, well-established techniques (da Silva Meirelles et al., 2006, 
Gronthos et al., 2001, Pittenger et al., 1999). 
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c) MSCs have a high proliferative potential and can be readily and rapidly 
expanded ex vivo, whilst crucially maintaining their multipotentiality to 
differentiate into clinically-significant derivatives such as bone, fat and 
cartilage. This property is essential as MSCs represent such a low 
proportion of the total cellular content isolate from bone marrow 
(approximately 0.001%). 
 
d) MSCs are suitable for use in allogeneic transplantation as well as 
autologous transplantation (Aggarwal and Pittenger, 2005). 
 
The latter point is attributable to the unique immunological properties of MSCs. 
Allogeneic transplantation can be clinically problematic, as the recipient’s body will 
recognise the allogeneic material as foreign, resulting in an immune response and 
possible rejection of the transplanted material. As such, allogeneic transplantation must 
be accompanied by rigorous immune suppression. MSCs are immunologically unique 
in that they express intermediate levels of MHC Class I antigens and negligible levels 
of MHC Class II antigens (Le Blanc et al., 2003). It has also been reported that MSCs 
do not express co-stimulatory molecules (Majumdar et al., 2003). Crucially, it is not 
just undifferentiated MSCs that lack expression of MHC Class II antigens, but their 
differentiated derivatives also. Le Blanc and colleagues examined expression of MHC 
Class I and II antigens in undifferentiated MSCs and MSCs that had been 
differentiated into their gold-standard derivatives bone, fat and cartilage. They reported 
that both undifferentiated MSCs and their differentiated counterparts lacked expression 
of MHC Class II antigens, strongly suggesting that MSCs are not immunogenic and 
would not evoke an immune response upon transplantation (Le Blanc et al., 2003). In 
support of these observations, Aggarwal and colleagues reported that, following 
allogeneic transplantation, MSCs evaded immune recognition and were readily 
detectable in recipients at extended time points (Aggarwal and Pittenger, 2005). A 
common complication of allogeneic transplantation is graft-versus-host-disease 
(GVHD), in which functional immune cells carried over from the donor in the 
transplanted material recognise the recipient as foreign and launch an immune 
response. Transplantation of MSCs has been reportedly associated with reduced 
incidence of GVHD, and there are even reports of MSC transplantation being used in 
the treatment of GVHD (Le Blanc et al., 2004). The potential of MSCs for use in 
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allogeneic transplantation as well as autologous transplantation has major clinical 
significance, since material could be transplanted between mismatched individuals. 
 
 
1.5 MSC-based therapy in the treatment of osseous and adipose 
tissue defects 
 
1.5.1 Overview of the potential use of MSCs in disorders of bone and fat tissue 
As MSCs are defined functionally owing to their ability to differentiate into 
mesodermal derivatives such as bone and fat, the most obvious clinical application of 
MSCs at present is in the treatment of osseous and adipose tissue defects, where their 
intrinsic differentiative capabilities could be exploited for the replacement of diseased 
bone and fat tissue (Barry and Murphy, 2004, Pittenger et al., 1999, Prockop, 1997).  
 
Adipose tissue defects, commonly referred to as soft tissue defects, can be defined as 
substantial voids within the subcutaneous fat layer. Such defects can be a consequence 
of numerous conditions, such as traumatic injury e.g. burns, hereditary and congenital 
conditions e.g. Poland syndrome and Romberg’s disease, tumour resection e.g. breast 
mastectomies, facial reconstructions and lipodystrophy associated with type II diabetes 
(Gomillion and Burg, 2006, Patrick, 2001, Langstein and Robb, 1999, Katz et al., 
1999, Tzikas, 2004, Rooney and Ryan, 2006). Currently, treatment options for adipose 
tissue defects consist mainly of plastic and reconstructive surgical procedures. Logic 
suggests that autologous adipose tissue from alternative sources on the patient’s body 
would provide the best and most obvious source of material for such surgeries, as 
adipose tissue is usually present in excess, providing a readily-available yet readily-
expendable source of material (Mauney et al., 2005). The implementation of 
autologous fat transplantation has been trialled in many cases. However, the outcome 
of these procedures has unfortunately been unpredictable and somewhat inconsistent 
(Gomillion and Burg, 2006, Patrick, 2000). There are several reasons for this. Due to 
inadequate revascularization of transplanted adipose tissue, graft volume can be 
reduced by up to 60%, whilst the viable tissue that remains is unable to function 
appropriately (Patrick, 2000).. Furthermore, adipocytes are extremely vulnerable to 
mechanical/pressure damage during aspiration procedures due to the high lipid content 
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of their cytoplasm (up to 90% cytoplasm volume is lipid) – up to 90% of adipocytes 
are damaged during aspiration (Mandrup and Lane, 1997). Even if only a small 
number of cells could be isolated, ex vivo expansion would allow sufficient numbers to 
be gained for clinical use. However, mature adipocytes are terminally differentiated, 
rendering them unsuitable for ex vivo expansion. Because of such limitations, the use 
of autologous adipose tissue in cellular therapies for the treatment of soft tissue defects 
is not ideal and, as such, there is a search for alternative cell sources. MSCs in 
particular present themselves as promising candidates for use in the cellular treatment 
of soft tissue defects, as they can be easily isolated and rapidly expanded in the tissue 
culture laboratory, and under appropriate culture conditions can be manipulated to 
undergo adipogenic differentiation to form pre-adipocytes and adipocytes. 
 
Perhaps the most obvious and realistically-achievable clinical use of MSCs at present 
is in bone tissue engineering strategies, designed to exploit the intrinsic osteogenic 
ability of MSCs as a means of replacing damaged bone tissue in osseous defects. New 
cellular therapies and tissue engineering strategies in the treatment of osseous defects 
are a major clinical goal and this impetus is set to significantly increase in the future as 
improved quality of life leads to increased life expectancy and therefore increased 
incidences of age-related disorders such as osteoporosis. A number of factors can 
contribute towards the development of osseous defects and bone trauma, such as 
fractures, tumour invasion or genetic disorders e.g. osteogenesis imperfecta (Hsu et al., 
2005, Zeitlin et al., 2003). Current treatment strategies consist predominantly of 
autologous bone grafts, and to a lesser extent allogeneic bone grafts, metallic implants 
and bioceramics (Hatano et al., 2005, Salgado et al., 2004). Unfortunately, as is the 
case for adipose tissue defects, the success of these current treatment methods is 
somewhat inadequate, not to mention distressful for the patient and extremely painful 
due to their invasive nature. Reasons for limited success include limited autograft 
supply/volume, infection due to pathogen transfer/immunological rejection following 
allografts, loss of function/donor site morbidity and, in some cases, even nerve damage 
(Damien and Parsons, 1991). It is therefore hardly surprising that alternative strategies 
in the treatment of osseous defects are currently sought, with a particular clinical goal 
being the development of bone tissue engineering technologies to replace tissue 
damaged as a result of disease. MSCs are highly appealing candidates for use in the 
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cellular treatment of osseous defects and in bone tissue engineering, due to their 
intrinsic osteogenic abilities upon appropriate stimulation.  
 
1.6 MSC-based therapy in the treatment of neurological and 
neurodegenerative disorders 
 
1.6.1 Overview of the potential of use of MSCs in disorders of the nervous system 
Besides the more generally accepted therapeutic applications of MSCs as mentioned 
above, MSCs are also attracting much interest as a potential resource for the treatment 
of neurological and neurodegenerative disorders.  The remainder of this literature 
review will focus of the recent developments in this area, starting with a consideration 
of the use of MSC transplantation as a means of treating such deficits. 
 
Neurological disorders result from disruption in the structure and/or function of 
nervous tissue, either in the central nervous system (CNS), peripheral nervous system 
(PNS), or both.  Neurodegenerative disorders are a further sub-classification of 
neurological disorders, and this term is used to describe disorders that result from a 
loss and/or degeneration of nervous tissue.  Examples of neurodegenerative disorders 
include Huntington’s disease, Parkinson’s disease, multiple sclerosis and Alzheimer’s, 
amongst many others. Current therapies for the treatment of neurological and 
neurodegenerative disorders are largely ineffective and, as such, inadequate. The 
development of effective therapies in this area is further complicated owing to the 
significantly varying pathologies between different disorders and even between 
individuals suffering from the same disorder. Consequently, the development of a 
standardised therapy in the treatment of such conditions has eluded us to date, as 
patients require treatments that are tailored specifically to their unique clinical 
symptoms. With the major impetus in stem cell research over the last few decades, the 
very real possibility of a cellular therapy involving the administration of stem cells to 
replace damaged and/or degenerated nervous tissue is a highly desirable and realistic 
clinical goal (Li and Chopp, 2009). 
 
With evidence to suggest that MSCs display a greater plasticity than previously 
anticipated, concomitant with their unique immunological properties which hold them 
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with such promise for both autologous and allogeneic transplantation, MSCs present 
themselves as extremely promising candidates in the treatment of neurological and 
neurodegenerative deficits. The following paragraphs will consider some of the key 
studies in this area. 
 
A number of factors need to be taken into consideration in order to ascertain whether 
MSCs are suitable candidates in the cellular treatment of neurological and 
neurodegenerative disorders. The first of these considerations is whether or not MSCs 
remain viable and functional upon transplantation into the nervous system, as the 
microenvironment of nervous tissue is far-reached from the native niche of MSCs in 
the bone marrow. It is becoming increasingly more apparent that the stem cell niche 
plays a crucial role in the maintenance and function of stem cells, providing a delicate 
balance between cell-cell interactions, extracellular matrix contact, oxygen tension, pH 
and exposure to growth factors etc. (Fuchs et al., 2004). These are just a handful of the 
factors which interplay within the niche to contribute towards stem cell maintenance 
and function. As such, it is necessary to investigate whether the microenvironment of 
the nervous system is permissive to the survival and engraftment of transplanted 
MSCs. 
 
1.6.2 MSC transplantation results in functional recovery in various animal models 
of neurological disease 
A number of studies have demonstrated that, upon transplantation into the brain, MSCs 
survive and undergo successful engraftment and migration.  A report published in 
1998 by Azizi and colleagues demonstrates this concept. In this study, Azizi and 
colleagues examined the transplantation of both rat and human MSCs, administering 
them directly into the corpus striatum of rat brains. The corpus striatum consists 
predominantly of the basal ganglia and its primary function is in the coordination of 
movement. Periodically up to 72 days post-transplantation, brain sections were 
examined in order to ascertain whether transplanted MSCs had a) successfully 
engrafted and b) undergone migration. Azizi et al also injected rat astrocytes in the 
corpus striatum, which served as a suitable control, as astrocytes have been previously 
shown to successfully engraft and migrate throughout the CNS following 
transplantation, in an analogous manner to neural stem cells (Andersson et al., 1993, 
Zhou and Lund, 1992). Two weeks post-transplantation, an engraftment success rate of 
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20% for human MSCs, and a comparable 30% for rat MSCs, was observed. This 
observation is of particular interest, with the group reporting that the success rate of 
human MSC transplantation into rat brain (essentially a model of xeno-transplantation) 
was only 10% less than that observed for rat MSC transplantation  (essentially a model 
of autologous transplantation). If such observations hold true, then this would suggest 
that the unique immunological properties of MSCs, as previously discussed, would 
render them suitable for xeno-transplantation as well as allogeneic and, of course, 
autologous transplantation. However, successful engraftment of MSCs into the host 
tissue is only part of the story. Azizi’s study went on to address another fundamental 
question, that is, whether engrafted MSCs were capable of undergoing migration 
throughout the brain. Recruitment of MSCs to neurologically damaged areas will be a 
crucial event if they are to elicit any kind of beneficial effect that would ultimately lead 
to functional recovery. Azizi and colleagues demonstrated that MSCs were in fact 
capable of undergoing migration following engraftment, following a migration 
pathway comparable to the astrocyte control and, by extension, neural stem cells. 
MSCs were found in several successive layers of the brain up to 72 days post-
transplantation, and this was mirrored in the pattern of astrocyte migration. Such 
observations only serve to intensify the excitement surrounding MSCs as potential 
candidates in cellular therapies of neurological and neurodegenerative disorders.  
 
In this chapter we have only examined a single study demonstrating the successful 
transplantation of MSCs into the nervous system, as the work by Azizi et al provides a 
logical and progressive example that clearly highlights the key principles involved. 
However, many other studies have been performed, and successful transplantation of 
MSCs into the nervous system has been reported in numerous other models, including 
mouse and even higher order primates (Deng et al., 2006b, Kopen et al., 1999, Isakova 
et al., 2006, Phinney et al., 2006, Ankeny et al., 2004). Such observations served to 
intensify the promise surrounding MSCs as potential candidates in cellular therapies of 
neurological and neurodegenerative disorders.   
 
Numerous studies have allowed us to establish that MSCs are capable of undergoing 
successful engraftment and migration following transplantation into the nervous 
system. The next question to address, and perhaps the most pivotal of all, is whether 
MSC transplantation elicits any degree of functional recovery in models of 
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neurological and neurodegenerative disorders. There is much evidence at present to 
suggest that MSC transplantation does indeed elicit functional recovery to various 
degrees, and this has been reported in many models of neurological and 
neurodegenerative disorders including, but by no means limited to, Huntington’s 
disease, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, stroke, 
traumatic brain injury and also damage to the spinal cord and peripheral nerves (Chen 
et al., 2003, Li et al., 2001a, Mahmood et al., 2001, Lescaudron et al., 2003, Mazzini et 
al., 2007, Dezawa et al., 2004, Chopp et al., 2000).  
 
Restoration of functional activity can be assessed in many ways, and these can range 
from simple behavioural tests to more complex cell function assays. These proof of 
principle studies in animal models suggest that MSC transplantation may be a 
promising therapy for neurological and neurodegenerative disorders. However, to date, 
the large majority of work in this area has been performed using animal models, and 
before this can be significantly trialled in humans a number of technical issues must be 
addressed. It is perhaps useful to end this section of the literature review with a 
consideration of these technical questions. In terms of the cellular material to be 
transplanted, should whole bone marrow be transplanted or should attempts be made to 
culture a more homogeneous starting population of MSCs? Once this has been 
addressed, how should the cells be administered? Should they be administered directly 
into the damaged nervous tissue, or should they be administered systemically? If 
MSCs were administered systematically, would they be homed to the neurologically 
damaged areas in sufficient quantity to elicit a beneficial effect? In terms of timescale, 
when should the MSCs be administered? Does administration need to be immediate 
following injury, or can a longer timescale be employed for the treatment of more 
chronic disorders? What numbers of cells should be transplanted? Is it possible to 
predict the success rate of engraftment? These questions represent just a handful of the 
technical issues that must be considered. 
 
1.6.3 Mechanisms via which MSCs elicit functional recovery in models of 
neurological and neurodegenerative disorders 
Before MSC-based cellular therapies and tissue engineering strategies become serious 
propositions for use in the clinic, a significant advance in our knowledge and 
understanding of the complex mechanism(s) via which MSCs commit to specific 
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lineages and undergo differentiation to demonstrate mature, functioning phenotypes is 
required. A more thorough understanding of these biological phenomena will not only 
benefit from a clinical perspective, but will also be of major significance in a research 
setting, as MSCs provide an ideal cellular system in which to study the complex events 
of cell differentiation. In terms of MSC transplantation in the therapy of neurological 
and neurodegenerative disorders, proof of principle studies in animal models 
demonstrate that MSC transplantation can result in significant functional 
improvements. However, the mechanism(s) by which MSCs elicit neurological 
recovery remain largely unknown. At present, opinion is divided between three main 
hypotheses: 
 
a) MSCs undergo ‘trans’-differentiation to produce neural cell types, thereby 
directly replacing neural tissue that has been damaged as a result of disease. 
 
b) MSCs undergo spontaneous fusion events with host neural cells, and in 
doing so acquire the phenotypic properties of the host neural cells. 
 
c) MSCs migrate to neurologically damaged areas but, rather than undergoing 
any phenotypic alterations, release a complement of trophic factors and 
cytokines that promote endogenous repair mechanisms, predominantly by 
the instructive, neurogeneic effects of these factors on resident neural stem 
and progenitor populations 
 
The relationship between these mechanisms is shown in Figure 1.6. 
 
 
1.6.3.1  ‘Trans’-differentiation of MSCs into neural cell types in vitro 
Reports of MSCs undergoing ‘trans’-differentiation in vitro to form neural cell types 
are numerous within the current literature and, as such, it is not possible to provide a 
thorough discussion of these studies here; instead, the two seminal studies 
demonstrating this concept will be considered. These are the studies of Sanchez-
Ramos and Woodbury (Sanchez-Ramos et al., 2000, Woodbury et al., 2000, 
Woodbury et al., 2002). A summary of the numerous other studies is given in Table 
1.1. 
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Figure 1.6. A diagrammatic representation of the mechanisms by which MSCs 
may elicit functional recovery following transplantation into models of 
neurological and neurodegenerative disorders. Three mechanisms are postulated to 
account for therapeutic benefits of MSC transplantation. Although ‘trans’-
differentiation and spontaneous fusion events are likely to contribute to a certain 
extent, the low frequency at which both phenomena occur means that they are unlikely 
to fully account for the benefits observed. It is gaining considerable momentum that 
the third, and predominant, mechanism by which MSCs contribute to functional 
recovery is via the release of diffusible soluble factors/cytokines which promote 
endogenous repair processes. (Adapted from Hardy et al., 2007). 
 
 
Sanchez-Ramos and colleagues (2000) reported that MSCs had the potential to 
demonstrate neural differentiation when cultured in ‘differentiation medium’, 
consisting of DMEM supplemented with a cocktail of factors that had been previously 
reported to exert a neurogeneic effect, including all-trans-retinoic acid (ATRA) and 
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brain-derived neurotrophic factor (BDNF). Following treatment of MSCs with this 
cocktail of neurogeneic factors, Sanchez-Ramos and colleagues examined cellular 
morphology and expression of cell-specific markers. When cultured under standard 
conditions, MSCs display a very characteristic, stromal-like morphology, with cultures 
consisting predominantly of large, flat, fusiform cells.  However, MSCs cultured in 
‘differentiation medium’ underwent significant radical changes and the distinctive 
stromal morphology of MSCs was replaced by a structure resembling that of neural 
cell types whereby cells became spindle-shaped and possessed several long processes. 
Marker analyses revealed that MSCs cultured in ‘differentiation medium’ expressed 
the neural progenitor marker, nestin, the neuronal marker, NeuN, and the glial marker, 
GFAP.  These data support the hypothesis that MSCs may be able to cross the germ 
layer boundary to form non-mesodermal cell types such as neural cells, which are 
ectodermal in origin. Adding more strength to the argument that MSCs were 
undergoing ‘trans’-differentiation to form neural cell types was the observation that 
the up-regulation of these neural antigens was concomitant with a down-regulation of 
fibronectin expression, a marker of MSCs. However, despite the observed down-
regulation in fibronectin expression, the percentage of cells expressing neural markers 
was proportionately lower than the percentage that retained fibronectin expression 
(<1% compared with 30% fibronectin). 
 
Woodbury and colleagues (2000) adopted a slightly different approach to that of 
Sanchez-Ramos, by culturing MSCs with a cocktail of chemicals as opposed to well-
characterised neurogeneic factors. In their chemical induction protocol, Woodbury and 
colleagues removed MSCs from their standard culture conditions, containing 10% 
FCS, and subsequently cultured them under serum-free conditions followed by 
exposure to antioxidants. However, immediately prior to the removal of serum from 
their culture medium, MSCs were first ‘pre-induced’ for 24 hours by the addition of β-
mercaptoethanol (BME) to their standard media. ‘Pre-induction’ was followed by 
‘induction’, which involved removal of serum from the culture media and 
supplementation with the antioxidants butylated hydroxyanisole (BHA) and 
dimethylsulfoxide (DMSO). Similarly to the observations of Sanchez-Ramos, MSCs 
underwent radical changes in both cell morphology and marker expression  in response 
to the chemical induction protocol. However, these changes occurred over an 
extraordinarily short timescale. Within a matter of hours following induction, MSCs 
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lost their typical stromal morphologies and exhibited tight, multipolar soma with many 
processes and cytoplasmic extensions emanating from the cell body, as is typical of 
neural cell types. During the very early stages of the experiment, the cytoplasmic 
processes were very simple, though by the end of the 5 hour time course their 
morphology had become somewhat more complex, with processes demonstrating 
secondary branching and terminating in growth cones. These morphological 
observations suggested that MSCs were acquiring an exclusively neuronal phenotype, 
at the expense of a glial phenotype. Subsequent marker analysis supported these 
morphological observations, as the development of complex neuronal morphologies 
were accompanied by an up-regulation in expression of the neuronal marker, neuron-
specific enolase (NSE). 
 
There are a substantial number of reports demonstrating the ability of MSCs to ‘trans’-
differentiate and adopt neuronal and/or glial fates in vitro.  Whilst these studies are too 
numerous to discuss in detail here a summary of some of these additional studies is 
provided in Table 1.1. Of interest are the widely varying culture conditions employed 
by different groups in order to induce neural differentiation of MSCs. For convenience, 
the various differentiation protocols have been grouped into three broad categories, as 
listed below and demonstrated in Figure 1.7: 
 
a) Chemical induction protocols 
Involving supplementation of MSC culture medium with cocktails of 
various chemicals in order to induce differentiation – Woodbury’s chemical 
induction protocol would fall into this category. 
 
b) Neurotrophic factor-based protocols or transfection with neurogeneic 
genes 
Involving supplementation of MSC culture media with various 
combinations of known neurotrophic agents such as ATRA and BDNF – as 
in the Sanchez-Ramos study (2000) – or transfection of MSCs with 
neurogeneic genes. 
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c) Co-culture-based protocols 
Involving co-culture of MSCs with neural cell types, in which MSCs are 
induced to adopt neural phenotypes as a consequence of direct cell-cell 
interactions and/or the interplay of soluble factors produced by each cell 
type. 
 
1.6.3.1.2 ‘Trans’-differentiation of MSCs into neural cell types in vitro: true ‘trans’-
differentiation or an artifact of cell culture conditions? 
It is not surprising that the concept of MSCs displaying a greater plasticity than 
previously anticipated such that they undergo ‘trans’-differentiation into neural cell 
types is somewhat controversial.  MSCs have long been held as a multipotent stem cell 
population which, by definition, means that they are restricted in their plasticity and 
form cell types specific to their germ layer of origin.  Since MSCs are mesodermal in 
origin, it was readily accepted that MSCs should possess an intrinsic ability to 
differentiate into mesodermal cell types, such as bone, fat and cartilage.  As discussed 
above, however, there are some data which suggest that MSCs are able to cross the 
germ layer boundary and differentiate to acquire a neural phenotype, indicative of 
ectoderm. Whilst this holds major promise for therapeutic applications, it also 
challenges the central dogma of adult stem cell biology. 
 
Regarding the in vitro ‘trans’-differentiation of MSCs into neural lineages, recent 
studies raise considerable doubt over the authenticity of the neural derivatives that 
result from these differentiation protocols, in particular those that result from chemical 
induction protocols such as those employed by Woodbury et al (2000). These studies 
raised initial concern owing to the remarkably short timescale over which 
differentiation occurred. According to the published data, MSCs could differentiate 
into neural cell types, literally a matter of hours (Woodbury et al., 2000). Neural 
differentiation is a highly complex and multifaceted process, and in vivo neurogenesis 
requires spatial and temporal regulation of the expression of a wide array of genes. 
Similarly, neuritogenesis is a dynamic process involving regulation of microtubules. 
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TREATMENT NEURAL PHENOTYPE REFERENCE 
CHEMICAL 
Isobutylmethylxanthine(IBMX) + dibutyryl 
cAMP 
Neuronal (Deng et al., 2001, Rismanchi et 
al., 2003) 
β-mercaptoethanol (BME), then butylated 
hydroxyanisole (BHA) and 
dimethylsulfoxide (DMSO) 
Neuronal (Woodbury et al., 2000, 
Woodbury et al., 2002, Munoz-
Elias et al., 2004, Rismanchi et 
al., 2003, Jori et al., 2005) 
5-azacytidine Neuronal (Kohyama et al., 2001) 
BME + retinoic acid (RA) Neuronal (Hung et al., 2002) 
BHA + dibutyryl cAMP + IBMX + RA + 
ascorbic acid 
Neuronal (Levy et al., 2003, Hellmann et 
al., 2006) 
bFGF for 24 hours, then BHA + KCl + 
valproic acid + forskolin 
Neuronal/glial (Krampera et al., 2007) 
 
NEUROTROPHIC/GLIAL  FACTORS OR GENE TRANSFECTION 
GDNF + PACAP + dibutyryl cAMP Neuronal (Tzeng et al., 2004) 
Generation of neurospheres, then induction 
with RA and Shh 
Neuronal (Locatelli et al., 2003) 
Transfection with Notch intracellular 
domain (NICD), then treatment with 
neurotrophic factors 
Neuronal (Dezawa et al., 2004, Kamada et 
al., 2005) 
Transfection with noggin Neuronal (Kohyama et al., 2001) 
Glial growth factor (GGF) Glial (astrocytic) (Tohill et al., 2004) 
Culture conditions as for neural stem cells 
(NSCs) 
Neurosphere formation (Hermann et al., 2004) 
bFGF, then BME+NT-3, then BHA + 
valprolic acid + forskolin + hydrocortisone 
+ insulin + NT-3 + NGF + BDNF 
Neuronal (Tatard et al., 2007) 
bFGF for 24 hours, then Shh + FGF-8 + 
RA, then BHA + valprolic acid + forskolin 
+ hydrocortisone + insulin + NT-3 + NGF 
+ BDNF + GDNF 
Neuronal (dopaminergic) (Tatard et al., 2007) 
Shh + FGF-8 + bFGF Neuronal (dopaminergic) (Trzaska et al., 2007) 
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EGF + FGF for 72 hours, then cAMP + 
IBMX for 72 hours, then GDNF + TGFβ3 
+ RA 
Neuronal (dopaminergic) (Barzilay et al., 2008) 
BDNF + EGF + NGF Neuronal (Choong et al., 2007) 
 
CO-CULTURE WITH NEURAL CELL TYPES 
Co-culture with fetal midbrain cultures Neuronal (Sanchez-Ramos et al., 2000) 
Co-culture with astrocytes Neuronal (Jiang et al., 2002, Jiang et al., 
2003) 
Co-culture with NSCs Glial (astrocytic) (Wislet-Gendebien et al., 2003) 
Co-culture with cerebellar granule neurons Neuronal/ glial (astrocytic) (Wislet-Gendebien et al., 2005) 
Co-culture with Schwann cells Glial (Schwann cells) (Krampera et al., 2007) 
Table 1.1. A table summarising the main studies reporting the in vitro neural 
differentiation of MSCs. Current in vitro protocols can be grouped into three broad 
categories – culture of MSCs with chemical-inducing agents, culture of MSCs with 
neurotrophic/glial-derived factors and co-culture of MSCs with neural cell types. Table 
updated from (Hardy et al., 2008), originally updated from (Chen et al., 2006). 
 
 
Therefore, the concept that MSCs display the ability to undergo the complex molecular 
events associated with neural differentiation within a matter of hours to form mature, 
functional neural derivatives, is highly questionable and improbable. Indeed, for MSCs 
to differentiate and form mesenchymal derivatives such as bone or fat occurs over a 
timescale of several days and weeks, with the earliest phenotypic indications of 
differentiation appearing only after 5 days post-induction of differentiation. Osteogenic 
and adipogenic differentiation represent processes for which MSCs have an intrinsic 
ability, and it is therefore not unlikely that MSCs will have much of the protein 
complement required for these processes already in place, prior to induction of 
differentiation. It is therefore a reasonable assumption that ‘trans’-differentiation of 
MSCs into neural cell types, which involves MSCs crossing the germ layer boundary 
to form a cell type originating from the ectoderm, would require a greater change in 
protein complement to bring about the events required for differentiation, and therefore 
would occur over a longer timescale than differentiation into mesodermal derivatives, 
rather than the 5 hours reported by Woodbury and colleagues. It was thought to be 
Chapter 1: Literature Review 
 
34 
 
highly unlikely that true neural derivatives could be formed in this short timescale and, 
as such, the precise mechanism(s) by which  chemical induction protocols were 
causing ‘neurogenesis’ became the subject of intense investigation.  
 
Figure 1.7. A diagrammatic representation of the predominant in vitro protocols 
used to induce the apparent neural differentiation of MSCs. Current in vitro 
protocols can be grouped into three broad categories – culture of MSCs with chemical-
inducing agents, culture of MSCs with neurotrophic/glial-derived factors and co-
culture of MSCs with neural cell types.  
 
 
A number of studies were published between 2004 and 2006 that provide convincing 
and highly compelling evidence that ‘trans’-differentiation of MSCs into neural cell 
types did not represent a pathway of true neural differentiation and was in fact an 
artifact of the culture conditions employed, with the acquirement of a neural 
morphology by MSCs being attributable to a cell-stress response to these culture 
conditions (Lu et al., 2004, Neuhuber et al., 2004, Bertani et al., 2005, Croft and 
Przyborski, 2006). The observations of these studies will be considered here. Firstly, 
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the quite radical changes in MSC morphology, from a stromal to a highly distinctive 
neural morphology, were considered. A principal event that occurs during neuronal 
differentiation is that of neurite outgrowth which is a highly dynamic process 
involving microtubule re-modelling and the outgrowth of neurites from a central cell 
body, or soma. This phenomenon was examined using sophisticated techniques such as 
time-lapse microscopy and video, over the short timescale reported by Woodbury and 
colleagues (2000). The transformation of MSCs to cells possessing a neural-like 
structure did not follow the traditional process of neurite extension; indeed, the 
opposite effect was observed. Rather than the outgrowth of neurites and processes, as 
would be expected during neural differentiation, the cell cytoplasm retracted from its 
periphery towards the centre of the cell, forming a tight, spherical cell body around the 
nucleus, resembling a neural soma (Neuhuber et al., 2004, Bertani et al., 2005, Croft 
and Przyborski, 2006). What were originally perceived to be neurites were in fact 
cytoplasmic extensions that remained following cytoplasmic retraction, a result of 
strong focal contacts made between the cells and the underlying substrata. These 
cytoplasmic extensions morphologically resembled neurites, hence indicating the 
acquirement of a neural phenotype. Further studies confirmed that retraction of the 
cytoplasm, causing MSCs to acquire an apparent neuronal morphology, was in fact a 
consequence of cytoskeletal disruption and/or cytoskeletal collapse. The 
morphological changes in MSCs treated with the chemical induction protocol could be 
mimicked by treating MSCs with pharmacological agents, such as cytochalasin B and 
D, which disrupt the cytoskeletal structure, with the resulting morphology being 
indistinguishable from that induced by chemical culture (Bertani et al., 2005, Croft and 
Przyborski, 2006, Neuhuber et al., 2004). Specifically, disruption and/or collapse of 
the actin cytoskeleton brought about the observed change in morphology. 
 
However, whilst these studies proved that culturing MSCs with the chemical induction 
protocol did not induce the formation of a true neural phenotype, they did not discount 
the possibility of MSCs possessing an intrinsic neurogeneic potential that may have 
contributed in part to the acquirement of a neural phenotype. To address this issue, 
several independent groups applied the chemical induction protocol to a range of other 
cell types in addition to MSCs. When treated with the chemical induction protocol, 
primary fibroblasts, HEK293 cells (a human embryonic kidney cell line) and PC-12 
cells (a human pheochromocytoma cell line) all underwent morphological changes that 
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were indistinguishable from the morphological changes in control MSCs (Lu et al., 
2004, Bertani et al., 2005, Croft and Przyborski, 2006, Neuhuber et al., 2004). These 
data indicated that the morphological changes observed in MSCs following chemical 
induction were most likely to be attributable to an aberrant response by the cell to the 
artificial culture conditions rather than any intrinsic neurogeneic potential possessed by 
MSCs. 
 
It appears therefore that under certain culture conditions, MSCs adopt a neural-like 
morphology as a result of cytoskeletal collapse.  However, in addition to structural 
changes Woodbury and colleagues also reported regulated expression of known neural 
markers (Woodbury et al., 2000). Whilst such data may partly support the concept of 
neural differentiation by MSCs, it must be recognised that analysis of marker 
expression is insufficient in itself to conclusively prove true differentiation and cell 
identity. Functional data provides the strongest evidence that a cell has differentiated 
into a mature, functional derivative and, in terms of assessing neural differentiation, 
this classically involves measurement of electrical activity. MSCs have been shown to 
spontaneously express neural proteins under their standard culture conditions, that is, 
even before induction to undergo neural differentiation (Lamoury et al., 2006, Deng et 
al., 2006a, Tondreau et al., 2004). Furthermore, in a study published by Lu et al, MSCs 
were able to acquire a neuronal morphology even when protein synthesis was totally 
blocked, which casts further doubts that neural morphology of MSCs relates to true 
neural differentiation (Lu et al., 2004). It is a highly unlikely scenario that a cell would 
be able to undergo differentiation without modifying its protein complement, let alone 
the changes in protein complement that would be required to cross the germ layer 
boundary to differentiate into a cell type of a different germ layer. An extension of this 
argument is provided in a study by Bertani et al who, using a microarray to examine 
the transcriptome of induced and uninduced MSCs, reported that chemical induction of 
MSCs did not significantly alter the transcriptome compared to uninduced controls 
(Bertani et al., 2005). Of particular interest, the expression of neural markers did not 
significantly differ between induced and control MSCs. 
 
Analysis of differentiation in cell biology and discrimination between stem cells and 
their differentiated counterparts can sometimes be more complicated than originally 
anticipated.  Morphological observations, although useful, are insufficient on their own 
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to conclude the identification of a particular cell type in culture.  By far the most 
common method of discriminating between different cell types involves analysis of 
cell-specific marker expression.  Whilst data provided from such cell marker analyses 
is usually informative, it should nonetheless be treated with caution, as has been 
highlighted above and careful validation of results is required before drawing a solid 
conclusion.  If possible, gene and protein expression data are best complemented by 
functional analysis of the differentiated cell phenotype to provide the best indication of 
cell type.  Only when all such information is brought together can a firm view on cell 
identity be determined. 
 
1.6.3.2  ‘Trans’-differentiation of MSCs into neural cell types in vivo 
Thus far, ‘trans’-differentiation of MSCs into neural cell types in an in vitro 
environment has been considered. The findings of these studies are somewhat 
controversial, particularly those regarding chemical induction protocols, such as that 
described by Woodbury and colleagues (2000). In the absence of functional data to 
support marker analysis in the majority of cases, it is therefore necessary to view in 
vitro ‘trans’-differentiation assays with an air of caution. It is generally accepted that 
the growth of cells outside the body in the culture environment is artificial and cells 
may respond abnormally to such conditions.  For example, culturing cells on the two-
dimensional (2D) environment of tissue culture plastic places them under immense 
stress by causing cells to adopt a highly unnatural conformation which in turn 
influences their behaviour and function.  It is therefore also appropriate to study MSC 
behaviour in an in vivo setting to gain a more physiologically-relevant understanding 
of whether MSCs can ‘trans’-differentiate into neural cell types. 
 
Using the work of Azizi et al as an example, we have previously demonstrated that 
MSCs are not only capable of surviving transplantation into the unfamiliar 
environment of the nervous system, but are also capable of undergoing successful 
engraftment and migration (Azizi et al., 1998). Numerous reports have stated that 
MSCs demonstrate marker expression profiles indicative of neural differentiation, and 
therefore the acquirement of a neural phenotype, following transplantation into the 
nervous system. Kopen et al proposed MSCs as potential alternatives to neural stem 
cells in the cellular therapy of neurological and neurodegenerative disorders (Kopen et 
al., 1999). In this study, MSCs proliferated and underwent migration throughout the 
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forebrain and cerebellum, in a manner pertinent to that of neural stem and progenitor 
cells following administration into the lateral ventricle of neonatal mice.  By labelling 
MSCs it was possible to distinguish between transplanted cells and host neural cells.  
Transplanted MSCs demonstrated strong expression of GFAP, indicative of astrocytic 
differentiation, and to a lesser degree expression of neurofilament, indicative of 
neuronal differentiation. Interestingly, since these observations were based on the 
transplantation of undifferentiated MSCs that had not been manipulated in vitro prior 
to transplantation, Kopen and colleagues proposed that the acquirement of a neural 
phenotype by MSCs was a consequence of exposure to the brain microenvironment 
alone. If such findings hold true, this would be of major interest from a clinical 
perspective, as it would permit MSCs to be administered to patients in their 
undifferentiated state, without any requirement for prior in vitro manipulation to 
produce the desired neural phenotype prior to transplantation. 
 
Another study, by Li et al, reported that MSCs had the potential to undergo ‘trans’-
differentiation in vivo to produce dopaminergic neurons, following transplantation into 
a mouse model of Parkinson’s disease (Li et al., 2001). The acquirement of a 
dopaminergic phenotype was supported by the expression of tyrosine hydroxylase 
(TH), a marker of dopaminergic neurons, in MSCs post-transplantation. If Li’s 
findings hold true and MSCs are in fact able to undergo ‘trans’-differentiation into 
TH-expressing dopaminergic neurons, this is of major clinical significance in the 
therapy of Parkinson’s disease. The main causative mechanism of Parkinson’s disease 
is insufficient action and/or efficacy of dopamine, which is a neurotransmitter 
produced predominantly by dopaminergic neurons. If MSCs can adopt a dopaminergic 
phenotype following transplantation and express functional TH, an enzyme required 
for the conversion of tyrosine to dihydroxyphenylalanine (DOPA, a precursor of 
dopamine), then MSC transplantation may be able to counteract the deficits causative 
of Parkinson’s disease. However, it was not fully established whether transplantated 
MSCs adopted a bona fide dopaminergic phenotype following transplantation. The 
same group reported in a later study that MSCs were able to demonstrate expression of 
two mature neuronal markers, NeuN and MAP2, and the mature astrocytic marker, 
GFAP following transplantation (Li et al., 2002). The number of MSCs induced to 
express markers of neural differentiation, as percentage of the total number of MSCs 
that successfully engraft following transplantation is very low.  Only 1% expressed 
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neuronal markers and only 5% of these expressed glial markers (Li et al., 2002).  
Whilst it is not possible to discount the possibility that the cells expressing markers of 
neural differentiation are functional, what is recognized is that such a rate of ‘trans’-
differentiation would be unable to fully account for the neurological improvements 
reported following administration of MSCs in models of neurological and 
neurodegenerative disorders. There are several other studies reporting the ‘trans’-
differentiation of MSCs into neural cell types in vivo; however, the exact 
mechanism(s) by which such observations occur remains to be fully elucidated. 
(Mezey and Chandross, 2000, Lu et al., 2006, Munoz-Elias et al., 2004, Deng et al., 
2006a). In the absence of sufficient functional data, the formation of true neural 
derivatives from MSCs in vivo cannot be confirmed, nor can it be discounted. 
 
1.6.3.3  Spontaneous cell fusion of MSCs with host neural cells 
As ‘trans’-differentiation of MSCs into neural cell types in vivo occurs at too low a 
frequency to fully account for the improvements observed following transplantation of 
MSCs into models of neurological and neurodegenerative deficits, alternative 
mechanisms to explain these observations are required. A second mechanism that has 
been proposed to explain how MSC transplantation results in such beneficial effects is 
that of spontaneous cell fusion events with host neural cells following transplantation.  
 
Two independent studies by Ying et al and Terada et al, both published in Nature in 
2002, examined these spontaneous cell fusion events (Terada et al., 2002; Ying et al., 
2002). In their studies they proposed that the ability of different cell types to 
demonstrate alternative phenotypes, originally perceived as ‘trans’-differentiation, 
could be attributable to an alternative mechanism of spontaneous cell fusion. They 
proposed that cells acquiring alternative phenotypes was not necessarily the result of 
‘trans’-differentiation, and that similar phenomena were observed following 
spontaneous fusion of two different cell types, resulting in the formation of hybrid 
cells that displayed phenotypic traits of the recipient cell. Detailed cytogenetic analysis 
would therefore be required to distinguish between cells that had truly undergone 
‘trans’-differentiation and cells that had undergone spontaneous fusion. Bringing us to 
MSCs, it has been reported that bone marrow cells can spontaneously fuse with other 
cell types in co-culture systems and, in doing so, acquire phenotypic traits of these 
cells (Ying et al., 2002, Terada et al., 2002). Interestingly, acquirement of these 
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phenotypic properties can extend to plasticity. However, it is necessary to stress that 
cell fusion events cannot be used to completely disregard the phenomena of ‘trans’-
differentiation, as Crain and colleagues have demonstrated that MSCs can ‘trans’-
differentiate into neural cell types by mechanisms independent of cell fusion (Crain et 
al., 2005). Alvazrez-Dolado and colleagues have shown that MSCs spontaneously fuse 
with neural cell types, as well as liver and heart (Alvarez-Dolado et al., 2003). 
Therefore, by applying the principles introduced by Terada and Ying in their 
respective studies, spontaneous fusion of MSCs with host neural cells following 
transplantation into the nervous system could cause MSCs to undergo genetic 
reprogramming and subsequently adopt phenotypic traits of the recipient neural cell. 
As such, spontaneous fusion events provide a potential mechanism by which MSC 
transplantation contributes towards functional recovery in neurological and 
neurodegenerative systems. However, as is the case for ‘trans’-differentiation of 
MSCs, spontaneous cell fusion occurs at an extremely low frequency. In Terada’s 
study, a fusion rate of 2-11 clones per million cells was reported (Terada et al., 2002). 
Together, the low frequency of both ‘trans’-differentiation and spontaneous cell fusion 
suggest that both of these phenomena are unlikely to fully account for the observed 
neurological improvements. A third possibility is gathering momentum as the 
mechanism most likely to be the major player in MSC-mediated neurological recovery. 
 
1.6.3.4  MSCs as trophic mediators of neural differentiation 
The low frequency at which ‘trans’-differentiation and cell fusion events occur means 
that they are unlikely to account for the neurological recovery observed following 
MSC transplantation in models of neurological and neurodegenerative disorders.  
However, that is not to discount these mechanisms completely.  It is possible that both 
may contribute in part towards observed functional recovery but the low frequency 
with which they occur suggests there may also be other mechanisms at play. 
 
By definition, stem cells are cells that that a) display the capacity for self-renewal and 
b) display the potential to differentiate into more mature cell types. This functional 
definition of a stem cell continues to evolve, and there is much evidence at present to 
suggest that stem cells have an important role within their niche that involves the 
release and/or uptake of trophic factors and cytokines. This intercellular 
communication occurs between cells in close proximity to one another and may be 
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paracrine or autocrine. The term ‘paracrine’ is used to describe signalling that occurs 
between two different cell types i.e. a cell-derived soluble factor acting upon a 
different cell type to that which secreted it. Conversely, the term ‘autocrine’ describes 
signalling that occurs between two cells of the same type i.e. a cell-derived soluble 
factor acting upon a cell of the same type as that which secreted it. The concept of 
stem cells having a trophic role in addition to their ‘foremost’ role in differentiation 
have been described for both embryonic and adult stem cell populations, including 
haematopoietic and neural stem cells, amongst others (Lu et al., 2003, Guo et al., 2006, 
Cabanes et al., 2007). Regarding MSCs, there are several studies demonstrating 
trophic roles in vivo, and perhaps the best characterised of these is the trophic role 
MSCs perform in the regulation of haematopoiesis (Haynesworth et al., 1996). It is 
proposed that the third, and predominant, mechanism by which MSCs promote 
functional recovery from neurological deficits is not from cell differentiation or fusion 
events, but instead via the release of trophic factors and cytokines. The cocktail of 
factors secreted by MSCs ameliorate neural damage by a paracrine mechanism, 
exerting a neurogeneic effect on resident neural stem and progenitor cells, thereby 
promoting endogenous repair processes in the host nervous system (Chen et al., 2007, 
Chen et al., 2005). Factors secreted by MSCs can be loosely categorised into two 
groups: neurotrophic factors and non-neurotrophic factors. Both will be considered 
here. 
 
1.6.3.4.1 Secretion of neurotrophic factors by MSCs 
There are numerous reports suggesting that MSCs secrete a wide array of 
neurotrophins, growth factors, cytokines and other soluble factors.  Work from both in 
vitro and in vivo settings indicate that MSC-derived factors promote cellular events 
such as proliferation, survival and differentiation. Several of the soluble factors 
secreted by MSCs are known to exert neurogenic effects on neural stem and progenitor 
cells and include molecules such as nerve growth factor (NGF), brain-derived 
neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), 
neurotrophin-3 (NT-3), basic fibroblast growth factor (bFGF), vascular endothelial 
growth factor (VEGF), hepatocyte growth factor (HGF) and ciliary neurotrophic factor 
(CNTF) (Chen et al., 2005, Chen et al., 2002, Chen et al., 2007). In addition to these 
highly documented neurotrophic factors, the ‘secretome’ of MSCs also consists of a 
wide variety of interleukin (IL) molecules, including IL-6, -7, -8, -11, -12, -14 and 15, 
Chapter 1: Literature Review 
 
42 
 
and this is in keeping with their housekeeping role as trophic mediators of 
haematopoiesis. It has long been established that a complement of IL molecules play 
key roles throughout the process of haematopoiesis, though it is now becoming 
increasingly apparent that IL molecules also play key roles during neural development, 
indicating that there maybe crosstalk between haematopoietic and neural 
differentiation pathways, further supporting MSCs as trophic mediators in both 
capacities (Majumdar et al., 1998, Mehler et al., 1993).  
 
As MSCs are essentially a population of stromal cells it comes as no surprise that, in 
addition to the array of soluble factors and cytokines, they also secrete a wide range of 
extracellular matrix proteins, including collagen, laminin and fibronectin, that may 
modify the niche of neural stem cells (Chen et al., 2007). Such extracellular matrix 
proteins may promote events that would facilitate neurological recovery e.g. neurite 
extension. The secretion of non-soluble factors will be subject to discussion in Section 
1.6.3.4.2. 
 
Proteomic analysis of the MSC secretome suggests that it is likely to be a cocktail of 
soluble factors and cytokines, rather than the activity of any single factor, that is 
responsible for neurological recovery following MSC transplantation (Schinkothe et 
al., 2008). The beneficial effects of MSC-derived factors in mediating neurological 
recovery are highly documented in the literature, and the effects of these factors can be 
broadly classified into five main categories (Fiore et al., 2002, Schanzer et al., 2004, 
Palmer et al., 1999, Hsu et al., 2007, Hagg, 2005, Chopp and Li, 2002, Chen and 
Chopp, 2006).: 
 
 Angiogenic effects 
Involving the formation of vasculature and new blood vessels 
 
 Neurogeneic effects 
Involving the formation of neural tissue 
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 Neuroprotective effects 
Involving the protection of neural tissue from apoptosis and 
degeneration. 
 
 Synaptogenic effects 
Involving the formation of synapses and synaptic contacts. 
 
 Inhibition of scarring 
Involving the prevention of scarring, which could potentially prevent 
reconstruction of neural circuitry following injury or damage. 
 
A few of the key studies demonstrating MSCs as trophic mediators of neurological 
recovery will be considered. 
 
One of the most interesting studies investigating the role of MSCs as trophic mediators 
of neural differentiation was that published by Chen and colleagues in 2002 (Chen et 
al., 2002). In this study, it was demonstrated that the major mechanism behind MSC-
mediated repair of neural tissue in an in vitro model of stroke was a result of cytokine 
and soluble factor secretion by MSCs. Even more intriguing was the convincing 
argument that the MSC secretome was significantly influenced by the 
microenvironment in which MSCs were cultured, suggesting that MSCs are capable of 
modifying their secretory profile in response to various environmental cues. 
Demonstration of this latter point involved an in vitro model system in which Chen 
and colleagues collected supernatant media that had been exposed either to normal rat 
brain tissue or to rat brain tissue that had been subjected to middle cerebral artery 
occlusion (MCAo), a model of stroke in rat. Human MSCs in culture were exposed to 
both supernatants and allowed to condition their media, which was subsequently 
collected and analysed using a human-specific ELISA to determine levels of the 
neurotrophic factors BDNF, NGF, bFGF, VEGF and HGF. However, the authors were 
keen to stress that, such was that nature of the ELISA technique used in their study, a 
degree of cross-reactivity with rat-derived cytokines could not be discounted 
(potentially carried over in the supernatants). Following exposure to ischemic brain 
supernatant compared to normal brain supernatant, Chen and co-workers observed that 
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MSCs produced and secreted elevated quantities of the neurotrophic factors BDNF, 
NGF, VEGF and HGF, suggesting that perhaps the main mechanism in vivo by which 
MSCs ameliorate neural damage is the result of production and secretion of 
neurotrophic factors and cytokines that stimulate endogenous recovery. Results 
regarding bFGF levels were inconclusive. This study was successful in demonstrating 
that not only do MSCs secrete neurotrophic factors and cytokines but, perhaps more 
importantly in terms of cellular therapy of neurological deficits, that MSCs are able to 
alter their secretory profile in response to specific microenvironmental cues i.e. 
increased secretion of neurotrophic factors in response to neural damage. Of additional 
interest from a clinical perspective, the secretome of MSCs not only varied in response 
to different environmental cues, but also varied depending on the time point at which 
the brain tissue was extracted following MCAo. This is a crucial factor requiring 
further investigation further if MSC-based cellular therapies are to be used 
successfully in the treatment of neurological and neurodegenerative disorders, as 
delayed administration of MSCs post-injury may not be as efficacious as when 
administered immediately. 
 
In a more recent study by the same group, Chen and colleagues used sciatic nerve 
injury in rat as a model to ascertain whether MSC transplantation could be used as a 
means of treating peripheral nerve damage in addition to CNS damage (Chen et al., 
2007). The sciatic nerve is one of the most commonly used in such studies, and is 
perhaps the most useful, as it is one of the longest nerves in the body, found in the 
lower limbs. Functional recovery following MSC transplantation was assessed using 
the sciatic function index (SFI). Whilst a detailed description of SFI is superfluous for 
the purposes of this chapter, it is useful to point out the scale on which SFI is 
measured, which runs from 0 to -100, where a value of 0 is indicative of normal nerve 
function and a value of -100 is indicative of complete sciatic nerve dysfunction. Sciatic 
nerve injury was induced, followed by MSC administration, to ascertain whether MSC 
transplantation could mediate functional recovery following damage to peripheral 
nerves. To assess functional recovery, SFI was determined periodically for up to 10 
weeks post-transplantation. Higher SFI values were reported in animals subjected to 
MSC transplantation compared to controls, and these differences were highly 
significant at the statistical level from the fifth week onwards. Chen and co-workers 
had therefore successfully demonstrated that MSC transplantation resulted in clear 
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beneficial effects following peripheral nerve damage. In terms of the potential 
mechanism(s) by which MSC transplantation mediated functional repair, an increase in 
the levels of NGF, BDNF, GDNF and CNTF, and similarly increased expression of the 
extracellular matrix proteins, collagens I and IV, fibronectin and laminin, were 
observed. This suggested that not only were MSCs secreting soluble neurotrophic 
factors and cytokines that potentially stimulated endogenous repair mechanisms via 
their effects on immature neural stem and progenitor cells, but they were also secreting 
molecules that modified the microenvironment within the neurologically damaged 
area. This phenomena may also have been key in mediating functional recovery by 
encouraging beneficial events, such as neurite outgrowth, that would aid in the 
reconstruction of neural circuitry. 
 
These data support the notion that transplanted MSCs release trophic factors and 
cytokines that mediate functional recovery following neurological damage in the CNS 
and to peripheral nerves. However, there is little evidence in these studies to 
demonstrate that these MSC-derived factors act directly on neural stem and progenitor 
cells. A study by Munoz et al in 2005 addressed this issue (Munoz et al., 2005). In this 
study, MSCs were administered directly into the dentate gyrus of the hippocampus, an 
area known to be rich in neural stem and progenitor cells. Munoz et al., (2005) 
observed a substantial increase in the proliferation and migration of host neural stem 
cells, at the expense of MSC proliferation and migration. The proliferation and 
migration of resident neural stem and progenitor cells was attributed to increased 
levels of NGF, VEGF, CNTF and bFGF in the hippocampus following MSC 
transplantation, strongly suggesting that MSCs were at least partly responsible for their 
secretion. In this study, Munoz and colleagues make a very interesting observation, 
claiming that MSC-derived soluble factors not only influence neural stem and 
progenitor cells to undergo proliferation and differentiation events, but also function 
by ‘activating’ resident astrocytes within the niche (Munoz et al., 2005). A 
contribution by ‘activated’ astrocytes towards the increased neurotrophin levels 
observed in the hippocampus following MSC transplantation cannot be discounted, nor 
can the possibility of ‘activated’ astrocytes directly influencing neurogenesis of 
resident neural stem and progenitor cells. An astrocytic contribution to neural recovery 
concomitant with the direct effects of MSC-derived factors is not unlikely, as there are 
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numerous reports that astrocytes have a trophic role in neurogenesis (Rudge et al., 
1992, Nakayama et al., 2003). 
 
1.6.3.4.2 Secretion of non-neurotrophic factors by MSCs 
The discussion in Section 1.6.3.4.1 focussed predominantly on MSCs as trophic 
mediators of neural recovery in terms of the secretion of soluble neurotrophic factors 
and cytokines that directly act upon and influence signalling pathways and gene 
expression in resident neural stem and progenitor cells. However, MSCs also secrete a 
wide array of extracellular matrix proteins, in keeping with their stromal origins. These 
proteins can modify the niche in which stem cells reside, and thereby influence the 
behaviour of themselves and their neighbours. Perhaps the best study to date 
examining the expression of extracellular matrix and adhesion molecules by MSCs, 
particularly with reference to the effects of these molecules on the behaviour of neural 
cell types, is that by Crigler et al in 2006 (Crigler et al., 2006, Tremain et al., 2001). 
By analysing the transcriptome of a clonal population of MSCs using a serial analysis 
of gene expression (SAGE) approach, Crigler and colleagues demonstrated (and 
validated) that MSCs express a range of extracellular matrix and adhesion molecules 
that may contribute to MSC-mediated recovery of neural injury in vivo. Examples of 
such molecules expressed by MSCs include netrin-4 and reticulon-4 (previously 
reported to be involved in axonal guidance), ninjurin-1/2 and astrotactin (previously 
reported to be involved in neural cell adhesion), and prosaposin and pleiotrophin 
(previously reported to be neurite-inducing factors), amongst others. Hence, expression 
and secretion of extracellular matrix and/or adhesion molecules may also contribute to 
the mechanism of MSC-mediated recovery of neural damage. In reality, MSC-
mediated amelioration of neural damage is likely to occur by a combination of 
neurotrophic factors acting directly on resident neural stem and progenitor cells, and 
also supporting extracellular proteins that exert a chemotactic effect on axonal and 
neurite outgrowth, which would aid in the reconstruction of neural circuitry. 
 
A general overview of MSCs as trophic mediators of neural differentiation is 
illustrated in Figure 1.8. 
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1.6.4 Studying MSC-derived soluble factors in an in vitro setting: a conditioned 
media approach 
One of the primary methods that has been used to analyse the secretome of various cell 
types involves the production and subsequent analysis of conditioned media (CM) 
produced by such cells under certain growth conditions.  CM is a term used to describe 
media in which cells have already been cultured, and thus may contain a mixture of 
trophic factors and cytokines that have been actively secreted by the cells.  A cocktail 
of cell-derived soluble factors may be useful in the subsequent culture of other cell 
types whether this be for routine growth or to induce other events such as cellular 
differentiation. Accordingly, the study of the effect(s) of MSC-conditioned media 
(MSC-CM) on cell fate decisions by neural stem and progenitor cells coupled with the 
appropriate analysis of MSC-CM media, may lead to the identification of the key 
combination of factors responsible for such activity. 
  
 
Figure 1.8. A diagrammatic representation of the predominant mechanisms by 
which MSCs may function as trophic mediators of neural differentiation. 
Molecules secreted by MSCs can be classified as either neurotrophic soluble 
factors/cytokines, which may act directly on neural stem/progenitor cells to induce 
cellular processes such as proliferation, migration and differentiation or may function 
indirectly via their influence on astrocytes within the niche, or extracellular matrix, 
which may promote neurogenic processes such as neurite extension. 
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In 2006, Rivera and colleagues demonstrated that MSC-derived soluble factors and 
cytokines induced neural stem cells to acquire a predominately oligodendrocytic 
phenotype, at the expense of an astrocytic one (Rivera et al., 2006). In this study, rat 
MSCs were cultured under standard culture conditions i.e. in the presence of 10% 
FCS, and were allowed to condition the medium for three days. The presence of serum 
in conditioned media can sometimes be problematic in subsequent analysis, as serum 
is a complex mixture of unknown nutrients, hormones and growth factors that are often 
necessary for routine cell culture. It can be extremely difficult to distinguish between 
proteins that have been secreted by the cells in culture and extraneous protein from the 
serum, unless sophisticated proteomic techniques are employed to distinguish between 
species-specific proteins. Additionally, high levels of proteins such as albumin and 
transferrin in serum may dominate subsequent analysis, masking cell-specific factors 
that have been secreted, which are likely to be present in much lower concentrations. 
After allowing MSCs to condition their standard, serum-containing media for 3 days, 
this MSC-CM was subsequently used for the culture of adult rat neural stem cells for a 
period of 7 days, after which the differentiative state of the cells was assessed by 
examining expression of mature neural markers. To serve as an appropriate control, 
neural stem cells cultured in unconditioned medium were also analysed. Neural stem 
cells cultured in MSC-CM for 7 days demonstrated a significant increase in expression 
of the oligodendrocytic markers galactocerebroside (GalC) and myelin basic protein 
(MBP), and this was concomitant with a significant decrease in the expression of the 
astrocytic marker, GFAP. These findings suggest that the cocktail of soluble factors 
secreted by MSCs into the MSC-CM induce adult neural stem cells to undergo 
gliogenesis, but particularly oligodendrogenesis at the expense of astrogenesis.   
Interestingly, in terms of neuronal differentiation, Rivera et al (2006) reported low 
levels of the neuronal marker, microtubule-associated protein 2ab (Map2ab), in both 
conditions, suggesting that MSC-derived soluble factors functioned independently of 
neurogenesis. 
 
The main mechanistic question addressed by Rivera and colleagues (2006) in this 
study was whether MSC-derived soluble factors were exerting an instructive or 
selective effect on the NSCs. If functioning by an instructive mechanism, then the 
soluble factors in MSC-CM could be said to cause immature, non-committed neural 
stem cells to undergo oligodendrocytic differentiation. Conversely, if operating via a 
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selective mechanism, then these factors would be providing conditions that select for 
the enhanced growth of precursors already committed toward an oligodendrocytic fate 
and/or providing sub-optimal growth conditions for precursors committed to astrocytic 
or neuronal fates. To address this issue, Rivera and colleagues evaluated the effect of 
MSC-CM on the rates of cell proliferation and cell death within different 
subpopulations of the neuro-progenitor cells that differentially expressed cell type 
specific markers of glia and neurons. These experiments concluded that the 
acquirement of an oligodendrocyte phenotype produced by the neural stem cells 
occurred independently of rates of cell proliferation and cell death in the different 
progenitor subpopulations, suggesting that MSC-derived soluble factors were 
functioning by an instructive rather than selective mechanism. 
 
In a separate study conducted in 2004, Wislet-Gendebien and co-workers investigated 
the effects of conditioned media derived from rat MSCs on the differentiation of 
mouse neuro-progenitor cells from the embryonic (E16) mouse (Wislet-Gendebien et 
al., 2004). In order to compare the observations between Wislet-Gendebien’s study 
and that by Rivera detailed above, a consideration of the differences in basic 
experimental setup is required. In addition to using embryonic neural cells as opposed 
to adult neural stem cells, the Wislet-Gendebien group produced and analysed media 
that had been conditioned by nestin-positive rat MSCs (npMSCs).  Under standard 
growth conditions, MSCs are largely negative for expression of neural antigens such as 
nestin.  However, appropriate manipulation of the culture conditions can induce MSCs 
to express nestin, namely by the removal of serum from the culture medium followed 
by a minimum of 25 population doublings; in crude terms, a minimum of 10 passages 
(Wislet-Gendebien et al., 2003). As MSCs have been reported in numerous studies to 
demonstrate neural antigen expression following transplantation in vivo, it may be 
considered more relevant to examine media conditioned by neural antigen-positive 
MSCs rather than neural antigen-negative MSCs.  
 
In their study, Wislet-Gendebien and colleagues allowed npMSCs to condition media 
for 3 days (npMSC-CM), followed by subsequent culture of mouse embryonic neural 
progenitors in this npMSC-CM for a period of 5 days. During this time, expression of 
the astrocytic marker, GFAP, increased whilst there was a concomitant decrease in the 
percentage of cells expressing neuronal (Tuj1) and oligodendrocytic (O4) markers 
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(Wislet-Gendebien et al., 2004). Similarly, the rates of cell proliferation and cell death 
were examined in the appropriate subpopulations of the mouse embryonic progenitor 
cultures following culture with npMSC-CM.  Although no changes in cell proliferation 
were noted, a significant decrease in the rate of cell death of the GFAP-positive 
subpopulation was recorded after the 48 hours treatment with npMSC-CM. It is 
possible that a component of the npMSC-CM inhibited the death of GFAP-positive 
cells. In an attempt to identify the factor(s) responsible for influencing the 
differentiation of astrocytes, npMSCs were screened for a number of candidate factors.  
It was found that npMSCs showed an up-regulation of the biologically-active form of 
bone morphogenetic protein 4 (BMP4) at both the mRNA and protein level.  MSCs 
that were negative for nestin expression did not express active BMP4.  Accordingly, it 
was concluded that the effect of npMSC-CM on astrocyte differentiation by embryonic 
neuro-progenitor cells was attributable, at least in part, to the secretion of active BMP4 
(Wislet-Gendebien et al., 2004). 
 
It is now becoming increasingly accepted that the likely predominant mechanism by 
which MSC transplantation results in functional recovery following neural injury is via 
the release of trophic factors and cytokines that act on resident neural stem and 
progenitor cells, thereby promoting endogenous repair processes. Whilst MSCs have 
been reported to secrete a wide range of neurotrophic factors and cytokines, our 
knowledge in this area remains at an early stage. The two studies discussed above 
demonstrate that the effect of MSC-derived soluble factors on the cell fate decisions of 
neural stem and progenitor cells can vary significantly, depending on a range of 
factors, including the developmental state of the MSC population and the source of 
neural stem cells (embryonic versus adult). However, despite the obvious gaps in our 
understanding, there have already been several efforts to exploit the natural beneficial 
properties of MSCs, by genetically engineering them to over-express the neurotrophic 
factors and cytokines that promote functional recovery from neurological deficits.  
There have recently been two studies using herpes simplex virus (HSV) as a vector to 
deliver target genes that enhance the expression and secretion of the growth factors 
HGF and FGF (Zhao et al., 2006, Ikeda et al., 2005). Results achieved in these studies 
have been extremely promising, with high rates of transfection efficiency reported, and 
the efficacy of genetically-engineered MSCs in mediating functional recovery from 
neural injury being enhanced above that of control MSCs. As such, MSCs may provide 
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useful vehicles for the delivery of highly-efficacious levels of neurotrophic factors and 
cytokines to areas of neurological and neurodegenerative damage. 
 
1.7 MSCs as trophic mediators in alternative biological systems 
 
1.7.1 Haematopoietic system 
In addition to their intrinsic ability to undergo differentiation into a range of 
mesodermal derivatives such as bone, fat and cartilage, MSCs also demonstrate a 
crucial role within their niche involving the release and/or uptake of diffusible soluble 
factors/cytokines, which serves to modulate the behaviour of other cell types within 
proximity such as haematopoietic cells and endothelial cells. Although trophic roles 
have been described for other stem cell types within their niches, including 
haematopoietic and neural stem cells amongst others, trophic roles are perhaps best 
characterised in MSCs and, as such, will be considered here (Lu et al., 2003, Caplan 
and Dennis, 2006; Guo et al., 2006, Cabanes et al., 2007). 
 
Although a major function of MSCs within their niche is to provide a solid, structural 
framework which is supportive of other cell types in the vicinity, such as 
haematopoietic cells, there is also significant evidence to suggest that an equally-
important function of MSCs within their niche involves the release of diffusible 
soluble factors/cytokines that can function via autocrine and paracrine mechanisms to 
modify the behaviour and function of other cell types within the niche appropriately 
(Bobis et al., 2006; Dennis and Caplan, 2006). For example, osteogenic and 
adipogenic differentiation of MSCs is significantly influenced by autocrine 
mechanisms in vivo, whereby MSCs secrete a range of soluble factors and cytokines 
that directly influence the differentiative process (Baylink et al., 1993; Spiegelman and 
Flier, 1996; Mohamed-Ali et al., 1998; Pages et al., 2000; Sykara and Opperman, 
2003). Furthermore, as differentiation proceeds and the MSC phenotype transforms 
accordingly, it has been reported that MSCs alter their secretory profile in keeping 
with this, serving to regulate their own behaviour via an autocrine feedback 
mechanism (Caplan and Dennis, 2006).  
 
Stem cell bifunctionality in terms of differentiative potential and trophic activity is not 
a novel concept; indeed, this paradigm has been acknowledged in MSCs since the mid-
Chapter 1: Literature Review 
 
52 
 
1980s, where a dual-role in both differentiation and regulation of haematopoiesis was 
reported (Owen, 1985). MSCs constitutively secrete a plethora of haematopoietic 
cytokines including, but by no means limited to, IL-1a, IL-1b,  IL-6, IL-7, IL-8, IL-11, 
IL-14, IL-15, macrophage colony-stimulating factor, granulocyte-macrophage colony-
stimulating factor (GM-SCF), LIF, foetal liver tyrosine kinase 3 (flt-3), 
thrombopoietin, HGF and stem cell factor (SCF), all of which are highly documented 
as regulators of vascular and haematopoietic stem cell function (Dexter, 1989; Dexter 
et al., 1990; Colter et al., 2001; Gronthos et al., 2003; Boiret et al., 2005; Katz et al., 
2005; Bobis et al., 2006; Dazzi et al., 2006; Brooke et al., 2007). MSC-mediated 
regulation of haematopoiesis has been demonstrated both in vitro and in vivo 
(Majumdar et al., 1998; Maitra et al., 2004; Mourcin et al., 2005). One particularly 
interesting study by Muguruma and colleagues demonstrated that GFP-labelled MSCs 
integrated into the haematopoietic microenvironment following transplantation into 
immune-deficient NOD-SCID mice, resulting in an increase in the number of 
haematopoietic cells; this was a consequence of soluble factor/cytokine activity 
(Muguruma et al., 2006). The intrinsic ability of MSCs to modulate haematopoiesis is 
of clinical significance; for example, in a study involving 28 breast cancer patients 
who had undergone extensive chemotherapy, haematopoietic recovery was greatly 
facilitated following administration of autologous MSCs (Koc et al., 2000). 
 
The ability of MSCs to modulate the behaviour of haematopoietic stem cells and 
regulate the process of haematopoiesis via the release of diffusible soluble factors and 
cytokines has been considered above. A similar phenomenon has been described in the 
nervous system, where MSC-derived soluble factors and cytokines promote 
endogenous recovery in numerous models of neurological and neurodegenerative 
disorders, presumably via their influence on neural stem and progenitor cell behaviour. 
Both scenarios are of significant clinical relevance. The remainder of this literature 
review will focus on current evidence supporting a trophic role for MSCs in other 
biological systems and their potential clinical significance; in particular, emphasis will 
be placed on MSC-mediated effects in the cardiac system, where many of the 
principles discussed for the nervous system hold true. 
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1.7.2 Cardiovascular system 
Diseases of the cardiovascular system are the most significant contributors to 
morbidity and mortality in the Western world, claiming approximately 17 million lives 
worldwide in 1999 and affecting many more (Bonow et al., 2002). As these figures 
demonstrate a propensity to increase – mirroring increasing rates of obesity and other 
significant risk factors – there is, consequently, a demand for more effective and 
satisfactory therapies. In particular, regenerative cell-based therapies using autologous 
stem cells remain a highly desirable therapeutic goal as adult cardiac tissue cannot 
regenerate following ischemic injury (Toma et al., 2002). 
 
MSCs present as ideal candidates for regenerative cell-based therapies against 
cardiovascular disease and, indeed, most clinically-important degenerative disorders, 
for the reasons detailed in Section 1.4.1. In addition to the general facets of MSC 
biology detailed in Section 1.4.1, their intrinsic ability to commit to and undergo 
myogenic differentiation makes them even more appealing as potential therapeutic 
agents in the cardiovascular system (Saito et al., 1995; Gussoni et al., 1999). Perhaps 
most promising are the numerous independent studies that have reported that MSC 
transplantation results in functional recovery, albeit to varying degrees, following 
myocardial infarction (MI), ischemic heart failure and dilated cardiomyopathy, as 
determined by measurement of functional parameters such as systolic/diastolic blood 
pressure, echocardiograms, blood flow and systolic wall thickness/function (Itescu et 
al., 2003; Perin et al., 2003; Stamm et al., 2003; Wollert et al., 2004; Amado et al., 
2005; Nagaya et al., 2005; Caplan and Dennis, 2006).  
 
However, a similar scenario to that observed in the nervous system presents, in that the 
precise mechanism(s) by which MSCs elicit functional recovery in the cardiovascular 
system are not known with any certainty. Numerous studies have reported the apparent 
differentiation of MSCs into cardiomyocytes and vascular endothelial cells both in 
vitro and in vivo (Makino et al., 1999; Wang et al., 2001; Toma et al., 2002). 
However, several studies question the authenticity of such derivatives and, similarly, 
no study has successfully demonstrated functional engraftment of putative MSC-
derived cardiomyocytes into cardiac tissue (Balsam et al., 2004; Murry et al., 2004; 
Brooke et al., 2007). The lack of evidence regarding functional engraftment of MSC-
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derived cardiomyocytes means a direct contribution of MSC differentiation to 
functional recovery cannot be claimed with any certainty. 
 
It is now widely accepted that the functional recovery and therapeutic benefits 
observed following transplantation of MSCs in numerous models of cardiovascular 
disease are predominantly the result of a paracrine mechanism, mediated by MSC-
derived soluble factors and cytokines such as HGF, VEGF and FGF, which promote 
beneficial processes such as angiogenic, anti-apoptotic, anti-fibrotic and anti-
inflammatory events (Rehman et al., 2003; Kinnaird et al., 2004a; Kinnaird et al., 
2004b; Rehman et al., 2004; Gnecchi et al., 2005; Nagaya et al., 2005; Gnecchi et al., 
2006; Miyahara et al., 2006; Ohnishi et al., 2007). Additionally, following the recent 
identification of a putative stem cell population within cardiac tissue, demonstrating 
the potential to differentiate into cardiomyocytes, smooth muscle and endothelial cell 
types, it can be envisioned that MSC-derived soluble factors promote endogenous 
repair processes via their influence(s) on host stem cell behaviour (Beltrami et al., 
2003). This is analogous to the scenario observed in the nervous system. Under normal 
physiological conditions, adult cardiomyocytes are largely under the influence of 
autocrine-derived growth factors and cytokines, including IGF, TGF and EGF, 
amongst others, which contribute towards many varied aspects of cardiomyocyte 
growth, survival and development (Perrella et al., 1994; Engelmann et al., 1996; Zhao 
et al., 1998). A greater understanding of the role(s) of soluble factors and cytokines in 
cardiomyocyte function and development will ultimately aid in the derivation of novel 
therapeutic strategies targeted against clinically-important diseases of the 
cardiovascular system. 
 
1.8 Concluding remarks and future directions 
 
In terms of their potential clinical use in cellular therapies and tissue engineering 
strategies, adult stem cells are garnering much interest at present as they are generally 
easily accessible and circumvent the significant ethical issues surrounding the use of 
embryonic stem cells. Although there are many different types of adult stem cell that 
can be isolated from many sources, MSCs present as perhaps the most promising 
alternative to embryonic stem cells, owing to unique properties which make them 
potential candidates for a number of clinical applications. At present, the most obvious 
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and perhaps most realistically achievable of these involves exploiting the intrinsic 
ability of MSCs to differentiate into mesodermal derivatives, such as bone and fat, for 
the treatment of osseous and adipose tissue defects. There is a huge niche in the clinic 
for alternative treatment strategies for these disorders, due to the considerable 
limitations of current treatment methods, and it is in this field that MSC-based cellular 
therapies initially become commonplace in the clinic. 
 
However, perhaps more exciting is the accumulating evidence to suggest that MSCs 
may be suitable candidates for use in a wider range of therapeutic applications than 
previously anticipated, and that they may be used in the treatment of disorders arising 
in tissues from alternative germ layers i.e. endoderm and ectoderm. The main crux of 
this literature review has therefore focussed on the potential use of MSCs in the 
treatment of neurological and neurodegenerative deficits. MSC transplantation in 
numerous models of neurological and neurodegenerative disorders can result in 
significant functional improvements. However, the mechanism(s) by which MSC 
transplantation mediates neurological recovery still eludes us to date. In the present 
literature review, the three most commonly-described hypotheses have been discussed, 
though it is now generally accepted that MSCs act predominantly as trophic mediators 
of neural differentiation involving the release of trophic factors and cytokines that act 
on resident neural stem and progenitor cells, promoting endogenous repair 
mechanisms. The other two proposed mechanisms – ‘trans’-differentiation and 
spontaneous cell fusion events – occur at far too low a frequency to be able to fully 
account for neurological improvements observed following MSC transplantation. This 
suggests that these are minor mechanisms involved in MSC-mediated neural recovery. 
The most compelling argument against a significant input from ‘trans’-differentiation 
and spontaneous cell fusion towards functional recovery centre around the timescale in 
which MSC-mediated recovery has been observed. Such mechanisms would require 
MSCs to successfully home to the neurologically-damaged area in the first instance, 
then successfully engraft into the tissue, differentiate into mature neural 
derivatives/acquire a mature neural morphology following fusion with host neural cell 
types and finally, and perhaps most complicated of all, form active neural connections. 
Only after all of these events have occurred successfully would any improvements in 
neurological function be observed. However, functional improvements following MSC 
transplantation have been observed as early as a few days following MSC 
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transplantation, which is an unrealistic period in which all of these events could occur 
(Chopp and Li, 2002). On the other hand, the ability of resident neural stem and 
progenitor cells to contribute to functional recovery during this timescale is far more 
likely, as these cells are already integrated within the host nervous system and, equally 
as importantly, already have much of the necessary cellular machinery in place to 
undergo differentiation. However, it must be stressed that a direct contribution of 
‘trans’-differentiation and spontaneous cell fusion events towards neurological 
recovery cannot be discounted. It is therefore likely that the initial, short-term 
therapeutic benefits observed following MSC transplantation are a consequence of the 
action of MSC-derived soluble factors/cytokines and their direct effect(s) on host 
neural tissue, namely neural stem and progenitor cells, whilst longer-term recovery 
may indeed be contributed to the integration of ‘trans’-differentiated MSCs within the 
nervous system and/or MSCs that have spontaneously fused with host neural cell types 
and acquired their phenotypic traits.  
 
MSCs have already received much attention as potential candidates for use in cellular 
therapies and tissue engineering strategies, and it is anticipated that this interest will 
only intensify in the near future. For the purposes of this literature review, the potential 
to exploit the intrinsic ability of MSCs to undergo mesodermal differentiation for 
regenerative cell-based therapies against osseous and adipose tissue defects has been 
considered; similarly, potential exploitation of MSCs in the treatment of neurological 
and neurodegenerative disorders has also been considered. However, these are by no 
means the only potential therapeutic applications of MSCs in the clinic or, indeed, the 
only areas in which MSC-based research is thriving. There is much interest in the 
potential use of MSCs in regenerative cell-based therapies of many other disorders, 
particularly those of the haematopoietic and cardiovascular systems, which have also 
been discussed above. There is accumulating evidence to suggest that MSCs also 
contribute to recovery from acute kidney injury, fulminant hepatic failure and 
pancreatic disorders, where MSC-derived soluble factors/cytokines promote survival 
and prevent apoptosis (Parekkadan et al., 2007; Togel et al., 2007; Park et al., 2010). It 
is therefore envisioned that a greater understanding of the paracrine effect(s) of MSCs 
will lead to more targeted therapies which promote endogenous recovery from organ 
failure. Ultimately, the unique properties of MSCs may allow their use in patient-
specific treatments for a whole range of clinical disorders. Identification of the 
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bioactive factors released by MSCs will also be important for the development of new 
pharmacological approaches to disease treatment and may also be of use from an 
industrial perspective in the development of new cell culture reagents. A general 
overview of the multifunctionality of MSCs is shown diagrammatically in Figure 1.9. 
 
 
 
 
 
Figure 1.9. A diagrammatic representation of the dual functionality of MSCs. In 
addition to their intrinsic potential to differentiate into mesodermal derivatives such as 
bone and fat, MSCs also have a predominant role within their niche involving the 
release and/or uptake of soluble factors and cytokines that may influence the behaviour 
of other cell types within the niche. (Adapted from Caplan and Dennis, 2006). 
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1.9 Aims of current study 
 
MSCs demonstrate dual functionality in terms of their intrinsic ability to differentiate 
into mesodermal derivatives such as bone and fat, concomitant with their ability to 
influence the behaviour of other cell types via the release and/or uptake of soluble 
factors and cytokines. Both facets of MSC behaviour are valuable from a clinical 
perspective. However, a more comprehensive understanding of the complex molecular 
and cellular mechanisms underlying these phenomena is necessary in order to facilitate 
the translation of MSCs from the laboratory bench to a clinical environment, and this 
will most likely involve the use of 3D cell culture systems that more accurately mimic 
the in vivo niche of MSCs. The major aims of the current study were therefore: 
 
 
a) To investigate the ability of MSCs to differentiate into the mesodermal 
derivatives bone and fat when cultured in two- and three-dimensional 
polystyrene substrates 
 
 
b) To investigate the ability of MSCs to mediate neural differentiation via the 
release of soluble factors/cytokines when cultured as three-dimensional 
aggregates, using a conditioned media approach 
 
 
c) To investigate the complement of bioactive soluble factors/cytokines secreted 
by three-dimensional MSC aggregates, using a combination of targeted 
transcriptional profiling and shotgun proteomics 
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2.1 Isolation of MSCs from the bone marrow of postnatal rats 
Rat mesenchymal stem cells (rMSCs) were isolated from the femurs and tibiae of 6-8 
month old Wistar rats using established procedures (Croft and Przyborski, 2006). Rats 
were euthanised by CO2 asphyxiation and their femurs and tibiae extracted, cleaned of 
connective tissue and placed on ice in 20ml complete culture medium (CCM). CCM 
consists of Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 10% 
FCS, non-essential amino acids (1x), L-glutamine (12M), penicillin (100 U/ml) and 
streptomycin (100 g/ml). The ends of the bones were cut to expose the bone marrow 
(BM), and aspirated with 10ml of CCM by inserting a 21-gauge needle into the shaft 
of the bone and flushing with the CCM. The aspirates from each bone were plated into 
a single T75 cm
2
 flask, and incubated at 37
o
C and 5% CO2 in a humidified incubator. 
The aspirates were left to allow stromal cells to adhere to the tissue culture plastic. 
After 2 days, non-adherent cells were removed, washed in phosphate-buffered saline 
(PBS) x 2 and maintained in CCM, with media changes every 3-4 days. Cultures were 
allowed to reach confluency. These cells were designated as passage 0 (P0). 
 
To passage cultures, MSCs were washed in PBS x 1 and detached from the cellware by 
incubation with 0.25% trypsin and 0.1% EDTA for 5-10 minutes at 37
o
C. Trypsin was 
inactivated by the addition of CCM. Cells were centrifuged at 250 x g for 5 minutes, 
the supernatant removed, and cells resuspended in 1ml of CCM to form a single cell 
suspension. For routine expansion, rMSCs were passaged in a 1:3 ratio. MSCs 
between passages 2 and 8 were used for all the experiments described herein. 
 
2.2 Adult hippocampal progenitor cell (AHPC) culture 
The rat adult hippocampal progenitor cell (AHPC) line was originally obtained from 
the Salk Institute as a generous gift from Professor Fred Gage. AHPCs were cultured 
in cellware coated with poly-L-ornithine (10μg/ml) and laminin (5μg/ml), in N2 
media. N2 media consists of DMEM:F12 (high glucose) supplemented with N2 
supplement (1x), L-glutamine (12M) and human recombinant fibroblast growth 
factor (FGF; 20ng/ml). Cells were routinely expanded in T75 cm
2
 flasks and incubated 
at 37
o
C and 5% CO2 in a humidified incubator, with media being replenished every 2-
3 days or until a confluency of 70-80% was reached. To passage cultures, media was 
removed and AHPCs detached from the cellware by quickly rinsing with 0.25% 
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trypsin and 0.1% EDTA for 1-2 minutes at 37
o
C. Rinsing with PBS prior to the 
addition of trypsin (as for passaging of MSC cultures) was not necessary due to the 
lack of serum in N2 media. Trypsin was diluted and cells were resuspended by the 
addition of N2 media, followed by centrifugation at 1200 x rpm for 3 minutes to pellet 
the cells. The supernatant was removed and cells resuspended in 1ml of N2 media to 
form a single cell suspension and, for routine expansion, were passaged in a 1:5-1:10 
ratio. AHPCs between passages 15-30 were used for all the experiments described 
herein. 
 
2.3 33B cell culture 
The rat 33B oligodendrocytoma (Schwannoma) cell line was originally obtained from 
Leeds University as a generous gift from Professor Eric Blair. For routine expansion, 
33B cells were cultured in CCM as described for MSCs previously. 33B cells were 
also passaged using the same protocol as for MSCs, though at a much higher splitting 
ratio (1:5-1:10 for 33B cells, as opposed to 1:3 for MSCs). 
 
2.4 Flow cytometry: general principles 
As the name implies, flow cytometry is a general laboratory method involving 
measurement of cells in a flow system. Cells are delivered through a beam of light and 
measurement is achieved following detection of their fluorescence and the light 
scattered by them. Flow cytometry is commonly used in laboratories due to its wide 
range of applications and the ability to measure thousands of cells at the individual 
level within only a few minutes. Examples of applications of flow cytometry include 
immunofluorescence, DNA analysis, cell cycle analysis, apoptosis analysis and cell 
sorting (FACS). Six parameters are measured using the FACSCalibur flow cytometer 
(www.bdbiosciences.com) used in studies throughout this thesis: 
 
 Forward scatter (FSC) 
Measures the size of a cell. 
 
 Side scatter (SSC) 
Measures the granularity of a cell. 
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 Fluorescence 1 (FL1)  
Measures light emitted in the green wavelength range, produced by 
excitation of fluorophores including AlexaFluor-488 and FITC. 
The detection range of the FL1 filter is 515-545nm. 
 
 Fluorescence 2 (FL2) 
Measures light emitted in the yellow wavelength range, produced by 
excitation of fluorophores including PE, AlexaFluor-546 and PI. 
The detection range of the FL2 filter is 564-606nm. 
 
 Fluorescence 3 (FL3) 
Measures light emitted in the red wavelength range, produced by 
excitation of fluorophores including AlexaFluor-700, PerCP and PI. 
The detection range of the FL3 filter is ≥ 670nm. 
 
 Fluorescence 4 (FL4) 
Measures light emitted in the red wavelength range, produced by 
excitation of fluorophores including APC and AlexaFluor-647. 
The detection range of the FL4 filter is 656-667nm. 
 
An obvious advantage of flow cytometry, in addition to analysis of thousands of 
individual cells within a short timescale, is the ability to measure multiple parameters 
within a single assay e.g. dual- and triple-labelling of cells. 
 
2.5 Analysis of cell surface antigen expression using flow cytometry 
Flow cytometry was used to analyse the expression of several cell surface antigens on 
isolated MSCs. Briefly, cells were trypsinised as described in Section 2.1, washed in 
PBS x 1, pelleted by centrifugation at 250 x g for 5 minutes and resuspended in FACS 
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buffer (2% natural goat serum (NGS) in PBS) to a single cell suspension. Cells were 
subsequently distributed into the appropriate number of wells of a 96 well plate, 
centrifuged at 250 x g for 5 minutes, supernatant removed and subsequently incubated 
with 50μl of the following rat-specific primary antibodies for 1 hour at 4oC: CD9, 
CD13, CD15, CD34, CD44, CD45, CD58, CD71, CD90, CD105 and CD138. All 
antibodies were used at a dilution of 1:50. Staining with P3X antibody was used as a 
negative control, to determine any levels of background/non-specific fluorescence and 
determine the threshold against which positive and negative events would be 
measured. Following this, cells were washed in FACS buffer x 3 and subsequently 
incubated in 50μl of the appropriate fluorochrome-conjugated secondary antibody for 
30 minutes at 4
o
C. All samples were stained with either an Alexa fluor 488-conjugated 
donkey anti-mouse secondary antibody or a FITC-conjugated goat anti-rabbit 
secondary antibody (both at 1:600 dilution). After 30 minutes, unbound secondary 
antibody was removed by washing in FACS buffer x 3. Following these final washing 
steps, cells were resuspended in 500μl FACS buffer and transferred to FACS tubes in 
preparation for running through the flow cytometer. To exclude non-viable/dead cells 
from our analyses, 10μl of propidium iodide (PI) (2.5mg/ml) was added to samples 
immediately prior to flow cytometric analysis. PI is excluded from viable cells, 
allowing us to gate for and only select viable cells in our analyses. Cell samples were 
passed through a FACSCalibur flow cytometer (www.bdbiosciences.com) and 
analysed using CellQuest Pro software. Both Alexa fluor 488- and FITC-fluorescence 
were detected in the FL1 band pass filter. Ten thousand events per sample were 
determined. 
 
2.6 Analysis of intracellular antigen expression using flow cytometry 
Flow cytometry was used to analyse the expression of several intracellular antigens in 
MSC and AHPC cultures. Briefly, cells were trypsinised as described in Section 2.1, 
washed in PBS x 1 and pelleted by centrifugation for 5 minutes (250 x g for MSCs, 
2000rpn for AHPCs). Cell pellets were fixed in 2% PFA at 4
o
C overnight by 
resuspension in 0.875ml cold PBS to form a single cell suspension, followed by 
addition of 0.125ml cold 2% PFA. Following overnight fixation, cells were processed 
for intracellular staining as follows. Cells were spun down at either 250 x g (MSCs) or 
2000rmp (AHPCs) for 5 minutes, and the supernatant removed. Pellets were 
resuspended gently in 1ml permeabilising solution (0.2% Triton-X in PBS) and 
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incubated at 37
o
C for 30 minutes. Then, 1ml FACS buffer (2% NGS and 0.2% Tween 
20 in PBS) was added, the cells spun down as described and the supernatant removed. 
The pellet was resuspended in FACS buffer to a single cell suspension and 
subsequently distributed into the appropriate number of wells of a 96-well plate, 
centrifuged at either 250 x g (MSCs) or 2000rpm (AHPCs) for 5 minutes, supernatant 
removed and subsequently incubated with 50μl of the following rat-specific primary 
antibodies (at the following dilutions) for 30 minutes at room temperature: nestin 
(1:200), Tuj-1 (1:600), GFAP (1:200) and GalC (1:200). Staining with P3X antibody 
was used as a negative control, to determine any levels of background/non-specific 
fluorescence and determine the threshold against which positive and negative events 
would be measured. Following this incubation, unbound primary antibody was 
removed by washing in FACS buffer x 3, and cells were subsequently incubated in 
50μl of the appropriate fluorochrome-conjugated secondary antibody for 30 minutes at 
room temperature. For MSCs, Tuj-1 was detected with a FITC-conjugated goat anti-
rabbit secondary antibody (1:600), whilst nestin, GFAP and GalC were detected with 
an Alexa fluor 488-conjugated donkey anti-mouse secondary antibody (1:600). For 
AHPCs, Tuj-1 was detected with an APC-conjugated goat anti-rabbit secondary 
antibody (1:300), whilst nestin, GFAP and GalC were detected with an APC-
conjugated rabbit anti-mouse secondary antibody (1:600). After 30 minutes, unbound 
secondary antibody was removed by washing in FACS buffer x 3 and, following these 
final washing steps, cells were resuspended in 500μl FACS buffer and transferred to 
FACS tubes in preparation for running through the flow cytometer. Cell samples were 
passed through a FACSCalibur flow cytometer (www.bdbiosciences.com) and 
analysed using CellQuest Pro software. Alexa fluor 488- and FITC fluorescence were 
detected in the FL1 band pass filter, whereas APC-fluorescence was detected in the 
FL4 band pass filter. 10,000 events were determined per sample. 
 
2.7 Immunofluorescence 
Immunofluorescence staining was used to determine the expression of intracellular 
antigens. Briefly, cell cultures were washed in PBS x 1 and fixed directly in their 
cellware by incubating them in 4% PFA for 30 minutes at room temperature. 
Following this, cells were further washed in PBS x 1 and permeabilised by incubation 
with blocking solution (2% NGS, 0.1% sodium azide, 1% bovine serum albumin 
(BSA) and 0.2% Triton-X in PBS) for 30 minutes at room temperature. After 
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permeabilisation, cells were incubated with appropriate rat-specific primary antibodies 
(diluted in blocking solution) for one hour at room temperature. The following 
dilutions were used for each primary antibody: α-smooth muscle actin (α-SMA) 
(1:400), β-actin (1:400), fibronectin (1:200), GalC (1:200), GFAP (1:200), nestin 
(1:400), Tuj-1 (1:600) and vimentin (1:400). Staining with no antibody (i.e. blocking 
solution alone) was used as a negative control, to determine any levels of 
background/non-specific fluorescence. Following this incubation, unbound primary 
antibody was removed by washing in PBS x 3, and cells were subsequently incubated 
with appropriate fluorescently-labelled secondary antibodies for 45 minutes at room 
temperature. For MSCs, Tuj-1 was detected with a FITC-conjugated goat anti-rabbit 
secondary antibody (1:600), whilst nestin, GFAP and GalC were detected with an 
Alexa fluor 488-conjugated donkey anti-mouse secondary antibody (1:600). For 
AHPCs, Tuj-1 was detected with a Cy3-conjugated mouse anti-rabbit secondary 
antibody (1:300), whilst nestin, GFAP and GalC were detected with a Cy3-conjugated 
goat anti-mouse secondary antibody (1:600). After 45 minutes, unbound secondary 
antibody was removed by washing in PBS x 3, and nuclei counterstained with 
Hoechsst-33342 in PBS. 
 
2.8 Viable cell number assay (MTS assay) 
Determination of the number of viable cells in culture was achieved using the 
commercially available CellTiter 96® AQueous One Solution Cell Proliferation Assay 
kit from Promega. The reagent adopted in this assay contains a tetrazolium compound, 
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium (MTS) and phenazine ethosulfate (PES), which combines with MTS to 
form a stable solution. Cells bioreduce this MTS compound to form a coloured 
formazan compound, and the amount of formazan product formed can be quantified by 
measuring absorbance at 490nm. Absorbance is directly proportional to the number of 
viable cells in culture. The structures of MTS and the resultant formazan product are 
shown in Figure 2.1 
 
200μl MTS reagent was added directly to the culture well for every 1ml of media, and 
incubated for 1-4 hours at 37
o
C. A control well containing no cells was also set up, to 
take into account background absorbance of the MTS reagent in the absence of any 
cells. Absorbance at 490nm was subsequently recorded using a Nanodrop 
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spectrophotometer. Each assay was performed in triplicate, and the mean calculated 
and subsequently normalised against background absorbance (control well). 
 
 
Figure 2.1. The structures of the MTS tetrazolium compound and its formazan product. Viable 
cells in culture bioreduce the MTS compound to form a coloured formazan product, the amount of 
which can be quantified spectrophotometrically by determining absorbance at 490nm. Absorbance 
values are directly proportion to the amount of formazan product formed, which is itself directly 
proportional to the number of viable cells in culture. Taken from http://www.promega.com/uk/ 
 
 
2.9 Isolation of RNA in preparation for gene expression analysis  
Total cellular RNA was isolated using the TRIreagent method, following the 
manufacturer’s protocol. Briefly, cells were lysed directly in their culture dish by the 
removal of media and washing in PBS x 1, followed by the addition of TRIreagent to 
the dish. Typically, 1ml of TRIreagent was added to a T25 and 3ml of TRIreagent 
added to a T75. Cells were incubated in TRIreagent for 5-10 minutes at room 
temperature, and homogenised by passing through a pipette several times. The 
homogenate was subsequently transferred from the culture dish to a 1.5ml Eppendorf 
tube for further manipulation. 0.2ml chloroform was added for every 1ml of 
TRIreagent used in the initial homogenisation step. Following this, samples were 
centrifuged at 12,000 x g for 15 minutes at 4
o
C, during which time the mixture 
separated into layers. RNA remained exclusively in the upper, aqueous phase, whereas 
DNA and protein remained in the lower, organic phase. The RNA-containing aqueous 
layer (approximately 400-500μl) was transferred to a fresh 1.5ml tube, and the organic 
phase was either stored at -80
o
C for DNA/protein extraction at a later date or disposed 
of appropriately. RNA precipitation was achieved by the addition of 0.5ml isopropanol 
(propan-2-ol) for every 1ml TRIreagent used in the initial homogenisation step. 
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Samples were incubated for 10 minutes at room temperature, followed by 
centrifugation at 12,000 x g for 10 minutes at 4
o
C, after which a pellet of RNA should 
be visible on the side of the tube. The supernatant was then removed and the pellet 
washed in 1ml 75% ethanol for every 1ml of TRIreagent initially used. An additional 
step of centrifugation at 10,000 x g for 10 minutes at 4
o
C was used to increase RNA 
yield. The supernatant was once again removed, and the RNA pellet air-dried for 5-10 
minutes at room temperature. In a final step, the RNA was subsequently dissolved in 
50μl RNase-free H2O by mixing and incubation at 65
o
C for 5 minutes. RNA was 
subsequently stored at -80
o
C until necessary. 
 
RNA concentration and purity was determined by using a Nanodrop 
spectrophotometer. 2μl of sample RNA was loaded onto the Nanodrop, and the RNA 
concentration and 260/280 ratio determined. Concentration was measured as ng/ml, 
whilst the ratio of the absorbances obtained for wavelengths of 260nm and 280nm 
gave an indication of the purity of the isolated RNA. A relatively pure sample of RNA 
has a 260/280 ratio of between 1.7 and 2. A ratio below 1.7 is indicative of protein 
contamination, whereas a 260/280 ratio above 2 is indicative of DNA contamination. 
Only RNA with a 260/280 ratio between 1.7 and 2 were used in subsequent 
downstream applications. RNA integrity was also assessed by running an RNA gel. 
Briefly, 10μg total RNA was loaded to a 1% RNAse-free agarose gel (1% agarose in 
TBE running buffer and 0.02% ethidium bromide) and visualised using a GelDoc EQ 
DNA visualisation machine and QuantityOne image analysis software. Pure, intact 
total RNA gives a characteristic two-band pattern, corresponding to 18S and 28S 
ribosomal RNA (rRNA). Only intact RNA was used for subsequent studies. An 
example of a non-degraded RNA is shown in Figure 2.2 
 
2.10 Reverse Transcription 
2μg total purified RNA was reverse transcribed using a commercially available reverse 
transcription (RT) kit. Each individual 20μl reverse transcription reaction consisted of 
the following components: 2μg total RNA, 2μl TaqMan RT buffer (10x), 4.4μl MgCl2 
(25mM), 4μl dNTPs (2.5mM), 1μl oligo d(T) (50μM), 0.4μl RNase inhibitor (20U/L), 
0.5μl RT enzyme (50U/μl) and made up to a total volume of 20μl with RNase-free 
water. The reaction mixture was vortexed and centrifuged at 12,000 rpm to ensure 
complete mixing of the reaction components, and the reverse transcription reaction 
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performed on a thermal cycler. Thermal cycling parameters were as follows: 25
o
C for 
10 minutes, 48
o
C for 30 minutes and 95
o
C for 10 minutes. The newly-synthesised 
cDNA was subsequently stored at 4
o
C for short-term storage, or -20
o
C for longer term 
storage. 
 
 
                                                       
Figure 2.2. An example of a non-degraded RNA. A characteristic two-band appearance is shown, 
corresponding to 18S and 28S rRNA respectively. Degraded RNA does not have the two band 
appearance, instead appearing as a smear down the gel. 
 
 
2.11 Quantitative PCR (qPCR) 
Quantitative polymerase chain reaction (qPCR) was performed using an Applied 
Biosystems 7500 Fast Real Time PCR system (Applied Biosystems), using the SYBR 
Green method. 
 
2.11.1 Overview of SYBR Green chemistry 
SYBR Green is a dye that binds specifically to double-stranded DNA. It is ideal for 
use in qPCR as it binds to double-stranded DNA as it is formed during the PCR 
reaction (PCR product) and this resultant SYBR Green-DNA complex emits 
fluorescence in the green spectra (λmax = 552nm). The intensity of fluorescence emitted 
by this complex is directly proportional to the amount of double-stranded DNA formed 
throughout the PCR reaction. Therefore, the amount of fluorescence detected allows 
absolute quantitation of PCR product present in our reaction and, by extension, the 
amount of original mRNA in our samples (for qRT-PCR). Fluorescence was detected 
at the end of each cycle during the exponential phase of the PCR reaction. A general 
overview of SYBR Green-based detection of PCR product is shown in Figure 2.3. The 
main advantage of SYBR Green over Taqman-based technologies is that the probe 
required in Taqman reactions is not necessary in SYBR Green reactions, reducing 
28S 
18S 
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setup time and running costs considerably. Paradoxically, the main disadvantage of 
SYBR Green technology is actually due to the lack of probe in the reaction, which can 
lead to a lack of specificity because SYBR Green will bind to any double-stranded 
DNA present in the reaction mix, including non-specific double-stranded products 
such as primer dimers. 
 
2.11.2 Quantitative reverse transcription PCR (qRT-PCR) 
Quantitative reverse transcription PCR (qRT-PCR) was performed using an Applied 
Biosystems 7500 Fast Real Time PCR system (www.appliedbiosystems.com), using 
the SYBR Green method, as introduced above. Each individual 10μl PCR reaction 
consisted of the following components: 5μl SYBR green mastermix (2x), 3.2μl MQ 
water, 0.4μl forward primer (diluted 1:40), 0.4μl reverse primer (diluted 1:40) and 1μl 
target cDNA (diluted 1:5). All reactions were performed in triplicate, for technical 
error. QRT-PCR plates were centrifuged at 2000rpm for 20-30 seconds to ensure 
complete mixing of the reaction components, and the reaction performed on an 
Applied Biosystems 7500 Fast Real Time PCR system. Thermal cycling parameters 
were as follows: 50
o
C for 2 minutes, 95
o
C for 10 minutes, 95
o
C for 15 seconds 
followed by 60
o
C for 1 minute (x40), followed by a dissociation step of 95
o
C for 15 
seconds, 60
o
C for 15 seconds and 95
o
C for 15 seconds. Data are collected during the 
exponential phase of the PCR at the end of each cycle and Figure 2.4 shows the 
formation of PCR product against cycle number for a typical multi-well plate. Specific 
primer sequences for specific genes are shown in Table 2.1. All primers were 
synthesised by VH Bio (www.vhbio.com) and received as solid oligonucleotides. 
Immediately upon receipt, primers were reconstituted in MQ water to make a 1μg/μl 
stock solution, aliquoted, and stored at -20
o
C until required. Standard curves were 
constructed for each primer pair using a positive cDNA control, to allow absolute 
quantitation of sample cDNA. Rat Universal RNA was reverse transcribed into cDNA 
and used in the construction of all standard curves herein, as Universal RNA contains 
gene transcripts isolated from a wide range of tissues and organs, and therefore serves 
as a good positive control for use in qRT-PCR. A minimum of 5 points were used to 
construct each standard curve, covering a wide range of dilutions as follows: undiluted, 
1:5, 1:10, 1:50, 1:100 and 1:1000. Only standard curves with an R2 value of 0.97 or 
greater were used for quantitation of sample cDNA. 
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Figure 2.3. An overview of SYBR Green-based detection of PCR product formed during a qPCR 
reaction. SYBR Green dye binds to double-stranded DNA formed throughout the PCR reaction, 
emitting a fluorescence that can be detected at 552nm. During the denaturation stage of the PCR, 
double-stranded DNA are separated into single strands and, consequently, fluorescence intensity is 
massively reduced. As the PCR reaction continues through the annealing and polymerisation stages, 
double-stranded DNA is formed and SYBR Green once again binds to these duplexes, emitting a 
fluorescence which can be readily detected. (Adapted from www.appliedbiosystems.com). 
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Figure 2.4. A typical trace showing the formation of PCR product against cycle number. For 
highly-expressed transcripts, detection of PCR product can be as early as 10-20 cycles. As the PCR 
progresses, the amount of product detected increases in an exponential manner until it eventually 
reaches a maximum, where rate of product formation remains constant. The above trace is a highly 
typical example of the rate of an enzyme-catalysed reaction versus time. 
 
 
An example standard curve is shown in Figure 2.5. A no template control (NTC), 
containing all the components of the PCR reaction but no target cDNA, was used as a 
negative control, to ensure that no non-specific amplification/formation of secondary 
products (such as primer dimers) was occurring. 
 
A dissociation step (95
o
C for 15 seconds, 60
o
C for 15 seconds and 95
o
C for 15 
seconds) was performed after all cycles of the PCR reaction had finished, in order to 
determining the melting temperature of products formed during the PCR reaction. This 
is an important quality control measure to determine the specificity of the reaction. A 
tight peak as shown in Figure 2.6A indicates that only one product has been formed 
during the reaction., indicating the primers used are specific and only amplifying the 
target region of interest. Multiple peaks, as shown in Figure 2.6B indicate that multiple 
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products are being formed in the PCR reaction and that the primers are not specific for 
the region of interest and/or forming secondary products such as primer dimers. 
 
 
 
 
Figure 2.5. An example of a typical standard curve, constructed using cDNA reverse-transcribed 
from rat Universal RNA. Five points were used in the construction of this curve (each in triplicate), 
using the range of dilutions detailed in Section 2.11.2 above. The R2 value for this curve was 0.984769. 
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Figure 2.6. Typical examples of dissociation curves demonstrating the formation of specific (A) 
and non-specific (B) double-stranded products during the PCR reaction. For every primer pair used 
in this thesis, a dissociation step was performed in order to confirm the specificity of the primers and the 
target region amplified during the PCR reaction. The above traces show the melting temperature of the 
double-stranded products formed during the PCR. A tight peak as shown in A indicates a high degree of 
primer specificity and the formation of a single PCR product. Multiple peaks as shown in B demonstrate 
a lack of specificity and the formation of multiple double-stranded products during the PCR, most 
probably primer dimers. 
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GENE FORWARD (SENSE) PRIMER 
5’ – 3’ 
REVERSE (ANTISENSE) PRIMER 
5’ – 3’ 
5-HT-1A TCTGTTGCTGGGTACTCTCA AGGAGCCGATGAGATAGTTG 
Adipsin CCGATGTCCTGCAGCAACT GTCCCTGCGGTTGCTCTCT 
Adipophilin CTGAACCAGCCAACATCTGA AGTAACTGCTCCTTTGGTCT 
AMPA3 GCTCCATGGGCTCTCAAGTA AGGGTCACACTTGGGAAATG 
BDNF CACTTTTGAGCACGTGATCGA CGTTGGGCCGAACCTTCT 
BMP4 ATGTGACACGGTGGGAAACTTTC ACCTCAATGGCCAGCCCATA 
CNTF CTTCAAGAGCTCTCACAGTG TGCTTATCTTTGGCCCCATAAT 
FGF2 GACGGCTGCTGGCTTCTAAGT TTTCCGTGACCGGTAAGTGTT 
GABA-A GCCATTGCCTTTTTAACACA CTAAAGCAACCAGGCCAGAG 
GAPDH AGTTCAACGGCACAGTCAAG TACTCAGCACCAGCATCACC 
Hes1 TACCCCAGCCAGTGTCAACA TTCATTTATTCTTGCCCGGC 
Hes5 ACCGCATCAACAGCAGCATT AGGCTTTGCTGTGCTTCAGGT 
Id1 TGGACGAACAGCAGGTGAAC TCTCCACCTTGCTCACTTTGC 
Id2 TTTCCTCCTACGAGCAGCAT CCAGTTCCTTGAGCTTGGAG 
Id3 TGCTACGAGGCGGTGTGCTG AGTGAGCTCAGCTGTCTGGATCGG 
IGF1 ACCCCACCCACAAAACAACA CGTCCCGGGTCGTTTACAC 
LIF TCTGTGCAACAAGTACCATGT GCAGCCCAACTTCTTCCTT 
Mash1 GATGAGCAAGGTGGAGACGC CGGAGAACCCGCCATAGAGT 
NGF CCAGCCTGCGGACATCAC GGCTCCTCAATGGGCAGAT 
Ngn1 CAGTAGTCCCTCGGCTTCAG AAGCAGGGTGTCGTATGGAG 
Ngn2 CGGGTCAGACGTGGACTACT GAGGACGAGAGAGGGAGACC 
Ngn3 AAGAGCGAGTTGGCACTGAGC AAGCTGTGGTCCGCTATGCG 
Nkx2.2 CACGCAGGTCAAGATCTG TGCCCGCCTGGAAGGTGGCG 
NMDA-2D GTTCGCTGGAGGACCTGAG CGCGTCATACCTCGGACT 
NT3 GATCCAGGCGGATATCTTGA AGCGTCTCTGTTGCCGTAGT 
Olig1 GCCCCACCAAGTACCTGTCTC GGGACCAGATGCGGGAAC 
Olig2 CACAGGAGGGACTGTGTCCT GGTGCTGGAGGAAGATGACT 
PPARγ CACAATGCCATCAGGTTTGG GCTGGTCGATATCACTGGAGATG 
Smad1 CCGCCTGCTTACCTGCCTCCTGAA GAACGCTTCGCCCACACGGTTGT 
Smad4 GATAGCGTCTGTGTGAACC GTACTGGTGGCATTAGACTC 
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Sox9 CGTGGACATCGGTGAACTGA GGCAAGTATTGGTCAAACTC 
STAT1 AGGTCCGTCAGCAGCTTAAA CGATCGGATAACAACTGCTT 
STAT3 GCGAAAGGAAACACCTATG GTGGACATTAACCAGGTTGA 
TGF-β-1 
 
GACGGAATACAGGGCTTTCG CCTCGACGTTTGGGACTGAT 
VEGF ACGAAGCGCAAGAAATCCC TTAACTCAAGCTGCCTCGCC 
 
Table 2.1. Primers used in qRT-PCR reactions. Details given include sequences of forward (sense) 
and reverse (antisense) primers. 
 
 
2.12 Purchase of reagents and chemicals 
All reagents and chemicals were purchased from Sigma-Aldrich 
(www.sigmaaldrich.com), unless otherwise stated in the main body of text.
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3.1   Introduction 
Traditionally, cell culture is performed in the two-dimensional environment (2D) of 
plastic tissue culture flasks and petri dishes. Although culturing cells using such 
methodology has increased our knowledge of biological processes and resulted in 
many important medical breakthroughs, culturing cells in tissue culture plastic makes 
an important assumption – that cells cultured in this artificial 2D environment behave 
in an analogous manner to which they would when functioning as part of a living 
tissue in vivo. It is now generally accepted that this is not the case as many different 
factors need to be taken into consideration when trying to artificially mimic the in vivo 
environment of a cell. Such factors include cellular geometry and arrangement, 
exposure to extracellular matrix components and cell-cell interactions, amongst others. 
Therefore, in spite of the obvious advantages of culturing cells in 2D in terms of 
convenience and high levels of standardisation, this methodology is fundamentally 
flawed in that the 2D plastic environment is far removed from the complex 
environment in which a cell exists in vivo. Factors such as extracellular matrix and 
cell-cell interactions all interplay to provide biochemical and mechanical cues that 
influence cellular behaviour such as proliferation and differentiation (Bissel et al., 
2002; Kleinman et al., 2003; Pampaloni et al., 2007). 
 
Reproducing the exact in vivo environment for cell growth within the lab is an 
extremely difficult and virtually impossible task, though efforts can be made to mimic 
certain elements of the in vivo environment e.g. coating flasks with extracellular matrix 
proteins such as laminin to provide an environment more permissive to the culture of 
neural cell types (Carbonetto and Cochard, 1987). Although a useful compromise, 
coating cellware with individual (or even combinations of) extracellular matrix 
proteins is not an ideal practise as extracellular matrix does not simply consist of a 
basic mixture of proteins; rather, it is a specific yet dynamic combination of proteins, 
arranged purposely and present at precise concentrations. It is this delicate balance 
between arrangement and concentration that results in the execution of specialised 
responses in cells in vivo (Adams and Watt, 1993). Unsurprisingly, simple changes in 
extracellular matrix architecture and component composition can radically alter the 
functional behaviour of a cell. 
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Because of the highly unnatural environment provided by conventional tissue culture 
plastic, there is a high demand for alternative systems in which to culture cells in vitro 
that would provide an environment more representative of that in which they exist in 
vivo (Elsdale and Bard, 1972). Many studies have demonstrated that culturing cells on 
3D scaffolds dramatically alters their behaviour compared to conventional 2D cultures 
and this has been shown in a number of different cellular systems (Beningo et al., 
2004; Witte and Kao, 2005). Malignant breast cells undergo dramatic changes in gene 
expression when cultured on 3D compared to 2D (Weaver et al., 1997; Wang et al., 
1998). Fibroblasts also demonstrate altered behaviour when cultured on 3D in terms of 
increased rates of proliferation and migration compared to control cultures (Cukierman 
et al., 2001). Perhaps most exciting of all are the numerous reports that embryonal 
carcinoma (EC) stem cells cultured on 3D demonstrate enhanced functionality 
compared to their 2D equivalents (Levenberg et al., 2003; Hayman et al., 2004; 
Bokhari et al., 2007a; Bokhari et al., 2007b). 
 
Although the advantages of culturing cells in 3D compared to 2D are generally well-
acknowledged and well-accepted, routine 3D culture is far from commonplace in the 
lab due to a lack of standardisation (Pampaloni, 2007; Bradley et al., 2009). That said, 
efforts have been and continue to be made to produce robust 3D in vitro cell culture 
models, as these could lead to more accurate and sensitive drug screening assays, 
significantly reducing the need for animal testing, and would also be invaluable in the 
fields of tumour biology, epithelial biology, gene expression studies and 
developmental studies in particular (Bissell et al., 1982; O’Brien et al., 2002; Friedl, 
2004; Kunz-Schughart et al., 2004; Marx and Sandig, 2006; Bradley et al., 2009). 
 
Some of the earliest successful examples of 3D cell culture involved culturing cells on 
biodegradable polymers such as poly(glycolic acid) and poly(lactic acid) (Mikos et al., 
1993; Bokhari et al., 2007). Biodegradable polymers have been shown to successfully 
promote proliferation, migration and differentiation of various neural cell types, 
providing great potential for repair of the damaged nervous system (Tabesh et al., 
2009). In such instances, the polymer would need to provide a suitable substratum with 
the crucial functional property of promoting axonal growth and encouraging 
reconstruction of neural circuitry. Biodegradable polymers have also received much 
attention for their potential use in the production of vascular structures in vitro, for 
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application such as bypass operations (Campbell and Campbell, 2007; Ko et al., 2007). 
Several studies also report the suitability of such polymers for delivery of cellular 
material to the damaged retina (Lu et al., 2001; Klassen, 2007). Likewise, their 
potential for use in bone and cartilage tissue engineering has been discussed at length 
(Temenoff and Mikos, 2000; Koch and Gorti, 2002; Liu and Ma, 2004). Although 
most interest in biodegradable polymers is tailored towards their potential use in 
cellular therapies and tissue engineering strategies, chitosan-based products have been 
used for controlled drug delivery (Prabaharan, 2008). The physical properties that 
make biodegradable polymers ideal for use in cellular therapy, however, also make 
them unsuitable for everyday use in the lab as they are subject to degradation 
following prolonged storage (Bokhari et al., 2007). 
 
More recent examples of 3D cell culture involve culturing cells on structures known as 
hydrogels. As the name would imply, hydrogels are hydrated polymers, in that they 
consist of a 3D network of polymer chains that spread out to form a gel due to the fact 
that the spaces between the chains are filled with water. In some cases, hydrogels can 
contain up to 99% water. This property of being able to retain water whilst maintaining 
their physical integrity and mechanical properties means that hydrogels are used for 
applications such as contact lenses. However, they are becoming more frequently used 
in cell culture applications, and can be made from a wide variety of materials such as 
agarose, collagen, fibrin, gelatin and laminin (Bokhari et al., 2007; Bradley et al., 
2009). Collagen-based gels are perhaps the most commonly used to date and have been 
used quite extensively in the culture of neural cell types. Ganglia can be maintained in 
collagen-based gels for up to 4 weeks in vitro (Blackshaw et al., 1997). Fibrin-based 
gels have also been reported to promote nerve regeneration due to their neurite-
promoting properties (Sakiyama et al., 1999). Agarose gels with laminin covalently 
attached have also been reported to promote axonal extension and neuronal 
regeneration (Yu et al., 1999). Although hydrogels are used extensively in the study of 
neural cell types, they are also ideal for the study of other cellular systems; for 
example, in cartilage grafts, as articular cartilage is a water-laden tissue (Fisher et al., 
2004; Park et al., 2005). Similarly to biodegradable polymers, there is also evidence to 
suggest that hydrogels may be suitable for the release of biomolecules (Lin and 
Anseth, 2009). 
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Although biodegradable polymers and hydrogels are the most commonly used 
substrates for the 3D culture of cells in vitro, they are by no means the only 
technologies being employed in the lab for 3D culture. For example, sponges have 
been examined for their potential as suitable growth substrates for MSCs in vitro 
(Takahashi et al., 2005). Sponges possess a similar structural morphology to gels but 
differ in that they possess larger pores and as such have a far more open structure to 
permit infiltration of larger cell types. This structure can be modified appropriately to 
influence cellular behaviour. The use of microcarriers is another method for culturing 
cells in 3D, though this methodology is very infrequent compared to those described 
above. Microcarriers are extremely small spheres of an approximate diameter of 500 
µm which can be coated with extracellular matrix molecules to permit attachment of 
cells. The main advantage of this technology is that these spheres provide an enormous 
surface area, allowing the culture of a large number of cells in a small volume (Bradley 
et al., 2009). Although infrequently used in an academic environment, the main 
advantage of this technology is found in industry where they are commonly used for 
mass bioproduction. 
 
Reinnervate Ltd manufactures a novel, polystyrene-based scaffold, with the aim of 
providing an easily-handled material that can be used as an everyday tool in the lab for 
3D cell culture. This scaffold is branded Alvetex
TM 
and demonstrates several 
advantages over the above technologies. For example, it is manufactured under robust 
and highly reproducible conditions, unlike sponges and gels which are subject to 
variability in their formation and can undergo structural alterations with long-term 
storage. Another major advantage of the scaffold is that it is produced under animal-
free conditions as cells generally attach to the scaffold without the need for coating 
with extracellular matrix molecules, though coating can be performed when required 
for the culture of particularly fastidious cell types such as neural cells. The chemistry 
behind the production of the scaffold will be considered briefly. 
 
The scaffold chemistry has been published extensively (Barbetta et al., 2000; Cameron 
and Barbetta, 2000; Krajnc et al., 2002). Scaffolds are commonly referred to as 
poly(HIPE)s as they are manufactured by polymerisation in high internal phase 
emulsions (HIPEs). A key property of HIPEs is that they consist of a heterogeneous 
liquid-liquid mixture possessing a large volume of internal (droplet) phase (Cameron 
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and Sherington, 1996; Bokhari et al., 2007). Phase droplets are deformed into 
polyhedra when the volume fraction exceeds 0.74 and these polyhedra are separated by 
thin layers of continuous (non-droplet) phase. In order for polymerisation to occur, two 
key criteria must be satisfied: firstly, at least one phase of the emulsion must contain a 
monameric species; secondly, a cross-linker must be present in the continuous, non-
droplet phase. Only when both criteria are satisfied can polymerisation occur. 
Accumulation of monomer units occurs around the dispersed, deformed phase 
droplets, creating polyhedral-like voids in the resulting material (Cameron and 
Sherington, 1996; Cameron, 2005). These voids are connected to surrounding voids by 
films of continuous phase known as ‘interconnects’ (Cameron et al., 2006). The 
resulting monolith can be sectioned into wafer thin slices of 120µm thickness, 
providing a robust material than can be easily used in cell culture. Physical parameters 
such as void size can be easily controlled using this methodology, which is 
advantageous as it allows scaffolds to be tailored specifically to meet the needs of the 
particular cells being cultured. This technology has been exemplified for use in routine 
cell culture using a number of different cellular systems, including the HepG2 (liver 
carcinoma) and TERA2.cl.SP12 (embryonal carcinoma) cell lines (Hayman and 
Przyborski, 2004; Hayman et al., 2005; Bokhari et al., 2007a; Bokhari et al., 2007b). 
 
The present study provides the first data regarding the culture of MSCs on 
Reinnervate’s novel 3D scaffold. MSCs are extremely exciting candidates for use in 
cellular therapies and tissue engineering for a number of reasons, as discussed in 
Section 1.4.1 . Because of the advantages of using MSCs in a clinical setting compared 
to other stem cell types e.g. embryonic stem cells, there is a huge interest in MSC 
research at present. However, before the use of MSCs in the clinic becomes more 
commonplace, it is crucial to gain a more comprehensive understanding of the 
complex molecular and cellular mechanism(s) by which MSCs commit to a given fate 
and undergo differentiation to produce mature, fully-functional derivatives. Much of 
our present knowledge has been gained from studies performed on the highly 
unnatural, 2D environment of tissue culture plastic. A better understanding of such 
complex processes therefore requires 3D cell culture systems that more accurate mimic 
the niche of MSCs in vivo. In the present study, the ability of Reinnervate’s scaffold to 
support the viable culture of MSCs in vitro and support their functional ability to 
undergo osteogenic and adipogenic differentiation is examined. Results obtained 
Chapter 3: Behaviour of MSCs cultured in 2D and 3D 
 
82 
 
suggest that the scaffold may provide a more realistic and physiologically-relevant 
system in which to study the processes of osteogenic and adipogenic differentiation in 
a manner more pertinent to that which occurs in vivo. 
 
 
Hypothesis 
MSCs cultured on Alvetex
TM
 will demonstrate enhanced cellular viability and 
functionality in terms of their potential to undergo osteogenic and adipogenic 
differentiation, compared to MSCs cultured on tissue culture plastic. 
 
Aims of chapter 
To isolate MSCs from the bone marrow of adult rats and produce primary in vitro 
cultures. Examine how the behaviour of MSCs is influenced following culture on 
Alvetex
TM
 compared to the conventional 2D environment of tissue culture plastic. 
 
 
 
Objectives 
 
1. Establish early passage cultures of MSCs from rat bone marrow. 
 
2. Verify the MSC-like phenotype of isolated cells in terms of cell surface and 
intracellular marker expression and potential to differentiate into mesodermal 
derivatives 
 
3. Assess the behaviour of MSCs cultured in 3D using AlvetexTM compared to 
conventional 2D cultures in terms of cell viability, osteogenic and adipogenic 
differentiation 
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3.2 Materials and methods 
3.2.1 Osteogenic differentiation of MSCs and von Kossa staining 
The osteogenic potential of MSCs was determined using the following differentiation 
protocol. Cells were seeded at a density of 3x10
3 
cells/cm
2
 into 6 well plates, in CCM, 
and allowed to reach 70-80% confluency. When the desired degree of confluency was 
reached, osteogenic differentiation was induced in MSCs by switching their culture 
medium from CCM to osteogenic medium (DMEM supplemented with 10% FCS, 
dexamethasone (100nM), ascorbic acid 2-phosphate (50μM) and β-glycerophosphate 
(10nM)). Cells were maintained in this osteogenic medium for 3 weeks, with media 
changes every 3-4 days. After 3 weeks, cells were washed in PBS and fixed in 4% 
PFA for 30 minutes at room temperature. In order to assess osteogenic differentiation 
and the formation of calcified bone nodules, von Kossa staining was performed. 
Briefly, cells were incubated in 5% silver nitrate solution for 10 minutes in the dark, 
washed thoroughly with distilled water, and exposed to bright light for 1 hour. 
Following this, cells were again washed with distilled water and counterstained with 
haematoxylin for 5 minutes. 
 
3.2.2 Adipogenic differentiation of MSCs and oil red O staining 
The adipogenic potential of MSCs was determined using the following differentiation 
protocol. Cells were seeded at a density of 2x10
4
 cells/cm
2
 into 12 well plates, in 
CCM, and allowed to reach 100% confluency. When the desired degree of confluency 
was reached, adipogenic differentiation was induced in MSCs by switching their 
culture medium from CCM to adipogenic induction medium (DMEM supplemented 
with 10% FCS, dexamethasone (1μM), indomethacin (0.2mM), insulin (10μg/ml) and 
3-isobutyl-1-methylxanthine (0.5mM)). After 3 days, adipogenic induction medium 
was replaced by adipogenic maintenance medium (DMEM supplemented with 10% 
FCS and insulin (10μg/ml)) for 2 days. This induction/maintenance cycle was repeated 
for 3 weeks. After 3 weeks, cells were washed in PBS and fixed in 4% PFA for 30 
minutes at room temperature. In order to assess adipogenic differentiation and the 
formation of neutral lipid droplets, oil red O staining was performed as follows. 
Briefly, cells were incubated in 0.3% oil red O (in isopropanol) for 30 minutes at room 
temperature and washed thoroughly with distilled water. Following this, cells were 
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counterstained with haematoxylin for 5 minutes, and blued (3% ammonia solution in 
water) for 30 seconds. 
 
3.2.3 Growth curve of MSCs and estimation of doubling time 
To assess the growth rate and doubling time of MSCs cultured under standard 
conditions (CCM), a growth curve was constructed by seeding MSCs at a wide range 
of densities into a standard 12-well plate and periodically determining the number of 
viable cells in culture. Five different densities were used – 1000, 2000, 3000, 5000 and 
10,000 cells/well – and this was designated as T=0. The number of viable cells in 
culture was determined every 24 hours periodically for up to 120 hours, using the MTS 
proliferation assay, as previously detailed in Section 2.8. All assays were performed in 
triplicate, and the means calculated and plotted ± SEM. 
 
3.2.4 Preparation of Alvetex
TM
 
Solid, highly porous 3D Alvetex
TM
 monoliths were prepared and fabricated as detailed 
in the literature (Bokhari et al., 2007a; Bokhari et al., 2007b). The resulting monolith 
was sectioned to a thickness of 120μm, using a vibratome, to produce wafer thin discs 
of scaffold suitable for use in cell culture. These scaffold discs were inserted into the 
wells of 6-well plates, and pre-wetted and sterilised in 70% ethanol for one hour at 
room temperature, followed by UV treatment (5 minutes). Following this, discs were 
subsequently washed in PBS x 3 before used for cell culture. 
 
3.2.5 Preparation of samples for scanning electron microscopy (SEM) 
To prepare biological samples for surface analysis using scanning electron microscopy 
(SEM), cells cultured on the 3D scaffold were fixed in 2% PFA and 2.5% 
glutaraldehyde in 0.1M Sorenson’s phosphate buffer (pH 7.4) for 1 hour at room 
temperature. Following fixation, samples were rinsed in 0.1M phosphate buffer and 
subsequently post-fixed in 1% OsO4 solution for 1 hour at room temperature, followed 
by sample dehydration by bringing the samples through progressive ethanol washes as 
follows: 50%, 70%, 95% and 100% ethanol (4 x 5 minutes in each condition). Dry 
scaffold samples were then sectioned into smaller pieces of approximately 25mm
2
 in 
area, mounted onto specimen holders (stubs) using an epoxy resin adhesive and dried 
from CO2 at 38
o
C at 1200 psi. The final preparation step involved low vacuum sputter 
coating with a 7nm layer of chromium (to prevent the accumulation of static electric 
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charge on the sample during electron irradiation), after which samples were ready for 
visualisation using a Hitachi S5200 scanning electron microscope. 
 
3.2.6 Histology preparation for MSCs cultured under osteogenic and adipogenic 
conditions on Alvetex
TM
 
MSCs were seeded onto the scaffold at a density of 1 x 10
6
 cells/scaffold and cultured 
under osteogenic and adipogenic conditions for 21 days, after which samples were 
prepared for histology analysis. To assess osteogenic differentiation, samples were 
washed in PBS x 1 and fixed directly in the 3D scaffold in 4% PFA overnight at 4
o
C. 
Following fixation, sample dehydration was achieved by bringing samples through 
progressive ethanol washes – 50%, 70%, 95% and 100% ethanol (4 x 5 minutes in 
each condition) – followed by embedment in paraffin and sectioning to produce 7m 
sections ready for staining. Von Kossa and Masson’s trichrome staining was 
performed to demonstrate the formation of calcified bone nodules and the deposition 
of extracellular collagen, respectively. Specific details of von Kossa staining are 
described in Section 3.2.1. For Masson’s trichrome staining, sections were first 
counterstained with haematoxylin for 5 minutes, followed by sequential staining with 
solutions A (10 minutes), B (5 minutes) and C (10 minutes). Solution A (plasma stain) 
consisted of 1% glacial acetic acid, 0.5% acid fuchsin and 0.5% xylidine ponceau in 
distilled water; solution B consisted of 1% phosphomolybdic acid in distilled water; 
and solution C (fibre stain) consisted of 2% glacial acetic acid and 2% light green SF 
yellowish in distilled water. To assess adipogenic differentiation, oil red O staining 
was performed to demonstrate the accumulation of neutral lipid droplets within the cell 
cytoplasm. MSCs were washed in PBS x 1 and trypsinsed out of the 3D scaffold, 
resuspended in CCM to inactivate the trypsin, cytospun onto non-coated glass slides at 
800rpm for 5 minutes and fixed in 4% PFA overnight at 4
o
C. Following fixation, oil 
red O staining was performed as described in Section 3.2.2. 
 
3.2.7 Determination of alkaline phosphatise (ALP) activity and osteocalcin levels 
Alkaline phosphatase (ALP) activity was determined using a commercially-available, 
highly sensitive colorimetric assay kit (Sigma, N7653), following the manufacturer’s 
instructions. The kit exploits the use of p-nitrophenyl phosphate (pNNP) as a substrate 
for ALP, where ALP catalyses the hydrolysis of pNNP to p-nitrophenol. This 
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hydrolysis reaction yields a yellow soluble end-product, which can be measured 
spectrophotometrically at 405nm. Absorbance at 405nm is therefore directly 
proportional to ALP activity. The methodology was adapted from the manufacturer’s 
protocols and what had previously been published in the literature (Wang et al., 2007). 
Briefly, MSCs were cultured under osteogenic conditions for 5, 7, 14 and 21 days on 
tissue culture plastic (2D) vs. scaffold (3D), and ALP activity determined at each of 
these time points. Cells were washed in ice-cold PBS x 2 and protein extracts made by 
homogenising the samples in 2ml lysis buffer (0.2% IGEPAL, 10mM Tris-HCl and 
1mM MgCl2 at pH 7.5). Lysates were centrifuged at 12,000 rpm for 10 minutes at 4
o
C 
and the supernatant removed and subsequently assayed for ALP activity. 50μl sample 
supernatant and 50μl pNNP (1mg/ml) were mixed together and incubated on a bench 
shaker for 30 minutes in the dark. Absorbances at 405m were determined immediately 
following this incubation. A standard curve was constructed using absorbance values 
determined for known concentrations of p-nitrophenol, allowing conversion of our 
sample absorbance values into protein concentrations. ALP activity was subsequently 
normalised to total protein content (determined using Bradford assay) and expressed as 
nmol/hour/mg protein. 
 
Levels of osteocalcin secreted into the culture media were determined using a 
commercially-available, rat-specific sandwich ELISA kit, following the 
manufacturer’s instructions (BT-490 kit, BTI, Stoughton, MA). The methodology was 
as follows. MSCs were cultured under osteogenic conditions for 14, 21 and 35 days on 
tissue culture plastic (2D) vs. scaffold (3D), and osteocalcin secretion into the culture 
media determined at each of these time points. The microtiter plate provided by the 
manufacturers was pre-coated with a monoclonal antibody specific for the N-terminal 
region of rat osteocalcin. 100μl sample media was added to each well and the plates 
incubated at 4
o
C for 24 hours. Following this, sample media was aspirated off and each 
well washed in PBS x 3. 100μl of a second antibody was then added to each well – a 
goat polyclonal antibody specific for the C-terminal region of rat osteocalcin – and 
plates incubated for 1 hour at 37
oC. Each well was washed in PBS x 3, and 100μl of a 
donkey anti-goat IgG peroxidase was subsequently added to each well, and plates 
incubated for 1 hour at room temperature. Following a further three washes in PBS, 
100μl of substrate mix (consisting of one volume of TMB solution: one volume of 
hydrogen peroxide) was added to each well and plates incubated in the dark for 30 
Chapter 3: Behaviour of MSCs cultured in 2D and 3D 
 
87 
 
minutes at room temperature. 100μl stop solution was added to each well to stop the 
reaction, and absorbance at 450nm measured immediately. Concentration of 
osteocalcin in the culture media was directly proportional to absorbance. A standard 
curve was constructed using absorbance values determined for known concentrations 
of osteocalcin, allowing conversion of our sample absorbance values into actual 
concentrations. The standard curve covered a range of concentrations from 0.25-
20ng/ml. Osteocalcin levels were subsequently normalised to total DNA content and 
expressed as ng/ml/µg DNA. 
 
3.2.8 Oil red O quantification 
Quantification of intracellular lipid accumulation was achieved by using a colorimetric 
assay based on elution of oil red O. MSCs were cultured under adipogenic conditions 
for 7 and 21 days on tissue culture plastic (2D) vs. scaffold (3D), and oil red O staining 
performed as previously described. Following staining with oil red O, cells were 
subsequently destained in 100% isopropanol for 30 minutes at room temperature, and 
the absorbance of the subsequent solution measured at 500nm using a Nanodrop 
spectrophotometer. Concentration of oil red O stain in the solution was directly 
proportional to absorbance at 500nm. Negative controls were ran in parallel, consisting 
of MSCs cultured on 2D and 3D under standard culture conditions i.e. non-adipogenic 
conditions. Each assay was performed in triplicate, and the means calculated and 
subsequently expressed as a percentage above control levels.  
 
3.2.9 Nile red staining and flow cytometric analysis 
Further quantification of intracellular lipid accumulation was achieved by staining 
cells with the lipophilic Nile red fluorescent dye, followed by flow cytometric analysis, 
using a methodology adapted from Bäckesjö et al., 2006. MSCs were cultured under 
adipogenic conditions for 21 days on tissue culture plastic (2D) vs. scaffold (3D). 
Following this 21 day differentiation period, cells were washed in PBS x 1, 
trypsinised, resuspended in CCM to inactive the trypsin and centrifuged at 2000 rpm 
for 5 minutes. The supernatant was removed and the cell pellets resuspended in 4% 
PFA and incubated at 4
o
C overnight. Following overnight fixation, cells were stained 
with Nile red (10μg/ml) for 45 minutes at room temperature, then analysed using a 
FACSCalibur flow cytometer (BD Biosciences). Fluorescent emission was detected in 
the FL1 band-pass filter, and the fraction of cells exhibiting positivity for Nile red 
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fluorescence was determined for MSCs cultured under adipogenic conditions on 2D 
and 3D, in terms of the percentage of positive cells and mean fluorescence intensity 
(MFI). Ten thousand events per sample were determined. 
 
3.2.10 Cyclic AMP (cAMP) enzyme immunoassay 
MSCs were cultured under adipogenic conditions on 2D and 3D for 7 and 21 days, and 
the cyclic AMP (cAMP) levels determined at both time points using a commercially 
available cAMP EIA kit (Cayman Chemical, Ann Arbor, MI), following the 
manufacturer’s protocol. Cells were trypsinised and centrifuged at 2000 rpm for 5 
minutes to form a pellet, which was subsequently dissolved in 1N NaOH and protein 
content measured using the Biorad protein assay. cAMP levels determined by the EIA 
were normalised to total protein levels, as determined by the above Biorad protein 
assay. The basis of the EIA assay is the competition between free cAMP and a cAMP 
tracer (cAMP-acetylcholinesterase (AChE) conjugate) for a limited number of rabbit 
antibody binding sites specific for cAMP. Throughout the assay the concentration of 
cAMP tracer remains constant, whereas the levels of free cAMP vary depending on the 
levels of cAMP present in the samples being tested, therefore the levels of cAMP 
tracer which bind to the rabbit antibody binding site is inversely proportional to the 
levels of cAMP in the sample. The subsequent mixture of rabbit antibody-cAMP and 
rabbit antibody-cAMP tracer complexes bind to a mouse anti-rabbit antibody which is 
pre-attached to an ELISA plate. In order to develop the plate, Ellman’s reagent, which 
contains the substrate to the cAMP tracer, must be added. The product of this reaction 
is yellow in colour, and the intensity of this colour is proportional the amount of cAMP 
tracer in the well, which in turn is inversely proportional to the amount of free cAMP 
in the well. Intensity of product absorption was determined by measuring absorbance 
at 415nm, and these absorbance values were used in subsequent downstream 
calculations in order to determine the exact levels of cAMP in the samples.  
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3.3 Results 
3.3.1 Stromal cells isolated from the bone marrow of postnatal rats demonstrate 
morphology in keeping with an MSC origin 
MSCs were isolated from the femurs and tibiae of Wistar rats, aged between 6-8 
months, using the methodology described in Section 2.1. Plastic adherence was used as 
the main criterion to allow selection of MSCs from the various other cell types that 
reside within the bone marrow, particularly the haematopoietic population. Whilst 
efforts continue to be made to exploit marker expression in order to produce a more 
homogeneous starting population, there is little standardisation between laboratories. 
As such, plastic adherence still remains the most commonly used method for MSC 
selection by far, despite the obvious limitations of the heterogeneous nature of the 
starting material. 
 
Figure 3.1 shows MSCs at various stages during the isolation and expansion process. 
Following the plating of whole bone marrow aspirates into T75 cm
2
 flasks, non-
adherent cells (haematopoietic) were removed after 48 hours, leaving behind an 
adherent (stromal/MSC) population (Figure 3.1A). Even at this early stage, 
morphological heterogeneity within the adherent population was evident. Cells were 
small in size, largely retractile and spindle-shaped. Contaminating haematopoietic 
cells, mainly erythrocytes, were readily observable at this stage of the isolation process 
even after several PBS washes/media changes, and remained as phase bright, highly 
refractile cells in suspension. Some contamination of MSC cultures with 
haematopoietic cells is inevitable, especially during the initial isolation procedure and 
early passage cultures. These contaminants are removed from culture via continual 
PBS washes, media changes and by passaging, with the end result being a 
heterogeneous mixture of stromal cells/MSCs at various stages of development. 
Within 2-3 days, the small, adherent, spindle-shaped cells began to divide rapidly and 
flatten out to form larger, flatter cells with a morphology more in keeping with that 
described for an MSC population (Figure 3.1B). The arrowheads in Figure 3.1B show 
actively dividing cells, which demonstrate a very spherical morphology as they 
undergo cytokinesis. Following division, the cells increased in size and spread out, 
acquiring a more stromal, fibroblastic-like morphology. Cells continued to proliferate 
and form colonies, which grew very rapidly and eventually merged together to form a 
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monolayer culture (Figure 3.1C). When a culture reached 70-100% confluency (Figure 
3.1D), typically taking between 7-14 days following initial plating of the bone marrow 
aspirate, we described this culture as Passage 0 (P0). A small degree of haematopoietic 
contamination (approximately 1-2%) was still evident in this confluent P0 culture. To 
passage confluent MSC cultures, the methodology described in Section 2.1 was 
followed. The resulting cultures were designated as Passage 1 (P1) and Figure 3.1E 
shows MSCs 24 hours post-passage. Cells were larger in size and demonstrated a more 
fibroblastic-like morphology than their initially-isolated counterparts (Figure 3.1A). 
These cultures typically reached confluency between 7-10 days (Figure 3.1F). 
 
3.3.2 Flow cytometric and immunocytochemical analysis of marker expression in 
bone marrow stromal cells verify the isolation of a true MSC population 
As described previously in Section 3.3.1 stromal cells isolated from rat postnatal bone 
marrow aspirates via plastic adherence display a morphological phenotype very 
characteristic of an MSC population. Although useful in many settings, morphological 
data alone is limited and insufficient to confirm with any certainty the isolation of a 
true MSC population. In order to verify that the cells isolated and subsequently used in 
all downstream studies demonstrated behaviour indicative of an MSC origin, two 
approaches were adopted. Firstly, expression of a wide range of generic cell surface 
and intracellular markers were examined to produce a detailed expression profile for 
the isolated cells. Secondly, the potential of the isolated cells to differentiate into 
mature mesodermal derivatives such as bone and fat was examined, and this will be 
considered in the proceeding section. 
 
Cell surface marker expression was assessed via live cell staining with antibodies 
directed against cell surface antigens, followed by flow cytometric analysis. Staining 
with P3X antibody served as a suitable negative control, allowing the flow cytometer 
parameters to be set to distinguish between specific fluorescence and non-specific 
fluorescence resulting from loosely-bound antibody/autofluorescence. Negative 
controls appear as clear traces in Figure 3.2. Confirming the isolation of a true MSC 
population is hindered by the lack of any definitive markers that are expressed purely 
in MSCs. 
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A B
C D
E F
 
Figure 3.1. Isolation of MSCs from the bone marrow of postnatal rat. A-F shows MSCs at various 
stages during the isolation procedure. A: 48 hours post isolation. MSCs adhere to tissue culture plastic, 
whereas contaminating haematopoietic cells remain in suspension as highly refractile, phase bright cells; 
B: Adherent cells begin to divide and flatten out, adopting a more fibroblastic-like morphology. 
Arrowheads indicate actively-dividing cells; C: Culture at 7 days, where colonies are expanding rapidly 
and beginning to merge to form a monolayer; D: A confluent P0 culture prior to passaging; E: Cell 
morphology of a passage 1 (P1) culture, 24 hours after passaging; F: A confluent P1 culture. Scale bar = 
100µm. 
 
 
Therefore it is necessary to examine the expression of a range of markers, none of 
whose expression is exclusive to MSCs. Representative flow cytometric traces for a 
wide range of cell surface markers are shown in Figure 3.2. CD34 and CD45 are both 
significantly expressed on the haematopoietic cell types present within the same bone 
marrow niche as MSCs. Contamination of MSC cultures with haematopoietic cell 
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types can be problematic, particularly during the initial isolation steps and in early 
passage cultures. The representative traces shown in Figure 3.2A are from passage 2 
(P2) cultures, the lowest passage used in any study throughout this thesis. As the traces 
clearly show, the cells are largely negative for CD34 and CD45 expression (black 
peaks), confirming that the cultures used throughout this thesis were not contaminated/ 
very minimally contaminated by any haematopoietic cell types. Expression of a wide 
range of positive markers were also assessed via flow cytometry, including CD9, 
CD13, CD15, CD44, CD58, CD71, CD90, CD105 and CD138 (Figure 3.2B). The 
isolated cells demonstrated positive expression for each of these markers when 
assessed via flow cytometry, although the traces do indicate that the markers are 
expressed at varying intensities. Some markers show a degree of overlap with the P3X 
negative control e.g. CD13 and CD58, whereas other markers show little, if any, 
overlap with the P3X negative control e.g. CD90 and CD105. Isolated cells were also 
examined for expression of neural markers including nestin, Tuj-1, GFAP and GalC, 
and were negative for expression in all instances (data not shown). 
 
In addition to flow cytometric analysis of cell surface marker expression, 
immunocytochemistry was employed to examine the expression of a range of 
intracellular cytoskeletal and extracellular matrix markers indicative of an MSC 
phenotype. Cells demonstrated intense staining for the mesodermal markers α-smooth 
muscle actin, vimentin, fibronectin and β-actin, which are largely associated with 
mesenchymal stem cell types (Figure 3.3). Immunocytochemistry was also performed 
for the neural markers nestin, Tuj-1, GFAP and GalC, and the isolated cells were 
negative in all instances (data not shown), confirming the observations made via flow 
cytometry. 
 
Whilst expression of these cell surface and intracellular markers give little information 
with regards the function of the isolated cells, the expression profile observed is 
indicative of an MSC origin. Results from both flow cytometric and 
immunocytochemistry analyses are summarised in Table 3.1. 
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CD34
CD44
CD45
CD90 CD105
CD71CD58
CD9 CD15
CD138
CD13
A
B
 
 
Figure 3.2. Flow cytometric analysis of cell surface marker expression in MSCs isolated from the 
bone marrow of postnatal rat. Representative traces showing typical cell surface marker expression 
profiles for haematopoietic (A) and non-haematopoietic (B) markers. Clear traces correspond to the P3X 
negative control and black traces correspond to specific positive fluorescence. MSCs are largely 
negative for haematopoietic marker expression, suggesting any haematopoietic contamination to be 
minimal, and positive for more specific MSC marker expression. 
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Figure 3.3. Immunocytochemical analysis of intracellular marker expression in MSCs isolated 
from the bone marrow of postnatal rats. Representative images showing expression of a range of 
intracellular antigens known to be present in immature MSCs: A, α-SMA; B, vimentin; C, fibronectin; 
D, β-actin. Negative control, consisting of staining with secondary antibody only (i.e. no primary 
antibody), is also shown (E). Scale bar = 100µm. 
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Antigen Reactivity 
CD9 + 
CD13 + 
CD15 + 
CD34 – 
CD44 + 
CD45 – 
CD58 + 
CD71 + 
CD90 + 
CD105 + 
CD138 + 
α-SMA + 
Vimentin + 
Fibronectin + 
β-Actin + 
 
Table 3.1. Summary of marker expression in MSCs. A combined summary of cell surface and 
intracellular marker expression in MSCs isolated from the bone marrow of postnatal rat, as determined 
using flow cytometry (cell surface) and immunocytochemistry (intracellular). 
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3.3.3 Bone marrow stromal cells demonstrate multilineage potential owing to their 
ability to differentiate into multiple mesodermal cell types such as bone and fat 
The previous section clearly demonstrates that stromal cells isolated from the bone 
marrow of postnatal rat display a marker expression profile highly indicative of an 
MSC origin. A second standard to authenticate the MSC-like behaviour of these cells 
was to assess their potential to differentiate into mature mesodermal derivatives such 
as bone and fat, a crucial property of MSCs. As the definition of a stem cell is a 
functional one, the demonstration that these cells have the potential to differentiate into 
more mature mesodermal derivatives is even more crucial in confirming the isolation 
of a true MSC population than marker expression alone. 
 
MSCs were induced to undergo osteogenesis and adipogenesis using the differentiation 
protocols described in Sections 3.2.1 and 3.2.2. MSCs were cultured under osteogenic 
conditions for a period of two weeks, after which the differentiative state of the 
cultures was assessed using the von Kossa histological stain to identify the formation 
of calcified bone nodules on the surface of the cellware. Bone nodules were readily 
detectable at time points as early as one week, though such nodules were small in size 
and very infrequent throughout the culture (data not shown). After culturing cells 
under osteogenic conditions for two weeks however, the majority of the cellware 
showed a significant level of calcification and large bone nodules were evident (Figure 
3.4B). Negative controls were run in parallel to differentiated cultures, consisting of 
cells grown under standard culture conditions (unsupplemented CCM). Von Kossa 
staining in such cultures showed little evidence of calcification or bone nodule 
formation (Figure 3.4A). 
 
MSCs were cultured under adipogenic conditions for a period of three weeks, after 
which the differentiative state of the cultures was assessed using the oil red O 
histological stain to identify the presence of neutral lipid droplets within the cytoplasm 
of the differentiated cells. Lipid droplets were readily detectable at time points as early 
as one week, though these droplets were small in size and very few in number (data 
not shown). After culturing cells under adipogenic conditions for three weeks 
however, large neutral lipid droplets were readily detectable in the cytoplasm of a 
significant proportion of all cells (approximately one-third), suggesting that cells were 
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differentiating into more mature pre-adipocytes and adipocytes (Figure 3.4D). Lipid 
droplets were not detectable in negative controls (Figure 3.4C). 
 
 
 
Figure 3.4. Histological analysis of osteogenic and adipogenic differentiation in MSCs. MSCs were 
cultured under osteogenic conditions for a period of 2 weeks and processed for von Kossa staining to 
allow visualisation of bone nodule formation and the deposition of a calcified matrix. A corresponds to 
the negative control and B corresponds to MSCs cultured under osteogenic conditions. Mineralisation is 
clearly evident in B. MSCs were also cultured under adipogenic conditions for a period of 3 weeks and 
processed for oil red O staining to allow visualisation of intracellular lipid droplets. C corresponds to 
negative control and D corresponds to MSCs cultured under adipogenic conditions. Accumulation of 
lipid droplets in D is clearly evident. Scale bar = 100µm. 
 
 
Taking into account the observations in Sections 3.3.2 and 3.3.3, stromal cells isolated 
from rat postnatal bone marrow using the selection criteria of plastic adherence 
demonstrate both a marker expression profile and potential for differentiation that is 
indicative of an MSC origin. Such data allow the confident conclusion that the cells 
isolated and used for subsequent downstream studies in this thesis are MSCs, and will 
be referred to as such for the remainder of this thesis. 
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3.3.4 MSCs cultured under standard culture conditions demonstrate density-
dependent growth kinetics and a doubling time of approximately 72 hours 
A growth curve was constructed by seeding MSCs at a range of densities – 1000, 
2000, 3000, 5000 and 10,000 cells/well – into a standard 12-well plate and determining 
the number of viable cells in culture using the MTS assay every 24 hours for a period 
of 120 hours (5 days). Data for each timepoint was performed in at least triplicate and 
the means calculated and plotted as a line graph, as shown in Figure 3.5. MSC 
doubling time worked out to be approximately 72 hours, though differences were 
evident depending on the initial seeding densities of the cells. Doubling time was 
lower for MSCs seeded at higher densities and higher for MSCs seeded at lower 
densities. This trend is in keeping with what has been previously published (Guillot et 
al., 2007). Doubling times of MSCs reported in the literature can vary quite 
significantly depending on the tissue from which the cells were isolated, age of donor 
etc. Doubling times as quick as one or two days have been reported in some instances, 
whereas other studies report doubling times as long as 111 hours (Kadiyala et al., 
1997; Conget and Minguell, 1999; Suva et al., 2004; Guillot et al., 2007; van der Bogt 
et al., 2009; Zhang et al., 2009).  
 
3.3.5 MSCs cultured on Alvetex
TM
 demonstrate enhanced ability in vitro to 
undergo osteogenic and adipogenic differentiation 
The two-dimensional (2D) environment in which cells are typically grown in culture is 
in no way representative of their highly complex three-dimensional (3D) niche in vivo. 
Because of this fundamental limitation of routine tissue culture, there has been much 
emphasis placed on the development and fabrication of 3D natural and synthetic 
structures/scaffolds on which to culture cells in vitro, with the aim of producing a 
growth environment more characteristic of that in which cells exist in vivo. Such 
products would be of huge benefit in a research setting, providing more accurate 
models to study complex cellular processes such as differentiation. 
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Figure 3.5. A curve showing the growth kinetics of MSCs cultured under standard culture 
conditions.  Number of viable cells in culture was determined every 24 hours for up to 120 hours using 
the MTS assay. Kinetics of MSC growth were density-dependent. 
 
 
Reinnervate, the spin-out company from Durham University funding this research, 
produce a novel 3D poly-HIPE scaffold (Alvetex
TM
) on which to culture cells in vitro, 
and this technology has been exemplified using many different biological systems, 
including HepG2 (human liver carcinoma) and TERA2.sp.12 (human embryonal 
carcinoma) cell lines (Bokhari et al., 2007a; Bokhari et al., 2007b; Hayman et al., 
2004; Hayman et al., 2005). The performance of MSCs cultured on this scaffold 
compared to routine 2D cultures is addressed in the remainder of this chapter, in terms 
of the capacity of the scaffold to permit the attachment and viable growth/expansion of 
MSCs, and also in terms of the potential of attached MSCs to differentiate along 
osteogenic and adipogenic lineages. MSCs cultured on the scaffold were compared to 
MSCs cultured on the 2D environment of standard cellware. 
 
3.3.6 MSCs cultured on Alvetex
TM
 display excellent morphology and scaffold 
coverage but poor scaffold penetration 
Scanning electron microscopy (SEM) was used to examine the surface topography of 
MSCs cultured on the scaffold under standard culture conditions (CCM) for 21 days 
(Figure 3.6). This allowed us to address several key questions, including: 
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a) Does the scaffold surface permit the attachment of MSCs? 
b) Does the scaffold surface support the viable growth and expansion of MSCs? 
c) Do MSCs demonstrate characteristic morphology when cultured on the 
scaffold? 
d) Do MSCs demonstrate extensive scaffold coverage following 21 days culture? 
e) Do MSCs penetrate throughout the scaffold to grow in multiple levels? 
 
Figure 3.6 contains several SEM micrographs of MSCs cultured on the scaffold under 
standard culture conditions (CCM) for 21 days, at various magnifications and angles. 
All five micrographs (Figure 3.6A-E) clearly demonstrate that the scaffold not only 
permits the attachment of MSCs, but maintains their viability and supports their 
growth to such an extent that the entire surface of the scaffold is covered by MSCs 
following 21 days in culture. Figure 3.6A is an excellent example to highlight this, as 
the surface of the entire sample is covered by MSCs. Tears in the sample are resultant 
from the many handling steps involved in sample preparation for SEM and are in no 
way indicative of any patches of non-cellular attachment on the scaffold. MSCs 
interact with one another to form many close associations, packing tightly together and 
exhibiting a characteristic ‘swirly’ pattern that was observed on all samples. This 
distinctive pattern can be seen at a higher magnification in Figure 3.6B. At this level of 
detail, the surface of the scaffold cannot be observed because the cells are so densely 
packed that they are completely covering the top surface of the scaffold. At higher 
magnification, however, it becomes possible to see more detail at the individual 
cellular level (Figure 3.6C). The surface of the scaffold can now be observed, though it 
is still difficult to visualise in any detail because the cells are very densely packed 
following 21 days in culture. Cells attached to the scaffold appear viable and healthy at 
the morphological level, demonstrating a typically large, flat, fibroblastic morphology 
that is highly characteristic of an MSC phenotype. Such is the availability of space on 
the scaffold that the MSCs spread out to their maximum capacity and interact with 
neighbouring MSCs within the 3D environment of the scaffold by extending cellular 
projections across voids. MSCs are also fed from above and below. Such interactions 
are likely to be more representative of the cell-cell interactions that occur within the 
niche of the bone marrow in vivo compared to those interactions that occur in standard 
2D in vitro culture. In terms of scaffold penetration, MSCs do not appear to be readily 
growing throughout all available levels of the scaffold (Figure 3.6D and 3.6E). These 
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micrographs do demonstrate a small degree of penetration as some MSCs do appear to 
be growing within the middle layers of the scaffold, though their appearance is 
sporadic and at low frequency. A sheet of healthy MSCs growing on the top surface of 
the scaffold is apparent despite the low levels of penetration (Figure 3.6D and 3.6E). 
 
A B
C D
E
 
Figure 3.6. SEM micrographs of MSCs cultured under standard conditions on Alvetex
TM
 for 21 
days at various magnifications and angles. Scale bars are as follows: A: 2mm; B: 100µm; C: 50µm; 
D: 200µm; E: 100µm. 
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3.3.7 MSCs cultured on Alvetex
TM
 show enhanced viability compared to their 2D 
counterparts 
SEM analysis clearly shows that the scaffold surface supports the attachment of MSCs 
and encourages their growth, resulting in complete coverage of the scaffold surface 
following 21 days in culture. Although morphological evidence suggests that MSCs 
adhered to the scaffold surface are healthy and viable, this data on its own is of limited 
use, especially due to its non-quantitative nature, as the aim of this section is to 
determine whether MSCs cultured on the scaffold show enhanced viability and cellular 
function compared to their culture on standard 2D cellware. The MTS assay provides 
an alternative, quantitative approach to assess viability of MSCs cultured on 2D vs. 
3D, and the methodology for this assay is described in detail in Section 2.8. MSCs 
were seeded at equivalent densities into standard 6-well plates for 2D culture and onto 
the scaffold for 3D culture as described in Section 3.2.6 and this was designated as 
Day 0. The number of viable cells was subsequently determined at days 7, 14 and 21 
for both conditions and the MTS absorbance values at 490nm are illustrated in Figure 
3.7. Viable cells were successfully cultured on both 2D and 3D at each of the 
timepoints examined with both substrates clearly supporting the proliferation of MSCs, 
as the MTS absorbance values increased with time for both 2D and 3D cultures. 
However, at all of the timepoints examined, the number of viable cells was greater in 
3D cultures compared to their equivalent 2D cultures, and this difference was highly 
significant at the statistical level (p<0.001). 
 
3.3.8 MSCs cultured under osteogenic conditions on 2D (tissue culture plastic) and 
3D (Alvetex
TM
) growth substrates demonstrate the acquirement of a mature 
osteoblastic phenotype as determined histologically using von Kossa and Masson’s 
trichrome staining 
MSCs were cultured under osteogenic conditions on tissue culture plastic (2D) and 
scaffold (3D) for a period of 21 days, as detailed in Section 3.2.6. In order to assess the 
phenotype of MSCs following this culture, histological techniques were employed to 
examine bone nodule formation and the deposition of a mineralised matrix, two crucial 
events in osteogenesis. Two histological methods were used in this section – von 
Kossa and Masson’s trichrome staining – which allow the identification of 
extracellular calcium and collagen deposits respectively. Visualisation at the cellular 
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level was achieved by counterstaining cells with the nuclear stain haematoxylin 
(staining nuclei a bright purple colour).  
 
 
 
 
Figure 3.7. MTS absorbance values for MSCs cultured on Alvetex
TM
 and tissue culture plastic 
under standard conditions for 7, 14 and 21 days. MSCs were simultaneously cultured on the scaffold 
(3D) and tissue culture plastic (2D) for up to 21 days under standard conditions, and the MTS assay 
used to determine the number of viable cells in culture at days 7, 14 and 21. Each bar represents the 
mean (n=3)+SEM, *** p<0.001. 
 
 
Figure 3.8 shows representative staining for MSCs cultured under osteogenic 
conditions on both 2D (Figure 3.8A and 3.8C) and 3D (Figure 3.8B and 3.8D) 
substrates. Von Kossa staining (Figure XA and XB) is the most commonly used 
technique to assess osteoblastic behaviour, staining calcified bone nodules an intense 
black colour (as indicated by arrowheads in Figures 3.8A and 3.8B). Although it is 
widely accepted that von Kossa staining identifies calcium, the stain itself is not 
actually specific for the calcium ion. Rather, it demonstrates the presence of the anion 
(carbonate or phosphate ions) rather than the cation (calcium ion). Carbonate and 
phosphate ions displace silver ions from the silver nitrate solution used in von Kossa 
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staining, which then appear as densely black areas. As carbonate and phosphate ions 
are virtually always tightly associated with calcium ions, this technique is considered 
to demonstrate the presence of calcium. Bone nodules formation and mineralisation 
were apparent for MSCs cultured on both 2D (Figure 3.8A) and 3D (Figure 3.8B) 
substrates, confirming that MSCs demonstrate a potential to differentiate into mature 
osteoblastic derivatives on both substrates. 
 
Another key element of osteogenesis is the production and secretion of collagen in the 
extracellular matrix (ECM) by cells displaying an osteoblastic phenotype. This process 
of collagen synthesis and deposition is a pre-requisite for bone nodule formation, 
therefore the presence of collagen should precede the presence of calcium in cells 
actively undergoing osteogenesis. Masson’s trichrome staining (Figure 3.8C and 3.8D) 
is another commonly used histological technique and can be used to stain various 
structures, including muscle (red), amongst others. From an osteoblastic perspective, 
Masson’s trichrome staining is used to identify collagen deposition in the ECM by 
cells displaying an osteoblastic phenotype. Masson’s trichrome stains collagen an 
intense green colour (Figure 3.8C and 3.8D). The presence of collagenous proteins 
were readily detectable for MSCs cultured on both 2D (Figure 3.8C) and 3D (Figure 
3.8D) substrates, providing further evidence that MSCs are able to differentiate into 
mature osteoblastic derivatives on both 2D and 3D substrates. Negative controls for 
both histological stains described above were performed using MSCs that had not been 
induced to undergo osteogenic differentiation, but instead were cultured 
(simultaneously) under standard culture conditions (CCM). These controls did not 
demonstrate any evidence of calcium or collagen deposition (data not shown). 
 
Due to the qualitative nature of histological analysis, coupled with the widely varying 
methods of staining 2D samples compared to 3D samples i.e. directly in the cellware 
for 2D vs. paraffin embedding and sectioning for 3D, it would be an inaccurate 
comparison to make any conclusions regarding the ability of MSCs to undergo 
osteogenesis on 2D vs. 3D from these data alone. The following sections will describe 
quantitative, functional assays that were performed as a more balanced approach to 
compare the osteogenic potential of MSCs cultured on 2D vs. 3D. 
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C D
 
Figure 3.8. Histological analysis of osteogenic differentiation in MSCs cultured on 2D and 3D. Von 
Kossa (A, B) and Masson’s trichrome (C, D) staining was performed on MSCs cultured under 
osteogenic conditions for 21 days on 2D (A, C) and 3D (B, D) to demonstrate calcium and collagen 
deposition respectively. Intensely stained black areas represent calcium deposition and bone nodule 
formation is indicated  by the arrowhead. Green staining represents collagen deposition. Scale bars: A, 
100μm; B, 200μm; C, 100μm; D, 200μm. 
 
 
3.3.9 MSCs cultured under osteogenic conditions on Alvetex
TM
 demonstrate 
enhanced osteoblastic functional behaviour including increased alkaline 
phosphatase activity and increased secretion of osteocalcin compared to their 2D 
counterparts 
Alkaline phosphatase (ALP) activity is one of the most commonly used markers of 
osteogenic differentiation/behaviour (Lian and Stein, 1992). In this section, ALP 
activity was determined for MSCs cultured under osteogenic conditions on tissue 
culture plastic (2D) and scaffold (3D) at days 5, 7, 14 and 21 post-induction of 
differentiation, as described in Section 3.2.7. Results are illustrated in Figure 3.9. ALP 
activity was detectable on both 2D and 3D substrates as early as day 5, albeit at low 
levels, indicating that even at this early timepoint MSCs were beginning to acquire 
functional characteristics more indicative of an osteoblastic phenotype rather than a 
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stem/progenitor cell phenotype. However, it was not possible to ascertain whether low 
levels of ALP activity were attributable to only a small percentage of cells undergoing 
differentiation at this point, or whether a large percentage of cells were undergoing 
differentiation but were still relatively immature at this point. With increasing time, 
ALP activity increased substantially for MSCs cultured on both 2D and 3D substrates 
as they became more committed to an osteogenic differentiation program and began to 
express a more mature functional osteoblastic phenotype. Maximum activity was 
attained at 14 days for both 2D and 3D cultures. Thereafter, ALP activity began to 
decrease, as determined at the 21 day timepoint, though the level of ALP activity at 21 
days was still relatively high and comparable with that observed at 7 days. This trend 
was comparable between MSCs cultured on both substrates, though at each of the 
timepoints examined ALP activity was significantly enhanced when MSCs were 
cultured on 3D compared to 2D, suggesting that MSCs cultured on 3D were acquiring 
a more mature osteoblastic phenotype than their 2D counterparts. These differences 
were highly significant at the statistical level for days 5, 7 and 14 (p<0.001). 
 
A further marker of osteogenic differentiation is osteocalcin, a late marker of 
osteogenesis whose production and secretion is highly indicative of the expression of a 
mature osteoblastic phenotype (Lian and Stein, 1992; Lian and Stein, 1993). In this 
section, osteocalcin production and secretion was determined for MSCs cultured under 
osteogenic conditions on 2D and 3D, as described in Section 3.2.7, as an indicator of 
more mature osteoblastic behaviour. As it is a late marker of osteogenesis, levels of 
osteocalcin were determined at the later timepoints of 14, 21 and 35 days post-
induction of differentiation. Results are illustrated in Figure 3.10. Osteocalcin was 
readily detectable in the culture media of MSCs cultured on both 2D and 3D substrates 
at each of the timepoints assessed, including the earliest timepoint of 14 days, 
indicating that cells were highly committed to an osteogenic differentiation pathway 
and were beginning to display functional behaviour indicative of a more mature 
osteoblastic phenotype. Levels of osteocalcin in the culture media increased with time 
in both conditions, with maximum levels observed after 35 days post-induction of 
differentiation, suggesting that cells were still differentiating and becoming more 
osteoblast-like even at this late timepoint. Although a clear increase in osteocalcin 
levels were observed for MSCs cultured on both 2D and 3D, levels were significantly 
higher for MSCs cultured on 3D compared to their 2D counterparts at all of the 
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timepoints assessed (p<0.001). These data further support for the conclusions made 
from the ALP data above that MSCs cultured on the scaffold display enhanced 
functional behaviour indicative of the acquirement of a more mature osteoblastic 
phenotype compared to equivalent 2D cultures. 
 
 
Figure 3.9. ALP activity in MSCs cultured on Alvetex
TM
 and tissue culture plastic under 
osteogenic conditions for up to 21 days. MSCs were simultaneously cultured on the scaffold (3D) and 
tissue culture plastic (2D) for up to 21 days under osteogenic conditions and ALP activity determined at 
days 5, 7, 14 and 21. Each bar represents the mean (n=3)+SEM, *** p<0.001. 
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Figure 3.10. Osteocalcin secretion by MSCs cultured under osteogenic conditions on Alvetex
TM
 
and tissue culture plastic for up to 35 days. MSCs were simultaneously cultured on the scaffold (3D) 
and tissue culture plastic (2D) for up to 35 days under osteogenic conditions and levels of osteocalcin 
secretion into the culture media determined at days 14, 21 and 35. Each bar represents the mean 
(n=3)+SEM, *** p<0.001. 
 
 
3.3.10 MSCs cultured under adipogenic conditions on Alvetex
TM
 demonstrate 
enhanced accumulation of intracellular lipid droplets compared to their 2D 
counterparts as determined histologically using oil red O staining and by using an 
oil red O elution method 
MSCs were cultured under adipogenic conditions on tissue culture plastic (2D) and 
scaffold (3D) for a period of 21 days, as detailed in Section 3.2.6. To assess the 
phenotype of MSCs following this culture period, oil red O staining was performed to 
allow identification of neutral lipid droplets within the cell cytoplasm and allow a 
measure of adipogenesis. Visualisation at the cellular level was achieved by 
counterstaining cells with haematoxylin followed by ‘blueing’ in 3% ammonia 
solution, as described previously in Section 3.2.6. Due to technical difficulties 
encountered when performing oil red O staining on paraffin-embedded sections 
(solvent extraction of lipoid material during paraffin processing), a cytospin method 
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was adopted whereby cells were trypsinised out of the scaffold and cytospun onto non-
coated glass slides as described in Section 3.2.6. This method of oil red O staining is 
advantageous over staining frozen sections (a viable alternative) because it allows 
visualisation of stained cells at an individual level, allowing direct comparisons to be 
made between cells cultured on 2D and 3D. Figure 3.11 shows representative oil red O 
staining for MSCs cultured under adipogenic conditions for 21 days on both 2D 
(Figure 3.11C) and 3D (Figure 3.11D) substrates. Intracellular lipid accumulation was 
apparent for MSCs cultured under both conditions, confirming that MSCs demonstrate 
a potential to differentiate into mature adipogenic derivatives on both substrates. 
Negative controls using MSCs that had not been induced to undergo adipogenic 
differentiation, but instead were cultured (simultaneously) under standard culture 
conditions (CCM), did not demonstrate any evidence of lipid droplet accumulation 
within the cell cytoplasm (Figures 3.11A and 3.11B). At this morphological level, 
MSCs that had been cultured under adipogenic conditions on 3D (Figure 3.11D) 
contained substantially more lipid droplets per cell than their 2D counterparts (Figure 
3.11C). In order to quantify these observations and allow a statistical comparison 
between MSCs cultured on 2D vs. 3D, an oil red O elution technique was performed as 
described in Section 3.2.8. Results are illustrated in Figure 3.12. At both 7 and 21 
days, MSCs cultured on the scaffold demonstrated significantly higher levels of oil red 
O compared to their 2D counterparts, validating the morphological conclusions above 
and confirming that MSCs cultured on the scaffold underwent enhanced adipogenic 
differentiation and displayed a more mature adipogenic phenotype compared to cells 
cultured on standard tissue culture plastic. Differences in oil red O elution were highly 
statistically significant at both time points (p<0.001). 
 
3.3.11 Culture of MSCs under adipogenic conditions on Alvetex
TM
 does not cause 
an increase in the percentage of cells undergoing adipogenic differentiation but does 
result in the demonstration of a more mature adipogenic phenotype compared to 2D 
counterparts, as determined by Nile red staining followed by flow cytometric analysis 
MSCs were cultured under adipogenic conditions on tissue culture plastic (2D) and 
scaffold (3D) for a period of 21 days. Oil red O is by far the most commonly used stain 
to demonstrate the presence of intracellular lipid droplets within differentiated cells. 
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Figure 3.11. Oil red O staining in MSCs cultured under adipogenic conditions on tissue culture 
plastic (2D) and Alvetex
TM
 (3D) for 21 days, using the cytospin method. Negative controls for both 
conditions (A, B) showed no evidence of intracellular lipid accumulation. MSCs cultured under 
adipogenic conditions on 2D (C) demonstrated some evidence of intracellular lipid accumulation and 
MSCs cultured on 3D demonstrated a significant degree of intracellular lipid accumulation (D). 
 
 
An alternative lipophilic stain is Nile red, which is advantageous over oil red O due to 
its fluorescent properties. Lipid-bound Nile red emits fluorescence at a wavelength of 
approximately 525nm, allowing analysis of adipogenesis using techniques such as 
immunofluorescence and flow cytometry.  
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Figure 3.12. Quantification of oil red O staining in MSCs cultured under adipogenic conditions on 
tissue culture plastic (2D) and Alvetex
TM
 (3D) using an elution method. MSCs were simultaneously 
cultured on the scaffold (3D) and tissue culture plastic (2D) for up to 14 days under adipogenic 
conditions and levels of oil red O staining determined at days 7 and 14. Each bar represents the mean 
(n=3)+SEM, *** p<0.001. 
 
 
Here, MSCs cultured under adipogenic conditions on 2D and 3D for 21 days were 
stained with Nile red followed by flow cytometric analysis, in terms of the percentage 
of positive cells for Nile red staining and mean fluorescence intensity (MFI) of 
staining, allowing a distinction between cells that were weakly positive and cells that 
were strongly positive for Nile red. Figure 3.13 shows representative flow cytometric 
traces for negative control (Figure 3.13A) and MSCs cultured under adipogenic 
conditions on both 2D (Figure 3.13B) and 3D (Figure 3.13C) substrates. The negative 
control consisted of undifferentiated MSCs cultured under standard culture conditions, 
to determine levels of background/non-specific fluorescence and determine the 
threshold against which positive and negative events would be measured (Figure 
3.13A). Any events to the left of this threshold (R1) were considered negative for Nile 
red staining and, as such, indicative of an undifferentiated phenotype. Conversely, any 
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events to the right of this threshold (R2) were considered positive for Nile red staining 
and, as such, indicative of an adipogenic phenotype. Collated results are shown 
graphically in terms of percentage of cells displaying positivity for Nile red staining 
(Figure 3.13D) and in terms of MFI (Figure 3.13E). 
 
Positive events were detected for MSCs cultured under adipogenic conditions on both 
2D (Figure 3.13B) and 3D (Figure 3.13C) substrates, though there was no statistical 
difference in the number of positive cells between these conditions, approximately 
30% each (Figure 3.13D). This demonstrates that around one-third of MSCs cultured 
under adipogenic conditions were actively undergoing differentiation to form more 
mature adipogenic derivatives and this was the case whether they were cultured on 2D 
or 3D. However, such is the sensitivity of flow cytometry that even weak fluorescence 
will be detected and reported as a positive event, therefore this analysis alone is 
insufficient to distinguish between cells that are only weakly positive and those that 
are strongly positive i.e. cells that have a low level of intracellular lipid accumulation 
compared to those with a high level of intracellular lipid accumulation. Determination 
of MFI allows an analysis of fluorescence intensity. MSCs cultured on the scaffold 
demonstrate a significantly higher MFI than their 2D counterparts (Figure 3.13E), 
validating the oil red O elution results above (Section 3.3.10) and providing further 
evidence to suggest that MSCs cultured on the scaffold display an enhanced ability to 
undergo adipogenic differentiation. These differences were significant at the statistical 
level (p<0.01). This difference in MFI can also be observed on the raw flow cytometric 
traces, as the positive events for MSCs cultured on 3D (Figure 3.13C) are shifted more 
towards the right than the corresponding 2D events (Figure 3.13B), which is indicative 
of a higher intensity of fluorescence. This data alone is insufficient to allow conclusion 
as to whether this increase in Nile red intensity is a consequence of an increase in the 
number of droplets per cell or an increase in the size of droplets per cell for MSCs 
cultured on 3D compared to 2D. However, the oil red O staining in Figure 3.11 clearly 
shows that MSCs cultured on the scaffold demonstrate a greater number of lipid 
droplets per individual cell compared to their 2D counterparts, suggesting that the 
increase in MFI of Nile red is likely to be attributable to a greater number of lipid 
droplets per cell rather than the presence of larger droplets. 
 
Chapter 3: Behaviour of MSCs cultured in 2D and 3D 
 
113 
 
 
 
Figure 3.13. Flow cytometric analysis of Nile red staining in MSCs cultured under adipogenic 
conditions on Alvetex
TM
 (3D) and tissue culture plastic (2D) for 21 days. Representative flow 
cytometric traces are shown for MSCs stained with Nile red following 21 days culture under adipogenic 
conditions: A, negative control; B, MSCs cultured on 2D; C, MSCs cultured on 3D. Results from three 
independent studies were combined and collated to give an indication of the cells demonstrating 
positivity for Nile red staining (D) and mean fluorescence intensity (MFI) of staining (E). Each bar 
represents the mean (n=3)+SEM, ** p<0.01. 
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3.3.12 MSCs cultured under adipogenic conditions on Alvetex
TM
 demonstrate a 
significantly higher level of metabolic activity compared to MSCs cultured on 
standard tissue culture plastic as indicated by increased levels of cyclic adenosine 
monophosphate (cAMP) 
To assess the functional phenotype of MSCs differentiated along an osteogenic lineage 
on 2D vs. 3D, functional assays were performed to determine ALP activity and levels 
of osteocalcin secreted into the culture media (Section 3.3.9). Unfortunately, there are 
a lack of reliable markers and biochemical assays to assess functional adipogenic 
behaviour, which is typically measured using non-functional methods such as oil red O 
(Section 3.3.10) and Nile red (Section 3.3.11) staining. In order to gain an appreciation 
of how functionally active cells were when cultured under adipogenic conditions on 
the scaffold (3D) compared to plastic (2D), levels of the signalling molecule cyclic 
adenosine monophosphate (cAMP) were determined using a commercially-available 
enzyme immunoassay (EIA) kit as detailed in Section 3.2.10. cAMP plays a 
fundamental role in adipogenesis, predominantly through its activation of protein 
kinase A (PKA), which in turn activates a number of transcription factors including 
cAMP-responsive element binding protein (CREB), a key transcription factor involved 
in expression of multiple genes crucial for adipogenic differentiation (Kurten et al., 
1988; Reusch et al., 2000; Petersen et al., 2008; Yang et al., 2008). In this section, 
cAMP levels were determined for MSCs cultured under adipogenic conditions on 
tissue culture plastic (2D) and scaffold (3D) at days 7 and 21 post-induction of 
differentiation, as described in Section 3.2.10. Results are illustrated in Figure 3.14. 
cAMP was readily detectable in samples from both growth substrates at both 
timepoints, indicating that cells were actively undergoing metabolic processes 
requiring cAMP-mediated signalling events. Although cAMP is a crucial mediator of 
adipogenesis, it is a universal second signalling molecule and as such is involved in a 
wide range of cellular processes besides adipogenic differentiation. It is therefore not 
possible to conclude with any certainty that levels of cAMP determined in the above 
assay were exclusively attributable to adipogenic differentiation, though increased 
levels of adipogenesis would certainly contribute to increased levels of cAMP. What 
can be concluded with confidence from these data is that MSCs cultured on Alvetex
TM
 
were significantly more metabolically active than their 2D equivalents, especially at 
the 7 day timepoint. At day 7, the level of cAMP was significantly greater in cells 
cultured on 3D compared to 2D, indicating that cells cultured on the scaffold were 
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more metabolically active than their 2D counterparts and it is probable that this higher 
metabolic activity was a direct consequence of an enhanced rate of adipogenesis. 
Levels of cAMP in 2D cultures were much lower, suggesting that these cells were 
undergoing adipogenesis much less efficiently or at a much lower rate of occurrence. 
At day 21, levels of cAMP increased in cells cultured on 2D but decreased in cells 
cultured on 3D compared to levels observed at the 7 day timepoint. Levels of cAMP 
were equivalent for both cultures at this timepoint. The increase in cAMP level for 
MSCs cultured on 2D is likely to be attributable to a greater degree of adipogenic 
differentiation occurring at this timepoint compared to the relatively early timepoint of 
7 days. For MSCs cultured on 3D, however, maximum levels of cAMP were observed 
at 7 days. Because the 3D structure of the scaffold appears to functionally enhance 
MSC performance during standard culture, a maximum cAMP level at day 7 suggests 
that cells cultured on the scaffold committed to differentiation earlier than their 2D 
counterparts due to a greater efficiency at undergoing the necessary changes in protein 
complement required to undergo adipogenesis. In crude terms, MSCs cultured on 2D 
may ‘lag’ behind those cultured on 3D, in terms of committing to the differentiation 
process and acquiring a more mature adipogenic phenotype. The difference between 
cAMP levels in MSCs cultured on 2D and 3D were significant at the statistical level 
for the 7 day time point (p<0.001) but not the 21 day timepoint. 
 
3.3.13 MSCs cultured under adipogenic conditions on Alvetex
TM
 demonstrate 
enhanced expression of adipocyte-related genes compared to MSCs cultured on 2D 
As mentioned in the previous section, there are a lack of reliable markers and 
biochemical assays to assess functional adipogenic behaviour. To circumvent this and 
gain a more mechanistic insight into how MSCs were behaving when cultured under 
adipogenic conditions on the scaffold (3D) compared to plastic (2D), expression of a 
number of adipocyte-related genes were examined, at various timepoints up to 14 days 
differentiation, using qRT-PCR. Specific genes were selected, based on current 
knowledge within the literature, to cover both the early and late stages of the 
adipogenic differentiation program. Expression of adiphilin, an early marker of 
adipogenesis, and PPARγ and adipsin, later markers of adipogenesis, were determined 
and normalised to GAPDH levels as detailed in Section 2.11.2. 
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Figure 3.14. Intracellular cAMP levels in MSCs cultured under adipogenic conditions on 
Alvetex
TM
 (3D) and tissue culture plastic (2D). Intracellular cAMP levels were determined in MSCs 
cultured under adipogenic conditions on 2D and 3D at 7 and 21 days using a commercially available 
ELISA-based method. Each bar represents mean (n=2)+SEM, *** p<0.001. 
 
 
The role(s) of all three genes in the adipogenic differentiation process have been 
highly documented in the literature (Chawla and Lazar, 1994; Schoonjans et al., 1996; 
Cowherd et al., 1999; Fruhbeck et al., 2001; Bildirici et al., 2003). Normalised levels 
of expression for each gene are shown, as a percentage of the maximum expresser, in 
Figure 3.15. mRNA transcript levels of all three genes were determined in MSCs 
cultured on 2D and 3D prior to induction of differentiation, to ensure that there were 
no differences in transcript levels prior to the start of the experimental timepoints (data 
not shown). 
 
Adipophilin is an early marker of adipogenesis, forming an association with minute 
lipid droplets formed during the initial stages of differentiation (Brasaemle et al., 
2007). At the 5 day timepoint, MSCs cultured on 3D demonstrated enhanced 
expression of adipophilin mRNA compared to their 2D counterparts, and this 
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difference was significant at the statistical level (p<0.01). Increased levels of 
adipophilin suggested that MSCs cultured on 3D were actively undergoing 
adipogenesis and were in the early stages of differentiation at this timepoint. Lower 
levels of expression in MSCs cultured on 2D suggested one of two things: a) MSCs 
cultured on 2D ‘lagged behind’ those cultured on 3D in terms of committing to 
differentiation, or b) MSCs cultured on 2D were committing to differentiation at the 
same time as those cultured on 3D, but were less efficient in bringing about the 
complex intracellular changes required for differentiation. At the 7 day timepoint, 
expression of adipophilin increased in MSCs cultured on both 2D and 3D, with those 
cultured on 2D demonstrating slightly higher levels of expression than those on 3D, 
though this difference was not significant at the statistical level. This pattern of 
expression indicated that MSCs cultured on 2D were entering the initial, adipophilin-
dependent stage of adipogenesis at this timepoint, whereas MSCs cultured on 3D were 
further along the linear pathway of events that occurs during adipogenesis and were 
making the transition from adipophilin-dependency to adipophilin-independency. At 
the 14 day timepoint, expression of adipophilin decreased in MSCs cultured on both 
2D on 3D, though expression remained significantly higher for those cultured on 2D 
compared to those cultured on 3D (p<0.01). This pattern of expression suggests that 
MSCs cultured on 2D are beginning to make the transition into the later, adipophilin-
independent stages of adipogenesis but are still largely in the earlier, adipophilin-
dependent stages of adipogenesis, whereas MSCs cultured on 3D are largely in the 
later stages of differentiation. 
 
PPARγ is a member of the peroxisome proliferator-activated receptor family nuclear 
hormone receptors and its expression is restricted to adipose tissue. It is known to play 
a crucial role during adipogenesis, controlling the expression of a large number of 
genes required throughout the later stages of differentiation and also in lipid 
metabolism (Schoonjans et al., 1996; Grimaldi et al., 2001). At the 5 day timepoint, 
levels of PPARγ expression were low and equal for MSCs cultured under adipogenic 
conditions on both 2D and 3D. At this timepoint, MSCs were in the early stages of 
adipogenesis (as indicated by expression of the early marker, adipophilin) which are 
largely independent of PPARγ-controlled transcriptional events. At the 7 day 
timepoint, however, there is a massive increase in PPARγ expression in MSCs cultured 
on 3D, suggesting that these cells were in the mid-late stages of the differentiation 
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process. Levels of expression of PPARγ remained unchanged in MSCs cultured on 2D. 
At the 14 day timepoint, levels of PPARγ returned to a low level for MSCs cultured on 
3D, to a level comparable with cells cultured on 2D. Increased expression of PPARγ in 
MSCs cultured on 3D is likely to be a major factor contributing to the enhanced 
adipogenic effect of MSCs cultured on 3D compared to 2D. 
 
Adipsin, a serine protease produced and secreted by mature adipocytes, is a very late 
marker of adipogenesis and its expression correlates with the last stages of the linear 
adipogenic pathway (Fruhbeck et al., 2001; De Gemmis et al., 2006). Prior to 
induction of differentiation, adipsin mRNA was undetectable in MSCs cultured on 
both 2D and 3D (data not shown). At the 5 day timepoint, however, adipsin mRNA 
transcripts were readily detectable in MSCs cultured under adipogenic conditions on 
both 2D and 3D substrates. Expression was slightly higher in MSCs cultured on the 
scaffold compared to tissue culture plastic, though this difference was slight and not 
significant at the statistical level. At the 7 day timepoint, MSCs cultured on the 
scaffold demonstrated a further increase in expression of adipsin, whereas MSCs 
cultured on 2D actually showed a decrease in expression. An increase in expression of 
adipsin mRNA suggested that MSCs cultured on the scaffold were beginning to 
demonstrate a more mature adipogenic phenotype, especially in comparison to their 
2D counterparts, as MSCs cultured on 2D demonstrated a significantly lower level of 
expression (p<0.01). At the 14 day timepoint, adipsin transcript levels had returned to 
low levels for MSCs cultured on 3D and remained relatively low for MSCs cultured on 
2D, though levels of transcript were higher in MSCs cultured on 2D compared to 3D. 
This was significant at the statistical level (p<0.01). This expression profile is 
representative of what has been previously reported in the literature for MSCs cultured 
on 3D substrates (De Gemmis et al., 2006). Lower levels of adipsin in MSCs cultured 
on 2D suggests that adipogenic derivatives formed by these cells do not appear to 
reach the levels of maturity of those formed by cells cultured on 3D. 
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Figure 3.15. Expression of adipocyte-specific genes in MSCs cultured under adipogenic conditions 
on Alvetex
TM
 (3D) and tissue culture plastic (2D). QRT-PCR comparing mRNA transcript levels of 
three adipocyte-specific genes – A, adipophilin; B, PPARγ; and C, adipsin – in MSCs cultured under 
adipogenic conditions for 5, 7 and 14 days. All values were normalised to GAPDH to account for any 
differences in RNA input and/or reverse transcription efficiencies. Normalised levels of expression are 
shown as percentages of the maximum expresser. Each bar represents the mean (n=3)+SEM, ** p<0.01, 
** p<0.01. 
Adipophilin 
PPARγ 
Adipsin C 
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3.3.14 MSCs demonstrate marked differences in expression of soluble factors and 
cytokines when cultured under both osteogenic and adipogenic conditions on 
Alvetex
TM
 compared to standard tissue culture plastic 
There are many studies throughout the literature examining the effects of various 
three-dimensional surfaces and scaffolds on the differentiation of MSCs and other cell 
types, and in many cases an enhanced differentiative effect is observed. Whilst this 
enhanced effect can be attributed to the profound effects of 3D cellular culture 
compared to 2D, little work has been done at the molecular level to ascertain what 
basic changes (if any) are occurring in cells cultured on 3D to bring about such 
significant results. This study aims to address that. It is well documented that bone and 
fat function as autocrine and paracrine tissues in vivo, with the proliferation and 
differentiation of osteoblasts and adipocytes being controlled to a certain extent by 
soluble factors and cytokines secreted by cells within their niche (Baylink et al., 1993; 
Spiegelman and Flier, 1996; Mohamed-Ali et al., 1998; Pages et al., 2000; Sykara and 
Opperman, 2003). Here, expression of a number of soluble factors and cytokines 
previously documented to exert a role of osteogenic and adipogenic differentiation 
were examined in MSCs cultured on the scaffold versus tissue culture plastic using 
qRT-PCR. All expressions were normalised to GAPDH as previous detailed in Section 
2.11.2, with normalised levels of expression shown as a percentage of the maximum 
level of expression in Figure 3.16 and Figure 3.17. 
 
Figure 3.16 shows the mRNA expression profiles of a number of soluble factors and 
cytokines (TGF-β1, VEGF, IGF-1, TNF-α, BMP2, BMP4 and BMP7) in MSCs 
cultured under osteogenic conditions for 5 and 7 days on 2D and 3D. Expression of 
TGF-β1, the founding member of the transforming growth factor beta superfamily of 
cytokines, was low in MSCs cultured on both 2D and 3D at the 5 day timepoint, but 
despite such low levels of expression MSCs cultured on 3D demonstrated significantly 
higher mRNA levels than their 2D counterparts (p<0.05). At the 7 day timepoint, 
expression of TGF-β1 increased in MSCs cultured under both conditions when 
compared to levels at the 5 day timepoint, with MSCs cultured on the scaffold 
demonstrating vastly greater expression than their 2D equivalents (p<0.001). VEGF, 
belonging to a subfamily of the platelet-derived growth factor family of cytokines, was 
undetectable at the mRNA level in MSCs cultured on 2D at the 5 day timepoint, 
though was detectable at very high levels in MSCs cultured on 3D (p<0.01). At the 7 
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day timepoint, however, VEGF was detectable at high levels in MSCs cultured on both 
2D and 3D, with MSCs cultured on 3D demonstrating slightly higher levels of 
expression, though this was not significant at the statistical level. IGF-1, a polypeptide 
hormone so called due to its similarity in structure to insulin, was undetectable in 
MSCs cultured under both conditions at the 5 day timepoint and remained undetectable 
at the 7 day timepoint for MSCs cultured on tissue culture plastic. MSCs cultured on 
the scaffold, however, demonstrated a significant upregulation in IGF-1 at this 
timepoint (p<0.05). TNF-α, belong to the TNF superfamily of cytokines, was virtually 
undetectable at the 5 day timepoint in MSCs cultured under both conditions, with 
MSCs cultured on tissue culture plastic lacking expression completely and MSCs 
cultured on the scaffold demonstrating only very slight expression. Expression 
remained low in MSCs cultured on the scaffold at the 7 day timepoint, though 
interestingly underwent a massive upregulation in MSCs cultured on tissue culture 
plastic (p<0.05). Bone morphogenetic proteins are perhaps the most well-characterised 
of all growth factors and cytokines known to influence osteogenesis and BMP2, BMP4 
and BMP7 were examined in this study. The pattern of expression of BMP2 mirrored 
that of TGF-β1, in that MSCs cultured on the scaffold demonstrated significantly 
higher levels of expression than their 2D counterparts at the both the 5 day (p<0.001) 
and 7 day (p<0.05) timepoints. BMP4 was undetectable in MSCs cultured on 2D at 
both the 5 and 7 day timepoints, but was detectable at high levels in MSCs cultured on 
3D at both the timepoints examined (p<0.01). BMP7 mRNA transcripts were not 
detectable in MSCs cultured under either conditions at the 5 day timepoint, though 
were detectable at the 7 day timepoint, with MSCs cultured on 2D demonstrating 
vastly higher levels of expression than their 3D counterparts. This difference, however, 
was not significant at the statistical level. 
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Figure 3.16. Expression of several soluble factors, as determined by qRT-PCR, in MSCs cultured 
under osteogenic conditions on Alvetex
TM
 (3D) and tissue culture plastic (2D). A: TGF-β1; B: 
VEGF; C: IGF-1; D: TNF-α; E: BMP2; F: BMP4; G: BMP7. Each bar represents the mean 
(n=3)+SEM, * p<0.05, ** p<0.01, *** p<0.001. 
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Figure 3.17 shows the mRNA expression profiles of a number of soluble factors and cytokines 
(IGF-1, TGF-β1, TNF-α, BMP2, BMP4 and BMP7) in MSCs cultured under adipogenic 
conditions for 5 and 7 days on 2D and 3D. There is a certain amount of redundancy and 
crosstalk between different soluble factor/cytokine-induced signalling pathways and, as such, 
many of the soluble factors reported to be involved in osteogenesis are similarly reported to 
play important roles in adipogenesis also (Zehentner et al., 2000; zur Nieden et al., 2004; Holly 
et al., 2006; Levi et al., 2010). IGF-1 mRNA transcripts were detectable in MSCs cultured on 
both 2D and 3D substrates at both 5 and 7 days and at both timepoints MSCs cultured on 3D 
demonstrated higher levels of expression than their 2D counterparts. However, these 
differences were not significant at the statistical level (p>0.05). TGF-β1 was expressed at 
extremely low levels at the 5 day timepoint in MSCs cultured on both 2D and 3D and remained 
at such low levels at the 7 day timepoint in MSCs cultured on 3D. MSCs cultured on 2D, 
however, demonstrated a significant upregulation in TGF-β1 expression at the 7 day timepoint 
(p<0.01). The expression profile of TNF-α demonstrated a remarkable similarity to the 
expression profile observed for IGF-1, in that TNF-α mRNA transcripts were detectable in 
MSCs cultured on both 2D and 3D substrates at both 5 and 7 days and at both timepoints MSCs 
cultured on 3D demonstrated higher levels of expression than their 2D counterparts. No 
statistically significant difference was observed (p>0.05). BMP2 was virtually undetectable in 
MSCs at the 5 day timepoint regardless of their growth substrate and remained at similarly low 
levels for MSCs cultured on 2D at the 7 day timepoint also. MSCs cultured on the scaffold, 
however, demonstrated a substantial increase in expression at the 7 day timepoint, but this was 
not significant at the statistical level (p>0.05). BMP4 was detectable at higher levels in MSCs 
cultured on the scaffold compared to tissue culture plastic at both timepoints examined and 
these differences were statistically significant for both the 5 day (p<0.01) and the 7 day 
(p<0.05) timepoint. At the 5 day timepoint, BMP7 was not detectable in MSCs cultured on 
either growth substrate and remained undetectable for MSCs cultured on the scaffold even at 
the 7 day timepoint. However, MSCs cultured on tissue culture plastic underwent a massive 
upregulation in BMP7 expression between 5 and 7 days, and this difference was highly 
significant at the statistical level (p<0.01).  
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Figure 3.17. Expression of several soluble factors, as determined by qRT-PCR, in MSCs cultured 
under adipogenic conditions on Alvetex
TM
 (3D) and tissue culture plastic (2D). A: IGF-1; B: TGF-
β1; C: TNF-α; D: BMP2; E: BMP4; F: BMP7. Each bar represents the mean (n=3)+SEM, * p<0.05, ** 
p<0.01. 
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3.4 Discussion 
 
Establishment of primary MSC cultures, marker expression profiles and multilineage 
differentiation potential 
In this study it was confirmed that stromal cells isolated from bone marrow, using 
plastic adherence as the main selection method, displayed a morphological phenotype, 
marker expression profile and differentiation potential that were highly characteristic 
of an MSC population. This method of MSC isolation is the traditional and most 
commonly used method to date, whereby whole bone marrow aspirates are plated out 
into tissue culture plastic for 48 hours, allowing sufficient time for MSCs to attach to 
the cellware (Luria et al., 1971). Haematopoietic cells do not attach to the cellware and 
remain as highly refractile cells in suspension, which are removed by continual media 
changes and passaging. Although plastic adherence remains the most commonly used 
approach for isolating MSCs from bone marrow, it is disadvantageous in that resulting 
cultures are highly heterogeneous, consisting of a mixture of cell types all at various 
stages of development. Variations on this protocol include centrifuging whole bone 
marrow aspirates over a Percoll gradient, allowing separation of the various cell types 
within the bone marrow according to density, and selecting only the nucleated fraction 
for culture. This again, however, has the disadvantage of non-specificity and 
heterogeneity (Dazzi et al., 2006). A major aim of research at present is to generate 
new protocols that result in the isolation of a more homogeneous starting population; 
this will ideally involve exploitation of cell surface marker expression to allow positive 
selection of a population expressing a specific stem cell marker using methods such as 
FACS and immunomagnetic sorting. Such methods have been in practice for many 
years regarding the isolation of haematopoietic stem cells (Spangrude et al., 1988; 
Morrison and Weissman, 1994; Yin et al., 1997) and similar methods of isolation are 
becoming commonplace in the isolation of stem cells from various other tissues such 
as embryonal carcinomas and even prostate (Przyborski, 2001; Richardson et al., 
2004). However, this situation is more complicated in MSC biology due to the lack of 
any cell surface markers whose expression is exclusive to MSCs. As such, expression 
of a range of cell surface markers was determined in this study to confirm the isolation 
of a true MSC population, including CD9, CD13, CD15, CD44, CD58, CD71, CD90 
CD105, CD138 and also the haematopoietic markers CD34 and CD45. This is by no 
means an exhaustive list of MSC markers. Notable absentees from this list include 
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CD29, CD31, CD54, CD63, CD73, CD106, CD117, CD140b, CD166, Stro-1 and Sca-
1 (Gronthos et al., 1944; Pittenger et al., 1999; Bobis et al., 2006; Jackson et al., 
2007). Likewise, CD34 and CD45 are not the only markers of haematopoietic cell 
types, with absentees including CD11b, CD14, CD31, CD33 and CD133 (Pittenger et 
al., 1999; Bobis et al., 2006). Because of a lack of consensus as to which markers are 
more indicative of an MSC phenotype than others, a common problem occurs in that 
different groups examine different panels of markers in order to assess the phenotype 
of putative MSCs. A lack of an exclusive marker of MSCs also means it is difficult to 
isolate a homogeneous starting population by methods such as those described above. 
Several efforts have been published in recent years to find an accurate combination of 
cell surface markers that allows for the selection of putative MSCs from their more 
differentiated derivatives. For example, Pittenger and colleagues report that co-
expression of CD105 and CD73 is sufficient to allow isolation of MSC from bone 
marrow, whereas a different study suggests that CD166 and CD105 are more 
important antigenic determinants of MSC phenotype (Pittenger et al., 1999; Alsalemah  
et al., 2004). Stro-1 antibody has also been reported to select for a pure population of 
cells demonstrating MSC characteristics (Simmons et al., 1999; Dennis et al., 2002; 
Gronthos et al., 2003). 
 
As the definition of a stem cell is a functional one, it is perhaps more important to 
demonstrate that stromal cells isolated from the bone marrow display the potential to 
differentiate into a range of mature mesodermal cell types, a fundamental property of 
MSCs. In this study, it was demonstrated that stromal cells displayed at least 
bipotentiality in that they demonstrated the ability to differentiate into bone and fat, 
using well-established protocols (Pittenger et al., 1999). This suggests the isolation of 
a true MSC population, rather than the isolation of pre-osteoblasts and/or pre-
adipocytes that were already committed to differentiate into bone and fat lineages 
respectively. 
 
Exemplification of Alvetex
TM 
As discussed in the introduction to this Chapter, routine cell culture performed on 
tissue culture plastic (2D) is fundamentally flawed in that it forces cells to adopt highly 
unnatural conformations/morphologies that are in no way representative of their in 
vivo growth environments (3D), where they develop highly complex interactions with 
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neighbouring cells and extracellular matrix within their niche. As such, there is a 
demand for 3D culture systems for in vitro use. Reinnervate produces Alvetex
TM
, a 
novel 3D polystyrene scaffold that can be used in the routine culture of cells in vitro, 
with the aim of providing more accurate analyses of complex cellular phenomena such 
as cellular differentiation. This technology has previously been exemplified using two 
main cell types: the HepG2 (liver carcinoma) and TERA2.cl.SP12 (embryonal 
carcinoma) cell lines (Hayman and Przyborski, 2004; Hayman et al., 2005; Bokhari et 
al., 2007a; Bokhari et al., 2007b). In each case, cells cultured on the scaffold 
demonstrated enhanced viability and functional activity compared to their counterparts 
that were cultured on the 2D environment of tissue culture plastic. HepG2 cells 
cultured on the scaffold displayed excellent morphology, higher levels of viability 
(determined via MTT assay) and enhanced functional activity (determined by 
production of albumin, a commonly-used marker of liver-specific function/metabolic 
activity) compared to their 2D counterparts (Bokhari et al., 2007a). In a further paper 
by the same authors it was demonstrated that HepG2 cells cultured on the scaffold 
displayed a greater resistance against the cytotoxic drug methotrexate (MTX) 
compared to those cultured on 2D, suggesting that the scaffold may provide a useful 
and more physiologically-relevant system in which to perform pharmaco-toxicological 
testing (Bokhari et al., 2007b). Hayman and colleagues also examined the suitability of 
the scaffold to permit the viable attachment and growth of TERA2.cl.SP12-derived 
neurons (Hayman and Przyborski, 2004; Hayman et al., 2005). The untreated scaffold 
did not support the attachment of viable neurons. However, upon coating the scaffold 
surface with the biologically active molecules poly-D-lysine and laminin, a large 
number of viable neurons attached to the scaffold surface (Hayman et al., 2005). 
Neurons cultured on coated scaffolds also demonstrated the formation of more 
extensive and complex neural networks compared to their 2D counterparts, and such 
complex 3D networks are likely to be more indicative of those which form in vivo 
(Hayman et al., 2004). Expression of neural markers in neurons cultured on 2D and 3D 
were also examined in this study. Neurons cultured on 2D demonstrated positive 
expression of markers associated with mature, post-mitotic neuronal phenotypes such 
as NeuroD and MAP2ab, but lacked expression of markers associated with the 
developing nervous system such as nestin, MAP2c and GAP43. Markers associated 
with developing neurons, however, were detectable in MSCs cultured on the scaffold, 
strongly suggesting that neural networks were still expanding and neurite outgrowth 
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was still occurring in neurons cultured on this system. Expression of mature neuronal 
markers were also readily detectable in these cells. 
 
Morphology and viability of MSCs cultured on Alvetex
TM
 
In the present study, it has been demonstrated for the first time that the novel 3D 
polystyrene scaffold manufactured by Reinnervate is biocompatible to support the 
attachment and growth of viable MSCs in vitro. SEM analysis revealed that the 
untreated scaffold surface supported the attachment and viable growth of MSCs, in 
keeping with previous studies performed on the HepG2 cell line (Bokhari et al., 
2007a). Although Hayman and colleagues reported that it was first necessary to coat 
the scaffold surface with the biologically active molecules poly-D-lysine and laminin 
to permit attachment and growth of TERA2.cl.SP12-derived neurons, this necessity 
can be attributable to the very particular growth substrate requirements of neural cell 
types in vitro (Hayman et al., 2005). This is also the case for neural cells cultured on 
tissue culture plastic. SEM analysis of MSCs cultured on the scaffold also revealed 
that these cells displayed excellent morphology – a characteristically large, fibroblastic 
morphology – with cells spreading out to their maximum capacity over the scaffold 
surface to form a sheet of healthy cells. Cell viability was determined quantitatively for 
MSCs cultured on 2D and 3D at a range of timepoints up to and including 21 days, 
using the MTS assay. The results from the assay allowed two main conclusions to be 
drawn: a) MSCs were proliferating over the 21 day time course of the experiment 
when cultured on both 2D and 3D substrates, and b) at each of the timepoints 
examined, there was a significantly higher number of viable cells on 3D compared to 
2D (p<0.001). It is anticipated that the observed increase in cell viability is a result of 
the scaffold enabling MSCs to grow in a manner more pertinent to that in which they 
grow within their bone marrow niche, allowing them to form cell-cell interactions that 
are more representative of events that occur in vivo. Culturing MSCs on the scaffold is 
therefore likely to provide a more accurate and physiologically-relevant system in 
which to study MSC biology. Several efforts have already been made to fabricate 3D 
scaffolds suitable for in vitro culture of MSCs, with many studies reporting that 3D 
culture promotes proliferation and increases viability of MSCs. Such examples include 
nanofibrous type I collagen scaffolds, hyaluronan-based scaffolds, chitosan-gelatin-
chondroitin-based scaffolds, gelatin/PLLA (poly(L-lactic acid))-based scaffolds and 
poly(lactic-co-glycolic acid) (PLGA)-based scaffolds (Shih et al., 2006; Machado et 
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al., 2007; Jin et al., 2008; Mattii et al., 2008; Pasquinelli et al., 2008). However, not all 
3D scaffolds increase viability and promote proliferation of MSCs in vitro. For 
example, MSCs cultured on a photocrosslinked oligo[(polyethylene glycol) fumarate] 
(OPF) hydrogel did not show any significant proliferation over a period of 14 days 
(Dadsetan et al., 2008). In another study, culturing MSCs on a nano-
hydroxyapatite/polyamide (m-HA/PA) scaffold did promote proliferation over a 7 day 
time period, however, there was no statistically significant difference between the 
number of viable cells cultured on the scaffold compared to routine 2D cultures (Wang 
et al., 2007). The present study clearly demonstrates that the polystyrene scaffold 
manufactured by ReInnervate not only promotes proliferation of MSCs over time, but 
increases viability beyond the level observed on tissue culture plastic. 
 
Osteogenic differentiation of MSCs 
In addition to cell morphology and viability analysis, this study also addressed the 
pivotal issue of whether MSCs cultured on the scaffold: a) retained their potential to 
differentiate into the mesodermal derivatives bone and fat, and b) whether this 
differentiative potential was enhanced following 3D culture compared to conventional 
2D culture. Mineralisation and deposition of a collagenous matrix were determined 
using von Kossa and Masson’s trichrome staining respectively. MSCs cultured on 2D 
had previously demonstrated the ability to differentiate into osteoblastic derivatives 
and histological analysis revealed that MSCs cultured on the scaffold retained this 
ability to differentiate. However, histological analysis alone is insufficient to allow 
comparisons to be made regarding the functionality of MSCs cultured on 2D vs. 3D 
due to its intrinsically qualitative nature and also the widely varying methodologies 
adopted for staining 2D vs. 3D cultures.  
 
Alkaline phosphatase and osteocalcin 
Fortunately, a number of functional assays are commercially available to assess 
osteoblastic behaviour. Alkaline phosphatase (ALP) activity is perhaps the most 
commonly used marker of osteogenic differentiation (Lian and Stein, 1992). ALP is an 
ectoenzyme produced by osteoblasts that is involved in the degradation of inorganic 
pyrophosphate to produce a sufficient location concentration of phosphate or inorganic 
pyrophosphate for matrix mineralisation to occur (Marom et al., 2005). The pattern of 
ALP activity observed in this study – an increase in activity up to a maximum at 14 
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days followed by a subsequent decrease at 21 days – is highly characteristic of what 
has previously been reported (Owen et al., 1990; Datta et al., 2006; Hosseinkhani et 
al., 2006; Donzelli et al., 2007; Na et al., 2007). Maximum ALP activity at 14 days is 
associated with the end of the proliferative stage and the subsequent decrease in 
activity is associated with advanced matrix mineralisation and the acquisition of a 
more mature osteoblastic phenotype. Although this trend was comparable between 
MSCs cultured on 2D and 3D, ALP activity was significantly enhanced in MSCs 
cultured on 3D compared to 2D at each the timepoints assessed, suggesting that these 
cells were displaying enhanced osteoblastic functional behaviour. 
 
A second commonly used marker of osteogenic differentiation is osteocalcin. 
Osteocalcin is a much later marker of osteogenesis than ALP that is produced and 
secreted by mature osteoblasts and contributes to the ground substance of bone 
extracellular matrix (Lian and Stein, 1992; Lian and Stein, 1993; Buranasinsup et al., 
2006). This ground substance, in combination with extracellular collagen, makes up 
bone extracellular matrix (osteoid). Osteocalcin was readily detectable in the media of 
MSCs cultured under osteogenic conditions on both 2D and 3D substrates at each of 
the timepoints assessed, with maximum levels observed at the 35 day timepoint. This 
is highly indicative of the expression of a mature osteoblastic phenotype. As for ALP 
activity, the trend in osteocalcin secretion was comparable between MSCs cultured on 
2D and 3D, though osteocalcin levels were significant greater in the media of MSCs 
cultured on 3D compared to 2D. These data further suggest that MSCs cultured on 3D 
displayed enhanced functional behaviour in keeping with the expression of a mature 
osteoblastic phenotype.  
 
Combined, these results suggest that the scaffold provides a superior environment in 
which to culture MSCs and support their differentiation into osteoblastic derivatives. 
Other scaffolds which support and enhance osteogenic differentiation of MSCs include 
OPF hydrogels, n-HA/PA scaffolds, collagen sponges (Gingistat1), collagen-based 
scaffolds and gels, silk-based scaffolds, peptide-amphiphile (PA)-based scaffolds, 
osteopontin-derived peptide (ODP)-based hydrogels, coralline-based scaffolds, poly-l-
caprolactone (PCL)-based scaffolds and gelatin-based sponges (Meinel et al., 2004; 
Shin et al., 2004; Takahashi et al., 2004; Abramovitch-Gottlib et al., 2005; Li et al., 
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2005; Yoneno et al., 2005; Hosseinkhani et al., 2006; Donzelli et al., 2007; Wang et 
al., 2007; Dadsetan et al., 2008). 
 
Adipogenic differentiation of MSCs 
The above results clearly demonstrate that culturing MSCs within the 3D environment 
of the scaffold not only supports but also enhances osteogenic differentiation of MSCs. 
As these cells previously demonstrated bipotentiality in their ability to differentiate 
into both osteogenic and adipogenic lineages in 2D culture, the next aim of this study 
was to investigate whether MSCs cultured on the scaffold retained their potential to 
undergo adipogenic differentiation and, if so, whether this potential was enhanced 
following 3D culture compared to conventional 2D culture. The formation and 
accumulation of neutral lipid droplets within the cell cytoplasm was examined using 
oil red O and Nile red staining, two synergistic methods for examining lipid formation.  
 
Oil red O and Nile red staining 
Adipogenic differentiation of MSCs cultured under conventional 2D conditions had 
previously been demonstrated and histological analysis using oil red O staining 
revealed that MSCs cultured on the scaffold retained this differentiative ability. 
However, whereas histological analysis was unsuitable to allow direct comparisons to 
be made between osteoblastic derivatives formed on 2D and 3D, the case is somewhat 
different here to due to varying methodology. The cytospin method of staining 
required differentiated cells to be trypsinised out of the scaffold and spun onto non-
coated glass slides prior to oil red O staining – this was advantageous as it permitted 
analysis at the individual cellular level and, as such, allowed direct comparisons to be 
made between MSCs cultured on 2D vs. 3D. Morphological observations in terms of 
the number of lipid droplets per cell demonstrated that MSCs cultured on 3D contained 
more droplets within their cytoplasm than their 2D counterparts, an observation further 
supported by oil red O elution studies. A more sophisticated method to examine 
intracellular lipid accumulation involved staining cells with the Nile red fluorescent 
dye, followed by flow cytometric analysis. These studies revealed that approximately 
one-third of MSCs actively underwent adipogenic differentiation regardless of their 
culture substrate, though MSCs cultured on the scaffold demonstrated a higher 
intensity of Nile red staining compared to their 2D counterparts. This strongly suggests 
that culturing MSCs on the scaffold did not result in an increase in the number of cells 
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undergoing differentiation, but rather caused those cells that did undergo 
differentiation to do so in a more efficient manner, resulting in these cells acquiring a 
more mature adipogenic phenotype than their 2D counterparts. 
 
However, analysis of lipid accumulation within differentiated cells only gives 
information with regards the final phenotype of the cells and gives little, if any, 
information regarding the functionality of differentiated cells. Whereas osteogenic 
differentiation can be assessed in vitro using a range of commercially-available 
functional assays such as determination of ALP activity and osteocalcin levels as has 
been performed in the present study, the study of adipogenesis is somewhat more 
complex due to the lack of functional biochemical assays available to assess 
adipogenic behaviour. In the absence of such biochemical assays, adipogenic 
behaviour is usually measured using non-functional methods, typically via the 
assessment of lipid droplet formation using lipophilic stains such as oil red O and Nile 
red. Although such methods are of some use, this information is limited when wanting 
to compare how cells are behaving when cultured on 3D compared to 2D.  
 
Cyclic AMP (cAMP) activity 
In order to gain a more functional insight into how MSCs were behaving when 
cultured on the scaffold compared to tissue culture plastic, cyclic AMP (cAMP) levels 
were determined using a commercially-available enzyme immunoassay kit. cAMP 
response element binding protein (CREB) is a central transcription factor in 
adipogenesis and plays a crucial role in initiation and during the early stages of 
adipogenesis, a role which has been documented extensively throughout the literature 
(Reusch et al., 2000; Petersen et al., 2008). It is constitutively expressed in 3T3-L1 
fibroblasts prior to induction of differentiation and is upregulated in preadipocytes and 
even mature adipocytes following their treatment with conventional adipogenic culture 
media containing cAMP-inducing agents such as dexamethasone and IBMX (Reusch 
et al., 2000). Convincing evidence for the key role of CREB in adipogenesis also 
comes from observations that adipogenesis is impaired in a number of CREB-deficient 
models (Zhang et al., 2004; Fox et al., 2006). From a more mechanistic perspective, 
CREB binds to putative cAMP response elements (CREs) present within the promoters 
of several adipocyte-specific genes, such as PPARγ and LPL, and can manipulate 
adipogenesis via its transcriptional regulation of these key adipogenic components 
Chapter 3: Behaviour of MSCs cultured in 2D and 3D 
 
133 
 
(Hansen et al., 2001; Madsen et al., 2003; Tzameli et al., 2004; Yang et al., 2008). 
CREB has also been suggested to play a role as a survival factor of adipocytes, 
controlling the expression of pro- and anti-apoptotic genes (Reusch and Klemm, 
2002). However, an interesting concern is raised by Reusch and colleagues in their 
study regarding the paradoxical role of cAMP signalling both adipogenesis and 
lipolysis, two conflicting processes (Reusch et al., 2000). Although they report that 
cAMP demonstrates a key role in potentiating adipogenesis consistent with previous 
observations in the literature, other studies have reports that chemically-induced 
stimulation of the cAMP signalling cascade results in increased lipid breakdown 
(MacDougald and Lane, 1995; Collins et al., 1997; Danforth and Himms-Hagen, 1997; 
Yarwood et al., 1998; Weyer et al., 1999; Reusch et al., 2000). There are several 
possible reasons regarding these opposing observations. For example, each of these 
studies has used different experimental models and cAMP is likely to have different 
roles depending on the cellular system in which it is studied. It is also likely to be 
dependent upon the differentiated state of the cell, as cAMP signalling in 
undifferentiated cells has been reported to exert a different effect to cAMP signalling 
in more mature adipocytes (Reusch et al., 2000; Petersen et al., 2008). As a universal 
signalling molecule, cAMP has many different downstream effectors besides CREB 
and as such it is highly probable that a CREB-independent mechanism could cause 
these different observations. In fact, even within the process of adipogenesis cAMP 
can act via protein kinase A (PKA)-dependent and independent mechanisms (Martini 
et al., 2009). Although cAMP is a universal second messenger molecule and has 
crucial roles in many different processes and functions outside adipogenesis, it was 
still considered a useful exercise to determine cAMP levels in MSCs cultured on 2D 
vs. 3D in order to give an idea as to how the cells were performing at a metabolic 
level. At the earlier timepoint of 7 days, cAMP levels were significantly higher for 
MSCs cultured on 3D compared to 2D, which is in keeping with previous reports of 
cAMP playing a crucial role during initiation and the early stages of adipogenesis. 
Low levels of cAMP in MSCs cultured on 2D at this timepoint suggest that few cells 
are undergoing adipogenesis at present or are doing so at a very low level. At the later 
timepoint of 21 days, cAMP levels decrease in MSCs cultured on 3D and increase in 
MSCs cultured on 2D, to comparable levels for the two conditions. This suggests that 
MSCs cultured on 3D are exiting the early, cAMP-dependent stages of adipogenesis 
whereas MSCs cultured on 2D are further behind the differentiation process and are 
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still in the earlier, cAMP-dependent stages. This strongly suggests that MSCs cultured 
on the scaffold are more efficient at undergoing adipogenic differentiation, a property 
that can be attributable, at least in part, to increased cAMP-signalling events. 
 
Expression of adipocyte-related genes 
Data regarding levels of cAMP in MSCs cultured on 2D and 3D are useful in that they 
allow an appreciation as to how cells are functioning at a metabolic level. Although 
elevated cAMP in MSCs cultured on the scaffold compared to tissue culture plastic 
strongly suggests that these cells were undergoing enhanced adipogenesis, it must be 
remembered that cAMP is not a specific marker of adipogenesis. A lack of specific 
functional assays is a major limiting factor in adipogenesis research. In order to gain a 
more mechanistic insight into how MSCs were behaving when cultured under 
adipogenic conditions on both 2D and 3D, expression of several adipocyte-related 
genes were examined using qRT-PCR – adipophilin, PPARγ and adipsin – the roles of 
which have been reported extensively throughout the literature. Adipogenesis is known 
to occur in four distinct stages – preconfluent proliferation, confluence growth arrest, 
hormonal induction and permanent growth arrest (terminal differentiation) – and these 
genes have been selected to cover a range of these stages (Cowherd et al., 1999). 
Adipophilin associates with minute droplets formed during the early stages of 
adipogenesis, suggesting a role for adipophilin in the nucleation of lipid droplets 
(Brasaemle et al., 1997). Therefore, adipophilin can be considered an early marker of 
adipogenesis. As differentiation proceeds and lipid droplets increase in size, 
adipophilin is gradually replaced by another protein, perilipin, to such an extent that 
mature adipocytes show virtually exclusive perilipin expression and little (if any) 
expression of adipophilin. PPARγ belongs to the peroxisome proliferator-activated 
receptor family of nuclear hormone receptors and, although there are three known 
families of receptor – α, β and γ – it is PPARγ whose expression is restricted to 
adipose tissue. Expression of PPARγ is increased rapidly after hormonal induction 
during stage 3 and it plays a key role during adipogenesis, controlling the expression 
of a number of crucial genes required during the differentiation process (De Gemmis et 
al., 2006). Adipsin is a serine protease secreted by mature adipocytes and, as such, is a 
very late marker of adipogenesis whose maximum expression occurs in stage 4 
(Fruhbeck et al., 2001; De Gemmis et al., 2006). Consequently, production and 
secretion of adipsin is largely dependent on differentiation occurring. MSCs cultured 
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on the 3D environment of the scaffold demonstrated enhanced expression of these 
genes compared to those cultured on 2D tissue culture plastic, keeping an expression 
profile expected during adipogenesis. Levels of expression in MSCs cultured on 2D 
tended to be lower than those in cultured on 3D and in some cases even failed to 
express (as was the case for PPARγ in particular and also adipsin). A lack of 
expression of adipocyte-related genes in cells cultured on 2D following appropriate 
stimulation with adipogenic factors has previously been reported (Hwang et al., 1997; 
Kang et al., 2007). Such observations are not unique to the study of adipogenesis. It is 
now commonly acknowledged that cells cultured in 3D demonstrate markedly 
different gene expression profiles than those cultured in 2D (Pampaloni et al., 2007). 
For example, melanoma cells cultured on 3D compared to 2D demonstrate an 
upregulation of genes whose expression is reported to be upregulated in cancerous 
tissue (Ghosh et al., 2005). This further demonstrates the limitations of culturing cells 
in a 2D environment and further stresses the need for more accurate models in which 
to study cell differentiation in vitro. 
 
Expression of soluble factors and cytokines 
Combined, results from this study clearly demonstrate that MSCs cultured on the 
scaffold display enhanced functionality in their ability to undergo osteogenic and 
adipogenic differentiation when compared to MSCs cultured on tissue culture plastic. 
However, whilst such observations are not totally unsurprising, with many studies 
reporting enhanced cellular viability and functionality following culture on 3D 
surfaces and scaffolds, the large majority of studies end their argument there and do 
not proceed to examine the molecular changes that occur in cells cultured on 3D to 
bring about such improvements. Experiments in this study aimed to address this. In 
vivo, osteogenic and adipogenic differentiation are influenced by autocrine and 
paracrine mechanisms, whereby cells within their niche secrete a range of soluble 
factors and cytokines that are able to influence proliferation and differentiation 
(Baylink et al., 1993; Spiegelman and Flier, 1996; Mohamed-Ali et al., 1998; Pages et 
al., 2000; Sykara and Opperman, 2003). Here, it is proposed that MSCs cultured on the 
scaffold demonstrate enhanced differentiation via an autocrine mechanism, with cells 
cultured on the scaffold upregulating a number of positive soluble factors and 
simultaneously decreasing expression of a number of inhibitory factors. Specific 
soluble factors to examine were selected based on literature searches and expression 
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was examined at the mRNA level using qRT-PCR. Although mRNA levels are not 
always indicative of actual protein levels and give no information as to whether the 
protein is actually secreted or not, it is advantageous in that it provides a rapid and 
straightforward technology in which to screen many factors. Changes at the 
transcriptional level are useful in themselves as indicators of cellular activity. 
 
MSCs cultured under osteogenic conditions on 2D and 3D demonstrated markedly 
different expression profiles of a number of key osteogenic factors at the mRNA level. 
TGF-β1, VEGF, IGF1, BMP2 and BMP4 were all upregulated in MSCs cultured on 
the scaffold compared to their equivalent cultures on tissue culture plastic, and these 
observations were significant at the statistical level. The osteogenic roles of these 
factors have all been highly documented in the literature. TGF-β1 is reported to be 
highly expressed in cells demonstrating an osteoblastic phenotype, with addition of 
free TGF-β1 to culture media resulting in further enhancement of osteogenic marker 
expression, such as ALP and osteocalcin (Long et al., 1995; Eingartner et al., 1999; 
Gosain et al., 2000; Weiss et al., 2002; Simionescu et al., 2005). It is also highly 
expressed during distraction osteogenesis, a surgical procedure designed to lengthen 
long bones (Yates et al., 2002). VEGF has also been reported to be a valuable soluble 
factor in the process of osteogenesis – however, as the majority of VEGF studies have 
been performed using in vivo models, such positive effects on osteogenesis have been 
attributed in main to increased angiogenesis, resulting in enhanced blood supply to 
osteoblastic tissue (Peng et al., 2002; Weiss et al., 2005; Casap et al., 2008). Despite 
this, there has been some evidence to suggest that VEGF can function as a positive 
mediator of osteogenesis via a non-angiogenic mechanism and, indeed, VEGF has 
been reported to be produced and secreted during osteogenesis itself, being a key 
process in the promotion of bone nodule formation and mineralisation (Mayer et al., 
2005; Mandu-Hrit et al., 2008). Although better known for its role in adipogenesis, 
IGF1 may also function as an osteogenic factor as it is highly expressed during 
distraction osteogenesis and is also reported to enhance cellular viability, which could 
be one mechanism to explain why cells cultured on the scaffold demonstrate enhanced 
viability compared to equivalent 2D cultures (Yates et al., 2002; Pountos et al., 2007; 
Jeong et al., 2008). Exogenous application of IGF1 is also reported to exert a positive 
influence on osteoblastic activity of cells during distraction osteogenesis (Stewart et 
al., 1999). The best characterised of all the soluble factors that influence osteogenesis 
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are, as their name suggests, the BMP family. MSCs cultured on the scaffold 
demonstrated a significant upregulation in expression of BMP2 compared to their 2D 
counterparts and BMP4 expression was found exclusively in MSCs cultured on the 
scaffold. BMP2 is a fundamental regulator of osteogenesis and has even been used in 
the clinic in the treatment of osteogenic defects, though high doses were required in 
order to observe any positive effects (Schwarz et al., 2008). Further support for this 
comes from studies in which inhibition of BMP2 expression prevented bone nodule 
formation and matrix mineralisation (Hassan et al., 2006; Bais et al., 2009). Cheng and 
colleagues even go as far as claiming that BMP2 was the most potent inducer of 
osteogenesis out of 14 BMPs examined in their study (Cheng et al., 2003). BMP4 is 
also an effective inducer of osteogenic differentiation, albeit not as efficacious as its 
family member, BMP2 (Li et al., 1998; Yates et al., 2002). MSCs cultured on 2D 
demonstrated significantly reduced levels of the above soluble factors at the mRNA 
level, providing compelling evidence to suggest that an autocrine mechanism was 
responsible, at least in part, for the enhanced differentiative effect observed when 
MSCs were cultured on the scaffold. 
 
However, MSCs cultured on 2D did not show reduced expression of all the soluble 
factors examined. TNF-α and BMP7 were expressed at greater levels in MSCs cultured 
on 2D compared to 3D, although this observation was only significant at the statistical 
level for TNF-α (p<0.05). Interestingly, BMP7 is reported to play a role in the 
commitment and differentiation of MSCs to an osteoblastic-like phenotype, though the 
function of BMP7 in osteogenesis has been studied less extensively than its 
counterparts, BMP2 and BMP4 (Hassan et al., 2006). Conversely, TNF-α has not been 
reported to exert a positive effect on osteogenesis, with several studies suggesting that 
TNF-α inhibits osteogenesis in vitro, an effect that can be reversed by blocking the 
TNF-α signalling cascade (Tomomatsu et al., 2009). TNF-α has even been reported to 
induce osteoclastogenesis, though this effect is usually seen in combination with 
interleukin molecules such as IL-1β (Wang et al., 2005). These results combined 
strongly suggest that increased expression of osteogenic-promoting soluble factors 
concomitant with a decrease in expression of the osteoclastic-promoting TNF-α in 
MSCs cultured on the scaffold result in enhanced expression of an osteoblastic 
phenotype in MSCs cultured on the scaffold compared to 2D counterparts. It is likely 
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that this phenomenon is a result of a combinatorial effect rather than just one 
individual factor or a couple of factors inducing this effect. 
 
MSCs cultured under adipogenic conditions on the scaffold and tissue culture plastic 
also demonstrated markedly different expression profiles of a number of adipogenic 
factors at the mRNA level. IGF1, TNF-α, BMP2, BMP4 were all upregulated in MSCs 
cultured on the scaffold compared to their equivalent cultures on tissue culture plastic. 
However, although these differences in expression are quite apparent graphically, only 
BMP4 was upregulated at a statistically significant level. The adipogenic roles of these 
factors have all been highly documented in the literature. IGF1 is a well-characterised, 
potent inducer of adipogenesis and is significantly upregulated in cells undergoing 
adipogenic differentiation, playing a crucial role in the proliferation stage of 
adipogenesis (stage 1) (Wright and Hausman, 1995; Rajkumar et al., 1999). It is such a 
potent inducer of differentiation that IGF1 is reported to be able to substitute for 
insulin in the traditional adipogenic cocktail and has also been suggested to function in 
an autocrine/paracrine fashion when in its free form (Smith et al., 1988; Hausman, 
1989; Blake and Clarke, 1990; Schmidt et al., 1990; Tchouklova et al., 2009). TNF-α, 
interestingly, is reported to be an anti-adipogenic factor, with one particular study 
demonstrating that treating mature adipocytes with TNF-α resulted in a loss of 
intracellular lipid material (Torti et al., 1989). The effect was so striking that the cells 
appeared to have undergone a dedifferentiation process and resembled their 
undifferentiated precursors. Although their name may suggest that their biological role 
is exclusive to promoting osteogenic differentiation, BMPs are also known to be 
important determinants of adipogenic differentiation. BMP2 has frequently been 
reported to stimulate adipogenesis as well as osteogenesis (Zehentner et al., 2000; zur 
Nieden et al., 2004). However, an adipogenic role of BMP2 is somewhat controversial, 
with some studies reporting BMP2 to be inhibitory to adipogenic differentiation, whilst 
another study reports that BMP2 strongly stimulates adipogenic in the presence of 
other adipogenic-inducing factors but is incapable of doing so on its own (Gimble et 
al., 1995; Gori et al., 1999; Sottile and Seuwen, 2000). A dual-role of BMP2 in 
osteogenesis and adipogenesis has been proposed to occur as a result of BMP2 acting 
through different receptor units for each process (Wang et al., 1993; Asahina et al., 
1996; Chen et al., 1998; Kang et al., 2009). The role of BMP4 in adipogenesis is much 
more straightforward. There is compelling evidence to suggest that BMP4 is a key 
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factor in adipogenesis, as BMP4-producing cells convert into adipocytes at high 
frequency and efficiency (Tang et al., 2004; Bowers et al., 2006; Taha et al., 2006; 
Bowers and Lane, 2007; Kang et al., 2009). As MSCs cultured on the scaffold 
demonstrate upregulation of a number of positive regulators (albeit only BMP4 at a 
statistically significant level), a similar argument holds here that, as for osteogenesis, 
an autocrine mechanism was responsible, at least partially, for the enhanced effect on 
differentiation observed when MSCs were cultured in 3D. 
 
However, MSCs cultured on 2D showed enhanced expression of TGF-β1 and BMP7 
compared to their 3D counterparts, and these differences were significant at the 
statistical level in both instances (p<0.01). TGF-β1 is a potent inhibitor of adipogenesis 
(Serrero and Mills, 1991; Bortel et al., 1994; Choy et al., 2000; Choy and Derynck, 
2003; Turner et al., 2008). BMP7, displaying a similar expression profile to TGF-β1, is 
reported to be involved in adipogenesis (Choy et al., 2000; Neumann et al., 2007; 
Kang et al., 2009). However, it is reported that BMP7 promotes differentiation of cells 
into brown adipocytes as opposed to white adipocytes, as is the case for all other 
members of the BMP family (Tseng et al., 2008). The decrease in expression in TGF-
β1 is likely to be a contributing factor to the increased adipogenic effect in MSCs 
cultured on the scaffold. 
 
Overall summary 
MSCs cultured in 3D using Alvetex
TM
, a novel, polystyrene scaffold, demonstrate 
enhanced viability and functionality in their ability to undergo osteogenic and 
adipogenic differentiation. Current tissue culture practise consists, on the main, of 
culturing cells in 2D plastic flasks, an environment which is far removed from the 
complexities of their niche in vivo. Considerations of cell shape and morphology, as 
well as interactions with other cells, is an aspect of cell biology that is often 
overlooked despite the critical role of such factors in influencing cell behaviour. For 
example, osteogenic and adipogenic differentiation of MSCs has been reported to be 
significantly controlled by cell shape and cytoskeletal tension (Sordella et al., 2002; 
McBeath et al., 2004; Jakkaraju et al., 2005; Meyers et al., 2005). As such, current 
knowledge obtained from studying osteogenic and adipogenic differentiation in a 2D 
environment may not be entirely accurate and there is an urgent need for scaffolds that 
can be used for routine in vitro culture which allow cells to adopt conformations and 
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form interactions that are more representative of those that occur in vivo. Although 
culturing cells in such scaffolds often results in increased cellular viability and 
functionality, little work has been done at present to determine what molecular 
changes, if any, are occurring in cells following this 3D culture. This study addresses 
that issue, providing evidence to suggest that MSCs cultured on the scaffold undergo 
enhanced differentiation, at least in part, as a result of increased autocrine behaviour.
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MSCs FUNCTION AS PARACRINE 
MEDIATORS OF NEURAL 
DIFFERENTIATION VIA THE 
RELEASE OF TROPHIC 
FACTORS AND CYTOKINES 
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4.1 Introduction 
 
For many years it was largely believed that the adult mammalian brain only had a very 
limited capacity for regeneration following injury. Neurogenesis – the process by 
which new neurons are generated in the nervous system – was thought to be restricted 
to the developing brain in keeping with Cajal’s central dogma of ‘no new nerve cells 
after birth’ (Ramón y Cajal, 1928; Ehninger and Kempermann, 2008). However, 
Cajal’s views are now known to be somewhat inaccurate, with a study being published 
as early as 1965 providing evidence to suggest that neurogenesis is a constitutively-
occurring process in the hippocampus of postnatal rats (Altman and Das, 1965). 
Although this was a pivotal study at the time, very little progress was made in terms of 
understanding this phenomenon until the development of more sophisticated 
techniques in the 1990s resulted in significant advances (von Bohlen and Halbach, 
2007). Currently, it is widely accepted that neurogenesis occurs in two distinct regions 
of the adult brain – the subgranular zone (SGZ) of the dentate gyrus of the 
hippocampus and the subventricular zone (SVZ) of the lateral ventricles (Eriksson et 
al., 1998; Gould et al., 1999; Garcia et al., 2004; Maslov et al., 2004; Ehninger and 
Kempermann, 2008). In both instances, neurogenesis and the development of new 
neurons has been attributed directly to the neuronal differentiation of neural stem and 
progenitor cells residing in nearby niches. For example, neural stem and progenitor 
cells located in the SVZ enter a rostral migratory stream and eventually differentiate 
into neurons in the olfactory bulb, whereas neural stem and progenitor cells located in 
the SGZ undergo proliferation and migration to the granule cell layer where they 
eventually differentiate into hippocampal granule cells (Altman and Das, 1965; 
Stanfield and Trice, 1988; Goldman, 1995; Kuhn et al., 1996). Interestingly, although 
neural stem and progenitor cells from the SGZ and SVZ occupy different niches in 
vivo i.e. the hippocampus and lateral ventricles of the adult brain respectively, they 
appear to demonstrate a degree of functional interchangeability in that hippocampal 
progenitors demonstrate the potential to migrate to the olfactory bulb and differentiate 
into olfactory bulb neurons following grafting into the rostral migratory stream 
(Suhonen et al., 1996). Such a key observation suggests that neural stem and 
progenitor cells isolated from the SGZ and SVZ are either a) extremely closely related 
to one another phenotypically and are able to respond in a similar manner to the same 
environmental cues or b) possess a greater plasticity than previously anticipated. 
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Although the vast majority of original research articles and review articles state that 
the SGZ and SVZ are the only regions of the adult brain retaining the capacity for 
neurogenesis, several studies have been published reporting that neurogenesis can 
occur in many other regions of the adult brain, including the amygdala, neocortex, 
striatum, subcallosal zone and substantia nigra (Gould et al., 1996; Bernier et al., 
2002; Zhao et al., 2003; Van Kampen et al., 2004; Bedard et al., 2006; Seri et al., 
2006). That said, rates of neurogenesis observed in these areas of the adult brain are 
substantially lower than those rates observed in the SGZ and SVZ (von Bohlen and 
Halbach, 2007). 
 
The existence of neural stem and progenitor cells throughout the SGZ and SVZ of the 
developed adult mammalian brain is supported by several fundamental experimental 
observations. Primary in vitro cultures of phenotypically-immature cells isolated from 
the adult mammalian brain demonstrated a high capacity for proliferation in the 
presence of mitogens such as EGF and FGF and underwent differentiation to express a 
more mature neural phenotype following removal of these growth factors from the 
culture media (Reynolds and Weiss, 1992; Kukekov et al., 1999). Retroviral tracing 
studies also demonstrated that a specific subpopulation of cells within the SGZ and 
SVZ always remained within the proliferative hotspots of these structures and cell 
cycle analysis allowed this cellular subpopulation to be further divided into one of two 
categories: a slowly dividing population (approximately 15 days) and a rapidly 
dividing population (<15 hours) (Morshead et al., 1994; Tropepe et al., 1997; 
Morshead et al., 1998; Doetsch et al., 1999). A slow rate of cell division is akin to a 
stem cell phenotype whilst a rapid rate of cell division is more akin to a progenitor 
phenotype, therefore by extension the slowly dividing cells were considered to belong 
to the neural stem cell population and the rapidly dividing cells were considered to 
belong to the neural progenitor cell population. The most crucial observation of all, 
however, was that after administration of cytarabine (Ara-C) to target and eliminate 
the rapidly dividing population, the rapidly dividing population was regenerated 
following subsequent removal of Ara-C from the culture media (Doetsch et al., 1999). 
This observation offers substantial support for the asymmetric division model 
discussed by Gage in his recent review (2000), whereby neural stem cells in the brain 
are largely quiescent in nature and undergo asymmetric division to produce two 
phenotypically and functionally distinct daughter cells – a stem cell phenotypically 
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identical to the mother cell (self-renewal) and a more lineage-restricted but rapidly 
proliferating progenitor cell (Michalopoulos and DeFrances, 1997; Zhu and Watt; 
1999; Gage, 2000). Although progenitor cells are rapidly proliferating they are only 
able to divide for a limited number of cycles after which they undergo terminal 
differentiation to produce more mature, fully-functioning neural cell types. Therefore, 
in Doetsch’s study described above, the rapidly dividing population is regenerated by 
the slowly dividing population as a consequence of asymmetrical cell division. 
 
Significant progress has been made over the last decade or so in terms of increased 
knowledge and understanding of neural stem cell biology within the adult mammalian 
brain. Intensity surrounding such research continues to escalate for a number of 
reasons. Neural stem and progenitor cells can be propagated as in vitro cultures, 
providing a crucial research tool with which to study complex biological phenomena 
such as neural differentiation and development. Perhaps more interestingly, however, 
is the very realistic possibility that neural stem and progenitor cells within the adult 
brain may be exploited as potential targets of regenerative therapy in the treatment of 
various neurological and neurodegenerative disorders (Reynolds and Weiss, 1992; 
Richards et al., 1992; Johansson et al., 1999). Such a distinct possibility is exciting in a 
system that, for many years, was considered incapable of regeneration following 
neurological injury/deficit. 
 
As modern medical advances have resulted in an ever-ageing population, there is an 
increasing demand for new, more effective therapies against age-related neurological 
and neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and 
multiple sclerosis, amongst many others (Ormerod et al., 2008). Such disorders are 
notoriously difficult to treat effectively due to the significantly varying pathologies 
between disorders and even between individuals with the same disorder and, as such, 
current treatment strategies are largely inadequate. An example is the treatment of 
Parkinson’s disease. The causative mechanism of Parkinson’s disease is substantial 
damage/death of dopaminergic neurons within the substantia nigra pars compacta 
region of the brain (Chiocco et al., 2007). Current clinical intervention involves 
administration of the neurotransmitter dopamine to replace that lost as a consequence 
of dopaminergic neuron damage/death. However, although administration of dopamine 
results in a transient amelioration of clinical symptoms, it fails to halt/slow the 
Chapter 4: MSCs as paracrine mediators of neural differentiation 
 
145 
 
progression of the disease. Therefore, if the complex mechanism(s) by which neural 
stem and progenitor cells differentiate into dopaminergic neurons could be elucidated, 
then the distinct possibility arises whereby either a) neural stem/progenitor cells are 
induced to undergo dopaminergic differentiation in vitro followed by subsequent 
engraftment into the damaged region of the brain or b) endogenous neural 
stem/progenitor cells are promoted to undergo dopaminergic differentiation in vivo. 
 
A more comprehensive understanding of the complex cellular and molecular 
mechanisms of neural differentiation and a greater appreciation of the niche-specific 
signals governing stem cell behaviour in vivo are required if promotion of endogenous 
repair is to become a viable clinical option (Emsley et al., 2005). The neural stem cell 
niche is composed many different structural and functional components such as 
neurons, astrocytes, oligodendrocytes, microglia, immune cells, vasculature and 
extracellular matrix, with each of these components interacting extensively in order to 
influence the behaviour of neural stem cells (Mercier et al., 2002). Astrocyte- and 
vasculature-derived factors are thought to be particularly important in 
maintenance/regulation of neural stem cell function (Palmer et al., 2000; Jin et al., 
2002; Song et al., 2002; Wurmser et al., 2004; Shapiro et al., 2005; Barkho et al., 
2006; Plumpe et al., 2006; Ehninger and Kempermann, 2008). 
 
In their review, Ormerod and colleagues propose three potential mechanisms by which 
stem cell transplantation may be used as a regenerative therapy for neurological and 
neurodegenerative disorders: 
 
1. Stem cells could act as delivery vehicles for soluble factors and cytokines 
to modulate biological activity of endogenous cell types 
 
2. Stem cells could undergo differentiation into mature neural cell types to 
directly replace the cells lost/damaged as a consequence of disease 
 
3. Stem cells could be differentiated into neural cell types in vitro followed by 
transplantation into a network to aid construction of neural circuitry 
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It is the first mechanism that is of principal interest to this thesis. MSCs have been 
previously shown to be able to significantly influence cellular differentiation via the 
expression of soluble factors and cytokines (Chapter 3). Similarly, the inaccessibility 
of neural stem and progenitor cells within the adult brain concomitant with the 
considerable technical challenges of culturing neural cells in vitro means that 
alternative stem cell sources are highly desirable from a clinical perspective. Many 
studies (Chapter 1) have previously shown that MSC transplantation in numerous 
models of neurological and neurodegenerative disorders results in beneficial effects 
and functional recovery to a certain degree. The mechanism behind such beneficial 
effects, though still controversial to an extent, is largely considered to be the result of a 
paracrine relationship between transplanted MSCs and host neural stem cells in that 
MSCs release a plethora of soluble factors and cytokines that direct the 
proliferation/migration/differentiation of endogenous neural stem cells. MSCs have 
been reported to synthesise and secrete a wide range of neurotrophins and neurotrophic 
factors both in vitro and in vivo and cellular-mediated delivery of such factors rather 
than exogenous administration may be advantageous as neurotrophins are large 
peptides that diffuse poorly through the blood brain barrier (Ebadi et al., 1997). An 
increased understanding of the paracrine relationship between MSCs and neural 
stem/progenitor cells would aid in the development of strategies to promote 
endogenous repair following neurological damage in the adult brain. 
 
The present study investigated the paracrine function(s) of MSCs in terms of their 
effect(s) on neural development and plasticity using an in vitro conditioned media 
(CM) model. Studies in Chapter 3 clearly demonstrate that MSCs behave differently 
when cultured in 3D compared to 2D. An alternative, scaffold-free method of 3D cell 
culture involves encouraging cells to form large, multicellular aggregates in order to 
promote structural interactions and re-establishment of mutual contacts between cells 
that are more representative of those that occur in vivo (Pampaloni et al., 2007). MSCs 
cultured as large, multicellular aggregates share many of the phenotypic properties of 
neural stem cell-derived neurospheres, and it has been demonstrated that MSCs 
cultured as 3D aggregates alter their secretory profile accordingly (Hermann et al., 
2004; Croft and Przyborski, 2009). In the present study, MSCs cultured as 3D 
aggregates were allowed to condition media for 3 days, after which CM was collected 
and used in the downstream culture of neural stem cells. Neural stem and progenitor 
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cells isolated from both adult and fetal brains have been propagated as genetically 
stable cell lines, making them extremely useful and a highly convenient tool for use in 
an in vitro setting (Palmer et al., 1997; Svendsen et al., 1998; Carpenter et al., 1999; 
Vescovi et al., 1999). The cell line used in the studies performed in this thesis was the 
HCN-nitGFP adult hippocampal progenitor cell (AHPC) line, originally propagated by 
and a generous gift from Fred Gage (Salk Institute). Although primary cultures are 
often advantageous and considered to be a more physiologically accurate system in 
which to perform studies, the AHPC cell line is beneficial in that it has been 
extensively characterised, highly used in our lab and can be cultured as a monolayer, 
which is much less technically demanding than culturing primary adult neural 
stem/progenitor cells as neurospheres. Similarly, isolation of neural stem/progenitor 
cells from primary sources is extremely technically challenging e.g. ensuring 
dissection of the same region of brain each time, a lack of standardisation means that 
culture conditions employed vary significantly between different laboratories and the 
strain of rodent is rarely controlled for (Gage, 2000). The influence of MSC aggregate-
derived soluble factors on AHPC fate was investigated at both the cellular and 
molecular level in this study. 
 
 
Hypothesis 
MSCs cultured as large, multicellular 3D aggregates secrete a specific complement of 
soluble factors and cytokines that influence the cell fate decisions of neural stem and 
progenitor cells. 
 
Aims of chapter 
To culture MSCs as multicellular spherical aggregates and examine the effect of 
soluble factor(s) secrete by such aggregates in terms of their ability to influence the 
cell fate decisions of the AHPC cell line. 
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Objectives 
1. Culture MSCs as multicellular 3D aggregates and examine the phenotype of 
such aggregates in terms of morphology and marker expression 
 
2. Examine the soluble factor(s) produced by aggregates by allowing them to 
condition media for 3 days and using this CM in the subsequent culture of 
AHPCs 
 
3. Examine the cellular mechanism(s) by which soluble factor(s) in CM were 
bringing about their effect 
 
4. Examine the molecular mechanism(s) by which soluble factor(s) in CM were 
bringing about their effect 
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4.2 Materials and methods 
 
4.2.1 Formation of 3D cellular aggregates by MSCs 
MSCs were induced to form 3D cellular aggregates using a previously published 
protocol (Hermann et al., 2004; Hermann et al., 2006a). Briefly, MSCs were 
maintained and expanded as monolayer cultures under standard conditions, as 
described in Section 2.1. When confluency was reached, cells were detached from the 
cellware by washing in PBS x 1, followed by incubation with 0.25% trypsin and 0.1% 
EDTA for 5-10 minutes at 37
o
C. Trypsin was inactivated by the addition of complete 
culture medium (CCM) to the tissue culture flask. Cells were centrifuged at 250 x g for 
5 minutes, the supernatant removed, and cells resuspended in 1ml of aggregate 
induction medium (AIM: DMEM:F12, supplemented with N2 supplement (1x), L-
glutamine (12M), penicillin (100 U/ml), streptomycin (100 g/ml), heparin (sodium 
salt, 40ng/ml), EGF (10ng/ml) and FGF (10ng/ml). Cells were seeded into normal 
cellware at a density of 1-2 x 10
5
 cells/cm
2
 and incubated at 37
o
C, 5% CO2 and in a 
low O2 (5%) environment. Aggregate formation on the surface of the tissue culture 
plastic was apparent within 1-3 days, and with continued culture aggregates enlarged 
in size and eventually lifted off the cellware surface (within approximately 5-14 days) 
to exist as free-floating 3D aggregates in the media. For routine culture of aggregates, 
growth factors (EGF and FGF) were replenished twice a week, and medium was 
changed once a week. 
 
4.2.2 Production and processing of conditioned media by 3D MSC aggregates 
As described in Section 4.2.1, MSCs can be induced to form cellular aggregates when 
cultured under appropriately-defined conditions, namely the removal of serum and 
addition of growth factors (EGF and FGF) to the culture medium. In order to examine 
the soluble factors and/or cytokines produced and secreted by these aggregates, and 
determine the effect(s) (if any) on the cell fate decisions of neural stem/progenitor 
cells, a conditioned media approach was adopted. MSCs were seeded out for aggregate 
formation into T25s as described in Section 4.2.1 (each T25 contained 8ml media) and 
allowed to condition the medium for 3 days, with day 0 starting from the initial 
seeding of the MSCs from standard culture conditions to aggregate-inducing 
conditions. After 3 days, the conditioned medium was removed from the flask, 
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centrifuged at 2000rpm for 5 minutes to remove cell debris, supernatant removed and 
filtered using a 0.22μm pore filter and stored at -20oC until required. 
 
4.2.3 Adult hippocampal progenitor cell (AHPC) culture with conditioned medium 
(CM) 
AHPCs were maintained and expanded as monolayer cultures under standard 
conditions, as described in Section 2.2. When a confluency of 70-80% was reached, 
cells were detached from the cellware by quickly rinsing with 0.25% trypsin and 0.1% 
EDTA for 1-2 minutes at 37
o
C and subsequently seeded out a density of 10,000 
cells/cm
2
 into cellware coated with poly-L-ornithine (10μg/ml) and laminin (5μg/ml), 
in N2 medium, and allowed 24 hours to settle (designated day –1). Following this 24 
hour settling period (day 0), medium was removed and replaced with CM or 
appropriate control medium (UC: unconditioned medium; PC: proliferation control) 
and AHPCs cultured for a further 7 days. Media were replenished on the 4
th
 day. UC 
medium consisted of DMEM:F12, N2 supplement (1x), L-glutamine, (12M), 
penicillin (100 U/ml), streptomycin (100 g/ml) in the absence of the growth factors 
EGF and FGF, as mass spectrometric analysis of CM revealed that these growth 
factors were depleted during the 3 day conditioning process (data not shown). 
 
4.2.4 Analysis of cell proliferation and cell death using flow cytometry 
To assess cell proliferation in AHPC cultures at days 4 and 7, 10μM 5-bromo-2-
deoxyuridine (BrdU) was added to the culture medium for a period of 24 hours prior to 
these timepoints i.e. at days 3 and 6. Following this, cells were then washed in PBS x 
1, fixed in 2% PFA overnight at 4
o
C and processed for dual staining as follows. Cells 
were spun down at 2000rpm for 5 minutes and the supernatant removed. Pellets were 
resuspended gently in 1ml permeabilising solution (0.2% Triton-X in PBS) and 
incubated at 37
o
C for 30 minutes. Then, 1ml FACS buffer (2% NGS and 0.2% Tween 
in PBS) was added, the cells spun down at 2000rpm for 5 minutes, the supernatant 
removed and the pellet gently resuspended in 2M HCl and incubated for 30 minutes at 
room temperature, to unravel DNA to form single strands. Following this, cells were 
spun down at 2000rpm for 5 minutes, the supernatant removed and cells washed in 
0.5M borate buffer (pH 8.5) for 10 minutes at room temperature, followed by 
additional washes in FACS buffer x 3. Cells were then dual-stained with primary 
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antibodies in the following combinations: anti-Tuj1/anti-BrdU, anti-GFAP/anti-BrdU 
and anti-GalC/anti-BrdU overnight at 4
o
C. Primary antibodies for Tuj1, GFAP and 
GalC were used at dilutions previously detailed, and the primary antibody for BrdU 
was used at a dilution of 1:40. Following this incubation, cells were then washed in 
FACS buffer x 3 and stained with appropriate fluorochrome-conjugated secondary 
antibodies for 30 minutes at room temperature. Tuj1 was detected with an APC-
labelled anti-rabbit secondary antibody (1:300), GFAP and GalC were detected with an 
APC-labelled anti-mouse secondary antibody (1:600) and BrdU was detected with a 
PE-labelled secondary antibody (1:600). Following this incubation, cells were then 
washed in FACS buffer x 3 and subsequently processed for flow cytometric analysis. 
PE-fluorescence was detected in the FL2 band pass filter and APC-fluorescence 
detected in the FL4 band pass filter, and the fraction of cells exhibiting positive 
staining for both BrdU and each of the neural markers Tuj1, GFAP and GalC was 
determined. 10,000 events were determined for each condition. 
 
To assess cell death in AHPC cultures at days 4 and 7, 50μg/ml propidium iodide (PI) 
was added to the culture medium for a period of 10 minutes in the dark. Following 
this, cells were then washed in PBS x 1, fixed in 2% PFA overnight at 4
o
C and 
processed for staining as follows. (Note – it was crucial to get cells floating in the 
media as well as adherent cells to assess cell death). Cells were spun down at 2000rpm 
for 5 minutes and the supernatant removed. Pellets were resuspended gently in 1ml 
permeabilising solution (0.2% Triton-X in PBS) and incubated at 37
o
C for 30 minutes. 
Then, 1ml FACS buffer (2% NGS and 0.2% Tween in PBS) was added, the cells spun 
down at 2000rpm for 5 minutes and the supernatant removed.  Cells were then stained 
with primary antibodies directed against Tuj1, GFAP and GalC overnight at 4
o
C at the 
dilutions previously described. Following this incubation, cells were then washed in 
FACS buffer x 3 and stained with appropriate fluorochrome-conjugated secondary 
antibodies for 30 minutes at room temperature. Tuj1 was detected with an APC-
labelled anti-rabbit secondary antibody, and GFAP and GalC were detected with an 
APC-labelled anti-mouse secondary antibody, at the dilutions previously described. 
Following this incubation, cells were then washed in FACS buffer x 3 and 
subsequently processed for flow cytometric analysis. PI-fluorescence was detected in 
the FL2 band pass filter and APC-fluorescence detected in the FL4 band pass filter, 
and the fraction of cells exhibiting positive staining for both PI and each of the neural 
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markers Tuj1, GFAP and GalC was determined. 10,000 events were determined for 
each condition. 
 
4.2.5 Analysis of apoptosis in GFAP
+
 and GalC
+
 AHPC subpopulations using flow 
cytometry 
To assess apoptosis in GFAP
+
 and GalC
+
 subpopulations of AHPCs at days 4 and 7, 
cells were washed in PBS x 1, fixed in 2% PFA overnight at 4
o
C and processed for 
staining as follows. (Note – it was crucial to get cells floating in the media as well as 
adherent cells to assess cell death). Cells were spun down at 2000rpm for 5 minutes 
and the supernatant removed. Pellets were resuspended gently in 1ml permeabilising 
solution (0.2% Triton-X in PBS) and incubated at 37
o
C for 30 minutes. Then, 1ml 
FACS buffer (2% NGS and 0.2% Tween in PBS) was added, the cells spun down at 
2000rpm for 5 minutes and the supernatant removed. Cells were then dual-stained with 
primary antibodies in the following combinations: anti-GFAP/anti-caspase 3 and anti-
GalC/anti-caspase 3, and incubated overnight at 4
o
C. Primary antibodies for GFAP and 
GalC were used at dilutions previously detailed, and the primary antibody for caspase 
3 was used at a dilution of 1:200. Following this incubation, cells were then washed in 
FACS buffer x 3 and stained with appropriate fluorochrome-conjugated secondary 
antibodies for 30 minutes at room temperature. GFAP and GalC were detected with an 
APC-labelled anti-mouse secondary antibody and caspase 3 was detected with a PE-
labelled anti-rabbit secondary antibody, at the dilutions previously detailed. Following 
this incubation, cells were then washed in FACS buffer x 3 and subsequently 
processed for flow cytometric analysis. PE-fluorescence was detected in the FL2 band 
pass filter and APC-fluorescence detected in the FL4 band pass filter, and the fraction 
of cells exhibiting positive staining for both caspase 3 and each of the neural markers, 
GFAP and GalC, was determined. 10,000 events were determined for each condition. 
 
4.2.6 Analysis of early- and late-apoptosis in 33B cells using flow cytometry 
To assess apoptosis in 33B cells following culture with CM media and appropriate 
controls (UC) for 4 and 7 days, cells were incubated with 50μg/ml propidium iodide 
(PI) for a period of 10 minutes in the dark. Following this, cells were then washed in 
PBS x 1, fixed in 2% PFA overnight at 4
o
C and processed for staining as follows. 
(Note – it was crucial to get cells floating in the media as well as adherent cells to 
assess cell death). Cells were spun down at 2000rpm for 5 minutes and the supernatant 
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removed. Pellets were resuspended gently in 1ml permeabilising solution (0.2% 
Triton-X in PBS) and incubated at 37
o
C for 30 minutes. Then, 1ml FACS buffer (2% 
NGS and 0.2% Tween in PBS) was added, the cells spun down at 2000rpm for 5 
minutes and the supernatant removed. Cells were than stained with an anti-caspase 3 
primary antibody (1:200) overnight at 4
o
C. Following this incubation, cells were then 
washed in FACS buffer x 3 and stained with an APC-labeled anti-rabbit secondary 
antibody (1:300) for 30 minutes at room temperature. Following this incubation, cells 
were then washed in FACS buffer x 3 and subsequently processed for flow cytometric 
analysis. PI-fluorescence was detected in the FL2 band pass filter and APC-
fluorescence detected in the FL4 band pass filter, and the fraction of cells exhibiting 
positive staining for caspase 3 alone and caspase-3/PI-dual staining was determined. 
10,000 events were determined for each condition. 
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4.3 Results 
4.3.1 MSCs can be induced to form cellular aggregates when cultured under 
serum-free conditions in the presence of mitogens, EGF and FGF 
The principal aims of the studies described in Chapter 3 were to investigate the 
effect(s) of culturing MSCs in the 3D environment of the novel polystyrene scaffold, 
Alvetex
TM
. These studies clearly demonstrated that MSCs cultured in 3D displayed 
markedly different behavioural traits, in terms of cellular viability and potential to 
undergo osteogenic and adipogenic differentiation, compared to their equivalent 
cultures on the 2D environment of tissue culture plastic. As such, culturing cells in 3D 
is advantageous in that it provides a more realistic and physiologically-relevant system 
in which to study complex biological phenomena such as differentiation. 
 
An alternative method of culturing cells in 3D involves encouraging them to form 
cellular aggregates. The formation of such aggregates in vitro has been reported to 
result in the re-establishment of mutual contacts between cells which better represent 
cell-cell interactions that exist in vivo (Pampaloni et al., 2007). This method of 3D 
culture is advantageous in that it does not require external scaffolds, such as the 
polystyrene scaffold used in Chapter 3, and the methodology of inducing cells to form 
aggregates is relatively simple. Many techniques employed in the literature exploit the 
ability of cells to naturally aggregate with one another when cultured using the 
hanging drop technique or, similarly, when cultured in rotating vessels (Pampaloni et 
al., 2007). However, in the present study a slightly different methodology was 
adopted. A number of studies have reported that MSCs can be induced to form cellular 
aggregates when cultured under identical conditions to those used for the propagation 
of neurospheres from neural stem cells (Croft and Pryzborski, 2004; Hermann et al., 
2004; Bossolasco et al., 2005; Hermann et al., 2006). It is this technique that has been 
employed in the present study and is described in Section 4.2.1. 
 
Figure 4.1 shows MSCs cultured under standard and aggregate-inducing conditions. 
Under standard culture conditions, MSCs demonstrated a large, flat, fibroblastic 
morphology as previously reported in Section 3.3.1 (Figure 4.1A). However, when 
switched to culture conditions described for the propagation of neurospheres from 
neural stem cells, MSCs formed cellular aggregates that were morphologically 
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indistinguishable from neural stem cell-derived neurospheres (Figure 4.1B and 4.1C). 
Aggregate-inducing culture conditions are described in detail in Section 4.2.1 and 
involve seeding MSCs at a high density (1-2 x 10
5
 cells/cm
2
) in serum-free (N2) media 
in the presence of mitogens (EGF and FGF). 
 
Within 24-72 hours, small spherical aggregations of cells were evident on the surface 
of the cellware (Figure 4.1B). However, not all of the seeded cells formed aggregates, 
with a small proportion of adherent cells forming flat morphologies as per standard 
culture, though the large majority of cells did form aggregates to the extent that 
multiple aggregates were present in each field of view, as illustrated in Figure 4.1B. 
With continued culture and further addition of mitogens to the culture media, cells 
within the aggregates continued to proliferate and aggregates continued to enlarge in 
size, eventually lifting off the cellware surface and forming free-floating aggregates 
suspended in the culture media (Figure 4.1C). This typically occurs between 5 and 14 
days. Free-floating aggregates remained highly viable in suspension and with 
prolonged culture began to co-aggregate with each other (Figure 4.1C). 
 
4.3.2 3D MSC aggregates demonstrate an increase in expression of neural 
antigens and a decrease in expression of mesenchymal antigens compared to 
standard 2D cultures 
Culturing MSCs under aggregate-forming conditions such as those detailed in Section 
4.2.1 is reported to result in the formation of spherical cellular masses that are 
morphologically indistinguishable from neural stem cell-derived neurospheres 
(Bossolasco et al., 2005). Morphological images of such MSC-derived aggregates are 
shown in Figure 4.1. One of the key, unique properties of MSC aggregates is that they 
express high levels of neural antigens such as nestin, Tuj-1 and GFAP, concomitant 
with a decrease in expression of characteristic MSC markers such as α-SMA (Kabos et 
al., 2002; Croft and Przyborski, 2004; Hermann et al., 2004; Suzuki et al., 2004; 
Hermann et al., 2006; Kim et al., 2006). In order to examine this behaviour in the 
present study, expression of the neural markers, nestin and GFAP, and the 
mesenchymal marker, α-SMA, were examined via immunocytochemical and flow 
cytometric methods. 
Chapter 4: MSCs as paracrine mediators of neural differentiation 
 
156 
 
 
Figure 4.1. Formation of cellular aggregates by MSCs. Under defined conditions, namely serum 
removal and addition of mitogens to the growth media, MSCs can be induced to form large cellular 
aggregates. Under standard culture conditions MSCs exist as large, flat cells in a monolayer (A). Upon 
aggregate inducing conditions, they form cellular aggregates, initially on the surface of the cellware (B), 
though as these aggregates continue to grow and enlarge, they eventually lift off the cellware surface 
and exist in suspension. These free-floating aggregates are perfectly viable and continue to grow, 
eventually co-aggregating with one another (C). Scale bars = 100µm. 
 
 
Aggregates were fixed directly as whole aggregates by incubation in 4% PFA 
overnight at 4
oC and processed for immunocytochemistry against nestin, GFAP and α-
SMA as described in Section 2.7. The neural markers, nestin and GFAP, demonstrated 
intense levels of staining in aggregates, suggesting very high levels of expression 
(Figure 4.2B and 4.2D). This is consistent with previous studies. However, expression 
of nestin and GFAP could not be detected in MSCs cultured under standard conditions 
(data not shown), demonstrating that aggregates were upregulating expression of 
neural antigens compared to standard cultures. Expression of the mesenchymal marker, 
α-SMA, was also readily detectable in aggregates, though levels of staining were far 
less intense than those observed for neural markers (Figure 4.2F). MSCs cultured 
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under standard conditions demonstrated intense levels of α-SMA expression, as shown 
previously in Figure 3.3. 
 
To confirm these immunocytochemical observations, expression of the previous 
markers in MSC-derived aggregates were also examined using flow cytometric 
methods (Figure 4.3). Flow cytometry circumvents potential problems associated with 
staining aggregates as whole structures – such as the possibility of false negative 
results occurring due to antibody entrapment within the aggregate rather than specific 
staining – as the methodology first requires aggregates to be dissociated into a single 
cell suspension. This was achieved enzymatically using trypsin. Once a single cell 
suspension had been achieved, cells were fixed in 2% PFA overnight at 4
o
C and 
processed for flow cytometry as detailed in Section 2.6. This method of analysis 
allows more confidence as the expression data achieved is at the individual cellular 
level. Cells derived from MSC aggregates demonstrated positive expression of the 
neural markers nestin and GFAP and, to a lesser extent, α-SMA, which is consistent 
with the immunocytochemical observations (Figure 4.3). 
 
4.3.3 MSC-derived aggregates secrete soluble factor(s) and cytokine(s) that 
influence cell fate decisions of neural stem and progenitor cells 
There is an abundance of evidence in the literature to suggest that MSC-based cellular 
therapies may provide a means of treating neurological and neurodegenerative 
disorders (Section 1.4.1). Although the significant improvements in neurological 
function observed in such studies were undoubted, the mechanism(s) via which MSCs 
elicited this recovery remained (and still remain to this date) a subject of intense 
debate. Proposed mechanisms included: a) ‘trans’-differentiation; b) cell fusion; and c) 
stimulation of endogenous repair, and all three mechanisms are discussed in detail in 
Section 1.6.3. However, it is now becoming more commonly accepted that the main 
mechanism by which MSCs promote functional recovery of neurological deficits is via 
the release of trophic factors and cytokines that stimulate endogenous repair processes 
in the host (Chen et al., 2001; Chen et al., 2002; Chen et al., 2004; Mahmood et al., 
2005). Such endogenous processes are likely to occur via the effect(s) of MSC-derived 
soluble factors on resident neural stem cells. Indeed, it has been reported that MSC 
transplantation results in an increase in the proliferation and migration of neural stem 
cells in the transplant recipient (Munoz et al., 2005). 
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Figure 4.2. Immunocytochemical analysis of expression of neural and mesenchymal markers in 
MSC aggregates. Images A, C and E correspond to the nuclear DAPI stain, whereas images B, D and F 
correspond to nestin, GFAP and α-SMA respectively. α-SMA is expressed highly in MSCs cultured 
under standard conditions (Figure 3.3); however, detection of the neural antigens nestin and GFAP 
could not be detected (data not shown). Scale bar = 100μm.  
 
 
Nestin 
GFAP 
α-SMA 
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Figure 4.3. Flow cytometric analysis of expression of neural and mesenchymal markers in MSC 
aggregates. Representative traces showing typical marker expression profiles for nestin (A), GFAP (B) 
and α-SMA (C) in MSCs cultured as aggregates. Clear traces correspond to the P3X negative control 
and black traces correspond to specific positive fluorescence.  
 
 
Previous work in our lab has demonstrated that MSC-derived aggregates are able to 
influence the cell fate decision of embryonic neural stem cells following co-culture in 
vitro (Croft and Przyborski, 2009). This effect had to be the result of a paracrine 
relationship between the two cell types as both cell types were separated by a porous 
membrane i.e. could only communicate with each other via the action of soluble 
factors and cytokines. This setup is advantageous in that it allows intercellular 
communication between the two cell types as would be the case in vivo, and MSCs 
have been previously reported to change their secretome depending on the specific 
cellular microenvironment (Chen et al., 2002). However, despite this major advantage, 
the setup is fundamentally flawed in terms of identifying the soluble factors present in 
the media as it would be extremely difficult to determine the cellular origin of soluble 
factors present. Even if cells from different species were used in such a study, such is 
the cross-reactivity of proteins from different species in experiments such as ELISAs 
that very little useful data would be achieved. 
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 A simpler approach would involve setting up a condition media (CM) assay, in which 
MSC-derived aggregates are allowed condition media for a specified time, after which 
the media removed and used to culture neural stem/progenitor cells. This allows that 
any cellular effect observed can be attributable to aggregate-derived soluble factors 
and, as such, would allow easier identification of the active component(s) present in 
the media. 
 
In the present study, an aggregate-based conditioned media (CM) system was set up 
using previously published protocols regarding the generation of CM from MSCs. The 
effect of this CM on neural development and the mechanisms by which such effect(s) 
occurred were evaluated using a progenitor cell line routinely used in our lab, the rat 
adult hippocampal progenitor cell (AHPC) line. This cell line can be easily expanded 
in the lab and has previously shown the ability to differentiate into all three major 
neural lineages; neurons, astrocytes and oligodendrocytes. 
 
4.3.4 Aggregate-derived soluble factors induce the formation of a glial morphology 
in AHPCs following 7 days culture 
MSCs were seeded out for aggregate formation and allowed to condition media for 3 
days, as described in Section 4.2.1. Following this, media was collected and prepared 
as detailed prior to downstream culture of AHPCs. For the remainder of this thesis, 
such media will be referred to as CM (conditioned media). As detailed in Section 
4.2.3, AHPCs were seeded onto cellware coated with PLO and laminin at a density of 
10,000 cells/cm
2
 in their normal proliferative media and were allowed 24 hours to 
settle (designated day –1). Following this 24 hour period (day 0), media was removed 
and replaced with CM or appropriate control media (UC: unconditioned control i.e. 
media in which no cells had been cultured; PC: proliferation control i.e. standard 
AHPC culture medium) and AHPCs cultured for a further 7 days. Media was 
replenished on the 4
th
 day. After 7 days, AHPCs were analysed for any obvious 
changes in cellular morphology (Figure 4.4). PC AHPCs were largely phase dark and 
very densely packed following 7 days culture (Figure 4.4A). Cell bodies were very 
rounded with no obvious evidence of processes or cytoplasmic extensions forming, 
suggesting that they were largely undifferentiated. This is in complete contrast to 
AHPCs cultured under UC and CM conditions, where the large majority of cells 
demonstrated phase-bright soma in contrast to the dark-phase soma observed in PC. In 
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addition, AHPCs cultured under UC conditions possessed numerous short processes, 
which again was in complete contrast to PC. Although possessing numerous processes 
per soma, UC cells still appeared largely undifferentiated, as these processes were very 
short in length and did not demonstrate any obvious characteristics of neuronal or glial 
morphologies (Figure 4.4B).  
 
AHPCs cultured with CM, however, possessed multiple processes per soma that did 
acquire morphologies very characteristic of a more mature neural phenotype (Figure 
4.4C). The presence of extensive multipolar soma suggested that AHPCs were 
producing glia under these conditions as opposed to neurons, whose morphologies 
would be typically bipolar with processes terminating in growth cones. Morphological 
evidence suggested that AHPCs were forming astrocytes as opposed to 
oligodendrocytes when cultured with CM, as they possessed a highly characteristic 
stellate, star-shaped morphology as opposed to a more intricate oligodendrocytic 
morphology consisting of extensive secondary and tertiary branching. 
 
4.3.5 Culturing AHPCs in CM for 7 days results in expression of the structural 
astrocytic marker, GFAP, as determined by immunocytochemistry and flow 
cytometric analysis 
Although morphological analysis is useful, it is limited in terms of what conclusions 
can be drawn from it because it cannot be used solely to confirm the phenotype of a 
specific cell type. In order to gain more information regarding the phenotype of 
AHPCs cultured in CM and appropriate controls for 7 days, expression of a range of 
neural markers were examined using immunocytochemistry and flow cytometry. 
Markers specific for neuroprogenitors and the three major neural cell types were used 
– nestin (neuroprogenitor marker), Tuj-1 (neuronal marker), GFAP (astrocytic marker) 
and GalC (oligodendrocytic marker). 
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Figure 4.4. Morphology of AHPCs after 7 days culture with conditioned media and appropriate 
controls. A: AHPCs cultured under their normal proliferative conditions; B: AHPCs cultured with 
unconditioned media; C: AHPCs cultured with conditioned media. Cells in A and B appear largely 
undifferentiated, whereas cells in C appear to have adopted a glial morphology, having multipolar cell 
bodies with numerous processes, as opposed to neuronal cell types, which are typically bipolar. Scale 
bar = 100µm. 
 
AHPCs were seeded out for marker analysis experiments as described in Section 4.2.3 
and cultured in CM and appropriate controls (PC and UC) for 7 days. Following 7 days 
culture, AHPCs were fixed in 4% PFA for 30 minutes at room temperature and 
processed for immunocytochemistry directed against nestin, Tuj-1, GFAP and GalC as 
described in Section 2.7. AHPCs cultured under all three conditions – PC, UC and CM 
– demonstrated intense staining for the neuroprogenitor marker, nestin (Figures 4.5A, 
4.5B and 4.5C). Patterns of staining corresponded with the cellular morphologies 
described in Section 4.3.4. Conversely, expression of the neuronal marker, Tuj-1, was 
undetectable in AHPCs cultured under all three conditions (Figures 4.5D, 4.5E and 
4.5F). In terms of GalC expression, the oligodendrocytic marker, AHPCs cultured 
under UC and CM conditions demonstrated very weak, diffuse staining that was 
present in the large majority of cells per field of view (Figures 4.5K and 4.5L). GalC 
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was undetectable in AHPCs cultured under normal proliferative conditions (Figure 
4.5J). However, the most striking result from these experiments was in terms of GFAP 
expression, the astrocytic marker. GFAP was undetectable in AHPCs cultured under 
PC and UC conditions (Figures 4.5G and 4.5H). AHPCs cultured with CM for 7 days, 
on the other hand, demonstrated a significant increase in expression of GFAP such that 
the large majority of cells per field of view stained intensely for GFAP (Figure 4.5I). 
The specificity of GFAP expression to CM cultures strongly suggested the presence of 
some unknown soluble factor(s) present in CM that induced expression of GFAP and 
hence an astrocytic phenotype in AHPCs. These marker analyses were in keeping with 
previous morphological observations which suggested that culturing AHPCs with CM 
caused them to adopt an astrocytic morphology (Figure 4.5C). Patterns of GFAP 
staining corresponded with this astrocytic morphology and can be seen at higher 
magnification in Figure 4.6. 
 
Analysis of cell marker expression using immunocytochemical methods is useful in 
that it allows a visualisation of cellular morphology and determination of protein 
location at the subcellular level. However, one major limitation of this technique is that 
it lacks the sensitivity of more sophisticated techniques such as flow cytometry. Flow 
cytometry allows even the slightest of changes in protein expression to be detected and 
similarly allows an accurate measurement of protein intensity to be made (MFI). 
Therefore, using these techniques simultaneously yields the most comprehensive 
results. 
 
AHPCs were seeded out as described above and cultured in CM and appropriate 
controls (PC and UC) for 7 days. Following 7 days culture, AHPCs were fixed in 2% 
PFA at 4
o
C overnight and processed for flow cytometry against nestin, Tuj-1, GFAP 
and GalC as described in Section 2.6. Data in terms of the percentage of cells 
expressing marker and MFI of marker expression are shown graphically in Figure 4.7 
in terms of raw data (Figures 4.7A and 4.7B) and as a fold-increase above PC (Figures 
4.7C and 4.7D). As AHPCs cultured under normal, proliferative conditions (PC) 
should remain largely undifferentiated, expression levels in PC samples should reflect 
endogenous levels of expression in undifferentiated AHPCs. Expressing UC and CM 
data as a fold-increase or fold-decrease compared to PC essentially normalises against 
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basal levels of expression and allows more useful comparisons to be made between 
UC and CM samples. 
 
In terms of the percentage of cells expressing each neural marker, there was very little 
difference between each of the samples (Figure 4.7A and 4.7C). Any differences in 
expression that were apparent – such as the increase in the percentage of cells 
expressing GFAP and GalC and the decrease in percentage of cells expressing nestin 
and Tuj-1 – were very slight and not significant at the statistical level. Such is the 
sensitivity of flow cytometry that cells expressing extremely low levels of antigen will 
be detected as positive events, even when the level is so low it is unlikely to be 
biologically relevant. That is why it is necessary to examine percentage of cells 
expressing marker simultaneously with MFI of marker expression, as it allows 
discrimination between cells that are weakly and strongly positive for expression. In 
terms of MFI of nestin, Tuj-1 and GalC expression, there was very little observable 
difference between UC and CM samples (Figures 4.7B and 4.7D). Any slight 
differences were not significant at the statistical level. However, in terms of MFI of 
GFAP expression, AHPCs cultured with CM for 7 days demonstrated a dramatic 
increase in marker intensity, a greater than 20-fold increase compared to PC and UC 
(Figures 4.7B and 4.7D). This observation was highly significant at the statistical level 
(p<0.001). This observation strongly supports the immunocytochemical data (Figure 
4.5). 
 
4.3.6 AHPCs cultured with CM for 7 days exit the cell cycle, providing further 
evidence that soluble factors present within CM induce differentiation in AHPCs 
There is a delicate balance between cell proliferation and cell differentiation that must 
be maintained in vivo for proper growth to occur and prevent disorders such as 
cancers. The process of cell proliferation is strictly controlled during the differentiation 
of stem cells, with differentiation of stem cells frequently occurring silmultaneously 
with exit from the cell cycle. Indeed, exit from the cell cycle has been reported to 
precede the differentiation of neural progenitors towards astrocytes (Galderisi et al., 
2003). Therefore, if the formation of an astrocytic morphology and increase in GFAP 
expression in AHPCs following culture in CM for 7 days is indicative of true 
astrocytic differentiation, it would be expected that AHPCs undergo exit from the cell 
cycle. This was examined in the present study. AHPCs were seeded out as previously  
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Figure 4.5. Expression of neural markers in AHPCs following 7 days culture with conditioned 
media and appropriate controls. A, B and C: expression of nestin; D, E and F: expression of Tuj-1; 
G, H and I: expression of GFAP; J, K and L: expression of GalC. Treatment of AHPCs with 
conditioned media results in a significant upregulation in GFAP expression, suggesting that MSC-
derived aggregates secrete a complement of soluble factors/cytokines that induce AHPCs to undergo 
gliogenesis. Scale bar = 100μm. 
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Figure 4.6. Morphology of GFAP
+
 AHPCs following culture with conditioned media for 7 days. 
Treatment of AHPCs with conditioned media for 7 days results in a significant upregulation of GFAP 
expression, suggesting that MSC-derived aggregates secrete a complement of soluble factors/cytokines 
that induce AHPCs to undergo gliogenesis. Analysis of GFAP
+
 AHPCs at the morphological level 
suggests that these cells are adopting a predominantly glial morphology, having multipolar cell bodies 
with numerous processes, as opposed to neuronal cell types, which are typically bipolar. Morphological 
evidence alone suggested AHPCs were forming astrocytes as opposed to oligodendrocytes, possessing a 
characteristic stellate, star-shaped morphology as opposed to a more intricate oligodendrocytic 
morphology consisting of extensive secondary and tertiary branching. Magnification is X40. 
 
 
detailed in Section 4.2.3, switched to CM and appropriate control conditions (PC and 
UC) and the number of viable cells in culture determined at the 1, 3 and 7 day 
timepoints using the MTS proliferation assay. At both the 1 and 3 day timepoints, there 
was little observable difference regarding the number of viable cells in culture between 
control (PC and UC) and CM conditions (Figure 4.8). At the 7 day timepoint, however, 
there was a huge difference between the number of AHPCs in PC cultures compared to 
UC and CM cultures – the presence of FGF2 as a component of the PC media 
stimulated the proliferation of AHPCs. Despite this marked difference in viable cell 
number between PC and the two other conditions, there was no observable difference 
between viable cell number in UC vs. CM cultures at the 7 day timepoint. Absorbance 
values at 490nm for UC and CM samples were approximately one-third the absorbance 
values of PC samples (Figure 4.8). These data clearly suggest that AHPCs cultured 
under UC and CM conditions were not proliferating and, by extension, were exiting 
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the cell cycle. The lack of FGF2 in the UC media explains why little proliferation of 
AHPCs was observed over the 7 day time course of the experiment compared to PC. 
An equivalent number of cells were observed in CM samples, strongly suggesting that 
soluble factors present in CM did not exert any proliferative effects. 
 
4.3.7 In addition to upregulation of structural astrocytic markers such as GFAP, 
AHPCs cultured with CM for 7 days also demonstrate a marked upregulation in the 
expression of functional biochemical markers indicative of an astrocytic phenotype 
Previous data in this study has demonstrated that aggregate-derived soluble factors 
present in CM induce AHPCs to acquire an astrocytic morphology concomitant with a 
significant upregulation in expression of the structural astrocytic marker, GFAP. 
Combined, these data strongly suggest that AHPCs are being induced to undergo 
astrocytic differentiation. In terms of assessing cell differentiation, however, it is 
perhaps functional behaviour rather than simple marker analysis that provides more 
convincing evidence of true differentiation. Such functional assays were performed in 
Chapter 3 to assess osteogenic (ALP activity and osteocalcin secretion) and adipogenic 
differentiation (cAMP activity).  
 
In terms of neuronal differentiation, functional assessment of differentiation would 
typically be measured in terms of electrical activity such as the generation of action 
potentials (Jurga et al., 2009). However, assessing the functional activity of astrocytes 
is somewhat more complex, as commonly reported functions of astrocytes include 
supporting neuronal growth by providing nutrients, influencing neuronal behaviour by 
releasing neurotrophic soluble factors and cytokines, maintenance of a proper ion 
balance in the extracellular space in vivo and forming the blood-brain barrier, amongst 
many others (Kimelberg, 1983; Nimmerjahn, 2009). Unsurprisingly, these are all 
functions that are extremely difficult to assess in vitro. Therefore, the most commonly 
used method of assessing functional astrocytic behaviour in vitro is by examining 
expression of various functional biochemical receptors. Here, expression of four major 
biochemical receptors indicative of an astrocytic phenotype were examined at the 
mRNA level for AHPCs cultured with CM and appropriate controls for 7 days. These 
were AMPA receptor 3 (AMPA3), GABA-A, NMDA receptor 3 (NMDA-2D) and 5-
HT 1A, all of which have been reported as functional biochemical markers of 
astrocytic behaviour (Kamnasaran et al., 2008).  
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Figure 4.7. Flow cytometric analysis of marker expression in AHPCs treated with conditioned 
media and controls. A: % cells expressing marker; B: mean fluorescence intensity of marker 
expression; C: fold change in the % cells expressing marker (compared to proliferation control); D: fold 
change in mean fluorescence intensity of marker expression (compared to proliferation control). 
Treatment of AHPCs with conditioned media results in ~25-fold increase in the intensity of GFAP 
expression, suggesting that MSC-derived aggregates secrete a complement of soluble factors/cytokines 
that cause AHPCs to undergo gliogenesis; in particular, astrogenesis at the expense of 
oligodendrogenesis. Each bar represents the mean (n=3)+SEM, *** p<0.001. 
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Figure 4.8. Determination of the number of viable AHPCs in culture following treatment with 
conditioned media and appropriate controls for 1, 3 and 7 days post-induction of differentiation. 
AHPCs were seeded out and cultured in conditioned media and appropriate controls (PC and UC) and 
the number of viable cells in culture determined using the colorimetric MTS assay. Each bar represents 
the mean (n=3)+SEM. 
 
 
Following 7 days culture with CM and appropriate controls (PC and UC), RNA was 
isolated from AHPCs using the TRIreagent (Section 2.9), reverse transcribed to cDNA 
(Section 2.10) and processed for qRT-PCR (Section 2.11) as detailed in the specified 
sections. Expression profiles are shown in Figure 4.9. Each of the four receptors were 
significantly upregulated in AHPCs cultured with CM compared to both controls, 
validating previous observations from this study and providing further evidence to 
suggest that soluble factors present in CM induced an astrocytic phenotype in AHPCs. 
AMPA3 was the only receptor that could be readily detected in AHPCs cultured under 
all three conditions (Figure 4.9A). PC and UC samples expressed AMPA3 at low and 
comparable levels to each other, whereas CM samples demonstrated a highly 
significant upregulation in expression, an observation that was highly significant at the 
statistical level (p<0.001). The remaining three receptors – GABA-A (Figure 4.9B), 
NMDA-2D (Figure 4.9C) and 5-HT 1A (Figure 4.9D) – demonstrated very similar 
expression profiles. All three receptors were expressed at extremely low levels in PC 
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samples and were undetectable in UC samples. However, significant upregulation was 
observed following culture with CM for 7 days, observations that were significant at 
the statistical level for all three receptors (p<0.01 for GABA-A and 5-HT-1A and 
p<0.001 for NMDA-2D). 
These data (representative of astrocytic function) combined with the previous 
structural marker data strongly suggest that MSC-derived aggregates secrete a soluble 
factor/combination of soluble factors that induce astrogenesis in AHPCs. 
 
Figure 4.9. Expression of functional biochemical markers indicative of an astrocytic phenotype in 
AHPCs cultured with conditioned media and appropriate controls for 7 days. QRT-PCR analysis 
was performed to compare mRNA transcript levels of four genes encoding functional biochemical 
markers indicative of astrocytic behaviour – A: AMPA3; B: GABA-A; C: NMDA-2D and D: 5-HT-1A 
– in AHPCs cultured in conditioned media and appropriate controls for 7 days. All values were 
normalised to GAPDH to account for any differences in RNA input and/or reverse transcription 
efficiencies. Normalised levels of expression are shown as percentages of the maximum expresser. Each 
bar represents the mean (n=3)+SEM, *** p<0.001, ** p<0.01. 
AMPA3 GABA-A 
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4.3.8 The astrocytic fate of AHPCs is specifically the result of the action(s) of 3D 
aggregate-derived soluble factors and cannot be reproduced following culture of 
AHPCs in media conditioned by MSCs as 2D adherent monolayers 
Results in this study so far have demonstrated that MSC-derived 3D aggregates secrete 
active component(s) into their culture media that exert an astrogenic effect on AHPCs 
following 7 days culture. However, these experiments do not answer the critical 
question of whether this astrogenic effect is a specific consequence of the action(s) of 
aggregate-derived soluble factors or is a consequence of the action(s) of more 
generally-secreted MSC-derived soluble factors. To address this key question, MSCs 
cultured as standard, adherent 2D monolayer cultures were allowed to condition media 
for 3 days (the same timeframe as for aggregate-derived CM), after which media was 
subsequently collected and processed as detailed in Section 4.2.2. AHPCs were seeded 
out under identical conditions to those used to assess the effect of aggregate-derived 
CM (Section 4.2.3) and cultured in this monolayer-conditioned media (MONO-CM) 
for 7 days, after which cell phenotype was assessed in terms of morphology and 
expression of neural markers (Figures 4.10, 4.11 and 4.12). 
 
4.3.9 AHPCs cultured with MONO-CM demonstrate no apparent changes in 
morphology compared to equivalent control cultures following a 7 day culture 
period 
As for the above studies, AHPCs were seeded onto cellware coated with PLO and 
laminin at a density of 10,000 cells/cm
2
 in their normal proliferative media and 
allowed 24 hours to settle (designated day –1). Following this 24 hour period (day 0), 
medium was removed and replaced with MONO-CM or appropriate control media 
(UC: unconditioned media; PC: proliferation control) and AHPCs cultured for a 
further 7 days. Medium was replenished on the 4
th
 day. After 7 days, AHPCs were 
analysed for any obvious changes in cellular morphology (Figure 4.10). As observed 
previously in Section 4.3.4, PC AHPCs were largely phase dark and very densely 
packed following 7 days culture (Figure 4.10A). Cell bodies were very rounded with 
no obvious evidence of processes or cytoplasmic extensions forming, suggesting that 
they were largely undifferentiated. Also in keeping with previous observations, 
AHPCs cultured under UC conditions were largely phase bright and possessed 
numerous short processes (Figure 4.10B). Although possessing numerous processes 
per soma, UC cells still appeared largely undifferentiated, as these processes were very 
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short in length and did not demonstrate any obvious characteristics of neuronal or glial 
morphologies. However, whereas AHPCs cultured with aggregate-derived CM 
demonstrated obvious differences in morphology compared to equivalent UC control 
cultures (Figure 4.4), AHPCs cultured with MONO-CM demonstrated no apparent 
differences in morphology compared to UC controls (Figure 4.10C). Culturing AHPCs 
with MONO-CM did not induce the formation of the stellate, star-shaped morphology 
that was observed following culture with aggregate-derived CM. Instead, cells 
possessed numerous short processes that were more indicative of an immature state as 
opposed to a more mature neural phenotype (Figure 4.10C). These morphological data 
combined suggest that soluble factors secreted by adherent 2D monolayer MSCs 
(MONO-CM) do not induce differentiation of AHPCs, whereas soluble factors 
secreted by MSC-derived 3D aggregates induce astrocytic differentiation of AHPCs 
following 7 days culture 
.  
Figure 4.10. Morphology of AHPCs following 7 days culture with MONO-CM and appropriate 
controls. A: AHPCs cultured under their normal proliferative conditions; B: AHPCs cultured with 
unconditioned media; C: AHPCs cultured with MONO-CM. AHPCs cultured under both control 
conditions (A and B) and with MONO-CM (C) appeared largely undifferentiated, though AHPCs 
cultured with MONO-CM did possess numerous short process; however, these were not representative 
of the stellate, star-shaped morphologies acquired following culture with MSC aggregate-derived CM. 
Scale bar = 100μm. 
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4.3.10 AHPCs cultured with MONO-CM for 7 days demonstrate expression of the 
neuroprogenitor marker, nestin, but not of the more mature neural markers, Tuj-1, 
GFAP and GalC 
In order to gain more information regarding the phenotype of AHPCs cultured in 
MONO-CM and appropriate controls for 7 days, expression of a range of neural 
markers were examined using immunocytochemistry and flow cytometry. Markers 
specific for neuroprogenitors and the three major neural cell types were examined – 
nestin (neuroprogenitor marker), Tuj-1 (neuronal marker), GFAP (astrocytic marker) 
and GalC (oligodendrocytic marker). AHPCs were seeded out for these experiments 
and processed for marker analysis as described in Section 4.2.3. Immunocytochemical 
images are shown in Figure 4.11 and flow cytometric data in Figure 4.12. 
 
AHPCs cultured under all three conditions – PC, UC and CM – demonstrated intense 
staining for the neuroprogenitor marker, nestin (Figures 4.11A, 4.11B and 4.11C). 
Patterns of staining corresponded with the cellular morphologies described in Section 
4.3.9. Conversely, expression of the three other neural markers – Tuj-1, GFAP and 
GalC – were undetectable in AHPCs cultured under all three conditions (Figure 
4.11D–L). For PC and UC samples, these observations are consistent with those 
previously observed (Figure 4.5). For MONO-CM samples, however, these 
observations differed from those previously observed following culture with 
aggregate-derived CM, which induced a significant increase in expression of GFAP 
such that the large majority of cells per field of view stained intensely for GFAP 
(Figure 4.5I). No such staining for GFAP was observed following culture under 
identical conditions with MONO-CM (Figure 4.11I). These marker analyses were in 
keeping with morphological observations which suggested that AHPCs cultured with 
MONO-CM retained an immature phenotype and did not acquire a more mature neural 
morphology. 
 
Expression of neural markers in AHPCs cultured with MONO-CM and appropriate 
controls were assessed using flow cytometry in terms of percentage of cells expressing 
marker and MFI of marker expression. Cells were processed as described previously in 
Section 2.6 and results shown in Figure 4.12 in terms of raw data (Figures 4.12A and 
4.12B) and as a fold-increase above PC (Figures 4.12C and 4.12D). In terms of the 
percentage of cells expressing each neural marker, there was very little difference 
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between each of the samples (Figures 4.12A and 4.12C). Any differences in expression 
that were apparent – such as a slight tendency for the percentage of cells expressing 
nestin, GFAP and GalC to increase and the percentage of cells expressing Tuj-1 to 
decrease – were very slight and not significant at the statistical level. These slight 
trends were similar to those previously observed following culture with aggregate-
derived CM and controls (Figure 4.7). In terms of MFI of nestin, Tuj-1 and GalC 
expression, there was very little observable difference between UC and MONO-CM 
samples (Figures 4.12B and 4.12D). Any slight differences were not significant at the 
statistical level. However, in terms of MFI of GFAP expression, AHPCs cultured with 
MONO-CM for 7 days demonstrated an almost 2.5-fold increase compared to UC 
control cultures (Figures 4.12B and 4.12D). This trend was also observed following 
culture of AHPCs with aggregate-derived CM for 7 days, though this effect was much 
more dramatic, a greater than 20-fold increase (Figure 4.7D). The observation 
following culture with MONO-CM was not significant at the statistical level, whereas 
it was highly significant (p<0.001) following culture with aggregate-derived CM. 
These data combined strongly support morphological observations that AHPCs 
cultured with MONO-CM retain their immature phenotype following 7 days culture, 
whereas AHPCs cultured with aggregate-derived CM are induced to undergo 
astrocytic differentiation. Although there is a slight tendency for expression of the 
astrocytic marker GFAP to increase following culture with MONO-CM this effect is 
not statistically significant and as such it is highly feasible that MSC-derived 
aggregates secrete additional component(s) into their media that are responsible for 
enhanced astrocytic differentiation. 
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Figure 4.11. Expression of neural markers in AHPCs following 7 days culture with MONO-CM 
and appropriate controls. A, B and C: expression of nestin; D, E and F: expression of Tuj-1; G, H 
and I: expression of GFAP; J, K and L: expression of GalC. MONO-CM did not induce the significant 
upregulation in GFAP expression observed following culture with MSC aggregate-derived CM. 
Expression of the mature neural markers Tuj-1, GFAP and GalC could not be detected in AHPCs 
cultured in either MONO-CM or appropriate controls. Scale bar = 100μm. 
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Figure 4.12. Flow cytometric analysis of marker expression in AHPCs treated with MONO-CM 
and controls. A: % cells expressing marker; B: mean fluorescence intensity of marker expression; C: 
fold change in the % cells expressing marker (compared to proliferation control); D: fold change in 
mean fluorescence intensity of marker expression (compared to proliferation control). In terms of the 
percentage of cell expressing each neural marker, there was very little difference between each of the 
samples. Similarly, in terms of intensity of marker expression, there was very little difference between 
each of the samples. Treatment of AHPCs with MONO-CM results in a ~2.5-fold increase in the 
intensity of GFAP expression, though this observation was quite variable and not statistically 
significant. Each bar represents the mean (n=3) + SEM 
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4.3.11 Oxygen tension is a crucial parameter in the culture of MSCs as cellular 
aggregates 
Cellular behaviour in standard in vitro cultures has been reported to be radically 
altered upon exposure to varying oxygen concentrations. Under standard culture 
conditions, cells are exposed to atmospheric levels of oxygen, which is approximately 
20%. However, this oxygen tension far exceeds the levels of oxygen which cells are 
exposed to in vivo, which is typically closer to 3-5% depending on the specific cell 
population and tissue in question (Ivanovic, 2009). In the bone marrow, physiological 
oxygen concentration has been reported as 5% (Zscharnack et al., 2009). As such, 
studies with cells cultured under atmospheric oxygen levels may be somewhat 
misleading and it may therefore be more accurate to study cells cultured under lower 
oxygen levels that are closer to physiologically-relevant concentrations. Evidence 
suggests that oxygen tension can dramatically affect many aspects of cellular 
behaviour and MSCs cultured under low oxygen tension have demonstrated enhanced 
rates of proliferation and mitogenic activity, reduced cell death and enhanced survival, 
reduced senescence, enhanced lifespan and enhanced levels of differentiation (Ren et 
al., 2006; Krinner et al., 2009; Zscharnack et al., 2009). Similar properties have been 
observed in other cell types, including neural stem cells (Clarke and van der Kooy, 
2009). 
 
The importance of oxygen tension as a parameter in cell culture is particularly 
significant in the culture of cellular aggregates and neurospheres, where control of 
gaseous exchange and diffusion of soluble factors has been reported to be a crucial 
aspect contributing to the longevity and viability of aggregates (Griffith and Swarz, 
2006). MSCs induced to form aggregates in these studies using the protocol described 
in Section 4.2.1 were cultured under lower oxygen levels (5%) in keeping with 
previously published protocols (Croft and Przyborski, 2004; Hermann et al., 2004; 
Bossolasco et al., 2005; Hermann et al., 2006). In order to ascertain how crucial a role 
oxygen tension played in the culture of MSC-derived aggregates, MSCs were seeded 
out for aggregate formation as described in Section 4.2.1 but maintained under 
atmospheric oxygen levels as opposed to lower, physiological levels of oxygen. 
Behaviour of aggregates was assessed in terms of morphology, marker expression, rate 
of proliferation and also in terms of their secretome to see if the astrocytic effect of 
aggregate-derived CM on AHPCs could be reproduced. 
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4.3.12 MSCs can be induced to form cellular aggregates when cultured under 
atmospheric oxygen conditions 
MSCs were seeded out for aggregate formation as detailed previously (Section 4.2.1) 
and maintained under atmospheric oxygen concentrations (20%) as opposed to 
physiological oxygen concentrations (5%). Figure 4.13 shows MSCs cultured in 
aggregate-inducing conditions under atmospheric oxygen concentrations after 72 
hours. Under such conditions, MSCs formed cellular aggregates that were 
morphologically indistinguishable from aggregates formed under low oxygen tension 
(Figure 4.13). Small, spherical aggregations of cells formed on the surface of the 
cellware and, as previously described for aggregates cultured under low oxygen 
tensions, not all of the seeded cells formed aggregates with a small proportion of 
adherent cells forming flat morphologies as per standard culture (Figure 4.13). 
 
 
Figure 4.13. Formation of large, multicellular aggregates by MSCs cultured under atmospheric 
oxygen tension for 72 hours. MSCs were seeded out for aggregate formation and maintained under 
atmospheric oxygen tension (20%) as opposed to physiological oxygen tension (5%). Under such 
conditions, MSCs formed cellular aggregates that were morphologically indistinguishable from 
aggregates formed under physiological oxygen tension. Therefore, oxygen tension itself appears not to 
be a critical parameter in the formation of large multicellular aggregates from MSCs. Scale bar = 
100µm. 
 
Chapter 4: MSCs as paracrine mediators of neural differentiation 
 
179 
 
4.3.13 MSC aggregates cultured under atmospheric oxygen conditions demonstrate 
a similar marker expression profile to MSC aggregates cultured under physiological 
oxygen conditions in terms of nestin, GFAP and α-SMA expression 
Previous studies in this thesis have shown that MSCs cultured as aggregates under low, 
physiological oxygen levels demonstrated intense expression of the neural markers, 
nestin and GFAP, concomitant with weak expression of the mesenchymal marker, α-
SMA (Section 4.3.2). These observations were in keeping with previously published 
data (Kabos et al., 2002; Croft and Przyborski, 2004; Hermann et al., 2004; Suzuki et 
al., 2004; Hermann et al., 2006; Kim et al., 2006). In order to ascertain whether MSCs 
cultured as aggregates under atmospheric oxygen levels retained this marker 
expression profile, aggregates were fixed and processed for marker analysis using 
immunocytochemistry and flow cytometry as previously described (Sections 2.6 and 
2.7). 
 
Aggregates were fixed in 4% PFA and processed for immunocytochemistry against 
nestin, GFAP and α-SMA as previously detailed in Section 2.6. As observed for MSCs 
cultured as aggregates under low oxygen tension (Section 4.3.2) the neural markers, 
nestin and GFAP, demonstrated intense levels of staining in aggregates cultured under 
high oxygen tension, indicative of very high levels of expression (Figure 4.14B and 
4.14D respectively). Similarly, expression of the mesenchymal marker, α-SMA, was 
readily detectable in aggregates cultured under high oxygen tension, though levels of 
staining were very weak and diffuse, indicative of only weak expression (Figure 
4.14F). This is also in keeping with observations from aggregates cultured under low 
oxygen tension (Figure 4.2). Expression of the previous markers were also examined 
using flow cytometric methods, as previously detailed in Section 4.3.2. Cells derived 
from MSC aggregates under atmospheric oxygen tensions demonstrated positive 
expression of the neural markers nestin and GFAP and, to a lesser extent, α-SMA, 
which is consistent with the immunocytochemical observations (Figure 4.14). 
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Figure 4.14. Immunocytochemical analysis of expression of neural and mesenchymal markers in 
MSC aggregates cultured under atmospheric oxygen tension (20%) as opposed to physiological 
oxygen tension (5%). Images A, C and E correspond to the nuclear DAPI stain, whereas B, D and F 
correspond to nestin, GFAP and α-SMA respectively. Expression profiles of markers in MSC aggregates 
cultured under atmospheric oxygen tension is highly comparable to the expression profiles observed 
following culture of MSC aggregates under physiological oxygen tension. Scale bar = 100μm.  
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Figure 4.15. Flow cytometric analysis of expression of neural and mesenchymal markers in MSC 
aggregates cultured under atmospheric oxygen tension (20%) as opposed to physiological oxygen 
tension (5%). Representative traces showing typical marker expression profiles for nestin (A), GFAP 
(B) and α-SMA (C) in MSCs cultured as aggregates. Clear traces correspond to the P3X negative 
control and black traces correspond to specific positive fluorescence. Expression profiles of markers in 
MSC aggregates cultured under atmospheric oxygen tension is highly comparable to the expression 
profiles observed following culture of MSC aggregates under physiological oxygen tension (Figure 4.3). 
 
 
 
4.3.14 MSC aggregates cultured under physiological oxygen conditions contain a 
greater number of viable cells compared to those cultured under atmospheric oxygen 
conditions 
One of the most crucial aspects of cellular behaviour that oxygen concentration is 
known to dramatically affect is mitogenic activity and proliferation, and this has been 
reported in a range of different cell types in culture (Held and Sönnichsen, 1984; 
Falanga and Kirsner, 1993; Studer et al., 2000; Krinner et al., 2009). This study aimed 
to address the question of how crucial a role, if any, oxygen concentration played in 
the proliferation of MSCs cultured as aggregates in vitro. 
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MSCs were seeded out for aggregate formation as previously described in Section 
4.2.1 and were maintained under low (5%) and high (20%) oxygen tensions for 3 days. 
After this period, the number of viable cells in each culture was determined 
quantitatively using the MTS proliferation assay, methodology for which is detailed in 
Section 2.8. The MTS proliferation assay is an accepted method for determining rates 
of proliferation in cellular spheroids and aggregates, and has been used in previously 
published studies (Qihao et al, 2007). Absorbance values at 490nm are directly 
proportional to the number of viable cells in culture and are shown in Figure 4.16. 
 
MSCs cultured as aggregates under low oxygen tension demonstrated an absorbance at 
490nm approximately two-fold higher than MSCs cultured as aggregates under high 
oxygen tension (Figure 4.16). This result was highly significant at the statistical level 
(p<0.001). These MTS data demonstrate that MSCs cultured as aggregates under low 
oxygen tension contain a significantly greater number of viable cells compared to their 
counterparts cultured under high oxygen tension. This is presumably a consequence of 
enhanced cellular proliferation following culture under low oxygen tension, though 
alternative mechanisms cannot be discounted e.g. reduced apoptosis, enhanced 
survival and reduced senescence, as all of these phenomena have been attributed to 
MSCs cultured under lowered oxygen states (Ren et al., 2006; Krinner et al., 2009; 
Zscharnack et al., 2009). 
 
4.3.15 Aggregates cultured under atmospheric oxygen conditions exert a similar but 
diminished effect on cell fate decisions of AHPCs following 7 days culture in CM 
compared to aggregates cultured under physiological oxygen conditions 
The final and perhaps most crucial aim of the studies investigating the effects of 
oxygen concentration on the behaviour of MSC aggregates in culture was to determine 
whether varying oxygen concentration had any effect on the secretory activity of 
aggregates. There are a number of studies reporting that oxygen concentration is a 
crucial parameter influencing secretory behaviour of a range of cell types (Koos, 1986; 
Papas et al., 1996; Zhao et al., 2009). In order to ascertain whether varying oxygen 
concentration influenced the secretome of MSC aggregates, media conditioned by 
aggregates under high oxygen tension was assessed to see if the astrocytic effect 
observed following the culture of AHPCs with media conditioned by aggregates under 
low oxygen tension (Section 4.3.5) could be reproduced. 
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Figure 4.16. Determination of the viable number of MSCs in aggregates cultured under 
physiological (low) and atmospheric (high) oxygen tensions for 3 days. MSCs were seeded out for 
aggregate formation and cultured under physiological (low) and atmospheric (high) oxygen tensions for 
three days and the number of viable cells in culture determined using the colorimetric MTS assay. Each 
bar represents the mean (n=3)+SEM, *** p<0.001. 
 
 
MSCs were seeded out for aggregate formation under low (5%) and high (20%) 
oxygen tensions and allowed to condition media for 3 days, after which the media was 
subsequently collected and prepared as described previously (Section 4.2.2). AHPCs 
were seeded out onto cellware coated with PLO and laminin at a density of 10,000 
cells/cm
2
 in their normal proliferative media and were allowed 24 hours to settle 
(designated day –1). Following this 24 hour period (day 0), media was removed and 
replaced with CM produced under low (CM/lo) or high (CM/hi) oxygen tensions and 
AHPCs cultured for a further 7 days. Media was replenished on the 4
th
 day. After 7 
days, AHPCs were processed for flow cytometry as described previously (Section 2.6) 
and analysed for expression of the neural markers nestin, Tuj-1, GFAP and GalC using 
flow cytometry (Figure 4.17). 
 
In terms of the percentage of cells expressing each neural marker, there was no 
statistically significant difference between AHPCs cultured with CM/lo or CM/hi for 
any of the markers examined (Figure 4.17A). Both media samples resulted in an 
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increase in the percentage of AHPCs expressing GFAP compared to PC control, 
though the percentage was slightly higher in AHPCs cultured with CM/lo compared to 
CM/hi. In terms of MFI of marker expression, there was little observable difference in 
intensity of nestin, Tuj-1 and GalC expression in AHPCs cultured with CM/lo and 
CM/hi (Figure 4.17B). Differences in intensity of GFAP expression, however, were 
observed. Culturing AHPCs with CM/lo and CM/hi resulted in a substantial increase in 
intensity of GFAP expression compared to PC control in both instances, which 
strongly suggested that aggregates cultured under both low and high oxygen tensions 
secreted soluble factor(s) that induced astrogenesis in AHPCs following 7 days culture. 
However, AHPCs cultured with CM/lo demonstrated an MFI more than 2-fold greater 
than that observed following culture with CM/hi, a value of approximately 1100 for 
CM/lo compared to a value of 400 for CM/hi. This difference was significant at the 
statistical level (p<0.05). These flow cytometry data strongly suggest that MSC 
aggregates secrete astrocytic-promoting soluble factor(s) regardless of the oxygen 
tension in which they are cultured, though aggregates cultured under low oxygen exert 
a more significant astrocytic effect than aggregates cultured under high oxygen in 
terms of MFI of GFAP expression. A greater intensity of GFAP expression is likely to 
be indicative of a more mature astrocytic phenotype being expressed. 
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Figure 4.17. Flow cytometric analysis of marker expression in AHPCs treated with media 
conditioned by aggregates cultured under physiological (CM/lo) and atmospheric (CM/hi) oxygen 
tensions. A: % cells expressing marker; B: mean fluorescence intensity of marker expression. In terms 
of the percentage of cells expressing each neural marker, there was no statistically significant difference 
between AHPCs cultured with CM/lo or CM/hi for any of the markers examined (A). In terms of MFI of 
marker expression, there was little observable difference in intensity of nestin, Tuj-1 and GalC 
expression in AHPCs cultured with CM/lo and CM/hi (B). However, culturing AHPCs with CM/lo and 
CM/hi resulted in a substantial increase in intensity of GFAP expression compared to PC control in both 
instances, though AHPCs cultured with CM/lo demonstrated an MFI more than 2-fold greater than that 
observed following culture with CM/hi. Each bar represents the mean (n=3)+SEM, * p<0.05. 
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4.3.16 The astrocytic-promoting effect of CM acts in a dose-dependent manner 
Previous studies in this Chapter have demonstrated that media conditioned by MSC 
aggregates contains soluble factor(s) that influence the cell fate decisions of AHPCs, 
such that following 7 days culture AHPCs exit the cell cycle and commit to an 
astrocytic differentiation program. This has been determined by examining changes in 
cellular morphology and examining expression of both structural and functional 
markers of astrocytic differentiation. Oxygen concentration has also been 
demonstrated to play a crucial role in the efficacy of this process. 
 
The next aims of this study were to examine the effect of MSC aggregate-derived CM 
on AHPCs at a more mechanistic level. One of the first experiments performed was a 
titration experiment in order to determine whether the astrocytic-promoting effect of 
CM occurred in a dose-dependent manner. Concentration of soluble factors and 
cytokines is perhaps the most crucial parameter to consider in terms of their biological 
activity, as soluble factors often have different efficacies at different concentrations 
and can even have completely different effects in the same cellular system when 
present at different concentrations. 
 
AHPCs were seeded out for these titration experiments under identical conditions to 
those previously described i.e. in their normal proliferative media, onto cellware 
coated with PLO and laminin, at a density of 10,000 cells/cm
2
 (Section 4.2.3). 
Following a ‘settling’ period of 24 hours, media was removed and replaced with CM 
of different dilution factors – undiluted, 1:2, 1:4, 1:8, 1:16 and negative control (PC) – 
and AHPCs cultured for a further 7 days, with media being replenished on the 4
th
 day. 
Following 7 days culture, the differentiative state of AHPCs at each dose was 
determined via flow cytometric analysis of neural marker expression, in terms of 
percentage of cells expressing marker and MFI of marker expression, as detailed in 
Section 2.6. 
 
The percentage of cells expressing each marker is shown in Figure 4.18a for nestin 
(Figure 4.18a-A), Tuj-1 (Figure 4.18a-B), GFAP (Figure 4.18a-C) and GalC (Figure 
4.18a-D). CM of varying dilutions did not appear to have any significant effects on the 
percentage of cells expressing each marker following 7 days culture. In particular, the 
percentage of cells expressing Tuj-1 and GalC remained constant throughout the 
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titration experiment, with approximately 80% of cells expressing both Tuj-1 and GalC 
at all dilutions of CM examined, including negative (PC) control (Figure 4.18-B and 
4.18-D). Expression of nestin appeared more sporadic throughout the titration but, 
despite these slight fluctuations, the percentage of cells expressing nestin remained at 
the same approximate level (around 50-60%). The percentage of cells expressing 
GFAP following culture with CM for 7 days remained constant up to a dilution factor 
of 1:8, with approximately 80% of cells demonstrating positivity for GFAP expression. 
Following further dilution however (a dilution factor of 1:16 and negative (PC) 
control) the percentage of cells expressing GFAP showed a tendency to decrease, with 
approximately 50-60% of cells expressing GFAP under these conditions. 
 
Such uniformity in percentage of AHPCs expressing neural markers following culture 
in CM of varying dilutions is not particularly unexpected, as previous studies in this 
Chapter have shown that AHPCs demonstrate positivity for neural marker expression 
under standard culture conditions (Figure 4.7). It was only when MFI of marker 
expression was examined that significant differences in cell phenotype were revealed. 
Figure 4.18b shows MFI of nestin (Figure 4.18b-A), Tuj-1 (Figure 4.18b-B), GFAP 
(Figure 4.18b-C) and GalC (Figure 4.18b-D) expression following culture with CM of 
varying dilutions for 7 days. Intensity of nestin expression decreased in a dose-
dependent manner with increasing dilution of CM, with AHPCs cultured under 
negative (PC) control conditions demonstrating the weakest level of expression (Figure 
4.18b-A). Tuj-1 was expressed at a relatively constant level through the titration, 
though there was a very slight tendency for intensity of expression to decrease from 
undiluted CM up to a dilution factor of 1:4 (Figure 4.18b-B). Intensity of GalC 
expression was somewhat more sporadic throughout the titration experiment, with MFI 
values fluctuating with increasing dilution factor but not adhering to any real trend 
(Figure 4.18b-D). In terms of intensity of GFAP expression, which is perhaps the most 
interesting given previous observations (Figure 4.7), there was a clear dose-dependent 
relationship between MFI values and dilution factor (Figure 4.18b-C). Intensity of 
GFAP expression decreased in a dose-dependent manner with increasing dilution of 
CM, such that AHPCs cultured with undiluted CM demonstrated the most intense 
expression of GFAP and AHPCs cultured under negative (PC) control conditions 
demonstrated the weakest expression. MFI values for GFAP in AHPCs cultured with 
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CM diluted 1:16 were on a par with negative control and it can be concluded that the 
effect is completely abolished at this dilution. 
 
Combined, these titration data clearly demonstrate that the astrocytic effect of CM acts 
in a highly dose-dependent manner, with maximum activity observed in undiluted CM 
and diminishing with increasing dilution of CM. 
 
 
 
Figure 4.18a. Dose-dependency of the astrocytic-promoting effect of MSC aggregate-derived 
conditioned media. AHPCs were seeded out and cultured in conditioned media of varying dilution 
factors for 7 days and processed for flow cytometry as previously described. Expression of nestin, Tuj-1, 
GFAP and GalC was examined in terms of the percentage of cells expressing each marker. Each bar 
represents the mean (n=3)+SEM.  
 
 
Chapter 4: MSCs as paracrine mediators of neural differentiation 
 
189 
 
 
Figure 4.18b. Dose-dependency of the astrocytic-promoting effect of MSC aggregate-derived 
conditioned media. AHPCs were seeded out and cultured in conditioned media of varying dilution 
factors for 7 days and processed for flow cytometry as previously described. Expression of nestin, Tuj-1, 
GFAP and GalC was examined in terms of MFI of marker expression. The astrocytic-promoting effect 
of MSC aggregate-derived CM on AHPCs was highly dose-dependent. Each bar represents the mean 
(n=3)+SEM.  
 
 
4.3.17 Aggregate-derived soluble factors present in CM are heat-sensitive 
In a further attempt to better understand the nature of the aggregate-derived soluble 
factors responsible for exerting the astrogenic effect in AHPCs, the temperature-
sensitivity of CM was assessed. Heat-sensitive factors in CM were inactivated by 
heating CM in boiling water for 10 minutes, as previously detailed in the literature 
(Rivera et al., 2006). The aim of this experiment was to ascertain whether inactivating 
heat-sensitive factors in CM would abolish the astrocytic effect previously observed in 
AHPCs following 7 days culture. 
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AHPCs were seeded out for these experiments and maintained as described for all the 
other studies in this thesis, detailed in Section 4.2.3. In these particular experiments, 
AHPCs were cultured under PC conditions (negative control) or in either untreated 
CM (positive control) or heat-inactivated CM for 7 days, with media being replenished 
on the 4
th
 day. Following 7 days culture, the differentiative state of AHPCs cultured 
under each condition was determined via flow cytometric analysis of neural marker 
expression, in terms of percentage of cells expressing marker and MFI of marker 
expression, as detailed in Section 2.6. 
 
In terms of the percentage of cells expressing each marker, there appeared to be no 
obvious differences between AHPCs cultured with untreated CM and heat-inactivated 
CM (Figure 4.19A). This uniformity of neural marker expression in AHPCs has been 
consistent throughout studies in this thesis and it has therefore been analysis of MFI of 
marker expression that has been more pertinent in highlighting differences in cellular 
phenotype between different samples. When intensity of neural marker expression was 
compared between AHPCs cultured with untreated CM and heat-inactivated CM, there 
were no obvious differences in terms of nestin, Tuj-1 and GalC expression (Figure 
4.19B). For nestin and GalC expression, MFI values were comparable to control (PC) 
values. MFI of Tuj-1 expression, however, increased slightly following culture with 
both untreated CM and heat-inactivated CM compared to PC control, though this 
increase was less than 2-fold and there was no statistically significant difference 
between the two CM samples. In terms of intensity of GFAP expression, AHPCs 
cultured with untreated CM and heat-inactivated CM both demonstrated a dramatic 
increase in MFI values compared to PC control (Figure 4.19B). This strongly 
suggested that AHPCs cultured with both media types were undergoing astrogenesis 
and adopting a more mature astrocytic phenotype. However, the intensity of GFAP 
expression in AHPCs cultured with untreated CM was substantially greater than that 
observed following culture with heat-inactivated CM, an MFI value of 700 compared 
to 400 respectively. This difference was significant at the statistical level (p<0.05). 
Although the intensity of GFAP expression in AHPCs cultured with heat-inactivated 
CM was lower than that observed following culture with untreated CM, the increase in 
GFAP expression observed was still a real result and significant compared to PC 
control. Therefore, these data demonstrate that heat-inactivation of CM only partially 
abolishes the astrocytic effect observed in AHPCs following 7 days culture, suggesting 
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that heat inactivation may change the proportion of active factor(s) in CM responsible 
for this effect. 
 
 
 
Figure 4.19. Heat-sensitivity of the astrocytic-promoting effect of MSC aggregate-derived 
conditioned media. AHPCs were seeded out and cultured in untreated conditioned media and heat-
inactivated conditioned media (heated in boiling water for 10 minutes) for 7 days and processed for flow 
cytometry as previously described. Expression of nestin, Tuj-1, GFAP and GalC was examined in terms 
of the percentage of cells expressing each marker (A) and MFI of marker expression (B). The astrocytic-
promoting effect of MSC aggregate-derived CM on AHPCs was significantly heat-sensitive. Each bar 
represents the mean (n=3)+SEM, * p<0.05. 
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4.3.18 Aggregate-derived soluble factors instruct AHPCs to adopt a glial cell fate, 
more specifically, an astrocytic fate at the expense of an oligodendrocytic fate 
The next series of experiments in this study aimed to address the fundamental issue of 
whether soluble factors present in CM exerted an astrocytic effect in AHPCs via an 
instructive and/or selective mechanism. Acting via an instructive mechanism would 
suggest that the active components in CM acted on uncommitted AHPCs and induced 
them specifically to commit to and undergo astrocytic differentiation. This is in 
contrast to a selective mechanism, which would suggest that the active components in 
CM provided culture conditions that encouraged the growth/survival of AHPCs 
already committed to the astrocytic lineages and/or encouraged the death of AHPCs 
committed to other neural lineages e.g. neuronal or oligodendrocytic. 
 
Two main studies were performed in order to determine the mechanism by which the 
active components in CM were exerting an astrocytic effect in AHPCs. 
 
a) Temporal effects of CM on neural marker expression in AHPCs were 
examined. 
 
b) Cell proliferation and cell death in specific subpopulations of AHPCs 
cultured with CM was examined. 
 
 
4.3.19 AHPCs cultured with CM demonstrate a temporal increase in GFAP 
expression 
AHPCs were seeded out for these experiments and maintained as described for all the 
other studies in this thesis, detailed in Section 4.2.3. In these particular experiments, 
AHPCs were cultured in CM or appropriate control (UC) and marker expression 
analysed at days 0, 4 and 7 via flow cytometric analysis in terms of percentage of cells 
expressing marker and MFI of marker expression, as detailed in Section 2.6. The day 
of cell seeding was designated day –1. Results are shown in Figure 4.20. 
 
The temporal expression profiles in terms of the percentage of cells demonstrating 
positivity for marker expression when cultured in CM or appropriate control (UC) are 
shown in Figure 4.20 for Tuj-1 (Figure 4.20A), GFAP (Figure 4.20C) and GalC 
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(Figure 4.20E). Culturing AHPCs with CM did not appear to significantly affect the 
kinetics of Tuj-1 and GalC expression over time (Figures 4.20A and 4.20E). There was 
a slight trend for the percentage of cells expressing both markers to increase over the 7 
day time course of the experiment, but this trend was apparent in both UC and CM 
cultures. In terms of the raw percentages, there was little observable difference 
between the two cultures. The kinetics of GFAP expression, however, did differ 
significantly between UC and CM cultures (Figure 4.20C). Culture with CM resulted 
in a significant time-dependent increase in the percentage of AHPCs expressing GFAP 
up to the 4 day timepoint; thereafter, no further increase was observed, with AHPCs 
examined at the 7 day timepoint demonstrating a similar level of expression to those 
examined at the 4 day timepoint. This temporal profile was in complete contrast to that 
observed in AHPCs cultured under UC control conditions, where the percentage of 
GFAP
+
 cells showed a slight tendency to decrease up to the 4 day timepoint, followed 
by a subsequent increase between days 4 and 7 (Figure 4.20C). 
 
The temporal expression profiles in terms of MFI of marker expression in AHPCs 
cultured in CM or appropriate control (UC) are shown in Figure 4.20 for Tuj-1 (Figure 
4.20B), GFAP (Figure 4.20D) and GalC (Figure 4.20F). As was the case for the 
percentage of cells expressing Tuj-1 and GalC, culturing AHPCs with CM did not 
appear to significant affect the kinetics of Tuj-1 and GalC intensity over time (Figures 
4.20B and 4.20F). Although there was a slight trend for the intensity of both markers 
to increase over the 7 day time course of the experiment, this trend was apparent in 
both UC and CM cultures. In terms of raw MFI values, intensity of expression was 
generally higher in AHPCs cultured with CM compared to UC controls, but such was 
the level of variation between independent repeats that the error bars at each timepoint 
overlapped extensively (Figures 4.20B and 4.20F). The kinetics of GFAP expression in 
AHPCs cultured under both conditions were more striking, such that AHPCs cultured 
in CM demonstrated a significant time-dependent increase over the 7 day time course 
of this experiment (Figure 4.20D). This temporal profile was in complete contrast to 
that observed in AHPCs cultured under UC control conditions, where intensity of 
expression remained extremely low and uniform throughout the 7 day time course 
(Figure 4.20D). 
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Combined, these data strongly suggest that soluble factors in CM induce AHPCs to 
differentiate into astrocytes at the expense of neurons and oligodendrocytes. 
 
 
 
Figure 4.20. Temporal expression of neural markers in AHPCs cultured in MSC aggregate-
derived conditioned media for up to and including 7 days. AHPCs were cultured in CM and 
appropriate control conditions (UC) and processed for flow cytometry at 4 and 7 days, as previously 
described. Expression of Tuj-1, GFAP and GalC was examined in terms of the percentage of cells 
expressing each marker (A, C and E) and MFI of marker expression (B, D and F). A significant 
temporal increase in the percentage of cells expressing GFAP (C) and similarly in the MFI of GFAP 
expression (D) was observed compared to UC controls. Each data point represents the mean 
(n=3)±SEM. 
Percentage positive cells MFI 
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4.3.20 The astrocytic effect of CM in AHPCs occurs independently of effects on cell 
proliferation but cell death of oligodendrocytic precursors may play an important 
role 
The previous study examining the temporal expression of neural markers in AHPCs 
cultured with CM and UC control suggested that AHPCs committed to and underwent 
astrocytic differentiation over the 7 day time course of this experiment. In order to 
ascertain whether a selective mechanism may also play an important role, cell 
proliferation and cell death were examined in specific subpopulations of AHPCs 
cultured with CM and UC control. Cell proliferation was assessed using 
bromodeoxyuridine (BrdU)-incorporation and cell death was assessed using propidium 
iodide (PI)-incorporation into AHPCs cultured with CM and UC control for 4 and 7 
days. These cells were then processed for dual-staining with antibodies directed 
against the above molecules and the neural markers, either Tuj-1, GFAP or GalC, 
followed by flow cytometric analysis as described in detail in Section 4.2.4. The 
percentage of cells demonstrating dual-positivity for BrdU/PI and Tuj-1/GFAP/GalC 
was determined and results are shown in Figure 4.21. 
 
Figure 4.21 demonstrates the rate of proliferation in specific subpopulations of AHPCs 
following culture in CM and UC control for 4 (Figure 4.21A) and 7 (Figure 4.21B) 
days. Subpopulations of AHPCs were defined as Tuj-1
+
, GFAP
+
 and GalC
+
. In terms 
of proliferation rate, no significant difference was observed between UC and CM in 
either the Tuj-1
+
, GFAP
+
 or GalC
+
 subpopulations, at both timepoints assessed 
(Figures 4.21A and 4.21B). These results strongly suggest that soluble factors in CM 
do not influence the rate of proliferation of any AHPC subpopulations. 
 
Figure 4.21 also demonstrates the rate of cell death in specific subpopulations of 
AHPCs following culture in CM and UC control for 4 (Figure 4.21C) and 7 (Figure 
4.21D) days. The most interesting trends emerged in the GFAP
+
 and GalC
+
 
subpopulations following culture in CM compared to UC control. At both the 4 and 7 
day timepoints, culturing AHPCs with CM resulted in a decrease in the percentage of 
GFAP
+
 cells undergoing cell death compared to UC control cultures, which 
demonstrated higher levels of cell death. Although this trend was apparent at both 
timepoints assessed, these observations were not significant at the statistical level. 
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The GalC
+
 subpopulation exhibited the complete opposite trend to the GFAP
+
 
subpopulation. At both the 4 and 7 day timepoints, AHPCs cultured with CM 
demonstrated significantly higher levels of cell death compared to UC control cultures, 
which demonstrated lower levels of cell death. Although this trend was apparent at 
both timepoints assessed, this observation was only statistically significant at the 7 day 
timepoint (p<0.05). 
 
Combined, these flow cytometric data suggest that the astrocytic effect observed in 
AHPCs following culture in CM occurs independently of effects on cell proliferation 
within specific AHPC subpopulations. Therefore, selection of a GFAP
+
 astrocytic-
committed precursor is unlikely to be occurring in this system, suggesting an 
instructive mechanism as opposed to a selective mechanism. However, an important 
mechanism by which soluble factors in CM could be exerting their effect is via their 
influences on cell death in specific AHPC subpopulations. AHPCs cultured in CM 
demonstrated lower rates of cell death in the GFAP
+
 subpopulation compared to 
controls (though not statistically significant) and higher levels of cell death in the 
GalC
+
 subpopulation compared to controls (p<0.05). Therefore, although results from 
these studies suggest that astrogenesis occurs via an instructive mechanism in AHPCs, 
it is also highly probable that increased cell death in the GalC
+
 oligodendrocytic 
subpopulation may play an important role, resulting in astrogenesis at the expense of 
oligodendrogenesis. 
 
4.3.21 Increased rates of cell death in the GalC
+
 AHPC subpopulation following 
culture with CM are a direct result of apoptosis rather than necrosis 
In the previous section, cell death was assessed in specific subpopulations of AHPCs 
following culture with UC and CM for 4 and 7 days, using PI-incorporation as an 
indicator of cell death. AHPCs cultured in CM demonstrated lower rates of cell death 
in the GFAP
+
 subpopulation compared to UC control (a statistically insignificant 
result) and, perhaps more interestingly, higher rates of cell death in the GalC
+
 
subpopulation compared to UC control (p<0.05). Although PI incorporation into dead 
cells (it is membrane impermeant and as such is excluded from viable cells) is perhaps 
the most commonly used method of assessing cell death, it has one major disadvantage 
in that it is unable to distinguish between cells whose membranes have been 
mechanically disrupted due to necrosis (cell death due to external factors) or those due 
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Figure 4.21. Flow cytometric analysis of rates of cell proliferation and cell death in specific 
subpopulations of AHPCs following culture in CM and UC control conditions for 4 and 7 days. 
AHPCs were seeded out and cultured in CM and appropriate control conditions (UC) and processed for 
flow cytometry at 4 and 7 days as previously described. Cell proliferation was assessed at 4 (A) and 7 
(B) days following addition of 10μM BrdU to the culture media 24 hours prior to processing i.e. at days 
3 and 6 respectively. Dual-staining was then performed, followed by flow cytometric analysis, to 
determine rates of proliferation in specific subpopulations of the AHPC cultures. There were no 
significant differences in rates of proliferation between UC and CM cultures. Cell death was assessed at 
4 (C) and 7 (D) days following addition of 50μg/ml propidium iodide (PI) to the culture media 10 
minutes prior to processing. Dual-staining was then performed, followed by flow cytometric analysis, to 
determine rates of cell death in specific subpopulations of the AHPC cultures. A significant increase in 
PI-incorporation into the GalC
+ 
subpopulation was observed. Each bar represents the mean (n=3)+SEM, 
* p<0.05. 
 
 
to apoptosis (cell death due to internal factors; ‘programmed’ cell death). Therefore, it 
is not possible to ascertain with any certainty whether the increased rates of cell death 
observed in the GalC
+
 subpopulation in the study above are a consequence of necrosis 
or apoptosis. 
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The next series of experiments aimed to determine the mechanisms of cell death in the 
GFAP
+
 and GalC
+
 AHPC subpopulations following culture with UC and CM, in terms 
of apoptosis vs. necrosis. Molecular events that occur during apoptosis are largely 
mediated by a family of cysteine proteases called caspases, of which caspase-3 is a 
central mediator in the apoptotic pathway (Porter and Jänicke, 1999; Fox and Aubert, 
2008; Mazumder et al., 2008). Activation of caspase-3 occurs during the early stages 
of apoptosis via the proteolytic cleavage (adjacent to Asp175) of the inactive 
proenzyme. Detection of cleaved caspase-3 in cells can therefore be used as a marker 
of apoptosis. 
 
AHPCs were seeded out for these experiments as for all previous studies in this thesis 
(Section 4.2.3) and cultured under UC and CM conditions for 4 and 7 days. Following 
these periods, AHPCs were fixed in 2% PFA and processed for dual-staining with 
antibodies directed against cleaved caspase-3 and either GFAP or GalC, followed by 
flow cytometric analysis, as described in detail in Section 4.2.5. The percentage of 
cells demonstrating dual-positivity for cleaved caspase-3 and GFAP/GalC were 
determined and results are shown in Figure 4.22. 
 
Although the reduced rates of cell death in the GFAP
+
 subpopulation were not 
significant at the statistical level (Figure 4.21), rates of apoptosis were still determined 
in this subpopulation in order to ascertain whether reduced rates of cell death were 
mirrored in apoptosis rates. At both the 4 (Figure 4.22A) and 7 (Figure 4.22B) day 
timepoints, culturing AHPCs with CM resulted in a decrease in the percentage of 
GFAP
+
 cells undergoing apoptosis compared to UC control cultures, which 
demonstrated higher levels of apoptosis. This trend was apparent at both timepoints 
assessed and mirrored rates of cell death determined by PI-incorporation (Figure 4.21). 
Similarly, these observations were not significant at the statistical level. 
 
As observed in the previous section (Section 4.3.20), the GalC
+
 subpopulation 
demonstrated the complete opposite trend to the GFAP
+
 subpopulation. At both the 4 
(Figure 4.22A) and 7 (Figure 4.22B) day timepoints, AHPCs cultured with CM 
demonstrated significantly higher levels of apoptosis in the GalC
+
 subpopulation 
compared to UC control culture, which demonstrated lower levels of apoptosis. This 
trend was apparent at both timepoints assessed and mirrored rates of cell death 
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determined by PI-incorporation (Figure 4.21). These observations were significant at 
both timepoints assessed (p<0.01). 
 
Data from the previous section (Section 4.3.20) suggested that soluble factors in CM 
could be exerting an astrocytic effect, at least in part, via their influences on cell death 
in the GFAP
+
 and GalC
+
 AHPC subpopulations. Analysis of apoptosis in these 
subpopulations provides further support and suggests that soluble factor(s) in CM 
activate apoptotic pathways in the GalC
+ 
subpopulation/ inhibit activation of apoptotic 
pathways in the GFAP
+
 subpopulation. Apoptosis in the GalC
+
 subpopulation is likely 
to be a key factor as to why astrogenesis is observed at the expense of 
oligodendrogenesis in AHPCs following culture in CM. A less significant factor is 
likely to be the ‘protective’ role observed in the GFAP+ subpopulation, as indicated by 
decreased detection of cleaved caspase-3 following culture with CM compared to UC 
control. 
 
4.3.22 Soluble factors in CM do not influence the number of viable cells in culture 
in the 33B oligodendroglioma cell line but demonstrate a slight tendency to induce 
apoptosis in this system 
Combined, the above data strongly suggest that there are soluble factor(s) present in 
CM that result in the activation of apoptotic pathways specifically in the GalC
+
 
subpopulation of AHPCs i.e. oligodendrocytic-precursor population. One of the major 
causative mechanisms of cancer is aberrant cell survival resulting from a failure of 
proper and timely apoptosis, resulting in the development of accumulated tissue 
masses and tumours (Green and Evan, 2002; Kasibhatla and Tseng, 2003; Gerl and 
Vaux, 2005). Therefore, if this apoptotic effect can be reproduced in other 
oligodendrocytic systems, further analysis of the active components in CM could offer 
potential in the treatment of brain tumours arising from transformed oligodendrocytes 
i.e. oligodendrogliomas. 
 
In order to ascertain whether this apoptotic effect was specific to AHPCs or could be 
reproduced in other oligodendrocytic culture systems, the effect of CM on cell 
viability and cell death was examined in the 33B cell line, an oligodendroglioma (more 
specifically, a Schwannoma) cell line derived from rat (Fields, 1977; Fields and 
Dammerman, 1985). These cells were a generous gift from Professor Eric Blair,  
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Figure 4.22. Flow cytometric analysis of apoptosis in the GFAP
+
 and GalC
+
 subpopulations of 
AHPCs following culture in CM and UC control conditions for 4 and 7 days. AHPCs were seeded 
out and cultured in CM and appropriate control conditions (UC) and processed for flow cytometry at 4 
and 7 days as previously described. Apoptosis was assessed at 4 (A) and 7 (B) days via dual-staining for 
GFAP/GalC and cleaved caspase-3, using the latter as a direct marker of apoptosis. Flow cytometric 
analysis was performed to determine the percentage of cells co-expressing these markers. Rates of 
apoptosis mirrored rates of cell death, as previously determined by measuring PI-incorporation into 
AHPC subpopulations, suggesting that rates of cell death were a direct consequence of apoptosis, as 
opposed to necrosis. A significant increase in cleaved caspase-3 expression was observed in the GalC
+ 
AHPC subpopulation following 7 days culture, suggesting that some unidentified factor in the 
conditioned media was inducing apoptosis specifically in the GalC
+
 subpopulation. Each bar represents 
the mean (n=3)+SEM, ** p<0.01. 
4 days 
7 days 
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University of Leeds, UK, and were maintained under standard conditions as described 
for MSCs, detailed in Section 2.3. 33B cells cultured under standard conditions 
demonstrated many morphological features in keeping with their neural origin, 
particularly demonstrating extensive cytoplasmic projections (Figure 4.23). The 
cancerous origin of these cells was also apparent in terms of their rapid rate of growth 
under standard culture conditions. 
 
 
Figure 4.23. Typical morphology of the 33B cell line under standard culture conditions. The 33B 
cell line was originally propagated from a rat oligodendrocytoma (Schwannoma) and demonstrates 
morphological features in keeping with their neural origin; in particular, extensive cytoplasmic 
projections. Scale bar = 100µm. 
 
 
4.3.23 33B cells cultured in CM do not demonstrate any apparent difference in the 
number of viable cells in culture compared to controls 
Initially, experiments were performed in order to ascertain whether soluble factor(s) in 
CM affected the viability of 33B cells in culture. Viability was assessed using the MTS 
proliferation assay as previously described (Section 2.8). 33B cells were seeded out for 
these experiments under conditions mimicking those previously used for AHPC 
studies where possible (Section 4.2.3). Briefly, 33B cells were seeded onto non-coated 
cellware at a density of 10,000 cells/cm
2
 in standard culture media (CCM) and allowed 
24 hours to settle (designated day –1). Following this 24 hour period (day 0), media 
was removed and replaced with CM or appropriate control media (UC: unconditioned 
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media; CCM: standard culture media) and 33B cells cultured for a further 7 days. 
Medium was replenished on the 4
th
 day. The number of viable cells in each culture 
were determined at days 1, 4 and 7 using the MTS assay as previously performed for 
AHPCs (Section 4.3.6) and results are shown graphically in Figure 4.24. 
 
At each of the timepoints examined there was no observable difference in the number 
of viable cells in culture regardless of the culture condition employed (Figure 4.24). 
These data therefore suggested that soluble factor(s) in CM did not have any 
significant effects on the viability of 33B cells in culture when compared to control 
cultures. However, in terms of examining phenomena such as apoptosis and necrosis in 
detail, the MTS assay is perhaps not the best approach as it is crude and lacks 
sensitivity in comparison to more sophisticated techniques such as flow cytometry. 
Therefore, although the MTS data revealed no significant change in viable cell number 
between CM and control conditions, further analyses are required to investigate any 
changes at the molecular level e.g. activation of apoptotic pathways. Such experiments 
were performed in the proceeding section. 
 
 
Figure 4.24. Determination of the number of viable cells in culture following treatment with 
conditioned media and appropriate controls for 1, 3 and 7 days. 33B cells were seeded out and 
cultured in conditioned media and appropriate controls (CCM and UC) and the number of viable cells in 
culture determined using the colorimetric MTS assay. There was no significant difference in the number 
of viable cells in culture between conditioned media and appropriate controls at any of the timepoints 
assessed. Each bar represents the mean (n=3)+SEM. 
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33B cells cultured in CM demonstrate a slight tendency to undergo apoptosis 
compared to controls 
In order to gain a greater appreciation of the apoptotic/necrotic phenotype of 33B cells 
cultured in CM and appropriate controls, cell death was analysed in detail using flow 
cytometric methods as described in Section 4.2.6. Briefly, 33B cells were seeded out 
as described previously in Section 4.3.23 and maintained in CM and appropriate 
controls (UC and CCM) for 4 and 7 days. Following these culture periods, cells were 
dual-stained against PI and caspase-3, followed by flow cytometric analysis, as 
detailed in Section 4.2.6. Such analysis allows discrimination between cells at various 
stages of cell death, as illustrated diagrammatically in Figure 4.25. 
 
 
 
Figure 4.25. Flow cytometric analysis of cell death can be achieved by dual-labelling with 
propidium iodide (PI) and cleaved caspase-3, followed by flow cytometric analysis to discriminate 
between various stages of cell death, including early apoptosis (PI
-
/caspase-3
+
), late apoptosis 
(PI
+
/caspase-3
+
) and necrosis (PI
+
/caspase-3
-
). 
 
 
 Healthy, viable cells (PI-/caspase-3-) Lower left quadrant 
 
 Early apoptotic cells (PI-/caspase-3+)  Lower right quadrant 
 
 Late apoptotic cells (PI+/caspase-3+)  Upper right quadrant 
 
 Necrotic cells (PI+/caspase-3-)  Upper left quadrant 
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Data from three independent repeats were collated and the results shown graphically in 
Figure 4.26 in terms of the percentage of early apoptotic (Figure 4.26A; PI
-
/caspase-
3
+
) and late apoptotic (Figure 4.26B; PI
+
/caspase-3
+
) cells. In terms of the percentage 
of cells in the early stages of apoptosis, there was no obvious difference between cells 
cultured with CCM or UC at either of the timepoints assessed (Figure 4.26A). 
Following culture with CM, however, there was a tendency for the percentage of cells 
in the early stages of apoptosis to increase compared to control conditions and this was 
apparent at both the 4 and 7 day timepoints (Figure 4.26A). These observations were 
not significant at the statistical level. Very similar trends were observed in terms of the 
percentage of cells in the later stages of apoptosis (Figure 4.26B). There was no 
obvious difference between cells cultured with CCM or UC at either of the timepoints 
assessed. However, culture with CM again resulted in a tendency for the percentage of 
cells in the later stages of apoptosis to increase compared to control conditions, a trend 
that was apparent at both timepoints assessed. Similarly, these observations were not 
significant at the statistical level. 
 
In summary, these data suggest that soluble factor(s) in CM induce a slight increase in 
rates of apoptosis in the 33B oligodendroglioma cell line compared to control cultures. 
Although 33B cells cultured in CM demonstrated a greater percentage of cells in both 
the early and later stages of apoptosis at both timepoints assessed, these observations 
were not significant at the statistical level. Despite the lack of statistical significance, 
these data still hold potential in that the trend for soluble factor(s) in CM to induce 
apoptosis in oligodendrocytic cell types has been reproduced here. 
Chapter 4: MSCs as paracrine mediators of neural differentiation 
 
205 
 
 
Figure 4.26. Flow cytometric determination of early-apoptotic and late-apoptotic 33B cells in 
culture following treatment with CM and appropriate controls (CCM and UC) for 4 and 7 days. 
33B cells were seeded out and cultured in CM and appropriate controls (CCM and UC) and processed 
for flow cytometry at 4 and 7 days as described previously. Dual-labelling with propidium iodide (PI) 
and cleaved caspase-3 was performed in order to discriminate between early apoptotic (A; PI
-
/caspase-
3
+
) and late-apoptotic (B; PI
+
/caspase-3
+
) cells. No statistically significant difference was observed in 
terms of apoptotic status between MSCs cultured with CM or under control conditions. Each bar 
represents the mean (n=3)+SEM. 
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4.3.24 Soluble factor(s) in CM induce dramatic changes in the transcriptional 
profiles of AHPCs in terms of patterns of expression of neural-related transcription 
factors 
Studies in this Chapter so far have demonstrated that MSC aggregates secrete soluble 
factor(s) that influence the cell fate decisions of AHPCs, causing them to commit to 
and undergo an astrocytic differentiation program. Investigation into the mechanisms 
by which this effect occurs has largely been based at the cellular level thus far. 
Although there is evidence to suggest that activation of apoptotic pathways in GalC
+
 
oligodendrocytic precursors is likely to be a major contributing factor, temporal 
analysis of marker expression also suggests the involvement of an instructive 
mechanism, whereby soluble factor(s) in CM induce uncommitted progenitors to 
commit to and undergo astrocytic differentiation. In order to provide further evidence 
in support of an instructive mechanism, in addition to providing data at a molecular 
level as opposed to a cellular level, expression of transcription factors known to play 
key roles in neural differentiation processes were examined in AHPCs cultured with 
CM and UC control at days 1, 3 and 7, using qRT-PCR. 
 
The transcription factors examined can be divided into several subcategories: 
 
1. Astrocytic-promoting transcription factors 
 
2. Oligodendrocytic-promoting transcription factors 
 
3. Neuronal-promoting transcription factors 
 
4. Neuronal-inhibiting transcription factors 
 
Expression of a range of transcription factors belonging to each category were 
examined using qRT-PCR and the results shown in Figures 4.27, 4.28, 429 and 4.30. 
AHPCs were seeded out for these experiments as for all previous studies in this thesis 
(Section 4.2.3) and cultured under UC and CM conditions for 1, 3 and 7 days. 
Following these culture periods, total cellular RNA was isolated using the TRIreagent 
method (Section 2.9) followed by reverse transcription to cDNA (Section 2.10) and 
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finally qRT-PCR using SYBR Green chemistry (Figure 2.3). Specific primer 
sequences are shown in Table 2.1. 
 
In terms of astrocytic-promoting transcription factors, expression of STAT1, STAT3, 
Smad1, Smad4 and Sox9 were determined at the mRNA level in AHPCs cultured with 
UC and CM for 1, 3 and 7 days. Results are shown in Figure 4.27. AHPCs cultured 
with CM demonstrated significant upregulation of each of these transcription factors 
compared to control cultures, albeit at various timepoints throughout the 7 day time 
course of this experiment. STAT1 was markedly upregulated at both the 1 (p<0.001) 
and 3 (p<0.01) day timepoints following culture with CM compared to UC controls, 
though mRNA levels dropped considerably at the 7 day timepoint to an equivalent 
level to UC control cultures (Figure 4.27A). Levels of STAT1 expression in control 
cultures remained relatively uniform throughout the 7 day time course of this 
experiment. STAT3 displayed a very similar expression profile, with very high levels 
of mRNA transcript being detected at the 1 (p<0.001) and 3 (p<0.01) day timepoints 
(Figure 4.27B). Interestingly, expression of STAT3 could not be detected in AHPCs 
cultured under UC control conditions at either of these timepoints. Transcripts were 
readily detectable at the 7 day timepoint for AHPCs cultured under both control and 
CM conditions, though expression was very low in both instances such that there was 
no statistically significant difference between UC and CM samples at this timepoint. 
Smad1 was expressed at significantly higher levels in AHPCs cultured with CM 
compared to UC control at the 1 day timepoint only (p<0.05). However, despite the 
statistical significance of this observation, levels of Smad1 transcript were very low in 
AHPCs cultured with CM and undetectable in AHPCs cultured with UC at this 
timepoint (Figure 4.27C). At the 3 day timepoint, expression of Smad1 was readily 
detectable in AHPCs cultured under both conditions, with levels of transcript being 
detected at virtually identical levels in each case. Interestingly, at the 7 day timepoint, 
expression of Smad1 increased in UC samples and decreased in CM samples, such that 
the difference in expression between the two samples was highly significant at the 
statistical level (p<0.001). Smad4 demonstrated an almost identical expression profile 
to that observed for STAT1 (Figure 4.27D), with AHPCs cultured in CM 
demonstrating significantly higher levels of mRNA transcript compared to controls at 
both the 1 (p<0.01) and 3 (p<0.05) day timepoints (Figure 4.27D). At the 7 day 
timepoint, expression of Smad4 decreased in AHPCs cultured with CM and increased 
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in AHPCs cultured with UC, such that levels of expression were comparable in 
AHPCs cultured under both conditions. No statistical significant was observed at the 7 
day timepoint. Expression of Sox9 was unique in that it was the only transcription 
factor that was upregulated in AHPCs cultured with CM at all of the timepoints 
examined (Figure 4.27E). These observations were significant at the statistical level at 
each of the timepoints – days 1 (p<0.05), 3 (p<0.01) and 7 (p<0.05). Expression of 
Sox9 in UC control cultures demonstrated a similar trend to that observed for CM 
cultures, in that expression increased with time over the 7 day time course of the 
experiment. However, at each of the timepoints examined, absolute levels were lower 
in UC cultures compared to CM cultures. Combined, these data demonstrate that 
soluble factor(s) in CM cause astrogenesis, at least in part, by upregulation of a 
number of key transcriptional regulators of astrocytic differentiation. 
 
However, regulation of astrogenesis at the transcriptional level is a complex, highly 
involved process involving extensive interaction and interplay between many positive 
and negative regulators of differentiation. It is now widely accepted that expression of 
astrocytic-promoting transcription factors, although a crucial event, is not sufficient to 
promote astrogenesis in uncommitted precursors – such positive regulators of 
astrocytic differentiation must be expressed concomitant with inhibitors of neuronal 
differentiation; likewise, neuronal- and oligodendrocytic-promoting transcription 
factors must be downregulated to permit astrogenesis (Guillemot, 2007). 
 
In terms of oligodendrocytic-promoting transcription factors, expression of Olig1, 
Olig2 and Nkx2.2 were examined at the mRNA level in AHPCs cultured with UC and 
CM for 1, 3 and 7 days. Interestingly, Nkx2.2 was not expressed at a detectable level 
in AHPCs cultured under either condition at any of the timepoints examined. Olig1 
and Olig2 on the other hand were readily detectable in AHPCs cultured under both 
conditions and results are shown in Figure 4.28. Olig1 was expressed at similar levels 
in AHPCs cultured with UC and CM at the earlier timepoints of 1 and 3 days (Figure 
4.28A). Any differences in mRNA transcript levels were very slight and not significant 
at the statistical level. However, at the 7 day timepoint, AHPCs cultured with CM 
demonstrated a significant decrease in expression of Olig1 compared to AHPCs  
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Figure 4.27. Expression of astrocytic-promoting transcription factors in AHPCs cultured with CM 
and UC control for 1, 3 and 7 days. QRT-PCR analysis was performed to compare mRNA transcript 
levels of five astrocytic-promoting transcription factors – A: STAT1; B: STAT3; C: Smad1; D: Smad4; 
E: Sox9 – in AHPCs cultured in CM and UC control for 1, 3 and 7 days. All values were normalised to 
GAPDH to account for any differences in RNA input and/or reverse transcription efficiencies. 
Normalised levels of expression are shown as percentages of the maximum expresser. Each bar 
represents the mean (n=3)+SEM, *** p<0.001, ** p<0.01, *p<0.05. 
 
STAT1 STAT3 
Smad1 Smad4 
Sox9 
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cultured with UC, where expression of Olig1 was maintained at a similar level to that 
observed at the earlier timepoints. This observation was significant at the statistical 
level (p<0.05). The expression profile of Olig2 was far more intriguing (Figure 4.28B). 
This oligodendrocytic-promoting transcription factor was actually upregulated in 
AHPCs following culture with CM compared to UC control at the earlier timepoints of 
1 and 3 days, with these observations being highly significant at the statistical level  
(p<0.001). At the 7 day timepoint, however, there was no observable difference in 
expression of Olig2 between AHPCs cultured under both conditions.  
 
In terms of neuronal-promoting transcription factors, expression of the neurogenin 
family members Ngn1, Ngn2, Ngn3 and Mash1 were determined at the mRNA level in 
AHPCs cultured with UC and CM for 1, 3 and 7 days. Results are shown in Figure 
4.29. In most instances, AHPCs cultured with CM demonstrated significant 
downregulation of these transcription factors compared to control cultures, albeit at 
various timepoints throughout the 7 day time course of this experiment. Ngn1 was 
significantly downregulated at the 1 day timepoint following culture with CM 
compared to UC control (p<0.01) (Figure 4.29A). At the later timepoints of 3 and 7 
days, however, expression of Ngn1 was very low and uniform in AHPCs cultured 
under both conditions. Any slight differences in expression that were apparent were 
not significant at the statistical level. Interestingly, Ngn2 showed no differences in 
expression throughout the 7 day time course of this experiment, regardless of the 
culture condition employed (Figure 4.29B). Levels of mRNA transcript remained 
constant throughout the entire experiment and were detectable at comparable levels in 
AHPCs cultured with UC and CM. Expression of Ngn3 was undetectable in AHPCs 
cultured under both UC and CM at the 1 and 3 day timepoints, though became readily 
detectable at the 7 day timepoint (Figure 4.29C). At this timepoint, mRNA transcript 
levels were significantly higher in AHPCs cultured under control conditions compared 
to CM (p<0.05) (Figure 4.29C). Mash1 mRNA transcripts were readily detectable in 
AHPCs cultured under both UC and CM conditions at all timepoints examined (Figure 
4.29D). At each of these timepoints, expression of Mash1 was greater in AHPCs 
cultured under control conditions compared to AHPCs cultured with CM; however, 
this observation was only statistically significant at the 7 day timepoint (p<0.01). 
Combined, these data demonstrate that soluble factor(s) in CM, in addition to 
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promoting the upregulation of astrocytic-promoting transcription factors, cause 
downregulation of a number of key neuronal-promoting transcription factors. 
 
 
 
 
Figure 4.28. Expression of oligodendrocytic-promoting transcription factors in AHPCs cultured 
with CM and UC control for 1, 3 and 7 days. QRT-PCR analysis was performed to compare mRNA 
transcript levels of two oligodendrocytic-promoting transcription factors – A: Olig1 and B: Olig2 – in 
AHPCs cultured in CM and UC control for 1, 3 and 7 days. All values were normalised to GAPDH to 
account for any differences in RNA input and/or reverse transcription efficiencies. Normalised levels of 
expression are shown as percentages of the maximum expresser. Each bar represents the mean 
(n=3)+SEM, *** p<0.001, *p<0.05. 
 
 
Olig1 
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Figure 4.29. Expression of neuronal-promoting transcription factors in AHPCs cultured with CM 
and UC control for 1, 3 and 7 days. QRT-PCR analysis was performed to compare mRNA transcript 
levels of four neuronal-promoting transcription factors – A: Ngn1; B: Ngn2; C: Ngn3; D: Mash1 – in 
AHPCs cultured in CM and UC control for 1, 3 and 7 days. All values were normalised to GAPDH to 
account for any differences in RNA input and/or reverse transcription efficiencies. Normalised levels of 
expression are shown as percentages of the maximum expresser. Each bar represents the mean 
(n=3)+SEM, ** p<0.01, *p<0.05. 
 
 
In the final series of experiments examining the expression profiles of neural fate 
determinants in AHPCs, expression of a number of neuronal-inhibitory factors was 
determined at the mRNA level in AHPCs cultured with UC and CM for 1, 3 and 7 
days. Expression of two members of the Hes protein family – Hes1 and Hes5 – along 
with three members of the Inhibitor of Differentiation (Id) protein family – Id1, Id2 
and Id3 – were determined and results shown in Figure 4.30. In all instances, AHPCs 
cultured with CM demonstrated significant upregulation of these neuronal-inhibitory 
Ngn1 Ngn2 
Ngn3 Mash1 
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factors compared to control cultures, albeit at various timepoints throughout the 7 day 
time course of this experiment. Hes1 was markedly upregulated in AHPCs cultured 
with CM compared to UC control cultures at all of the timepoints examined, though 
this observation was only significant at the 1 day timepoint (p<0.05) (Figure 4.30A). 
Levels of expression increased throughout the 7 day time course of the experiment 
such that maximum expression was observed at the 7 day timepoint. This trend was 
also observed in AHPCs cultured under UC control conditions, though expression was 
undetectable at the 1 day timepoint and remained at much lower levels at the later 
timepoints of 3 and 7 days compared to AHPCs cultured with CM. Similar to the 
trends in Hes1 expression, expression of Hes5 was also markedly upregulated in 
AHPCs cultured with CM compared to UC at the 1 and 3 day timepoints (Figure 
4.30B). This observation was only statistically significant at the 1 day timepoint 
(p<0.05). At the 7 day timepoint, however, expression of Hes5 decreased in AHPCs 
cultured with CM, concomitant with increased expression in AHPCs cultured with UC, 
such that there was no observable difference in expression in AHPCs cultured under 
either condition at this timepoint. In terms of Id1 expression, AHPCs cultured with 
CM demonstrated a significant upregulation in mRNA transcript levels compared to 
controls at the 7 day timepoint only (Figure 4.30C). This observation was highly 
significant at the statistical level (p<0.001). At the earlier timepoints of 1 and 3 days, 
levels of Id1 transcript were extremely low in AHPCs cultured under both UC and CM 
conditions; however, despite such low levels of expression, AHPCs cultured under UC 
demonstrated significantly higher levels of expression at both of these early timepoints 
(p<0.05 at the 1 day timepoint, p<0.001 at the 3 day timepoint). Another member of 
the Id protein family – Id2 – was significantly upregulated in AHPCs cultured with 
CM compared to UC control at the 1 day timepoint only (p<0.01) (Figure 4.30D). 
However, this expression profile changed over the 7 day time course of the experiment 
such that AHPCs cultured under UC conditions demonstrated significantly higher 
levels of expression compared to equivalent CM cultures (p<0.01). The final neuronal-
inhibitory factor examined in this study was Id3. At the earlier timepoints of 1 and 3 
days, Id3 was expressed at significantly higher levels in AHPCs cultured with CM 
compared to UC (Figure 4.30E). These observations were significant at the statistical 
level at both the 1 (p<0.05) and 3 (p<0.01) day timepoints. However, whereas 
expression of Id3 underwent a massive reduction at the 7 day timepoint in AHPCs 
cultured with CM, expression in AHPCs cultured with UC showed the exact opposite 
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trend and underwent a massive upregulation in expression. Expression of Id3 in 
AHPCs cultured with UC at the 7 day timepoint was significant higher than expression 
observed in CM cultures at this timepoint (p<0.001). 
 
In summary, the above data demonstrate that soluble factor(s) in CM significantly 
influence the behaviour of AHPCs at both the cellular and molecular level. 
Observations in this section of the thesis show that AHPCs cultured with CM 
demonstrate markedly different transcriptional profiles compared to control cultures, in 
terms of expression of neural fate determinants. Such differences are likely to be major 
contributing factors to the astrogenic effect observed in AHPCs following culture with 
CM for 7 days. Upregulation of astrocytic-promoting and neuronal-inhibitory factors, 
concomitant with downregulation of pro-neuronal and pro-oligodendrocytic factors, 
are crucial molecular events in the intricate and highly complex process of 
astrogenesis. 
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Figure 4.30. Expression of neuronal-inhibitory transcription factors in AHPCs cultured with CM 
and UC control for 1, 3 and 7 days. QRT-PCR analysis was performed to compare mRNA transcript 
levels of five neuronal-inhibitory transcription factors – A: Hes1; B: Hes5; C: Id1; D: Id2; E: Id3 – in 
AHPCs cultured in CM and UC control for 1, 3 and 7 days. All values were normalised to GAPDH to 
account for any differences in RNA input and/or reverse transcription efficiencies. Normalised levels of 
expression are shown as percentages of the maximum expresser. Each bar represents the mean 
(n=3)+SEM, *** p<0.001, ** p<0.01, *p<0.05. 
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4.4 Discussion 
 
Culture of MSCs as large, multicellular 3D aggregates 
As discussed in Chapter 3, general cell culture methodology using tissue culture plastic 
is fundamentally flawed in that the 2D environment of tissue culture plastic forces 
cells to adopt highly unnatural conformations/morphologies that are in no way 
representative of their in vivo growth environments (3D), where they develop highly 
complex interactions with neighbouring cells and extracellular matrix within their 
niche. As such, there is an increasing demand for 3D culture systems for in vitro use. 
Studies in Chapter 3 investigated the behaviour of MSCs cultured on a novel 
polystyrene scaffold, Alvetex
TM
, manufactured by Reinnervate. Data from these 
studies clearly demonstrated that MSCs cultured on the scaffold displayed markedly 
different behavioural traits, in terms of enhanced cellular viability and enhanced 
functionality in terms of their ability to undergo osteogenic and adipogenic 
differentiation, compared to equivalent cultures on 2D tissue culture plastic. It can 
therefore be argued that culturing cells on the 3D environment of the scaffold provides 
a more realistic and physiologically-relevant system in which to study complex 
biological phenomena such as differentiation. 
 
Although findings from Chapter 3 of this thesis and many other studies in the literature 
demonstrate that cells cultured on 3D scaffolds behave in a manner more 
representative of that in which they behave in vivo, there are alternative methods of 3D 
cell culture that are advantageous in that they encourage such phenotypic behaviour 
but do not require the use of external scaffolds. For example, encouraging cells to form 
large, multicellular aggregates is a method of 3D cell culture that promotes structural 
interactions, such as the re-establishment of mutual contacts between cells, and 
functional behaviour more reflective of that observed in real tissues (Pampaloni et al., 
2007; Lin and Chang, 2008). To date, the large majority of studies exploiting the 
advantages of using cellular aggregates as 3D model systems have been in tumour 
biology and other oncology-related studies (Mueller-Klieser, 1987; Kunz-Schughart et 
al., 1998; Santini and Rainaldi, 1999; Bates et al., 2000; de Ridder et al., 2000; 
Gottfried et al., 2006). However, there is also increasing evidence to suggest that 
culturing cells as aggregates and spheroids may be useful in developmental biology, 
with studies reporting enhanced viability and functionality in stem and progenitor cells 
Chapter 4: MSCs as paracrine mediators of neural differentiation 
 
217 
 
cultured as aggregates compared to standard monolayer cultures (Lin and Chang, 
2008). Such observations are analogous to those reported in Chapter 3 for MSCs 
cultured on the scaffold. 
 
Strategies for the 3D culture of cells as large, multicellular aggregates and spheroids 
vary quite significantly throughout the literature. Two methods exploit the tendency of 
cells to naturally aggregate with each other in culture: the hanging drop technique 
(used extensively in the culture of embryonic stem cells to promote the formation of 
embryoid bodies) and culturing cells in rotating bioreactors (Pampaloni et al., 2007). 
Both techniques have been described to promote the formation of aggregates from 
MSCs, though neither technique has been used extensively (Chen et al., 2006; Elvenes 
et al., 2009). 
 
Similarities between MSC-derived aggregates and NSC-derived neurospheres 
A significant number of studies have reported that MSCs can be induced to form large, 
multicellular, free-floating aggregates when cultured under identical conditions to 
those used for the propagation of neurospheres from neural stem cells (Croft and 
Przyborski, 2004; Hermann et al., 2004; Bossolasco et al., 2005; Hermann et al., 
2006). These culture conditions are described in Section 4.2.1, with key points of note 
including the absence of serum and addition of mitogens, EGF and FGF, to the culture 
media. Such are the phenotypic similarities between MSCs and NSCs cultured under 
these defined conditions that they are morphologically indistinguishable from one 
another. In some studies, such as that published by Suzuki and colleagues in 2004, 
aggregates formed by MSCs are even referred to as ‘neurospheres’ – however, this is 
somewhat misleading as neurospheres are, by definition, free-floating aggregations of 
cells derived from NSCs (Bez et al., 2003; Campos, 2004; Suzuki et al., 2004). To 
avoid such confusion, the terminology ‘neurosphere’ has been avoided throughout this 
thesis and MSC-derived aggregates have been referred to as ‘aggregates’ rather than 
‘neurospheres’ throughout these studies. 
 
MSCs cultured under defined, aggregate-inducing conditions in this study formed 
large, spherical cellular masses that were morphologically indistinguishable from those 
observed in previous studies (Hermann et al., 2004; Bossolasco et al., 2005; Croft and 
Przyborski, 2009). Enhanced functionality in terms of potential to undergo osteogenic, 
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adipogenic and cartilaginous differentiation has been reported in MSCs cultured as 
aggregates and such cultures have also been reported to possess a greater plasticity 
than previously anticipated, demonstrating a potential to ‘trans’-differentiate into 
hepatocyte-like cells (Qihao et al., 2007; Boeuf et al., 2008; Wang et al., 2009). 
However, because MSC-derived aggregates are so phenotypically similar to NSC-
derived neurospheres, the large majority of studies involving MSC-derived aggregates 
have been aimed at a neurological perspective. 
 
One of the key properties of MSC aggregates that is consistently reported in studies 
throughout the literature is that they express very high levels of neural antigens such as 
nestin, Tuj-1 and GFAP concomitant with very low levels of expression of 
mesenchymal antigens such as α-SMA (Kabos et al., 2002; Croft and Przyborski, 
2004; Hermann et al., 2004; Suzuki et al., 2004; Hermann et al., 2006; Kim et al., 
2006). In keeping with such previous studies, MSCs cultured as aggregates in this 
Chapter demonstrated enhanced expression of the neural antigens, nestin and GFAP, 
concomitant with reduced expression of the mesenchymal marker, α-SMA, compared 
to MSCs cultured under standard conditions. These expression profiles were confirmed 
using both immunocytochemical and flow cytometric techniques to provide 
information at the whole aggregate and individual cellular level respectively. 
 
Several studies investigating the neural-like behaviour of MSCs cultured as 
neurosphere-like aggregates demonstrated that they lost phenotypic traits characteristic 
of their mesenchymal origin and gained phenotypic traits more in keeping with a 
neural origin. Separate studies led by Suzuki et al (2004) and Hermann et al (2004) 
both demonstrated that MSCs cultured as aggregates displayed the potential to 
differentiate into the three main neural cell types – as determined by morphological 
analysis and expression of mature markers indicative of the acquirement of a neuronal, 
astrocytic and oligodendrocytic cell fate – following plating out onto laminin-coated 
cellware and treatment with suitable neurogeneic factors respectively (Hermann et al., 
2004; Suzuki et al., 2006). Other studies support such observations (Kabos et al., 
2002; Kim et al., 2006). However, when observations in the previous chapter of this 
thesis are taken in account (Chapter 3), it is the study recently published by Croft and 
Przyborski that is perhaps the most interesting and relevant (Croft and Przyborski, 
2009). In this study, it was demonstrated that MSCs cultured as aggregates were able 
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to influence the cell fate decisions of primary embryonic NSCs in a co-culture system. 
The co-culture system adopted in this study was unique in that the two cell populations 
in culture – MSC-derived aggregates and NSCs – were separated by a porous 
microfilter membrane, such that the two cell populations were only able to 
communicate using paracrine mechanisms i.e. via the release of trophic factors and 
cytokines. MSC aggregates released a combination of soluble factors that induced 
NSCs to commit to and undergo a neuronal differentiation program (as determined by 
expression of Tuj-1) whereas MSCs cultured as standard monolayers released a 
combination of soluble factors that induced NSCs to commit to and undergo an 
astrocytic differentiation program (as determined by expression of GFAP), at the 
expense of a neuronal one. Such evidence that MSC-derived aggregates demonstrated 
a paracrine relationship with NSCs is particularly interesting and relevant to previous 
studies in this thesis (Chapter 3) demonstrating that enhanced osteogenic and 
adipogenic differentiation of MSCs cultured on the scaffold was a consequence, at 
least in part, of enhanced autocrine activity, with MSCs cultured on the scaffold 
demonstrating enhanced expression of positive soluble factors concomitant with 
reduced expression of inhibitory factors that would aid these differentiative processes. 
Therefore, MSCs can be described as both autocrine and paracrine regulators of 
differentiation. 
 
MSCs as paracrine mediators of neural differentiation 
Following on from the study recently published by Croft and Przyborski in 2009, the 
major aims of this Chapter were to investigate the paracrine function(s) of MSC-
derived aggregates in terms of their effect(s) on neural development and plasticity 
using an in vitro conditioned media (CM) model. A number of studies adopting a CM 
approach in order to investigate the effects of MSC-derived soluble factors and 
cytokines on the differentiative state of NSCs have already been published (Wislet-
Gendebien et al., 2004; Rivera et al., 2006). In 2006, Rivera and colleagues reported 
that adult rat MSCs cultured under standard culture conditions (in CCM containing 
10% serum) secreted a complement of proteins and/or other metabolic factors into 
their media that induced adult rat NSCs to commit to and undergo oligodendrogenic 
differentiation at the expense of astrocytic differentiation, as determined by increased 
expression of the oligodendrocytic markers, GalC and MBP, concomitant with 
decreased expression of the astrocytic marker, GFAP (Rivera et al., 2006). Levels of 
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neuronal differentiation did not differ between CM and control cultures in this system, 
as determined by expression of the neuronal marker, Map2ab. Conversely, Wislet-
Gendebien and colleagues reported that adult rat MSCs cultured under conditions that 
promoted the expression of the neuroprogenitor marker, nestin,  secreted a 
complement of proteins and/or other metabolic factors into their media that induced 
embryonic (E16) NSCs to commit to and undergo astrocytic differentiation, as 
determined by expression of GFAP (Wislet-Gendebien et al., 2004). Increased 
expression of GFAP occurred simultaneously with decreased expression of Tuj-1 and 
O4 (another marker of oligodendrocytic fate) and this effect was demonstrated to be, at 
least partially, a consequence of active BMP4 secretion. 
 
Although the differences in observations between these studies are likely to be largely 
a consequence of the obvious differences in experimental setup i.e. the use of adult 
NSCs in the Rivera (2006) study compared to the use of embryonic NSCs in the 
Wislet-Gendebien (2004) study, these observations also suggest that the conditions in 
which MSCs are cultured and maintained considerably influence their secretory 
properties. This is consistent with previous studies reporting that MSCs are able to 
significantly vary their secretion patterns depending on specific microenvironments 
(Chen et al., 2002). An interesting question to address in the near future will be 
whether MSCs should be administered to areas of neurological damage in patients 
under standard conditions or whether they should first be cultured under defined 
conditions in vitro in order to promote a more direct response in vivo. 
 
MSC aggregate-derived soluble factors influence the cell fate decisions of AHPCs 
In the present study, CM was produced from MSC-derived aggregates using 
methodology identical to that used in the previously-discussed studies (Wislet-
Gendebien et al., 2004; Rivera et al., 2006). These studies reported an optimal 
conditioning period of 3 days in order to gain a suitable balance between allowing 
sufficient time for cells to secrete a concentration of soluble factors/cytokines that is 
likely to exert a biological effect without depleting the basal media of essential 
nutrients which would be deleterious to the further culture of cells. In order to assess 
the neurogenic properties of aggregate-derived soluble factors, CM was collected and 
used in the subsequent culture of a rat adult hippocampal progenitor cell (AHPC) line 
for 7 days. These self-renewing, multipotent cells were a generous gift from Professor 
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Fred Gage (Salk Institute) and have been extensively characterised (Palmer et al., 
1997). Routine use of this cell line in our lab confirmed the stem cell-like behaviour of 
these cells in terms of their ability to self-renew and differentiate into all three of the 
major neural cell types – neurons, astrocytes and oligodendrocytes. 
 
Morphology and expression of neural markers 
Following culture with CM for 7 days, AHPCs were induced to commit to and 
undergo gliogenesis, in particular, astrogenesis at the expense of oligodendrogenesis. 
This was determined using morphological analyses and, perhaps more convincingly, 
using neural marker analysis. One particularly prominent feature of the AHPC cell line 
used in this study, however, is that undifferentiated, proliferating cells demonstrate 
positivity not only for markers indicative of a neuroprogenitor phenotype, such as 
nestin, but also demonstrate positivity for expression of markers indicative of a more 
mature neural phenotype, such as NSE, Map2c and O4 (Sommer and Schachner, 1982; 
Black and Kurdyla, 1983; Iwanaga et al., 1989; Lendahl et al., 1990; Palmer et al., 
1997). These markers are reportedly expressed at levels of greater than 80% (Palmer et 
al., 1997). Expression of other neural markers has also been reported in AHPCs 
cultured under standard, proliferative conditions, such as A2B5 and GFAP, though 
these levels are much lower, at levels of less than 2% (Palmer et al., 1997). Expression 
of the neural markers GalC, MBP, NF200, Tau and NeuN were negligible (Palmer et 
al., 1997). Combined, these marker analyses therefore raise a potential issue, as 
extensive co-expression of neural markers could lead to ambiguity in terms of 
interpretation of results. The potential for ambiguity intensifies when more 
sophisticated marker analyses are performed using highly sensitive techniques such as 
flow cytometry, as the marker expression profiles constructed in the previous studies 
were derived from immunocytochemical observations alone. For example, previous 
characterisation studies have reported that AHPCs are largely negative for GFAP as 
determined using immunocytochemical methods (Palmer et al., 1997). 
Immunocytochemical observations from this study support such observations. 
However, when GFAP expression is examined in AHPCs maintained under identical 
conditions using flow cytometry, approximately 90% of cells demonstrate positivity, 
albeit at weak MFI. Therefore, marker expression profiles constructed using 
immunocytochemical analyses alone could yield false negative results due to its lack 
of sensitivity. 
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In order to assess the differentiative state of AHPCs cultured with CM, expression of 
the neural markers nestin, Tuj-1, GFAP and GalC were examined, using 
immunocytochemistry and flow cytometry, as indicators of neuroprogenitor, neuronal, 
astrocytic and oligodendrocytic phenotypes respectively. The most striking 
observation was in terms of GFAP expression – AHPCs cultured with CM 
demonstrated intense, highly significant levels of expression compared to AHPCs 
cultured under the two control conditions, which demonstrated very low, weak levels 
of expression. However, caution must be aired when using GFAP as an exclusive 
marker of astrocytic differentiation as GFAP, in addition to nestin, is widely reported 
to be expressed in immature neural stem and progenitor cells isolated from the 
hippocampus (Filippov et al., 2003; Fukuda et al., 2003; von Bohlen and Halbach, 
2007). It has also been widely reported that, during adult neurogenesis, new neurons 
originate from GFAP
+
 cells displaying astrocytic traits (Doetsch et al., 1997). 
Therefore, it is crucial to be able to discriminate between GFAP
+
 cells that express an 
immature, undifferentiated phenotype and GFAP
+
 cells that express a more mature, 
astrocytic phenotype. The GFAP
+
 cells observed in this study following culture with 
CM are likely to be astrocytes rather than progenitors for two reasons: 
 
 
1. During adult neurogenesis, GFAP is downregulated prior to neuronal 
differentiation (von Bohlen and Halbach, 2007). The converse is observed 
in this study in that AHPCs cultured with CM increase expression of 
GFAP. 
 
 
2. GFAP+ progenitor cells demonstrate unipolar and bipolar morphologies 
with few cytoplasmic processes (von Bohlen and Halbach, 2007). AHPCs 
cultured with CM, however, demonstrate multipolar soma with extensive 
cytoplasmic extensions, forming stellate, star-shaped morphologies. 
 
 
Another interesting observation to arise from these marker analysis studies was in 
terms of nestin expression – AHPCs cultured under both control and CM conditions 
demonstrated very high, intense levels of expression. Since nestin is traditionally 
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considered to be a marker of immature neural stem and progenitor cells, it could be 
anticipated that nestin expression would be downregulated in AHPCs actively 
undergoing differentiation. However, although there is a slight tendency for the 
percentage of cells expressing nestin to decrease following culture with CM for 7 days, 
this observation was not significant at the statistical level and intensity of expression 
(MFI) was comparable between AHPCs cultured with CM and AHPCs cultured under 
standard, proliferative conditions. It is now widely accepted that nestin is upregulated 
in astrocytes following cellular stress or pathological events e.g. cerebral ischemia, 
traumatic brain injury and neurotoxicity, such that nestin is considered to be an 
accurate marker of reactive astrocytes (Clarke et al., 1994; Duggal et al., 1997; 
Holmin et al., 1997; Brook et al., 1999; Sahin et al., 1999; Holmin et al., 2001; Yoo et 
al., 2005). That is not to suggest that the GFAP
+
 astrocytic-like cells formed by 
AHPCs following culture with CM for 7 days are necessarily experiencing cell stress 
events, however, as continued nestin expression has been reportedly observed in 
astrocytes in non-pathological states (Schmidt-Kastner and Humpel, 2002). A further 
study by Gu and colleagues reported that, in the mature human CNS, nestin expression 
was readily detectable in at least three mature neural cell types; among them, 
astrocytic-like cells isolated from the subependymal zone and subgranular layer of the 
dentate gyrus of the hippocampus (Gu et al., 2002). 
 
There is no evidence in the literature at present reporting the expression of GalC, 
traditionally a marker of oligodendrocytes, in astrocytic-like cells. However, 
immunocytochemical analysis revealed diffuse patterns of GalC staining in AHPCs 
cultured under both UC and CM conditions, though staining was extremely weak and 
of very low intensity (MFI). Previous studies using this particular AHPC cell line have 
reported that density arrest in the presence of FGF favoured the survival and 
differentiation of GalC
+
 oligodendrocytic cell types, whereas density arrest in the 
absence of FGF favoured the survival and differentiation of neuronal and astrocytic 
cell types (Palmer et al., 1997). As FGF is not a component of UC media and is 
depleted by aggregates during the three day conditioning period (as determined using 
mass spectrometry, data not shown), it would be anticipated that such conditions 
would facilitate neuronal and astrocytic differentiation and encumber oligodendrocytic 
differentiation. However, trace amounts of FGF may remain following transfer of 
cultures from proliferative media (containing FGF) to UC/CM media (lacking FGF), 
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which may account for diffuse levels of expression. Similarly, the possibility of MSC-
derived aggregates secreting low levels of FGF into the CM cannot be discounted. 
Certainly, no oligodendrocytic morphologies are observed in AHPCs following culture 
with UC or CM, suggesting that weak expression of GalC may be attributable to 
underlying expression and not oligodendrocytic differentiation. 
 
Combined, these marker analyses provide strong evidence to suggest that aggregate-
derived soluble factors present in CM induce AHPCs to commit to and undergo 
astrocytic differentiation. As previously discussed, however, expression of a range of 
markers indicative of a more mature neural fate in undifferentiated AHPCs, 
concomitant with extensive co-expression of markers, can lead to ambiguity in terms 
of interpretation of results.  Therefore, although marker analysis is extremely useful in 
allowing discrimination between different cell types, it is perhaps functional analysis 
that is more convincing in demonstrating/confirming the expression of a particular 
cellular phenotype. 
 
Expression of functional astrocytic markers 
Assessing the functional behaviour of GFAP
+
 astrocytic-like cells in vitro is extremely 
challenging. Although astrocytes represent greater than 90% of the total cell 
population in the mammalian brain, until very recently they were considered to be 
passive cells whose main function was to provide structural and metabolic support to 
neurons (He and Sun, 2007). Their significance was considered to be largely secondary 
to that of neurons. This attitude has changed somewhat over recent years and an 
increasing number of studies have been published suggesting that the function of 
astrocytes is far more widespread than previously anticipated. Although the function of 
astrocytes still remains largely undefined to this date, they are known to perform a 
wide range of diverse functions throughout the CNS, including: 
 
 Formation and maintenance of the blood-brain barrier, preventing large 
macromolecules entering the brain from blood plasma (Abbott, 2002). 
 
 Balance ionic concentration in extracellular space surrounding neurons and 
control levels of neurotransmitters and ions, such as glutamate and dopamine, 
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around the synapse (Henn and Hamberger, 1971; Porter and McCarthy, 1997; 
Temburni and Jacob, 2001; He and Sun, 2007). 
 
 Control many aspects of synaptogenesis, including synapse formation, synaptic 
function and transmission, synaptic organisation, synaptic homeostasis and 
synapse number (Temburni and Jacob, 2001; Ullian et al., 2001; Piet et al., 
2004; Allen and Barres, 2005). 
 
 Vasomodulation i.e. control of blood flow to neurons (Parri and Crunelli, 
2003). 
 
 Control of myelinating activity of oligodendrocytes (Ishibashi et al., 2006). 
 
 Immunological behaviour – astrocytes have been reported to become 
phagocytic scavengers following neuronal injury/death (Dong and Benveniste, 
2001; He and Sun, 2007). 
 
This is by no means an exhaustive list of all the functions of astrocytes and is merely 
meant as a representation of their more commonly reported functions. Taking such 
complex functions into account, producing an in vitro assay to assess the functional 
behaviour of astrocytes would be extremely complicated and technically demanding. 
Therefore, to circumvent these difficulties and gain an appreciation of how astrocytic-
like cells are behaving at a functional level, the most commonly adopted method is by 
examining expression of a range of biochemical receptors known to be indicative of an 
astrocytic phenotype. Several studies have reported that astrocytes express a range of 
ligand-gated and voltage-dependent ion channels, allowing them to clear 
neurotransmitters and ions away from the synapse (Henn and Hamberger, 1971; Porter 
and McCarthy, 1997; Temburni and Jacob, 2001). In this study, expression of AMPA 
receptor 3 (AMPA3), GABA-A, NMDA receptor 3 (NMDA-2D) and 5-HT 1A were 
examined at the mRNA level in AHPCs cultured with CM and appropriate controls for 
7 days. All four receptors have previously been reported as functional biochemical 
markers of astrocytic behaviour (Kamnasaran et al., 2008). These receptors are just a 
handful of those known to contribute to astrocytic function, however, with others 
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including nicotinic acetylcholine (nACHR), glutamate, opioid, dopamine, glycine, 
serotonic, β-adrenergic and purinergic receptors (Araque et al., 1999; Parpura and 
Haydon, 2000; Verkhratsky and Steinhauser, 2000; Sharma and Vijayaraghavan, 2001; 
Santello and Volterra, 2008). Each of the receptors examined were upregulated in 
AHPCs cultured with CM compared to controls, with each of these observations being 
significant at the statistical level, strongly suggesting that AHPCs cultured with CM 
were induced to commit to a bona fide astrocytic differentiation program, rather than 
induced to aberrantly express the structural astrocytic marker, GFAP. 
 
Effect of oxygen tension on the secretory profile of MSC-derived aggregates 
Observations in this Chapter have thus far demonstrated that MSC aggregate-derived 
soluble factors in CM induced AHPCs to express an astrocytic phenotype, as 
determined by positive expression of structural and functional astrocytic markers. 
Further studies in this Chapter went on to investigate the effect(s) of oxygen tension on 
fundamental aspects of aggregate behaviour and function, in particular, their ability to 
direct the differentiation of AHPCs via paracrine signalling. It is now becoming more 
generally accepted that oxygen tension is a crucially-overlooked parameter in cell 
culture, as oxygen tension is a critical signal for virtually all cellular processes (Csete, 
2005). Routine, highly standardised methods of cell culture results in exposure of cells 
to atmospheric concentrations of oxygen (approximately 20%); however, cells within 
their natural environment in vivo are exposed to much lower concentrations of oxygen 
(approximately 2-10%, depending on tissue type, tissue arrangement etc.) (Csete, 
2005; Sullivan et al., 2006). Therefore, the behaviour of cells cultured under 
atmospheric oxygen levels in vitro may be far removed from their actual physiological 
behaviour in vivo. Exposure to high concentrations of oxygen can also be damaging to 
cells, as oxygen is toxic at higher concentrations due to the formation of reactive 
oxygen species, such as free radicals and peroxides (Bellomo, 1991). 
 
Taking this into account, a significant number of studies have reported that varying 
oxygen tension dramatically influences the behaviour of numerous cell types in vitro, 
particularly stem cells, in terms of cellular processes such as proliferation, 
differentiation, migration and apoptosis (Csete, 2005). Rates of proliferation are 
reportedly enhanced in stem cells cultured under low oxygen compared to atmospheric 
oxygen tensions and this phenomenon has been observed in a range of different stem 
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cell types, including neural stem cells, skeletal muscle satellite cells, haematopoietic 
stem cells and even MSCs (Reykdal et al., 1999; Morrison et al., 2000; Studer et al., 
2000; Csete et al., 2001; Lennon et al., 2001). Cellular senescence, a biological 
process corresponding to the ageing of cells as a consequence of increased cell 
division, has also been reported to be delayed in cells following culture under low 
oxygen tension (Parrinello et al., 2003). There is also much evidence to suggest that 
apoptosis is reduced in stem cells following culture in low oxygen compared to 
atmospheric oxygen tension, as fewer reactive oxygen species are generated under 
lower oxygen conditions (Erkkila et al., 1999; Studer et al., 2000; Mostafa et al., 
2002). Functionality of stem cells in terms of their differentiative potential has also 
reported to be extensively influenced by oxygen tension – for example, neural stem 
cells cultured under low oxygen tension demonstrated a bias to undergo dopaminergic 
differentiation (Studer et al., 2000). Likewise, MSCs cultured under low oxygen 
tension demonstrated a bias to undergo myogenesis at the expense of adipogenesis 
(Csete et al., 2001). Such unique properties of cells following culture under lower 
oxygen tensions compared to atmospheric oxygen tension are not exclusive to stem 
cells, with phenomena such as enhanced viability/proliferation/survival/functionality/ 
physiology and reduced senescence being reported in a range of more lineage-
restricted cell types, including liver sinusoidal endothelial cells (LSECs), amniotic 
fluid cell cultures, fibroblasts, skin microvascular endothelial cells, mouse embryonic 
fibroblasts (MEFs), hepatocytes and chondrocytes (Suleiman and Steven, 1987; Zhou 
et al., 2000; Murphy and Sambanis, 2001; Balin and Pratt, 2002; Parrinello et al., 
2003; Held and Sönnichsen, 2005; Martinez et al., 2008). 
 
However, several studies have also been published claiming that culturing cells under 
lowered oxygen tensions can actually be detrimental to cellular viability and function. 
For example, osteogenic differentiation of MSCs has been reported to be most 
efficacious at atmospheric oxygen levels, with oxygen tensions below 5% having an 
inhibitory effect on differentiation (Raheja et al., 2009). Similarly, T cell clones 
reportedly demonstrated reduced proliferative capacities and lifespan when cultured 
under low oxygen compared to atmospheric oxygen tension (Duggan et al., 2004). 
Perhaps most interestingly, in complete contrast to the studies with stem cells 
described above, both mouse and human embryonic stem cells have been reported to 
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demonstrate reduced rates of proliferation following cultured under low oxygen 
tensions compared to atmospheric tension (Kurosawa et al., 2006; Chen et al., 2008). 
 
The significance of oxygen tension is of particular importance when considering the 
optimal culture conditions of 3D structures such as the MSC-derived aggregates used 
in this Chapter, as large cellular aggregates require a careful control of gaseous 
exchange (Griffith and Swarz, 2006). Protocols used for aggregate formation in this 
study clearly stated that MSCs should be seeded out under low oxygen tension rather 
than atmospheric oxygen tension (Hermann et al., 2004; Hermann et al., 2006). In 
order to ascertain whether the behaviour of the MSC-derived aggregates used in this 
study was influenced by oxygen tension, MSCs were seeded out for aggregate 
formation under both low (5%) and atmospheric (20%) oxygen tensions. Although 
aggregates cultured under both low and atmospheric oxygen tensions were 
indistinguishable from one another in terms of morphological appearance and 
expression of neural/mesenchymal markers, MSCs seeded out for aggregate formation 
under low oxygen tension demonstrated a significantly enhanced rate of proliferation 
compared to counterparts seeded out under atmospheric oxygen tensions (p<0.001). 
An enhanced rate of proliferation following culture under low oxygen tension is in 
keeping with the vast majority of studies described above. Furthermore, when the 
secretory activity of aggregates cultured under varying oxygen tensions was examined 
– in terms of their ability to secrete soluble factors that promote astrogenesis of 
AHPCs following 7 days culture – it was observed that the astrogenic effect was 
significantly diminished following culture with CM derived from aggregates cultured 
under atmospheric oxygen tension compared to low oxygen tension (p<0.05). One 
possible explanation for this observation could be the enhanced proliferation in 
aggregates cultured under low oxygen tension, resulting in a greater number of cells 
and, by extension, an increased concentration of active biological factor being secreted 
into CM. However, an additional possibility could be that aggregates cultured under 
varying oxygen tensions demonstrate different behaviour at the secretory level. This is 
a likely scenario, as oxygen tension has previously been reported to dramatically affect 
the secretory activity of a range of cell types. For example, oxygen concentration plays 
a pivotal role in the secretion of insulin from islet cells – insulin secretion decreases 
with decreasing oxygen concentration and this effect is so pronounced that in the 
absence of oxygen, insulin secretion cannot be detected (Aleyassine, 1970; Dionne et 
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al., 1989; Ohta et al., 1990; Dionne et al., 1993; Papas et al., 1996). Oxygen 
concentration has also been reported to regulate the production and secretion of a range 
of angiogenic factors, with one study reporting that CM derived from granulosa cells 
exerted a different effect on vascular endothelial cells depending on whether they were 
cultured under low or atmospheric oxygen tension (Koos, 1986). In addition to protein-
based soluble factors, oxygen has also been reported to influence the secretion of non-
protein-based soluble factors such as steroidal hormones (Raff et al., 1990). A lowered 
oxygen environment also results in enhanced secretion of extracellular matrix from 
endothelial cells (Zhao et al., 2009). 
 
Combined, these results suggest that lowered oxygen tension significantly enhanced 
the viability and function of MSC-derived aggregates compared to counterparts 
cultured under atmospheric oxygen tensions, in terms of proliferation rate and 
secretory activity. The mechanism(s) behind the enhanced astrogenic effect of CM 
produced under low oxygen is likely to be a combination of enhanced rate of 
proliferation (and hence an increased number of cells in culture) concomitant with 
altered secretory activity of aggregates cultured under lowered oxygen tension. 
 
Temporal analysis of neural marker expression 
The final aims of the study in this Chapter were to investigate the cellular and 
molecular mechanisms causing the observed astrocytic effect in AHPCs. When marker 
analysis in AHPCs was monitored temporally over the 7 day time course of the 
experiment, expression of GFAP increased with time both in terms of the percentage 
of cells positive for expression and MFI of marker expression. The percentage of 
GFAP
+
 cells reached a maximum at the 4 day timepoint, suggesting that cells had 
committed to the process of astrogenesis by this timepoint, whilst MFI of GFAP 
expression increased up to a maximum at the 7 day timepoint, suggesting that 
committed cells were continuing to undergo astrogenesis and express a more mature 
astrocytic phenotype. The kinetics of GFAP expression, coupled with the observation 
that proliferation of the GFAP
+
 subpopulation was not influenced following culture 
with CM compared to control, strongly suggested the soluble factors in CM were not 
positively selecting for astrocytic-committed precursors. As such, these data suggest an 
instructive mechanism is at play rather than a selective one. 
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Cell proliferation and cell death 
Interestingly, however, increased rates of cell death were observed in the GalC
+
 
subpopulation of AHPCs at both the timepoints assessed following culture with CM 
compared to control. Although this observation was apparent at both timepoints 
assessed, it was only statistically significant at the 7 day timepoint (p<0.05). Selective 
cell death of the GalC
+
 oligodendrocytic precursor subpopulation following culture 
with CM could be another key mechanism contributing to the astrogenic effect 
observed in AHPCs, resulting in astrogenesis at the expense of oligodendrogenesis. 
Although the vast majority of published studies report that MSC-derived CM exerts a 
positive influence on neural development in terms of neuroprotection and 
differentiation, there is also evidence to suggest that MSC-derived factors may, in 
some cases, be detrimental to neural cell systems. For example, MSC-CM has recently 
been reported to be cytotoxic and increase rates of cell death in hippocampal slice 
cultures (Horn et al., 2009). 
 
Apoptosis  
One major limitation of the above data, however, is that PI positivity does not 
discriminate between necrotic and late apoptotic cells. Cells can be induced to undergo 
apoptosis, or programmed cell death, via a combination of intracellular and/or 
extracellular signals, which raises the interesting question of whether soluble factor(s) 
present in CM induce activation of apoptosis in the GalC
+
 subpopulation of AHPCs or 
whether the increased rates of cell death observed are a consequence of necrosis. In 
terms of extracellular induction of apoptosis in oligodendrocytes, soluble factors 
including TNF-α and NGF have been reported to be potent inducers of apoptosis in 
this cell system (Selmaj and Raine, 1988; Casaccia et al., 1996). Signalling events that 
occur during apoptosis are mediated by a family of cysteine proteases known as 
caspases, of which caspase-3 is a central mediator in the apoptotic pathway (Ellis et 
al., 1991; Alnemri et al., 1996; Gu et al., 1999; Porter and Jänicke, 1999; Fox and 
Aubert, 2008; Mazumder et al., 2008). Activity of caspases is most commonly 
modulated at the post-translational level, where inactive proenzymes are cleaved to 
produce active enzymes – activation of caspase-3 occurs during the early stages of 
apoptosis via the proteolytic cleavage (adjacent to Asp175) of the inactive proenzyme. 
Therefore, detection of cleaved caspase-3 can be considered a positive marker of 
apoptosis and its expression can be determined using flow cytometric methods. Rates 
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of apoptosis observed in the GalC
+
 subpopulation following culture with CM and 
controls directly mirrored rates of cell death as determined using PI incorporation, with 
rates of apoptosis being significantly higher following culture with CM at both 
timepoints assessed (p<0.01). These data therefore suggest that MSC-derived 
aggregates secrete soluble factor(s) that induce activation of apoptotic pathways 
specifically in the GalC
+
 subpopulation of AHPCs. 
 
Analysis of cell death in the 33B oligodendrocytoma cell line 
Such observations are of particular interest from an oncological perspective. One of 
the major causative mechanisms resulting in cancer development is 
uncontrolled/accelerated cellular proliferation, resulting in a massive accumulation of 
tissue mass i.e. tumour formation (Kasibharla and Tseng, 2003). However, an equally 
significant causative mechanism is a failure/dysregulation of cellular apoptosis and 
death, which can contribute to initiation and progression of cancer development (Lowe 
and Lin, 2000; Kasibharla and Tseng, 2003). Therefore, some of the most promising 
therapeutic strategies in the treatment of cancer are those that induce and/or increase 
rates of apoptosis in transformed cells (Searle et al., 1975; Lowe and Lin, 2000; Gerl 
and Vaux, 2005). Therefore, by extension, if soluble factor(s) present in CM induce 
apoptosis specifically in oligodendrocytic-like (GalC
+
) cells, then this is a promising 
avenue for investigation in cancers arising from transformed oligodendrocytes – 
oligodendrocytomas. 
 
Oligodendrocytomas represent a small percentage of tumours of the central nervous 
system, accounting for approximately 10% of all gliomas i.e. tumours with their 
origins in glial cell types (Ney and Lassman, 2009; Vesper et al., 2009). Current 
therapies for oligodendrocytomas are inadequate despite increasing knowledge into the 
aetiology of these tumours (Vesper et al., 2009). Therefore, if the apoptotic effect of 
soluble factor(s) in CM could be exploited to induce apoptosis in transformed 
oligodendrocytes, this would potentially provide a novel therapy in the combat against 
cancers such as oligodendrocytomas. However, this apoptotic effect has only been 
observed in the AHPC system. In order to ascertain whether this effect could be 
translated to other oligodendrocytic systems, the effect of CM was examined on the 
33B cell line – an oligodendrocytoma (more specifically, a Schwannoma) cell line 
derived from rat (Fields, 1977; Fields and Dammerman, 1985). Culture with CM did 
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not affect cellular viability compared to controls (using the MTS assay) and, likewise, 
there was no statistically significant difference in the percentage of cells detected in the 
early or late stages of apoptosis (using flow cytometry). Although these data were not 
significant at the statistical level, they still offered much promise in that CM cultures 
demonstrated a higher percentage of cells in the early and late stages of apoptosis. 
Perhaps with further optimisation a greater induction of apoptosis could be achieved in 
this oligodendrocytoma cell line – possible ideas include concentrating CM to produce 
a more potent cocktail of soluble factor(s); an increased aggregate-conditioning time; 
an increased 33B cell culture time; and identification of the active apoptotic factor in 
CM and recreation of this effect using the optimal concentration of recombinant 
protein. 
 
Expression of signalling pathway components and transcription factors 
Investigation into the molecular mechanisms controlling the specification of 
astrogenesis in AHPCs following culture with CM was performed by assessing the 
expression of a range of signalling pathway components and transcription factors 
known to play key roles in neural differentiation processes. Expression of such factors 
was determined at the mRNA level in AHPCs cultured with CM and UC control at 
days 1, 3 and 7, using qRT-PCR. The transcription factors examined can be divided 
into one of four categories based on the differentiative processes in which they are key 
components – astrocytic-promoting; neuronal-promoting; oligodendrocytic-promoting; 
and neuronal-inhibitory proteins. Combined, expression profiles constructed from 
these studies suggested that uncommitted AHPCs committed to an astrocytic 
differentiation program at the genetic level following culture with CM. 
 
Expression of astrocytic-promoting transcription factors 
AHPCs demonstrated significant upregulation of the five astrocytic-promoting 
transcription factors examined in this study – STAT1, STAT3, Smad1, Smad4 and 
Sox9 – and these observations were significant at the statistical level at various 
timepoints examined. The crucial roles these factors play in astrogenesis have been 
highly documented in the literature and are extensively reviewed by Guillemot 
(Guillemot, 2007). The two main highly conserved signalling pathways reported to 
play a key role in astrogenesis of uncommitted neural stem and progenitor cells are the 
janus kinase-signal transducer and activator of transcription (JAK-STAT) and BMP 
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signalling pathways (Gross et al., 1996; Bonni et al., 1997; Rajan and McKay, 1998; 
Guillemot, 2007; Nakashima et al., 2001; He et al., 2005; Kessaris et al., 2008). Notch 
signalling has also been implicated in astrogenesis but has been omitted from analysis 
for the purpose of this study as Notch signalling requires interaction of membrane-
bound cell surface receptors on cells – as the approach adopted in this study is a CM 
approach, it can be assumed that the mechanism at play is a result of soluble factor-
mediated signalling (Gaiano et al., 2000; Tanigaki et al., 2001). The downstream 
effectors of JAK-STAT signalling are the STAT family of transcription factors, of 
which STAT1 and STAT3 are the most commonly implicated in astrogenesis (Bonni et 
al., 1997; Nakashima et al., 1999). In terms of the BMP signalling, the downstream 
effectors of this pathway are the Smad family of transcription factors, of which Smad1 
and Smad4 are the most commonly implicated in astrogenesis (Guillemot, 2007; 
Kessaris et al., 2008). Upregulation of STAT1, STAT3, Smad1 and Smad4 in AHPCs 
following culture with CM strongly suggests that the astrogenic-promoting JAK-STAT 
and BMP signalling pathways are activated. There is even evidence to suggest that the 
components of these two pathways can crosstalk extensively, with STAT1/STAT3 and 
Smad1/Smad4 forming a complex (bound by co-activator P300) that is actively 
recruited to the GFAP promoter (Nakashima et al., 1999). The situation is further 
complicated by a study reporting that the two signalling pathways function to generate 
distinctive cell populations, with JAK-STAT signalling resulting in a GFAP
+
, 
astrocytic-like but immature phenotype and BMP signalling resulting in a GFAP
+
 
mature astrocytic phenotype (Bonaguidi et al., 2005). AHPCs cultured with CM also 
upregulated expression of Sox9, a transcription factor reportedly expressed in 
immature astrocytes and throughout astrocyte maturation (Stolt et al., 2003). 
 
Expression of oligodendrocytic-promoting transcription factors 
Expression of the oligodendrocytic-promoting transcription factors Olig1 and Olig2 
were then examined in AHPCs cultured with CM compared to control. The crucial role 
these factors play in oligodendrogenesis have been highly documented in the literature 
and are extensively reviewed by Guillemot (Guillemot, 2007). Olig1 and Olig2 are 
members of the basic helix-loop-helix (bHLH) family of transcription factors and are 
key transcriptional determinants of oligodendrocytic fate (Lu et al., 2002; Zhou and 
Anderson, 2002). Both factors are expressed in oligodendrocytic-committed precursors 
and more mature oligodendrocytes, with abolishment of either factor resulting in a 
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dramatic loss of oligodendrocytic material in the CNS (Zhou et al., 2000; Lu et al., 
2002; Zhou and Anderson, 2002). Although data from this study reveals that AHPCs 
do not demonstrate any significant decrease in expression of Olig1 until the 7 day 
timepoint (p<0.05), continued expression of Olig1 is unlikely to be inhibitory to the 
astrogenic differentiation process as Olig1 is only involved in the very later stages of 
oligodendrogenesis (Lu et al., 2002; Arnett et al., 2004). It is Olig2 that plays the more 
crucial role in terms of commitment and specification of uncommitted precursors to 
the oligodendrocytic fate. Paradoxically, Olig2 is significantly upregulated in AHPCs 
cultured with CM at the early timepoints of 1 and 3 days (p<0.001), which is opposite 
to the predicted expression profile. Studies have even reported Olig2 as a potent 
inhibitor of astrogenesis (Fukuda et al., 2004). However, evidence has been published 
to suggest a role for Olig2 in the development of astrocytes (Marshall et al., 2005). 
Furthermore, since expression of Olig2 has been associated with inhibition of neuronal 
differentiation, it is perhaps this inhibitory activity that is supporting the astrocytic 
differentiation of AHPCs following culture with CM, rather than its oligodendrocytic-
promoting activity (Lee et al., 2005; Cai et al., 2007; Guillemot, 2007). 
 
Expression of neuronal-promoting transcription factors 
AHPCs demonstrated significant downregulation of three of the four neuronal-
promoting transcription factors examined in this study – Ngn1, Ngn3 and Mash1 – and 
these observations were significant at the statistical level at various timepoints 
examined. Expression of the fourth neuronal-promoting transcription factor examined 
– Ngn2 – was unchanged compared to control cultures. The crucial roles these factors 
play in neurogenesis have been highly documented in the literature and are extensively 
reviewed by Guillemot (Guillemot, 2007). Proneural genes such as Ngn1, Ngn2, Ngn3 
and Mash1 play crucial roles in many of the processes involved in neuronal 
differentiation, from initial commitment of immature neural stem and progenitor cells 
to differentiation right through to maintenance of a mature neuronal phenotype (Nieto 
et al., 2001; Sun et al., 2001; Bertrand et al., 2002; Britz et al., 2006). Overexpression 
of proneural genes is sufficient to induce neuronal differentiation in uncommitted 
precursors (Farah et al., 2000; Nakada et al., 2004).  Similarly, downregulation of 
proneural genes results in reduced neuronal differentiation concomitant with increased 
astrocytic differentiation, suggesting that such factors play an important role not only 
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in neuronal differentiation but also in preventing premature astrocytic differentiation 
(Nieto et al., 2001). 
 
Expression of neuronal-inhibitory factors 
Expression of the five neuronal-inhibitory proteins examined in this study – Hes1, 
Hes5, Id1, Id2 and Id3 – were upregulated in AHPCs cultured with CM compared to 
control and these observations were significant at the statistical level at various 
timepoints examined. The crucial roles these factors play in astrogenesis have been 
highly documented in the literature and are extensively reviewed by Guillemot 
(Guillemot, 2007). Hes1 and Hes5 have been reported to play crucial roles in 
maintenance of an undifferentiated state in neural stem and progenitor cells (Nakamura 
et al., 2000; Ohtsuka et al., 2001). That said, however, there is also much evidence to 
suggest that both Hes1 and Hes5 play critical roles in promotion of astrocytic 
differentiation, most probably through inhibition of proneural gene activity such as 
those described above (Hojo et al., 2000; Guillemot, 2007). Hes proteins may also 
have a more direct role in promoting astrogenesis as they have previously been 
reported to activate components of the JAK-STAT signalling cascade, itself a key 
requirement for astrogenesis (Kamakura et al., 2004). Other neuronal-inhibitory 
proteins examined in this study included three members of the Inhibitor of 
differentiation (Id) family – Id1, Id2 and Id3. Id proteins are reportedly activated by 
BMP signalling pathways and are key determinants of astrocytic differentiation 
(Nakashima et al., 2001). They inhibit neuronal differentiation by sequestering E 
proteins, which are the dimerisation partners of proneural bHLH transcription factors, 
blocking their neuronal-promoting activities (Vinals et al., 2004). Similarly, Id 
proteins have been reported to dimerise with Olig transcription factors and their E 
protein dimerisation partners, thus blocking their oligodendrocytic-promoting activity 
also (Samanta and Kessler, 2004). Therefore, increased expression of Olig2 in AHPCs 
cultured with CM may be counteracted by increased expression of the sequestering Id 
proteins, providing a further possible mechanism whereby astrogenesis is observed at 
the expense of oligodendrogenesis. 
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Overall summary 
Studies in this Chapter have demonstrated that MSCs cultured under conditions 
previously established for the propagation of neurospheres resulted in the formation of 
large, multicellular aggregates sharing many phenotypically similar traits to NSC-
derived neurospheres. Aggregates were able to influence neural development by 
paracrine mechanisms involving the release of trophic factors and/or other metabolic 
products that induced the expression of an astrocytic phenotype in the AHPC system. 
Immature AHPCs were induced to express both structural and functional markers 
indicative of an astrocytic phenotype following culture with CM for 7 days and this 
effect was exclusively the result of culture with MSC-derived soluble factors. In terms 
of cellular and molecular mechanisms bringing about this astrocytic effect, kinetics of 
GFAP expression concomitant with the observation that proliferation of the GFAP
+
 
subpopulation was not influenced following culture with CM suggested that the 
soluble factor(s) present in CM were not positively selecting for astrocytic-committed 
precursors and, as such, suggested an instructive mechanism was operational. 
However, analysis of cell death demonstrated that culture of AHPCs with CM resulted 
in an increase in the rate of cell death specifically in the GalC
+
 subpopulation. Further 
analysis confirmed the activation of apoptotic pathways specifically in the GalC
+
 
subpopulation following culture with CM. Therefore, selective apoptosis in the GalC
+
 
subpopulation could be a further contributing mechanism resulting in astrogenesis at 
the expense of oligodendrogenesis. From a transcriptional perspective, astrogenesis 
was induced in AHPCs by increased expression of astrocytic-promoting and neuronal-
inhibitory transcription factors concomitant with decreased expression of neuronal- 
and oligodendrocytic-promoting transcription factors. As neural differentiation is such 
an intricate, complicated process in vitro and even more so in vivo, it is not surprising 
that multiple changes are required at the molecular level to bring about specific 
differentiation events. However, it must be acknowledged that this expression data is at 
the mRNA level and, although mRNA levels are not always indicative of actual 
protein levels, qRT-PCR is advantageous in that it provides a rapid and easy 
technology in which to screen many factors. Although transcription factor activity is 
often controlled at the post-translational level, changes at the transcriptional level are 
useful in themselves as indicators of cellular activity. 
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5.1 Introduction 
A major fundamental flaw of in vitro stem cell-based assays is that the artificial 
environment of 2D tissue culture plastic in no way resembles the complex 3D 
environment in which stem cells reside in vivo – the ‘stem cell niche’. At the basic 
physiological level, the stem cell niche can be described as a basic unit of tissue 
structure which serves a crucial role in maintenance of stem cell viability/function, 
physically protecting it from harm and integrating signals that mediate the appropriate 
response of the stem cell to the specific needs of the organism in terms of tissue 
generation, maintenance and repair (Scadden, 2006). At the more-detailed molecular 
level, the stem cell niche can be described as a dynamic entity in which complex 
interactions occur between the stem cell and its neighbouring cells (typically involving 
direct cell-cell interaction and/or the release of soluble factors/cytokines produced by 
identical cells (autocrine) or different cells (paracrine) within the niche), extracellular 
matrix and oxygen tension, amongst many other factors (Fuchs et al., 2004; Scadden, 
2006). Although the concept of the ‘stem cell niche’ and its crucial role in 
maintenance/regulation of stem cell behaviour/function is not a novel one – originally 
proposed by Schofield over 30 years ago – the concept remained largely theoretical in 
the years that followed and it is only recently, as understanding of the plethora of 
interacting factors at play within the stem cell niche has improved, that interest in this 
area has begun to intensify (Schofield, 1978; Presnell et al., 2002; Fuchs et al., 2004; 
Scadden, 2006). 
 
As such, a more comprehensive understanding of the complex cellular and molecular 
mechanisms of neural differentiation will require a greater appreciation of the niche-
specific signals governing neural stem cell behaviour in vivo. In mammals, neural stem 
cells are maintained in two main niches in the adult brain – the subgranular zone 
(SGZ) of the dentate gyrus of the hippocampus and the subventricular zone (SVZ) of 
the lateral ventricles (Eriksson et al., 1998; Gould et al., 1999; Garcia et al., 2004; 
Maslov et al., 2004; Ehninger and Kempermann, 2007). That said, there is increasing 
evidence to suggest that neural stem cells may reside in additional niches located 
throughout the adult brain, including the amygdala, neocortex, striatum, subcallosal 
zone and substantia nigra (Gould et al., 1996; Bernier et al., 2002; Zhao et al., 2003; 
Van Kampen et al., 2004; Bedard et al., 2006; Seri et al., 2006; Gould, 2007). The 
Chapter 5: Characterisation of the MSC secretome 
 
239 
 
neural stem cell niche is highly complex and is composed of many different structural 
and functional components such as neurons, astrocytes, oligodendrocytes, microglia, 
immune cells, vasculature and extracellular matrix, amongst many other factors, with 
each of these components interacting extensively in order to modulate the 
function/behaviour of neural stem cells in terms of proliferation, migration and 
differentiation (Mercier et al., 2002). Although considerable effort can be made (and 
has been) to mimic particular aspects of the neural stem cell niche in vitro, such as 
coating cellware with poly-L-ornithine and laminin to provide an environment more 
permissible to the culture of AHPCs, these efforts are generally unsatisfactory. For 
example, the extracellular matrix component of the neural stem cell niche in vivo 
consists of a highly intricate balance/combination of extracellular proteins – typically 
consisting of large glycoproteins such as fibronectin, collagen, laminin and 
proteoglycans – arranged purposely to provide a scaffold for cellular support and 
present at precise concentrations in order to induce specific responses in stem cells 
within the niche (Adams and Watt, 1993; Tate et al., 2004; Ma et al., 2008). 
Furthermore, it is now widely accepted that astrocyte- and vasculature-specific soluble 
factors/cytokines are likely to be the most significant factors within the niche involved 
in maintenance/regulation of neural stem cell function/behaviour (Palmer et al., 2000; 
Alenghet and Ingber, 2002; Jin et al., 2002; Song et al., 2002; Wurmser et al., 2004; 
Shapiro et al., 2005; Barkho et al., 2006; Plumpe et al., 2006; Ehninger and 
Kempermann, 2008). That said, it is unwise to consider the roles of the various 
component(s) of the stem cell niche in isolation, as there is extensive overlap between 
them; for example, extracellular matrix proteins have been reported to bind specific 
growth factors and increase their local concentration within the niche whilst certain 
growth factors regulate the synthesis and breakdown of extracellular matrix proteins 
(Watt, 1986; Sporn et al., 1987; Gordon, 1988; Roberts et al., 1988; Rothenberg et al., 
1988). Accordingly, the stem cell niche should be considered as a dynamic entity 
(Scadden, 2006). 
 
However, despite the clear overlap between the role(s)/function(s) of the various 
components of the stem cell niche, studies to date have concentrated on individual 
components of the niche and their influence on stem cell behaviour/function. For 
example, studies involving the in vitro culture of cells on 3D structures such as 
biodegradable scaffolds, hydrogels, sponges, microcarriers and polystyrene-based 
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scaffolds all share the common aim of encouraging cells to adopt conformations and 
form cell-cell interactions more representative of those that occur within their niche in 
vivo compared to the highly unnatural restraints imposed upon them during routine 2D 
culture (Mikos et al., 1993; Takahashi et al., 2005; Bokhari et al., 2007; Bradley et al., 
2009; Lin and Anseth, 2009). Indeed, this was subject to investigation in Chapter 3 of 
this thesis. Likewise, the influence of extracellular matrix on cellular 
behaviour/function can be assessed by coating cellware with various 
combinations/concentrations of extracellular matrix proteins such as collagen, laminin 
and fibronectin; Reinnervate Ltd. has been involved in collaborations investigating the 
immobilisation of peptide fragments corresponding to putative functional domains of 
extracellular matrix proteins and determining their influence(s) on cellular attachment, 
proliferation and differentiation (Cooke et al., 2008; Cooke et al., 2009). However, it 
is perhaps the influence of diffusible molecules such as soluble factors and cytokines 
within the stem cell niche that are of most interest (Hall and Watt, 1989). The 
significance of soluble factor/cytokine signalling in the regulation of stem cell 
function/behaviour is best exemplified in the haematopoietic system where stromal 
cells (and other cell types) within the niche produce a complement of factors which 
promote haematopoietic cell survival, proliferation and differentiation (Clark and 
Kamen, 1987; Dexter and Spooncer, 1987). This phenomenon is discussed in further 
detail in Section 1.7.1. A similar phenomenon has been described in the epidermis, 
where keratinocytes secrete a complement of factors, including TGF-α and TGF–β, 
which function via autocrine mechanisms to regulate the growth rate of other 
keratinocytes within the niche; interestingly, the expression profiles of such factors in 
keratinocytes change in response to appropriate environmental stimuli (Coffey et al., 
1987; Akhurst et al., 1988). Far less is known regarding the role of soluble 
factors/cytokines in modulating stem cell behaviour within the intestinal crypt, though 
one study reports that TGF-β is secreted by terminally-differentiated cells at the tip of 
the villus which functions to inhibit crypt cell proliferation (Barnard et al., 1989).  
 
Neural stem and progenitor cells within their niche are also under the influence of 
soluble factors and cytokines – the majority of which are astrocytic and/or vasculature-
derived in origin – which function to provide structural and trophic support for various 
aspects of neural activity including proliferation, migration, differentiation, neurite 
extension and synaptogenesis (Qian et al., 1992; Mercier et al., 2002; Bachoo et al., 
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2004; Deumens et al., 2004; Hagg, 2005; Moore et al., 2009). Astrocytes in particular 
have been demonstrated to secrete an intricate combination of extracellular matrix, 
such as laminin, and soluble factors/cytokines, such as FGF-2, which significantly 
influence neural behaviour both in vitro and in vivo (Costa et al., 2002; Le Roux and 
Esquenazi, 2002; Moore et al., 2009). There is considerable evidence to suggest that 
MSCs are able to function in an analogous manner to astrocytes following 
transplantation into the mammalian nervous system and this extends to the release of 
extracellular matrix components and neurotrophic factors within the neural niche 
(Azizi et al., 1998; Tremain et al., 2001; Chen et al., 2002; Chopp and Li, 2002; 
Munoz et al., 2005; Chen and Chopp, 2006; Crigler et al., 2006; Deng et al., 2006). 
Indeed, MSC-mediated paracrine activity is considered to be the major mechanism 
contributing to functional recovery following transplantation of MSCs into models of 
neurological and neurodegenerative disorders (Chen et al., 2002; Chen et al., 2005; 
Chen et al., 2007). 
 
Several efforts have been made to artificially reproduce the paracrine relationship 
between MSCs and neural stem/progenitor cells in vitro, predominantly using 
conditioned media-based approaches, though variant approaches such as co-culture 
have also been used successfully (Wislet-Gendebien et al., 2004; Rivera et al., 2006; 
Croft and Przyborski, 2009). Conditioned media assays are advantageous in that 
conditioned media is easily produced and biologically tested in vitro, particularly when 
a hypothesised autocrine/paracrine mechanism is under investigation. Co-culture 
assays have the added advantage of permitting intercellular signalling between the two 
cell systems under investigation, allowing for feedback mechanisms; however, the 
significant disadvantage of co-culture assays is that it is extremely difficult to 
determine the cellular origin of proteins within the culture media (Chen et al., 2002; 
Croft and Przyborski, 2009). Indeed, even if the cell systems used were derived from 
different species, extensive homology between many growth factors/cytokines means 
extensive crosstalk during antibody-based techniques such as ELISA cannot be 
discounted (Chen et al., 2002). 
 
Ultimately, the aim of all conditioned media-based studies should be as follows: 
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a) Observation of a biological effect. 
 
b) Identification of the bioactive factor(s) responsible for exerting the 
biological effect.  
 
Chapter 4 addressed the first of these key issues, demonstrating that MSC-derived 
aggregates secreted a complement of soluble factors/cytokines that induced an 
astrogenic effect in AHPCs. It is therefore envisioned that MSCs may present as 
vehicles for the delivery of highly-efficacious levels of neurotrophic factors and 
cytokines to areas of neurological and neurodegenerative damage following 
transplantation. Identification of the bioactive factor(s) present in MSC aggregate-
derived CM may bypass the need for cellular therapy at all, instead permitting 
exogenous application of such molecules directly to neurologically-damaged areas. 
Similarly, increased knowledge in this area may lead to the generation of new media 
supplements that can be used to direct the differentiation of neural stem cells in a 
highly controlled manner, providing a convenient method by which to generate in vitro 
culture of astrocytes. 
 
The paracrine function(s) of MSCs in terms of their effect(s) on neural development 
and plasticity using an in vitro conditioned media (CM)-based model was examined 
previously in Chapter 4. The present study aims to extend upon the results generated in 
the previous Chapter in order to scrutinise the MSC aggregate-derived secretome in 
further detail, with the ultimate aim of identifying the bioactive factor(s) responsible 
for exerting the biological effects observed in the previous chapter. To date, most 
conditioned media studies make little effort to identify the bioactive factors present 
within the highly complex mixture of proteins in conditioned media and those that do 
typically pursue a traditional approach, involving characterisation of only one or a 
handful of secreted proteins (Moore et al., 2009). For example, Rivera and colleagues 
adopted a random screening approach using recombinant proteins and blocking 
antibodies targeted against various soluble factors and cytokines, whilst Wislet-
Gendebien and colleagues used targeted expression profiling using qRT-PCR and 
Western blotting, based on current knowledge within the literature (Wislet-Gendebien 
et al., 2004; Rivera et al., 2006).  
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In the present study, a combinatorial approach involving targeted transcriptional 
profiling using qRT-PCR and shotgun proteomics using LC-MS/MS was adopted in 
order to scrutinise the MSC aggregate-derived secretome in further detail, paying 
particular attention to those factors implicated in neural activities such as neural stem 
cell proliferation, migration and differentiation. Proteomic-based methodologies have 
previously been employed in several studies in order to scrutinise the MSC-derived 
secretome in detail; Sarojini and colleagues successfully used 2D LC-MS/MS to 
identify pigment epithelial-derived growth factor (PEDF) as the major fibroblast 
chemoattractant in MSC-derived CM, whilst De Kleijn and colleagues adopted a 
similar LC-MS and antibody array-based approach in order to identify the soluble 
factors/cytokines that could account for the therapeutic effect of MSC transplantation 
following myocardial infarction (De Kleijn et al., 2008; Sarojini et al., 2008). 
However, to our knowledge, the present study is the first to examine the MSC-derived 
secretome from a neural perspective. 
 
 
Hypothesis 
Induction of astrogenesis in AHPCs following culture in MSC aggregate-derived CM 
is a consequence of the activity of soluble factors and cytokines secreted directly into 
the medium by 3D MSC aggregates.  
 
 
Aims of chapter 
To identify the bioactive factor(s) present in MSC aggregate-derived CM responsible 
for the astrogenic effect in AHPCs observed in Chapter 4. 
 
 
 
 
 
Chapter 5: Characterisation of the MSC secretome 
 
244 
 
Objectives 
1. Targeted transcriptional profiling against astrocytic-promoting and astrocytic-
inhibitory soluble factors, using qRT-PCR, based on current knowledge within 
the literature. 
 
2. Examine influence of oxygen tension on transcriptional activity of MSC-
derived aggregates. 
 
3. Shotgun proteomic analysis of MSC aggregate-derived CM, using LC-MS/MS, 
to identify secreted peptides. 
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5.2 Materials and methods 
5.2.1 RNA isolation, reverse transcription and qRT-PCR analysis of soluble factor 
expression 
Expression of a range of soluble factors/cytokines with known neural associations 
(based on current knowledge within the literature) were examined at the mRNA level, 
using a qRT-PCR approach, in MSCs cultured under standard conditions and as 
aggregates under physiological and atmospheric oxygen tensions. Briefly, MSCs were 
seeded out under standard conditions and for aggregate formation under physiological 
and atmospheric oxygen tensions, as described in Sections 2.1 and 4.2.1 respectively, 
and maintained for 3 days i.e. to the point where CM would be collected for 
subsequent downstream studies. Following 3 days culture, total cellular RNA was 
isolated using the TRIreagent method (Section 2.9) followed by reverse transcription 
to cDNA (Section 2.10) and finally qRT-PCR using SYBR Green chemistry (Section 
2.11), as detailed in the relevant sections. All expressions were normalised to GAPDH 
as previous detailed in Section 2.11, with normalised levels of expression shown as a 
percentage of the maximum expresser. Specific primer sequences are shown in Table 
2.1. 
 
5.2.2 Concentration of CM samples and 1D SDS-PAGE 
CM was concentrated approximately 10-fold to a final volume of 200-400μl 
(approximate concentration 1.5μg/μl) by centrifugation in a 2 kDa molecular weight 
cut-off filter (Vivaspin 15R) at 3000 x g for 2 hours. Protease inhibitors were added to 
a final concentration of 1:1000 to prevent degradation of proteins of interest in the 
concentrate. Total protein was quantified using the Bradford assay and equivalent 
amounts of protein for each sample (12µg) were loaded onto a 4-12% bis-tris 1D SDS-
PAGE gel. Therefore, all comparisons within the 1D gel were made on an 
equivalently-loaded basis. Gels were then stained in three successive solutions of 
Coomassie Brilliant Blue R-250 – 1) 10% acetic acid, 25% isopropanol, 2% 
Coomassie Brilliant Blue R-250; 2) 10% acetic acid, 10% isopropanol, 0.25% 
Coomassie Brilliant Blue R-250; and 3) 10% acetic acid, 0.25% Coomassie Brilliant 
Blue R-250 – to allow visualisation of protein bands. 
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5.2.3 Preparation of samples for proteomic analysis by the North East Proteome 
Analysis Facility (NEPAF) 
Three biologically-independent batches of MSCs were seeded out for aggregate 
formation in media supplemented with ITS and ITS+P+P to form pairwise samples, 
using an identical methodology to that described in Section 4.2.1 (please refer to 
Section 5.3.5 for explanation of ITS and ITS+P+P media). After 3 days, the CM was 
removed from the flasks, centrifuged at 2000rpm for 5 minutes to remove cellular 
debris and the supernatant collected and filtered using a 0.22μm pore filter to remove 
further contaminants. Samples were stored at -20
o
C until required. 
 
CM was concentrated approximately 10-fold to a final volume of 200-400μl 
(approximate concentration 1.5μg/μl) by centrifugation in a 2 kDa molecular weight 
cut-off filter (Vivaspin 15R) at 3000 x g for 2 hours. Protease inhibitors were added to 
a final concentration of 1:1000 to prevent degradation of proteins of interest in the 
concentrate. Total protein was quantified using the Bradford assay and equivalent 
amounts of protein for each sample (12µg) were loaded onto a 4-12% bis-tris 1D SDS-
PAGE gel. Therefore, all comparisons within the 1D gel were made on an 
equivalently-loaded basis. Gels were stained in three successive solutions of 
Coomassie Brilliant Blue R-250 – 1) 10% acetic acid, 25% isopropanol, 0.025% 
Coomassie Brilliant Blue R-250; 2) 10% acetic acid, 25% isopropanol, 0.003125% 
Coomassie Brilliant Blue R-250; and 3) 10% acetic acid, 0.003125% Coomassie 
Brilliant Blue R-250 – to allow visualisation of protein bands. The gel was 
subsequently stored in destaining solution (10% acetic acid, 1% glycerol) prior to 
manipulation by the North East Proteome Analysis Facility (NEPAF), a state-of-the-art 
facility providing proteomic-based services to groups/companies in both the private 
and public sector in the UK (http://www.nepaf.com/home.html). 
 
5.2.4 Preparation of gel slices, tryptic digestion, liquid chromatography and 
MALDI-TOF MS/MS 
Following fractionation of paired CM samples on a 1D SDS-PAGE gel, this gel was 
passed onto NEPAF for high-throughput shotgun proteomics analysis. All subsequent 
steps were therefore performed by NEPAF; however, a consideration of the relevant 
methodologies will be considered here. 
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Each of the six sample lanes (3 x ITS-CM, 3 x ITS+P+P-CM) on the 1D gel were 
laterally sliced into 8 sections and prepared for in-gel tryptic digestion. Note that the 
regions of the gel corresponding to the transferrin and BSA bands (~60-80 kDa) were 
excluded from analysis (the presence of BSA being attributable to carry-over from 
serum-containing media). In-gel tryptic digestion results in the generation of shorter 
fragments i.e. peptides, which have distinctive masses, ultimately aiding in 
identification of the parental protein. Peptides were extracted from the gel matrix and 
resolved using reversed phase nano-HPLC in-line with the MS. Chromatography was 
performed on a Dionex Ultimate 3000 NanoLC System, Dionex Pepmap100 C18 
Column (25cm x 75um i.d., 3 μm, with C18 trap column) at 60°C at a flow rate of 300 
nl/minute over 102 minutes. Eluted peptides were then directly analysed using a 
tandem MS methodology (nanospray MS/MS, LTQ Orbitrap XL, ThermoScientific) in 
order to identify individual peptides. 
 
5.2.5 Protein identification 
MS/MS spectra generated by NEPAF were searched against the international 
X!Tandem search engine, available through the Global Proteome Machine 
Organisation interface (www.thegpm.org). This algorithm matches MS/MS spectra 
with peptide sequences on its database in order to identify the parent protein from 
which the peptide was generated and gives data in terms of a wide range of convenient 
parameters, including a description of the identified protein, ENSEMBL identifiers, 
description of protein function, an estimated molecular weight of the protein and a 
log(e) score, amongst others. Information for each protein was gathered using the 
description given in the GPM result file and also the corresponding ENSEMBL 
identifier (www.ensembl.org). 
 
5.2.6 Spectral counting 
Semi-quantitation of the shotgun proteomic data generated above was achieved using a 
spectral counting method. Here, it is assumed that the number of peptides detected for 
each protein is indicative of the relative abundance of that protein within the complex 
sample mixture, such that the greater the number of peptides detected for a particular 
protein, the more abundant that protein must be in the mixture. However, large 
proteins will generate a greater number of peptides compared to smaller proteins; 
therefore, normalisation against protein size is necessary. Abundance rankings were 
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calculated for each identified protein based on the number of peptides contributing to 
its positive identification. These figures were subsequently used to calculate ratios of 
upregulation/downregulation in biologically-inactive (ITS) versus biologically active 
(ITS+P+P) samples. 
 
5.2.7 Data processing 
In order to create a manageable list of putative candidate soluble factors from the 2429 
hits generated using the above methodology, a number of stringent criteria were 
applied: 
 
a) Protein must be identified from at least two peptides 
b) Protein must be either exclusively detected or upregulated 2-fold or more in 
at least 2 out of 3 pairwise samples 
c) Log(e) score must be ≤-3 
 
Data is presented in terms of a number of parameters, including ENSEMBL identifier, 
protein description, pairwise comparisons, gel slice in which protein was identified, 
number of peptides contributing to each protein identification, log(e) score, normalised 
abundance ratio biologically active/biologically inactive samples, estimated molecular 
weight of protein and calculated molecular weight. 
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5.3 Results 
5.3.1 MSCs demonstrate marked differences at the transcriptional level following 
culture under aggregate-inducing conditions compared to standard culture 
conditions; similarly, oxygen tension also presents as a critical determinant of 
transcriptional activity 
Studies in the previous chapter demonstrated that MSCs cultured as large multicellular 
aggregates secreted a specific complement of soluble factors/cytokines that induced 
AHPCs to commit to and undergo astrogenesis following 7 days in culture. This 
differentiative effect was only observed following culture with aggregate-derived CM 
and could not be reproduced following culture with monolayer-derived CM. Adopting 
a CM approach to examine the secretory activities of various cell types in vitro is not a 
unique strategy to this investigation and many studies throughout the literature have 
employed similar tactics in order to examine autocrine and paracrine mechanisms of 
cellular behaviour and function. However, the major shortcoming of most studies is 
that few make any attempt to characterise the secretome of the cells in order to identify 
the soluble factor(s) responsible for bringing about the observed biological effect, 
whether this be a consequence of increased expression of active factors or a decrease 
in expression of inhibitory factors, or both. It is ultimately the identification of these 
active (or inhibitory) factors that will be of significant use in a research/industrial 
setting. 
 
The principal aim of this Chapter is therefore to provide a detailed analysis of the MSC 
secretome – more specifically, the secretome of MSC-derived aggregates – in order to 
identify the bioactive soluble factor(s) responsible for the observed astrogenic effect in 
AHPCs. Initial assessment of the secretome was achieved using a transcriptional 
profiling approach. Here, expression of a range of soluble factors known to play key 
roles in neural differentiation and development were examined in MSC-derived 
aggregates vs. standard MSC monolayer cultures at the mRNA level using qRT-PCR. 
The effect of oxygen tension on the expression of soluble factors in aggregates was 
also determined as previous results demonstrated that oxygen tension significantly 
influenced the secretory activity of MSC-derived aggregates. Specific soluble factors 
were selected on account of previous observations and a review of the current 
literature, allowing identification and subsequent targeted analysis of potential 
Chapter 5: Characterisation of the MSC secretome 
 
250 
 
candidates. All expressions were normalised to GAPDH as previous detailed in 
Section 2.11, with normalised levels of expression shown as a percentage of the 
maximum expression level recorded. 
 
The soluble factors examined were grouped into subcategories according to the 
specific protein family to which they belonged including BMP, gp130 (IL-6)-related, 
classic neurotrophins, EGF, PDGF, TGF and miscellaneous protein families. Results 
are shown in Figures 5.1, 5.2, 5.3, 5.4, 5.5, 5.6 and 5.7 respectively. In terms of 
members of the BMP family, expression of BMP2, BMP4 and BMP7 were determined 
at the mRNA level in MSCs cultured under standard conditions and as aggregates 
under physiological and atmospheric oxygen tensions. Results are shown in Figure 5.1. 
Expression of BMP2 was relatively uniform and transcript levels comparable in MSCs 
cultured under all three conditions (Figure 5.1A). The lowest levels of expression were 
detected in MSCs cultured under standard conditions with increased expression 
observed following subsequent culture in aggregate-inducing conditions, though this 
was not significant at the statistical level. Aggregates cultured under atmospheric 
oxygen conditions demonstrated greater levels of expression than aggregates cultured 
under physiological oxygen conditions though, similarly, this difference was very 
slight and not significant at the statistical level. BMP4, the BMP family member most 
frequently associated with astrogenesis, was expressed at maximum levels in MSCs 
cultured under standard conditions (Figure 5.1B). Levels of BMP4 transcript were 
detected at significantly lower levels in MSCs cultured as aggregates under both 
physiological (p<0.01) and atmospheric (p<0.001) oxygen tensions. Interestingly, 
although BMP4 expression appeared to be only very slightly increased in aggregates 
cultured under physiological oxygen compared to atmospheric oxygen tensions, this 
difference was highly significant at the statistical level (p<0.001). The expression 
profile of BMP7 mirrored that observed for BMP4, with maximum levels of 
expression detected in MSCs cultured under standard conditions followed by a 
dramatic reduction in expression following culture under aggregate-inducing 
conditions (Figure 5.1C). This decrease in expression was statistically significant for 
MSCs cultured as aggregates under both physiological (p<0.05) and atmospheric 
(p<0.01) oxygen tensions. Although the difference in transcript levels appeared to be 
far more dramatic than that observed for BMP4, this observation was not significant at 
the statistical level. 
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Figure 5.1. Expression of members of the BMP protein family at the mRNA level in MSC 
aggregates cultured under varying oxygen tensions and in MSCs cultured under standard 
conditions for 3 days. QRT-PCR analysis was performed to compare mRNA transcript levels of three 
members of the BMP protein family – A: BMP2; B: BMP4; C: BMP7 – in MSCs cultured as aggregates 
under varying oxygen tensions and in MSCs cultured under standard conditions for three days. All 
values were normalised to GAPDH to account for any differences in RNA input and/or reverse 
transcription efficiencies. Normalised levels of expression are shown as percentages of the maximum 
expresser. Each bar represents the mean (n=3)+SEM, *** p<0.001, ** p<0.01, *p<0.05. 
BMP2 
BMP4 
BMP7 
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In terms of members of the gp130 (IL-6)-related family of cytokines, expression of 
CNTF, LIF and IL-6 were determined at the mRNA level in MSCs cultured under 
standard conditions and as aggregates under physiological and atmospheric oxygen 
tensions. Results are shown in Figure 5.2. The expression profile observed for CNTF 
mirrored that previously observed for BMP7, with maximum levels of expression 
detected in MSCs cultured under standard conditions followed by a dramatic reduction 
in expression following culture under aggregate-inducing conditions (Figure 5.2A). 
Decreased expression of CNTF in aggregates compared to MSCs cultured under 
standard conditions was significant at the statistical level for aggregates cultured under 
both physiological (p<0.01) and atmospheric (p<0.01) oxygen tensions. Differences in 
expression between aggregates cultured under varying oxygen tension were not 
significant at the statistical level.  Expression of LIF was low in MSCs cultured under 
standard conditions and was significantly upregulated in aggregates cultured under 
both physiological (p<0.001) and atmospheric (p<0.01) oxygen tensions (Figure 5.2B). 
Maximum expression was observed in aggregates cultured under physiological oxygen 
conditions with aggregates cultured under atmospheric oxygen conditions 
demonstrating high levels of expression compared to standard MSCs but lower levels 
of expression compared to aggregates cultured under physiological oxygen conditions 
(p<0.05). The expression profile observed for IL-6 demonstrated extensive similarity 
to that observed for CNTF, with maximum levels of expression detected in MSCs 
cultured under standard conditions followed by a dramatic reduction in expression 
following culture under aggregate-inducing conditions (Figure 5.2C). Decreased 
expression of IL-6 in aggregates compared to MSCs cultured under standard 
conditions was significant at the statistical level for aggregates cultured under both 
physiological (p<0.05) and atmospheric (p<0.05) oxygen tensions. Although 
aggregates cultured under physiological oxygen tensions demonstrated slightly higher 
levels of IL-6 expression than counterparts cultured under atmospheric oxygen 
tensions, this difference was not significant at the statistical level. 
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Figure 5.2. Expression of members of the gp130 (IL-6) family of cytokines at the mRNA level in 
MSC aggregates cultured under varying oxygen tensions and in MSCs cultured under standard 
conditions for 3 days. QRT-PCR analysis was performed to compare mRNA transcript levels of three 
members of this protein family – A: CNTF; B: LIF; C: IL-6 – in MSCs cultured as aggregates under 
varying oxygen tensions and in MSCs cultured under standard conditions for three days. All values were 
normalised to GAPDH to account for any differences in RNA input and/or reverse transcription 
efficiencies. Normalised levels of expression are shown as percentages of the maximum expresser. Each 
bar represents the mean (n=3)+SEM, *** p<0.001, ** p<0.01, *p<0.05. 
CNTF 
LIF 
IL-6 
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In terms of members of the classical neurotrophin family of cytokines, expression of 
NGF and BDNF were determined at the mRNA level in MSCs cultured under standard 
conditions and as aggregates cultured under physiological and atmospheric oxygen 
tensions. Results are shown in Figure 5.3. The expression profile observed for NGF 
mirrored that previously observed for LIF, with low levels of expression in MSCs 
cultured under standard conditions and significantly greater levels of expression in 
aggregates cultured under both physiological (p<0.05) and atmospheric (p<0.05) 
oxygen tensions (Figure 5.3A). Analogous to the LIF expression profile, maximum 
expression of NGF was detected in aggregates cultured under physiological oxygen 
conditions with aggregates cultured under atmospheric oxygen conditions 
demonstrating high levels of expression compared to standard MSCs but lower levels 
of expression compared to aggregates cultured under physiological oxygen conditions 
(p<0.05). Expression of BDNF was relatively uniform with no discernable differences 
in transcript levels being detected between MSCs cultured under standard or 
aggregate-inducing conditions (Figure 5.3B). 
 
In terms of members of the EGF family of cytokines, expression of EGF and 
neuregulin were determined at the mRNA level in MSCs cultured under standard 
conditions and as aggregates cultured under physiological and atmospheric oxygen 
tensions. Results are shown in Figure 5.4. Expression of EGF was unique in that 
transcript levels were relatively uniform between MSCs cultured under standard 
conditions and as aggregates under physiological oxygen tensions, with significantly 
lower transcript levels being detected in aggregates cultured under atmospheric oxygen 
tensions (Figure 5.4A). Decreased expression of EGF following aggregate culture 
under atmospheric oxygen tension was moderately significant at the statistical level 
when compared to both other culture conditions (p<0.01 in both instances). Expression 
of neuregulin mirrored that previously observed for several other cytokines including 
BMP4, BMP7, CNTF and IL-6, with maximum levels of expression observed in MSCs 
cultured under standard conditions (Figure 5.4B). Although levels of transcript were 
detected at lower levels in MSCs cultured as aggregates under both physiological and 
atmospheric oxygen tensions, this decrease in expression was only significant at the 
statistical level following aggregate culture under atmospheric oxygen tensions 
(p<0.01). Expression of neuregulin was greater in aggregates cultured under 
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physiological oxygen tensions compared to atmospheric oxygen tensions and this 
observation was highly significant at the statistical level (p<0.001).  
 
 
   
Figure 5.3. Expression of members of the classical neurotrophin family of cytokines at the mRNA 
level in MSC aggregates cultured under varying oxygen tensions and in MSCs cultured under 
standard conditions for 3 days. QRT-PCR analysis was performed to compare mRNA transcript levels 
of two members of this protein family – A: NGF; B: BDNF – in MSCs cultured as aggregates under 
varying oxygen tensions and in MSCs cultured under standard conditions for three days. All values were 
normalised to GAPDH to account for any differences in RNA input and/or reverse transcription 
efficiencies. Normalised levels of expression are shown as percentages of the maximum expresser. Each 
bar represents the mean (n=3)+SEM, *p<0.05. 
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Figure 5.4. Expression of members of the EGF family of cytokines at the mRNA level in MSC 
aggregates cultured under varying oxygen tensions and in MSCs cultured under standard 
conditions for 3 days. QRT-PCR analysis was performed to compare mRNA transcript levels of two 
members of this protein family – A: EGF; B: Neuregulin – in MSCs cultured as aggregates under 
varying oxygen tensions and in MSCs cultured under standard conditions for three days. All values were 
normalised to GAPDH to account for any differences in RNA input and/or reverse transcription 
efficiencies. Normalised levels of expression are shown as percentages of the maximum expresser. Each 
bar represents the mean (n=3)+SEM, *** p<0.001, ** p<0.01. 
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In terms of members of the PDGF family of cytokines, expression of PDGF-A and 
VEGF were determined at the mRNA level in MSCs cultured under standard 
conditions and as aggregates cultured under physiological and atmospheric oxygen 
tensions. Results are shown in Figure 5.5. Expression profile observed for PDGF-A 
was unique and antagonistic to that previously observed for NGF, with highest levels 
of expression observed in MSCs cultured under standard conditions and as aggregates 
under atmospheric oxygen tensions (Figure 5.5A). Lowest levels of expression were 
observed in MSCs cultured as aggregates under physiological oxygen tensions. 
However, no statistically significant difference was found in terms of PDGF-A 
expression between MSCs cultured under any of the various conditions. In terms of 
VEGF, maximum expression was observed in MSCs cultured under standard 
conditions, with MSCs cultured as aggregates under both physiological and 
atmospheric oxygen tensions demonstrating significantly lower levels of expression 
(p<0.01 in both instances) (Figure 5.5B). Although there was a slight tendency for 
expression to increase in aggregates cultured under atmospheric oxygen compared to 
physiological oxygen tensions, this observation was not significant at the statistical 
level. 
 
In terms of members of the TGF family of cytokines, expression of activin-A and 
TGF-β1 were determined at the mRNA level in MSCs cultured under standard 
conditions and as aggregates cultured under physiological and atmospheric oxygen 
tensions. Results are shown in Figure 5.6. Expression profile observed for activin-A 
mirrored that previously observed for BMP7, CNTF and IL-6, with maximum levels of 
expression detected in MSCs cultured under standard conditions followed by a 
dramatic reduction in expression following culture under aggregate-inducing 
conditions (Figure 5.6A). This decrease in expression was statistically significant for 
MSCs cultured as aggregates under both physiological (p<0.001) and atmospheric 
(p<0.001) oxygen tensions, with transcripts being undetectable in aggregates cultured 
under the latter condition. The expression profile observed for TGF-β1 was very 
similar to that observed for activin-A, with maximum levels of expression also being 
detected in MSCs cultured under standard conditions followed by a dramatic reduction 
in expression following culture under aggregate-inducing conditions (Figure 5.6B). 
Similarly, this decrease in expression was statistically significant for MSCs cultured as 
aggregates under both physiological (p<0.001) and atmospheric (p<0.01) oxygen 
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tensions. However, whereas activin-A transcripts were undetectable in aggregates 
cultured under atmospheric oxygen tensions, TGF-β1 transcripts were actually 
detected at higher levels in aggregates cultured under atmospheric oxygen tensions 
compared to those cultured under physiological oxygen tensions, though this 
difference was very slight and not significant at the statistical level. 
 
 
Figure 5.5. Expression of members of the PDGF family of cytokines at the mRNA level in MSC 
aggregates cultured under varying oxygen tensions and in MSCs cultured under standard 
conditions for 3 days. QRT-PCR analysis was performed to compare mRNA transcript levels of two 
members of this protein family – A: PDGF-A; B: VEGF – in MSCs cultured as aggregates under 
varying oxygen tensions and in MSCs cultured under standard conditions for three days. All values were 
normalised to GAPDH to account for any differences in RNA input and/or reverse transcription 
efficiencies. Normalised levels of expression are shown as percentages of the maximum expresser. Each 
bar represents the mean (n=3)+SEM, ** p<0.01. 
PDGF-A 
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Figure 5.6. Expression of members of the TGF family of cytokines at the mRNA level in MSC 
aggregates cultured under varying oxygen tensions and in MSCs cultured under standard 
conditions for 3 days. QRT-PCR analysis was performed to compare mRNA transcript levels of two 
members of this protein family – A: Activin-A; B: TGF-β1 – in MSCs cultured as aggregates under 
varying oxygen tensions and in MSCs cultured under standard conditions for three days. All values were 
normalised to GAPDH to account for any differences in RNA input and/or reverse transcription 
efficiencies. Normalised levels of expression are shown as percentages of the maximum expresser. Each 
bar represents the mean (n=3)+SEM, *** p<0.001, ** p<0.01. 
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The final group of cytokines examined were a miscellaneous selection consisting of 
cystatin C, FGF2, GDNF, IGF-1 and TNF. Expression of each of these factors was 
determined at the mRNA level in MSCs cultured under standard conditions and as 
aggregates cultured under physiological and atmospheric oxygen tensions. Results are 
shown in Figure 5.7. Expression profiles observed for cystatin C and TNF followed 
very similar trends and mirrored those previously observed for activin-A, BMP7, 
CNTF and IL6, with maximum levels of expression detected in MSCs cultured under 
standard conditions followed by a dramatic reduction in expression following culture 
under aggregate-inducing conditions (Figures 5.7A and 5.7E). For TNF, this decrease 
in expression was significant at the statistical level for MSCs cultured as aggregates 
under both physiological (p<0.01) and atmospheric (p<0.01) oxygen tensions, whereas 
for cystatin C, decreased expression was insignificant at the statistical level. When 
levels of expression were compared between aggregates cultured under physiological 
versus atmospheric oxygen tensions, aggregates cultured under physiological oxygen 
tension demonstrated significantly higher expression for both cystatin C (p<0.05) and 
TNF (p<0.05) compared to their atmospheric counterparts. The expression profile 
observed for FGF2 was extremely similar to that previously observed for EGF, with 
uniform levels of expression detected in MSCs cultured under standard conditions and 
as aggregates under physiological oxygen tension, with significantly lower levels of 
expression detected in aggregates cultured under atmospheric oxygen tension (Figure 
5.7B). Decreased expression of FGF2 following culture as aggregates under 
atmospheric oxygen tension was moderately significant at the statistical level when 
compared to both other culture conditions (p<0.01 in both instances). Expression of 
GDNF demonstrated a degree of similarity to the expression profiles observed for 
NGF and LIF, with moderate levels of expression in MSCs cultured under standard 
conditions compared to significantly higher levels of expression in aggregates cultured 
under physiological oxygen tension (Figure 5.7C). This difference was significant at 
the statistical level (p<0.01). However, whereas expression of the cytokines NGF and 
LIF were also elevated in aggregates cultured under atmospheric oxygen tension 
compared to standard MSCs, the opposite trend was observed for GDNF, in that 
aggregates cultured under atmospheric oxygen tension demonstrated the lowest levels 
of expression. Reduced expression of GDNF in aggregates cultured under atmospheric 
oxygen tension was significant at the statistical level when compared to expression in 
standard MSCs (p<0.01) and aggregates cultured under physiological oxygen tensions 
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(p<0.001). Finally, the expression profile observed for IGF-1 demonstrated similarity 
to the expression profile previously observed for BMP4, with maximum levels of 
expression detected in MSCs cultured under standard conditions (Figure 5.7D). Levels 
of IGF-1 transcript were detected at significantly lower levels in MSCs cultured as 
aggregates under both physiological (p<0.01) and atmospheric (p<0.01) oxygen 
tensions. However, differences in expression between aggregates cultured under both 
oxygen tensions were only very slight and were not significant at the statistical level. 
   
Figure 5.7. Expression of miscellaneous cytokines at the mRNA level in MSC aggregates cultured 
under varying oxygen tensions and in MSCs cultured under standard conditions for 3 days. QRT-
PCR analysis was performed to compare mRNA transcript levels of five miscellaneous cytokines – A: 
cystatin C; B: FGF2; C: GDNF; D: IGF1; E: TNFα – in MSCs cultured as aggregates under varying 
oxygen tensions and in MSCs cultured under standard conditions for three days. All values were 
normalised to GAPDH to account for any differences in RNA input and/or reverse transcription 
efficiencies. Normalised levels of expression are shown as percentages of the maximum expresser. Each 
bar represents the mean (n=3)+SEM, *** p<0.001, ** p<0.01, * p<0.05. 
Cystatin C FGF2 
GDNF IGF-1 
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5.3.2 Conditioned media is not amenable to proteomic analysis due to abundant 
levels of transferrin 
Transcriptional profiling of MSC-derived aggregates and MSCs cultured under 
standard conditions, as performed in the first section of this Chapter, offers a 
convenient starting point for the detailed analysis of MSC-derived secretomes, 
particularly as prior knowledge of the biological activity of these secretomes allowed 
targeted analysis of soluble factors/cytokines specifically known to be mediators of 
such activity. However, this approach does have several disadvantages in that: 
 
a) RNA levels are not always indicative of actual protein levels, a consequence of 
extensive RNA processing prior to protein synthesis. 
b) Making the assumption that RNA levels are indicative of actual protein levels 
in this study, it is not possible to demonstrate that these proteins are secreted 
into the culture media.  
c) Targeted analysis of soluble factors/cytokines introduces a bias into the study, 
such that resulting knowledge will be limited only to those factors examined 
i.e. the role of novel factors, or factors previously unassociated with this 
process, will remain undetected. 
 
Therefore, to address these three important issues, an additional approach was adopted 
in this study in order to examine MSC-derived secretomes at the protein level in an 
unbiased manner. This involved application of proteomic-based techniques in order to 
identify proteins present in CM, making the assumption that a significant proportion of 
the proteins identified (which were not components of the basal culture media) were 
cell-derived secretory products as opposed to intracellular components released from 
lysed cells. 
 
Conditioned media from MSCs cultured under standard conditions and as aggregates 
under physiological oxygen tensions were concentrated to a final volume of 200-400μl 
(approximate concentration 1.5μg/μl) by centrifugation in a 2 kDa molecular weight 
cut-off filter and equivalent amounts of protein for each sample loaded onto a 4-12% 
bis-tris 1D SDS-PAGE gel as described in Section 5.2.2. Gels were stained in three 
successive solutions of Coomassie Brilliant Blue R-250 as described to allow 
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visualisation of protein bands. Figure 5.8 shows a typical 1D-PAGE gel, with lanes 1-3 
corresponding to molecular weight marker, standard MSC and MSC-derived aggregate 
respectively. The 1D-PAGE profiles observed for standard MSCs and MSC-derived 
aggregates were both dominated by a heavy single band located in the 59-109 kDa 
range of the gel (Figure 5.8). This band was not a consequence of gel overloading and 
the observation that the band was equal between the two samples strongly suggested 
that it was a common component of the media and not a result of cell secretion. 
Excision of this band followed by tryptic-based digestion and analysis by MALDI-
TOF MS identified this protein as transferrin, the major constituent of N2 supplement, 
present in basal media. Such high abundance proteins can be problematic to proteomic 
analyses as they create a massive artificial dynamic range in the sample and may mask 
the detection of lower abundance proteins, which are often of much more interest. 
 
Figure 5.8. A typical 1D SDS-PAGE gel showing the protein profile of conditioned media derived 
from MSCs cultured under standard conditions (Lane 2) and as aggregates under physiological 
oxygen tension (Lane 3). Both protein profiles are dominated by a single, heavy band located in the 59-
190 kDa range of the gel. This protein was subsequently identified as transferrin. 
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5.3.3 Substitution of N2 supplement with ITS supplement in basal media produces 
conditioned media that is more amenable to proteomic analysis due to reduced levels 
of transferrin 
High abundance proteins such as transferrin present in CM pose many problems in 
terms of proteomic analysis, predominantly by obscuring detection of lower abundance 
proteins which usually are more likely to be relevant to the biological question 
addressed by the study. This is particularly true of this study, where the predicted 
molecular size of candidate growth factors/cytokines means they are likely to be 
masked by the large region covered by the heavy transferrin band on the gel. Although 
immunodepletion of transferrin is possible (several assays are commercially-available) 
this is not ideal as binding of candidate proteins to transferrin and, similarly, non-
specific binding of candidate proteins to the antibody used in the immunodepletion 
assay, means some loss of target protein(s) is inevitable. Ideally, use of an alternative 
growth supplement with lower levels of transferrin would be better as it would allow 
exclusion of the transferrin band from further analysis without affecting a wide region 
of the gel. ITS supplement presents as a promising alternative to N2 supplement as it 
contains significant lower levels of transferrin compared to N2 (Table 5.1). ITS 
supplement contains approximately 20-fold lower levels of transferrin than N2 
supplement, meaning that the dominant band observed in 1D-PAGE gels should be 
approximately 20-fold lower in density in gels using ITS-containing CM. This is 
shown in Figure 5.9. Other notable differences in composition are that ITS contains 
double the amount of insulin of N2 supplement and also lacks progesterone and 
putrescine. 
 Transferrin Insulin Selenium Progesterone Putrescine 
N2 100mg/L 5mg/L 5.2µg/L 6.3µg/L 16.11mg/L 
ITS 5.5mg/L 10mg/L 5µg/L – – 
Table 5.1. Composition of the commercially available cell culture supplements, N2 and ITS. ITS 
supplement contains approximately 20-fold lower levels of transferrin compared to N2 supplement 
which means that it will be more amenable to proteomic analysis as the transferrin band that dominates 
1D SDS-PAGE gels should be of a density approximately 20-fold less. Other notable differences in 
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terms of composition of N2 and ITS supplements include that the ITS supplement contains 2-fold higher 
levels of insulin and lacks progesterone and putrescine. 
 
 
Figure 5.9. A typical 1D SDS-PAGE gel showing the protein profile of conditioned media derived 
from MSCs cultured under standard conditions (Lane 1) and as aggregates under physiological 
oxygen tension (Lane 2) where N2 supplement has been replaced by ITS supplement in both cases. 
Both protein profiles still possess a dominant single, heavy band located in the 59-190 kDa range of the 
gel corresponding to transferrin. However, the density of the transferrin band is significantly lower than 
that previously observed with N2 supplement meaning ITS-containing conditioned media will be more 
amenable to proteomic analysis. 
 
5.3.4 Substitution of N2 supplement with ITS supplement in aggregate-derived CM 
abolishes the previously observed astrogenic effect in AHPCs, both in terms of 
morphological and marker expression analyses 
Although substitution of N2 supplement with ITS supplement was advantageous in 
terms of producing CM with lower levels of transferrin, specific details of the 
biological activity of ITS-containing CM were not assessed at that point. As the 
composition of N2 and ITS supplements vary in terms of basic constituents and the 
concentration of common constituents (Table 5.1), it was essential to reassess 
biological activity of ITS-containing CM using methodologies analogous to those used 
in Chapter 4 for the initial characterisation of N2-containing CM, using the AHPC 
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system. Biological activity of ITS-containing CM was assessed in AHPCs following 7 
days culture in ITS-containing CM and appropriate controls, both in terms of 
morphological phenotype and expression of mature neural markers. Neural marker 
expression was examined using flow cytometry due to its high sensitivity. 
 
Briefly, MSCs were seeded out for aggregate formation and allowed to condition 
media for 3 days, as described in Section 4.2.2, differing only in terms of media 
supplementation – ITS instead of N2 – with all other exogenously-added media 
constituents remaining identical. After three days, medium was collected and prepared, 
as detailed previously, prior to application in the subsequent culture of AHPCs. As per 
the original CM assay (Section 4.2.3), AHPCs were seeded onto cellware coated with 
PLO and laminin at a density of 10,000 cells/cm
2
 in their normal proliferative media 
and allowed 24 hours to settle (designated day –1). Following this 24 hour settling 
period (day 0), medium was removed and replaced with ITS-containing CM or 
appropriate control media (UC: unconditioned media; PC: proliferation control) and 
AHPCs cultured for a further 7 days. Medium was replenished on the 4
th
 day. After 7 
days, AHPCs were analysed for any obvious changes in cellular morphology (Figure 
5.10).  
 
As previously observed in the original CM assay, PC AHPCs were largely phase dark 
and very densely packed following 7 days culture, with evidence of extensive 
overgrowing (Figure 5.10A). Cell bodies were very rounded and showed no obvious 
evidence of process/cytoplasmic extension, indicating that cells in these cultures were 
largely undifferentiated. On the whole, these cultures appeared very unhealthy. In 
contrast, AHPCs cultured under UC and CM conditions appeared healthy and typically 
demonstrated phase-bright soma (Figures 5.10B and 5.10C). AHPCs cultured under 
UC conditions possessed numerous short processes, again in contrast to PC cultures, 
though these processes were short in length and did not demonstrate any obvious 
neuronal or glial characteristics (Figure 5.10B). This was consistent with previous 
observations from the original CM assay (Figure 4.4B). Interestingly, AHPC 
morphology following culture with ITS-containing CM differed significantly to that 
observed following culture with N2-containing CM in the original CM assay (Figures 
4.4C and 5.10C respectively). AHPCs cultured with N2-containing CM generally 
displayed a mature neural morphology, with multipolar soma forming a stellate, star-
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shaped morphology indicative of a glial morphology, in particular, an astrocytic 
morphology (Figure 4.4C). Culture of AHPCs with ITS-containing CM, however, did 
not induce the same morphological traits (Figure 5.10C). Although AHPCs cultured 
under these conditions also possessed multipolar soma as observed in the original 
assay, the processes themselves were very short and demonstrated little evidence of 
tertiary branching. 
 
 
 
Figure 5.10. Morphology of AHPCs following 7 days culture with ITS-CM and appropriate 
controls. A: Following culture in normal proliferative media, AHPCs are largely phase dark, consisting 
of very rounded cell bodies and very few (if any) processes. After 7 days culture under these conditions, 
AHPCs appear undifferentiated and unhealthy. B: Following culture in unconditioned media (UC), 
AHPCs are largely phase bright and display numerous short processes. However, the morphology of 
these cells suggests they are largely undifferentiated. C: Following culture in ITS-CM, AHPCs 
demonstrate a similar morphology to that observed following culture in UC (B). These morphological 
data suggest that AHPCs cultured with ITS-CM remain largely undifferentiated following 7 days 
culture. Scale bar = 100μm. 
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Figure 5.11. Flow cytometric analysis of marker expression in AHPCs treated 
with ITS-CM and appropriate controls. A: % cells expressing marker; B: mean 
fluorescence intensity of marker expression. In terms of the percentage of cell 
expressing each neural marker, there was very little difference between each of the 
samples. Similarly, in terms of intensity of marker expression, there was very little 
difference between each of the samples. These data suggest that the astrogenic effect 
observed following culture of AHPCs with N2-containing CM is abolished following 
substitution of N2 supplement with ITS supplement. 
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Although examination of cellular morphology is an easy and convenient starting point 
in terms of assessing cell phenotype, expression of a range of neural markers was 
examined at the flow cytometric level in order to provide a more accurate indication of 
AHPC behaviour following culture with ITS-containing CM and appropriate controls 
for 7 days. AHPCs were seeded out as described previously (Section 4.2.3) and 
cultured in ITS-containing CM and appropriate controls (PC and UC) for 7 days. 
Following 7 days culture, AHPCs were fixed in 2% PFA at 4
o
C overnight and 
processed for flow cytometry against nestin, Tuj-1, GFAP and GalC, as per the 
original CM assay. Data in terms of the percentage of cells expressing marker and MFI 
of marker expression are shown graphically in Figure 5.11. 
 
In terms of the percentage of cells expressing each neural marker, there was very little 
observable difference between each of the samples examined (Figure 5.11A). Any 
differences in expression that were apparent were very slight and not significant at the 
statistical level. Similarly, in terms of MFI of each neural marker, there was once again 
very little observable difference between each of the samples examined (Figure 
5.11B). Any differences in MFI that were apparent were only very slight and not 
significant at the statistical level. Such trends in neural marker expression were 
generally consistent with those previously observed in the original CM assay, with the 
exception of MFI of GFAP expression. Soluble factor(s) present in ITS-containing CM 
did not induce the significant upregulation in intensity of GFAP expression observed 
following culture with N2-containing CM. Combined, such morphological 
observations and neural marker expression data suggested that the astrogenic effect of 
aggregate-derived soluble factor(s) was completely abolished following the 
substitution of N2 supplement with ITS supplement. Marker expression analyses also 
demonstrated that the astrogenic effect was not abolished at the expense of another 
effect taking its place. It must also be noted here that, although data has not been 
included in Figure 5.11, AHPCs cultured in equivalent N2-containing CM were 
included in each independent assay as positive controls to ensure that the experimental 
setup was functioning correctly at both the technical and biological level. 
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5.3.5 Reduced levels of transferrin in ITS supplement are tolerable during the 
conditioning process if the medium is also supplemented with progesterone and 
putrescine 
Results in the previous section demonstrate that aggregate-derived CM exerts very 
different biological effects in AHPCs depending on whether N2 or ITS supplement is 
used as a basic component of the culture media. AHPCs cultured in N2-containing CM 
for 7 days underwent astrogenesis, an effect characterised by the acquirement of an 
astrocytic morphology concomitant with increased expression of both structural and 
functional markers indicative of astrocytic differentiation (Figures 4.4, 4.5, 4.7 and 
4.9). However, following substitution of N2 supplement with ITS supplement, this 
astrogenic effect was completely abolished, with AHPCs demonstrating no astrocytic-
like morphology and no upregulation in expression of GFAP in comparison to control 
cultures (Figures 5.10 and 5.11). Furthermore, expression of other neural markers 
(Tuj-1 and GalC) remained unchanged compared to control cultures, suggesting that 
the astrogenic effect had not been abolished at the expense of another neural effect 
taking its place. 
 
Therefore, as the primary difference between the two experimental setups was in terms 
of the compositions of N2 and ITS supplements (as shown in Table 5.1), it was a 
reasonable assumption that the compositional differences between N2 and ITS 
supplements were the reason for the differences observed between the two 
experimental assays. In order to identify the critical component(s) in N2 supplement 
that were essential to generating the astrogenic effect in AHPCs, the CM assays were 
repeated using ITS supplement combined with various other additives (based on the 
published formulation for N2 supplement, as shown in Table 5.1). Briefly, MSCs were 
seeded out for aggregate formation as described previously (Section 4.2.1) in media 
supplemented with N2 supplement, ITS + transferrin + progesterone + putrescine 
(ITS+T+P+P), ITS + transferrin (ITS+T) and ITS + progesterone + putrescine 
(ITS+P+P). MSCs were also seeded out for aggregate formation in N2-containing 
media as a positive control. Following this, as per the original CM assay (Section 
4.2.3), AHPCs were seeded onto cellware coated with PLO and laminin at a density of 
10,000 cells/cm
2
 in their normal proliferative media and allowed 24 hours to settle 
(designated day –1). Following this 24 hour settling period (day 0), media was 
removed and replaced with the various CMs described above and AHPCs cultured for 
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a further 7 days. Medium was replenished on the 4
th
 day. After 7 days, AHPCs were 
processed for flow cytometric analysis and expression of the astrocytic marker GFAP 
examined in terms of percentage of cells expressing GFAP and MFI of expression 
(Figure 5.12). 
 
Consistent with previous observations, expression of GFAP in terms of the percentage 
of cells positive for expression was very uniform and there was very little observable 
difference between each of the samples (Figure 5.12A). Any differences in expression 
that were apparent were extremely slight and were not significant at the statistical 
level. However, in the original CM assay, the astrogenic effect was characterised by a 
highly significant increase in MFI of GFAP expression (Figure 4.7). A similar trend 
was observed in all of the samples examined in the current assay in that AHPCs 
cultured with the various CMs for 7 days demonstrated dramatic increases in intensity 
of GFAP expression compared to PC control cultures (Figure 5.12B). AHPCs cultured 
in ITS+T+P+P – an almost identical formulation to N2 supplement – demonstrated 
almost identical levels of GFAP expression compared to AHPCs cultured in N2-
containing CM, following 7 days culture. Similarly, AHPCs cultured in ITS+T and 
ITS+P+P also demonstrated a significant upregulation in intensity of GFAP 
expression, though the absolute values were slightly lower than those observed 
following culture in N2 or ITS+T+P+P. MFI of GFAP expression was lowest in 
AHPCs cultured in ITS+P+P; however, the difference in intensity of expression 
between AHPCs cultured in ITS+P+P compared to equivalent counterparts cultured in 
N2 was not significant at the statistical level. Therefore, the use of ITS+P+P CM 
provides an ideal culture system in which to analyse the MSC aggregate-derived 
secretome at the proteomic level because a) it contains low levels of transferrin 
compared to N2-containing CM and b) it still produces the astrogenic effect in AHPCs. 
Furthermore, the lack of biological activity of the original ITS-containing CM means 
that this can be used as a suitable control against which to compare ITS+P+P-CM. 
 
5.3.6 Biological activity of ITS+P+P-CM was verified in terms of induction of 
GFAP expression in AHPCs prior to proteomic analysis 
In order to examine the secretome of MSC-derived aggregates at the proteomic level 
and identify the astrocytic-inducing bioactive factor(s) secreted by aggregates, MSCs 
were seeded out for aggregate formation, as previously described (Section 4.2.1), in 
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media supplemented with ITS only (biologically inactive control) and ITS+P+P 
(biologically active sample of interest). Three biologically-independent paired samples 
were prepared and analysed using a shotgun proteomics approach by the North East 
Proteome Analysis Facility (NEPAF), based on LC-MS/MS, to allow scrutinisation of  
 
 
Figure 5.12. Flow cytometric analysis of GFAP expression in AHPCs cultured in conditioned 
media supplemented with ITS in combination with various additives, in keeping with the 
published formulation for N2 supplement. AHPCs were seeded out and cultured in conditioned media 
supplemented with ITS in combination with various additives, including 
transferrin/progesterone/putrescine, transferrin alone and progesterone/putrescine, for 7 days and 
processed for flow cytometry as previously described. Expression of GFAP was examined in terms of 
the percentage of cells expressing GFAP (A) and MFI of GFAP expression (B). Supplementation with 
progesterone and putrescine was sufficient to rescue the astrogenic effect previously observed in Section 
4.7. Each bar represents the mean (n=3)+SEM.  
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the entire protein complement of MSC aggregate-derived CM produced under both 
conditions. However, before the paired samples were analysed by NEPAF, the 
biological activity of the samples were assayed by seeding AHPCs out followed by 
subsequent culture in the different CMs for 7 days, as per the previous CM assays 
(Section 4.2.3), followed by analysis of GFAP expression using immunocytochemical 
methods. Results are shown in Figure 5.13. Consistent with previous observations 
from this Chapter, AHPCs cultured in ITS-CM were biologically inactive 
(demonstrating only very weak, diffuse staining for GFAP; Figures 5.13D, 5.13E and 
5.13F) whereas AHPCs cultured in ITS+P+P-CM were biologically active 
(demonstrating very strong, intense staining for GFAP; Figures 5.13A, 5.13B and 
5.13C). 
 
  
  
 
Figure 5.13. Validation of the biological activity of ITS-CM and ITS+P+P-CM paired samples 
prior to high-throughput shotgun proteomic analysis, performed by NEPAF. AHPCs were seeded 
out as described previously and cultured in paired ITS-CM (D, E and F) and ITS+P+P-CM (A, B and 
C) samples for 7 days, such that A/D, B/E and C/F are corresponding paired samples. Following 7 days 
culture, expression of GFAP was examined using immunocytochemical methods. AHPCs cultured in 
ITS+P+P-CM demonstrated significant upregulation of GFAP, whereas their counterparts cultured in 
ITS-CM did not demonstrate any upregulation of GFAP. This is in keeping with previous observations. 
Scale bar = 100μm. 
 
ITS+P+P- 
CM 
ITS-CM 
Paired sample 1 Paired sample 2 Paired sample 3 
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5.3.7 The biologically-independent paired (ITS/ITS+P+P) CM samples were 
concentrated and fractionated by 1D SDS PAGE in-house prior to shotgun 
proteomic analysis by NEPAF 
Following validation of the biological activity of the three biologically-independent 
paired (ITS/ITS+P+P) CM samples, in-house verification of sample integrity was 
achieved by concentration of each CM sample using a Vivaspin molecular weight cut-
off filter followed by fractionation using 1D SDS-PAGE, as described in Section 5.2.3. 
Each sample was equivalently loaded onto a 1D SDS-PAGE gel, followed by staining 
with three successive Coomassie R-250 solutions. The gel was subsequently stored in 
destaining solution prior to shotgun proteomic analysis by NEPAF. Fractionation of 
complex protein mixtures such as CM is crucial prior to mass spectrometric analysis in 
order to enhance the dynamic range of analysis and improve identification of low 
abundance proteins, which are likely to be representative of candidate factors in this 
study. Figure 5.14 shows the 1D SDS-PAGE gel of the paired samples, along with a 
table describing protein concentration data. 
 
Loading of the gel was organised to allow distinction between the three biologically-
independent paired samples, such that samples 1, 3 and 5 corresponded to biologically-
inactive ITS control cultures and samples 2, 4 and 6 corresponded to their equivalent 
biologically-active ITS+P+P cultures. There appeared to be a high degree of 
reproducibility between equivalent samples e.g. samples 1 vs. 3 vs. 5 and samples 2 vs. 
4 vs. 6 and, even at the paired level, there were no obvious distinctions between the 
samples e.g. samples 1 vs. 2, 3 vs. 4 and 5 vs. 6. Putative transferrin bands were much 
lower in the six samples than previously observed in N2-containing media, which 
would ultimately aid in unmasking some of the lower abundance factors in the 
complex protein mixture. 
 
5.3.8 Identification of proteins in CM using a shotgun proteomics approach based 
on LC-MS/MS, performed by NEPAF 
The three biologically-independent paired CM samples fractionated on the 1D SDS-
PAGE gel above were passed onto NEPAF for high-throughput shotgun proteomics 
analysis, based on LC-MS/MS. Detailed methods are described in the Materials and 
Methods section. Briefly, this involved an SDS-PAGE prefractionation prior to slicing 
each sample lane laterally into 8  equal sections. The gel region containing transferrin 
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and BSA bands (~60-80 kDa) were excluded from the analysis (with the presence of 
BSA being attributable to carry-over from serum-containing media). Each gel slice 
was prepared for protein digestion with trypsin and the subsequently extracted peptides 
from each gel slice were separately resolved using reversed phase nano-HPLC in-line 
with the MS. Eluted peptides were directly analysed by nanospray MS/MS (LTQ 
Orbitrap XL, ThermoScientific). Tandem MS allowed identification of the individual 
peptide fragments by searching MS/MS spectra against the international X!Tandem 
search engine. 
 
The raw data from these analyses generated an unmanageable number of hits – 2429 in 
total. However, a systematic approach was adopted in order to generate a more 
manageable list of putative candidate factors and this approach is shown 
diagrammatically in Figure 5.15. The original dataset contained considerable 
redundancy due to multiple peptides from the same protein being identified. Similarly, 
known media-based protein contaminants such as transferrin, albumin and keratin 
were also identified. Removal of redundancy/contaminants reduced the number of hits 
significantly, from 2429 to 621, though this was still an unmanageable dataset. 
Application of stringent selection criteria was then applied to reduce this dataset 
further. The criteria were as follows: 
 
a) Protein must be identified from at least two unique peptides 
b) Protein must be either exclusively detected or upregulated 2-fold or more in 
ITS+P+P-CM compared to ITS-CM, in at least 2 out of 3 pairwise samples 
c) Log(e) score (significance score) must be ≤-3 
 
Application of the above criteria narrowed down the number of hits from an 
unmanageable 621 to a more manageable 38 (Table 5.2). Detailed information 
regarding the reported function(s) of these 38 proteins offered further selection in 
terms of putative candidate factors responsible for exerting the astrogenic effect in 
AHPCs. A number of identified proteins are reported to be secreted soluble factors 
with roles in neural developmental processes, including gamma enolase (neuron 
specific enolase), glia-derived nexin precursor, calumenin precursor and cortistatin. 
Similarly, some intracellular proteins have been reported to undergo active secretion 
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from cells, including translationally controlled tumor protein (TCTP; or lens epithelial 
protein) and thioredoxin-dependent peroxide reductase (Söderberg et al., 2000; 
Amzallag et al., 2004). 
 
 
 
Figure 5.14. 1D SDS-PAGE gel showing the protein profile of conditioned media derived from 
MSCs cultured as aggregates in ITS- (samples 1, 3 and 5) and ITS+P+P- (samples 2, 4 and 6) 
containing CM. Conditioned media samples are organised such that samples 1 and 2, 3 and 4, 5 and 6 
are equivalent pairs seeded from the same batch of cells. Additionally, each pair are biologically 
independent of one another. 
Sample 
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Also of considerable interest is the large number of extracellular matrix 
proteins/proteins involved in extracellular matrix remodelling identified, including 
collagens, fibronectins and metalloproteinase inhibitor 2 (TIMP-2). Such molecules 
are reported to play crucial roles in neural developmental processes (Jaworski and 
Perez-Martinez, 2006; Li et al., 2009). The highly complex nature of neural 
differentiation means that the astrogenic effect observed in AHPCs is likely to result 
from interplay between several of these candidate factors as opposed to the effect(s) of 
a single factor. 
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Figure 5.15. Diagrammatic representation of the data processing strategy adopted. The original 
dataset contained considerable redundancy due to multiple peptides from the same proteins being 
identified. These was removed, along with any hits corresponding to known contaminants e.g. 
transferrin, albumin and keratin. Stringent selection criteria was applied to narrow down the dataset 
further still. Firstly, the protein had to be identified from (or by) at least 2 peptides. Then identified 
proteins had to be either a) detected exclusively in active sample or b) upregulated by at least 2-fold in 
at least 2 out of 3 pairwise active vs. control samples. A total number of 38 candidate factors adhered to 
this selection criteria. 
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Table 5.2 
Proteins exclusively detected or up-regulated by greater than 2-fold in at least 2 out of 3 pairwise active vs. control CM samples 
Information is provided in terms of ENSEMBL identifier; protein description; result reproducibility; gel slice in which protein was identified; number of peptides contributing 
to each identification; log(e) significance score; normalised abundance ratio in active vs. control CM samples, based on total number of peptides normalised for dataset 
size/protein molecular weight; estimated Mr based on gel slice in which protein was identified; calculated Mr based on database interrogation; and function of protein, based 
on database interrogation and literature searches. 
Ensembl database 
identifier Protein description 
Sample pairs in 
which elev/exclus in 
active sample 
Gel 
slice No. peptides 
Score 
log(e) 
Abundance ratio 
[active]/[cont] 
Mr gel 
(kDa) 
Mr 
calc 
(kDa) 
Function 
ENSRNOP00000001095 
 
Tubulin beta-5 chain 
 
2 3 5 -22 ndc 45-60 
 
49.6 
 
Microtubule protein, cytoskeleton 
 3 3 45 -199 2.21 
ENSRNOP00000001383 
 
Translationally-controlled tumor protein 
(Lens epithelial protein) 
2 5 7 -36.5 ndc 25-35 
 
19.4 
 
Putative roles in calcium binding and microtubule stabilization 
Neural differentiation of ESCs (PMID: 1804727) 3 5 4 -22 3.70 
ENSRNOP00000004091 
 Calreticulin precursor (CRP55) (Calregulin) 
2 3 12 -37.5 4.01 45-60 
 
48 
 
Calcium binding protein chaperone 
 1 3 12 -79.6 2.24 
ENSRNOP00000004520 
 
 
ARP3 actin-related protein 3 homolog 
 
 
2 3 6 -23.8 ndc 
45-60 
 
 
47.5 
 
 
Regulation of actin polymerization 
Filopodia formation, growth cone motility and neuritogenesis 
(PMCID: PMC2291425) 
Neuronal morphology and formation of neural networks 
(PMCID: PMC1852583) 
Development of dendritic spines and synapses (PMID: 
18430734) 
1 3 2 -14.8 2.62 
3 3 7 -35.4 2.15 
ENSRNOP00000005601 
 Gamma-enolase (Neuron-specific enolase) 
2 3 8 -19.7 ndc 45-60 
 
47.1 
 
Glycolytic enzyme with possible function as a neurotrophic 
factor 3 3 4 -23.8 ndc 
ENSRNOP00000005987 
 
Clathrin heavy chain 
 
2 1 6 -67.2 ndc 
150+ 
 
191.4 
 
Vesicle-mediated transport 
Neurotrophin signalling (PMID: 11007890) 
CNS regeneration and homeostasis (PMID: 17376807) 
Component of neuromuscular junctions (PMID: 15133132) 1 1 2 -11.3 2.62 
ENSRNOP00000006122 
 
Melanoma-associated antigen MG50 
(Fragment) 
1 1 3 -17.1 ndc 
150+ 
 
128.6 
 
Response to oxidative stress 
No specific information on MG50 in terms of neural activity. 
However, family members (i.e. members of the melanoma 
antigen family) are implicated in neural processes: Necdin – 
expressed predominantly in post-mitotic neurons, promotes 
neuronal differentiation and neuronal survival (PMID: 18753379) 2 1 7 -46 2.33 
ENSRNOP00000006322 
 
Tubulin alpha-1A chain (Tubulin alpha-1 
chain)  
1 3 9 -53.5 ndc 
45-60 
 
50 
 
Microtubule protein, cytoskeleton 
Expressed specifically in neurons (PMID: 7731546) 
Neuronal morphology (PMID: 7837290) 3 3 44 -168 2.03 
ENSRNOP00000006607 
 
Actin-related protein 2 
 
2 4 8 -47.5 ndc 
35-60 
 
44.7 
 
Regulation of actin polymerization 
 
Clathrin-mediated endocytosis (PMID: 15085951) 3 3 6 -44.8 5.55 
ENSRNOP00000007398 
 
Myosin-9 (Myosin heavy chain, non-
muscle IIa) 
3 2 13 -114 2.62 
75-150 
 
226.3 
 
Roles in cell-cell adhesion and cell morphogenesis during 
differentiation 
Light chain has been implicated in various processes such as 
astrocyte growth/migration, but no evidence to suggest that the 
heavy chain is involved (PMID: PMC2289411) 1 2 4 -35.1 2.62 
ENSRNOP00000008356 
 
Calumenin precursor (Crocalbin) 
 
2 4 14 -99.9 ndc 
35-60 
 
37 
 
Calcium binding which also binds crotoxin, a neurotoxic 
phospholipase A2  
Secreted by astrocytes (PMID: 19469553) 3 3 13 -81.8 3.00 
ENSRNOP00000010720 
 
Cullin-associated NEDD8-dissociated 
protein 1 
1 2 3 -18.2 ndc 75-150 
 
136.3 
 
Regulation of protein ubiquitination with role in cell 
differentiation 2 2 6 -44.7 ndc 
ENSRNOP00000011773 
 
Actin, alpha cardiac muscle 1 
 
2 4 39 -150 ndc 
35-60 
 
42 
 
Actin filament protein, cytoskeleton, role in cell motility 
Extensive component of neurites (PMID: PMC2110351) 
Neural differentiation processes such as neurite extension (PMID: 
15041197) 3 3 95 -229 2.28 
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ENSRNOP00000012334 
 
Collagen alpha-1(V) chain precursor 
 
3 1 5 -29.8 2.77 150+ 
 
184.8 
 
Fibril forming collagen, ECM 
1 1 3 -18.2 2.09 
ENSRNOP00000012796 
 
Filamin-B (Beta-filamin) 
 
2 1 23 -206 7.68 
150+ 
 
277.7 
 
Cytosketon organization, predominantly expressed in brain 
including SVZ and lateral ventricles 
Expressed in soma and leading process of migratory neurons 
(PMID: 12393796) 
Determines shape of neurons during migration and maintains 
polarity (PMID: 15509752) 1 1 10 -85.4 2.62 
ENSRNOP00000014859 
 
Protein Family: Importin subunit beta 3 
karyopherin beta 3 
2 2 2 -16.3 ndc 
75-150 
 
123.8 
 
Intracellular protein transport 
Important in trafficking various transcription factors to and from 
the nucleus, which is important in regulating neural 
differentiation (PMID: 17159997) 
Overexpression of importin 5 results in neural differentiation 
(Science 5 January 2007 315: 18-19) 
Increased expression observed with neural differentiation (PMID: 
17276333) 1 2 2 -8.6 2.62 
ENSRNOP00000015186 
 
Thioredoxin-dependent peroxide reductase, 
mitochondrial precursor 
2 5 2 -13.1 ndc 
25-35 
 
28.3 
 
Response to oxidative stress 
Neuroprotective against oxidative stress (PMID: 18262354) 
Involved in photoreceptor protection PMCID: (PMC2277329) 3 5 5 -33.1 4.62 
ENSRNOP00000015598 
 
Ras-related protein Rab-11A 
 
2 5 3 -28.7 ndc 25-35 
 
24.4 
 
Regulation of endosomal trafficking 
3 5 3 -14.7 ndc 
ENSRNOP00000015956 
 
Aspartate aminotransferase, mitochondrial 
precursor 
2 4 7 -53.7 ndc 
35-60 
 
47.3 
 
Amino acid metabolism and putative role in cellular uptake of 
long chain fatty acids 
Decreased aspartate aminotransferase activity in various brain 
regions associated with Huntington’s disease PMID: 2988404 
3 3 7 -53.5 2.15 
ENSRNOP00000018310 
 
Thioredoxin domain-containing protein 5 
precursor (ER protein ERp46) 
2 3 3 -22.8 ndc 45-60 
 
46.3 
 
Cell redox homeostasis 
1 3 2 -13 2.62 
ENSRNOP00000019152 
 
Fibronectin precursor  
 
1 1 81 -487 ndc 
150+ 
 
262.6 
 
ECM component implicated in regulation of cell adhesion and 
neurite outgrowth 
Fibronectin role in guidance of neurite outgrowth is a possible 
mechanism of MSC-mediated neurogenesis PMID: 19422806 2 1 148 -804 ndc 
ENSRNOP00000020919 
 
Glia derived nexin precursor (protease 
nexin 1, serpin E2) 
3 3 2 -14.5 ndc 
35-60 
 
44 
 
Cell differentiation, nervous system development, promotes 
neurite extension 
Known neurotrophin released by astrocyes PMID: 9160969 
 
PN-1 has an anti-apoptotic effect on cultured neuronal cells, and 
its expression is up-regulated in the brain by injury or ischemia 
 
The potential functions of PN-1 are proposed to be neurotrophic 
support and inhibition of cell death during brain injury or 
alteration of the blood-brain barrier 
 
For references see PMID: 16797167 2 4 3 -22.6 ndc 
ENSRNOP00000022007 
 
 
Col4a1 protein (Fragment) 
 
 
2 1 5 -40.3 ndc 150+ 
 
 
158.1 
 
 
Network forming collagen, ECM 
Mutations in Col4a associated with hereditary cerebrovascular 
disorders PMID: 19506372; 19477666 
3 1 2 -12.7 ndc 
1 1 2 -11.5 2.62 
ENSRNOP00000022401 
 
Talin1 protein 
 
2 1 17 -173 ndc 150+ 
 
270.9 
 
Actin binding, cytoskeleton 
1 1 5 -40.2 6.55 
ENSRNOP00000022983 
 
Serpin H1 precursor (Collagen-binding 
protein) 
1 3 33 -190 3.93 45-60 
 
46.5 
 
Collagen biosynthetic process 
 2 3 19 -76.4 3.17 
ENSRNOP00000024106 
 
Alpha-enolase (Non- neural enolase) 
 
2 3 36 -142 ndc 45-60 
 
47.1 
 
Multiple functions including glycolysis and growth control 
1 3 10 -88.2 2.62 
ENSRNOP00000024721 
 
Tropomyosin alpha-1 chain 
 
2 4 19 -126 ndc 
35-45 
 
32.5 
 
Actin filament-binding protein implicated in nervous system 
development 
Brain specific isoforms may play important roles in neurogenesis 
via interaction with actin filaments PMID: 2320008 3 4 39 -197 3.61 
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ENSRNOP00000025939 
 
Glutathione S-transferase Mu 2 
 
2 5 4 -28.5 ndc 
25-35 
 
25.7 
 
Role in olfactory processing 
Potential role in detoxification of neurotoxins PMID: 8090363, 
7566694 3 5 4 -17.5 ndc 
ENSRNOP00000026075 
 
Olfactomedin-like 3 
 
2 3 3 -6.8 ndc 
45-60 
 
45.9 
 
Unknown, found throughout mammalian brain 
Olfactomedin protein family implicated as important regulators 
of nervous system development  
 
For refs see PMID: 18037275 1 3 3 -9.5 1.96 
ENSRNOP00000026719 
 
Procollagen, type VI, alpha 3 
 
2 1 75 -642 ndc 150+ 
 
186.6 
 
Beaded filament-forming collagen, ECM 
1 1 37 -308 2.10 
ENSRNOP00000026794 
 Alpha glucosidase 2 alpha neutral subunit 
2 2 5 -43.7 ndc 75-150 
 
109.4 
 
Carbohydrate metabolism 
1 2 4 -23.2 5.24 
ENSRNOP00000032845 
 
 
Collagen alpha-1(II) chain precursor 
 
 
2 1 4 -19.2 ndc 150+ 
 
 
141.8 
 
 
Fibril-forming collagen, ECM 
3 1 4 -10.5 ndc 
1 1 2 -8 2.62 
ENSRNOP00000038110 
 
Cortistatin precursor 
 
2 3 10 -55.6 ndc 45-60 
 
117.2 
 
Neuropeptide, neuronal depressant properties 
For review see PMID: 17342027 1 3 5 -34.9 3.27 
ENSRNOP00000041462 
 
60S ribosomal protein L12 
 
3 5 2 -7.8 ndc 15-35 
 
17.8 
 
Protein synthesis 
2 6 5 -18.7 ndc 
ENSRNOP00000042384 
 
Metalloproteinase inhibitor 2 precursor 
(TIMP-2) 
2 5 4 -25.9 ndc 
25-35 
 
24.4 
 
Positive regulation of neuron differentiation 
Possible component of the neurogenic signaling cascade PMID: 
16805810 3 5 7 -25.9 ndc 
ENSRNOP00000044473 
 
Tropomyosin beta chain 
 
2 6 4 -15 ndc 
15-45 
 
32.9 
 
Actin filament-binding protein 
Brain specific isoforms may play important roles in neurogenesis 
via interaction with actin filaments PMID: 2320008 3 4 48 -189 3.70 
ENSRNOP00000053546 
 
Procollagen-lysine,2-oxoglutarate 5-
dioxygenase 2 precursor 
2 2 11 -89.1 ndc 75-150 
 
87 
 
Collagen stabilisation via lysine hydroxylation 
3 2 8 -53.8 ndc 
ENSRNOP00000057490 
 
Septin 6 
 
2 3 2 -8.5 ndc 45-60 
 
48.9 
 
Microtubule cytoskeleton organization and biogenesis 
3 3 8 -67.7 ndc 
ndc = not detected in corresponding control; Pair 1: lane 1 (control) vs lane 2 (active); Pair 2: lane 3 (control) vs lane 4 (active); Pair 3: lane 5 (control) vs lane 6 (active). Log(e) is the score for each identification i.e. gives an indication of how significant the hit is (a bit like BLAST) – ignore 
hits below the -3.0 cut off in the initial analysis. A = active; C = control.
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5.4 Discussion 
Stem cells as trophic mediators of differentiation 
Stem cells are typically characterised at the functional level in terms of their potential 
to differentiate into a range of mature cell types. However, it is now largely 
acknowledged that, in addition to this differentiative function, many stem cell types 
also function as trophic mediators of differentiation, whereby they express and secrete 
a range of soluble factors and/or cytokines that are able to influence the proliferation 
and/or differentiation of other cells within their niche. This phenomenon has been 
described for both embryonic and adult stem cell types and is particularly relevant 
regarding MSCs, where their trophic role in the regulation of haematopoiesis has been 
documented for many years (Haynesworth et al., 1996; Lu et al., 2003, Guo et al., 
2006; Cabanes et al., 2007). Furthermore, earlier studies in this investigation have 
demonstrated that MSCs are able to regulate osteogenic and adipogenic differentiation 
via autocrine mechanisms, involving increased expression of osteogenic- and 
adipogenic-promoting factors concomitant with decreased expression of inhibitory 
factors (Chapter 3) and, similarly, are able to regulate neural differentiation via 
paracrine mechanisms (Chapter 4). The aim of this chapter is to examine the paracrine 
effects of MSC-derived aggregates on neural differentiation in further detail, by 
scrutinising the MSC aggregate-derived secretome using a combination of targeted 
transcriptional profiling and shotgun proteomics. 
 
Analysis of the protein complement of MSC conditioned medium 
Although several studies have demonstrated that MSCs are able to function as 
paracrine mediators of neural differentiation, using CM assays similar to those used in 
this study, significant advancements in this field have been hindered due to technical 
difficulties in analysing the highly complex MSC secretome. Rivera and colleagues 
adopted a random screening approach using recombinant proteins and blocking 
antibodies targeted against various soluble factors and cytokines, based on current 
knowledge in the literature, in order to ascertain whether the oligodendrogenic effect 
observed following culture with CM could be reproduced (Rivera et al., 2006). No 
reproducibility was observed. Wislet-Gendebien and colleagues, on the other hand, 
used targeted expression profiling using qRT-PCR and Western blotting in order to 
ascertain whether any astrocytic-promoting factors were upregulated in MSCs (Wislet-
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Gendebien et al., 2004). Secretion of the biologically-active form of BMP4 was 
detected in CM and addition of blocking antibodies directed against BMP4 into CM 
resulted in abolishment of the astrocytic effect, albeit not completely, suggesting that 
BMP4 may at least partially be responsible for the astrogenic effect observed in this 
study. 
 
Transcriptional profiling of astrocytic-promoting and astrocytic-inhibitory factors 
In the present study, a combinatorial approach involving targeted transcriptional 
profiling (qRT-PCR) and shotgun proteomics was adopted in order to scrutinise the 
MSC aggregate-derived secretome in detail. The astrogenic effect observed in AHPCs 
and subject to characterisation in Chapter 4 was a direct consequence of the biological 
activity of aggregate-derived soluble factors/cytokines present in the CM, by virtue of 
the nature of CM assays. Therefore, as a convenient starting point, expression of a 
range of astrocytic-promoting and astrocytic-inhibitory soluble factors were examined 
at the mRNA level, using qRT-PCR, in MSCs cultured under standard conditions and 
as aggregates under both physiological and atmospheric oxygen tensions, where it is 
anticipated that aggregates will demonstrate an upregulation in expression of a number 
of positive regulatory factors concomitant with downregulation of a number of 
negative regulatory factors. Specific soluble factors were selected based on current 
knowledge within the literature. The influence of oxygen tension on the transcriptional 
activity of MSC-derived aggregates was also examined here in order to corroborate 
previous findings in this study regarding the enhanced viability and functionality of 
aggregates cultured under physiological compared to atmospheric oxygen tensions 
(Chapter 4). One possibility to account for these observed functional differences was 
that aggregates cultured under varying oxygen tensions demonstrated different 
behaviour at the secretory level, in keeping with previously published studies 
(Aleyassine, 1970; Koos, 1986; Dionne et al., 1989; Ohta et al., 1990; Raff et al., 
1990; Dionne et al., 1993; Papas et al., 1996; Zhao et al., 2009). It must be 
remembered that mRNA levels are not always indicative of actual protein levels and 
give no information as to whether the protein is actually secreted; however, mRNA 
studies are advantageous in that they provide a rapid and easy method in which to 
screen expression of many factors. Furthermore, changes at the transcriptional level 
are useful in themselves as indicators of cellular activity. 
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MSCs cultured under standard conditions and as aggregates under physiological and 
atmospheric oxygen tensions demonstrated markedly different expression profiles of a 
number of soluble factors at the mRNA level. LIF, NGF and GDNF were all 
upregulated in MSCs cultured as aggregates under physiological oxygen tension 
compared to those cultured under standard conditions and these observations were 
highly significant at the statistical level. The astrogenic role of LIF has been highly 
documented in the literature (Guillemot, 2007). LIF belongs to the gp130 (IL-6) family 
of cytokines and plays a key role in astrogenesis owing to its intrinsic ability to 
activate the JAK-STAT signalling pathway, one of the highly conserved signalling 
pathways implicated in astrogenesis (Bonni et al., 1997; Rajan and McKay, 1998; He 
et al., 2005; Guillemot, 2007). AHPCs cultured in aggregate-derived CM previously 
demonstrated significant upregulation of STAT1 and STAT3, downstream effectors of 
JAK-STAT signalling, strongly suggesting that JAK-STAT signalling was one of the 
predominant mechanisms causing astrogenesis in the AHPC system (Chapter 4). 
Therefore, increased expression/secretion of LIF by MSC-derived aggregates would be 
in keeping with activation of JAK-STAT signalling in AHPCs.  
 
GDNF has been highly implicated in neuronal differentiation processes (Roussa and 
Krieglstein, 2004; Sun et al., 2004; Huang et al., 2005; Pozas and Ibanez, 2005; 
Murata et al., 2008; Wissel et al., 2008). However, it has yet to be documented as an 
astrocytic-promoting factor. Although it cannot be ruled out that GDNF is directly 
contributing to the astrocytic effect observed in the AHPC system in this thesis, it is 
unlikely. A more realistic possibility is that GDNF is making an indirect contribution 
to astrogenesis by inducing expression of LIF. One study examining GDNF-mediated 
neuronal differentiation in MPC cells observed that GDNF induced expression of LIF 
in these cells via activation of the MEK/ERK pathway, resulting in autocrine 
regulation of neuronal differentiation in these cultures (Park et al., 2004). Although the 
differentiative effect reported in this study is different to that in the present study 
(neuronal as opposed to astrocytic differentiation) it is a possibility that cell-type 
specific action of LIF prevented activation of JAK-STAT signalling in MPC cells (an 
observation reported in the study) explaining why neuronal differentiation was 
observed at the expense of astrocytic differentiation. 
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Similarly to GDNF, NGF has been highly implicated in neuronal differentiation 
processes but has yet to be documented as an astrocytic-promoting factor (Klesse et 
al., 1999; Stipic et al., 2001; Lee et al., 2005). Of particular interest to this 
investigation, however, is the reported role of NGF in promotion of apoptosis in 
oligodendrocytes via activation of caspases 1, 2 and 3 (Casaccia-Bonnefil et al., 1996; 
Chenghua et al., 1999). Analysis of cell death in AHPCs cultured with CM revealed 
the activation of apoptotic pathways specifically in the GalC
+
 subpopulation (using 
expression of cleaved caspase 3 as an indicator of apoptosis); therefore, the association 
of NGF with apoptosis in oligodendrocytes concomitant with its increased expression 
in MSC-derived aggregates suggests that NGF may be mediating apoptosis in the 
GalC
+
 subpopulation. However, this hypothesis is somewhat controversial as NGF has 
paradoxically been reported to protect oligodendrocytes from TNF-α-mediated 
apoptosis (Takano et al., 2000). 
 
In addition to significant upregulation of LIF, NGF and GDNF as discussed above, 
MSCs cultured as aggregates under physiological oxygen tension also demonstrated 
significant downregulation of a large subset of factors examined, including BMP4, 
BMP7, CNTF, IL-6, VEGF, Activin-A, TGF-β1, IGF-1 and TNF-α. These 
observations were highly significant at the statistical level. Of this subset, it is the 
downregulation of both BMP4 and BMP7 that is perhaps the most interesting, as both 
molecules have been reported to be potent inducers of astrogenesis (Gross et al., 1996; 
Nakashima et al., 2001; Guillemot, 2007; Imura et al., 2008). This astrogenic effect is 
reported to be particularly pronounced in older neuroprogenitor cultures (>E14) such 
as the AHPC system used in this study, wherein BMP4 promotes astrogenesis at the 
expense of neurogenesis/oligodendrogenesis (Gross et al., 1996; Nakashima et al., 
2001). This is in keeping with neural development in vivo, where neurogenesis is 
primarily associated with the embryonic period and gliogenesis is primarily associated 
with the postnatal period (Jacobsen, 1991). Furthermore, Imura and colleagues observe 
BMP7 production by endothelial cells in vivo, promoting astrogenesis in postnatal 
cortical progenitors; this effect was inhibited following the introduction of BMP 
antagonists into this system (Imura et al., 2008). However, several studies have 
reported that BMPs can also function as potent inducers of neuronal differentiation (Li 
et al., 1998; Mabie et al., 1999; Lopez-Coviella et al., 2000). A particularly interesting 
study by Chang and colleagues adopted a conditioned media approach in order to 
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investigate the effect(s) of both neuron- and astrocyte-derived soluble factors on neural 
differentiation (Chang et al., 2008). Their study demonstrated that BMPs secreted by 
neurons induced neuronal differentiation whereas BMPs secreted by astrocytes 
induced astrocytic differentiation of cortical stem cells. Although this effect was 
concentration-dependent, with neurons secreting lower levels of BMPs than astrocytes, 
Chang and colleagues also demonstrated a context-dependent effect in that BMP 
combined with other neurogenic molecules promoted neuronal differentiation 
regardless of concentration. This study highlights the fundamental principle that the 
biological activity of soluble factors is highly dependent upon context and is very often 
system-specific. Downregulation of BMP4 and BMP7 expression in MSC-derived 
aggregates suggests that their astrogenic role in the AHPC system is secondary to the 
combined effects of LIF, GDNF and NGF. Although Smad1 and Smad4 – effectors of 
BMP signalling – are upregulated in AHPCs following culture in CM (Chapter 4), this 
effect could be attributable to extensive crosstalk between signalling pathways as BMP 
signalling is reported to be strongly enhanced by JAK-STAT signalling (Guillemot, 
2007). Similarly, significantly reduced expression of Ngn1 in AHPCs following 
culture in CM (Chapter 4) could permit low concentrations of BMPs to be biologically 
effective, as high levels of Ngn1 repress the astrogenic effect of BMPs (Sun et al., 
2001). 
 
MSCs cultured as aggregates under physiological oxygen tension also demonstrated 
significant downregulation of IL6 and CNTF, both members of the conserved IL6 
(gp130) family of cytokines, which are reported to be potent inducers of JAK-STAT 
signalling, one of the main mechanisms promoting astrogenesis (Johe et al., 1996; 
Bonni et al., 1997; Rajan and McKay, 1998). Astrocytes have even been reported to 
regulate their own differentiation via an autocrine mechanism involving the production 
and secretion of CNTF (Chang et al., 2003). Similarly to BMPs, downregulation of 
IL6 and CNTF expression in MSC-derived aggregates suggests that their astrogenic 
role in the AHPC system is secondary to the combined effects of LIF, GDNF and 
NGF. The fundamental principle recurring in this discussion is that the biological 
effect of soluble factor activity is highly context-dependent and this is likely to be the 
case here. As discussed previously, neural development in vivo is characterised 
predominantly by neurogenesis in the embryonic stage of development followed by a 
switch to gliogenesis in the postnatal stage; the precise mechanism controlling this 
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transition is largely unknown, though it is considered to be highly regulated by both 
intrinsic and extrinsic signals (Jacobsen, 1991; Temple, 2001). Barnabe-Heider and 
colleagues report that IL6 (gp130)-related cytokines such as CNTF are expressed by 
neurons and may therefore form a negative feedback mechanism whereby newborn 
neurons promote the neurogenesis-astrogenesis transition (Barnabe-Heider et al., 
2005). Therefore, it could be that IL6 and CNTF are more important in the early 
transition from neurogenesis to astrogenesis rather than promotion of astrogenesis in 
later developmental stages. Activin-A and TGF-β1, both members of the TGF-β 
superfamily of cytokines, are downregulated in MSCs cultured as aggregates under 
physiological oxygen tensions. Such observations are consistent with what would be 
predicted based on current knowledge within the literature, as activin-A is implicated 
in the promotion of neurogenesis rather than astrogenesis and TGF-β1 is largely 
reported to function as a neuroprotective factor (Henrich-Noack et al., 1996; Zhu et 
al., 2001; Abdipranoto-Cowley et al., 2009). Likewise, downregulation of IGF-1 could 
be anticipated based on current knowledge within the literature, as IGF-1 is reported to 
be a potent inducer of oligodendrogenesis in adult neuroprogenitor cells and O2A 
bitpotent precursor cells (Kuhl et al., 2002; Kuhl et al., 2003; Hsieh et al., 2004; 
Rivera et al., 2006). Mature oligodendrocytes have been reported to provide trophic 
support to cortical neurons, an effect mediated predominantly by the production and 
secretion of IGF-1 (Wilkins et al., 2001). There is currently no evidence to suggest that 
IGF-1 plays any role in astrogenesis or survival of mature astrocytes. Finally, although 
one study reported that TNF-α had the potential to induce astrogenesis in neural stem 
cells in response to injury, it was observed that this astrogenic effect was not 
attributable to TNF-α alone; rather, TNF-α in combination with two other cytokines, 
IL-1β and IFN-γ (Ricci-Vitiani et al., 2006). 
 
Effect of oxygen tension on expression of astrocytic-promoting and astrocytic-
inhibitory factors 
As discussed above, MSCs cultured under standard conditions and as aggregates under 
physiological oxygen tension demonstrated significantly different transcriptional 
profiles for astrocytic-promoting and astrocytic-inhibitory soluble factors, which could 
account (at least in part) for the astrogenic effect of MSC aggregate-derived CM. 
Previous studies described herein also demonstrated that oxygen tension is a crucial 
parameter to consider when culturing MSC-derived aggregates, with aggregates 
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cultured under physiological oxygen tension demonstrating enhanced viability and 
secretory activity compared to aggregates cultured under atmospheric oxygen tension 
(Chapter 4). Therefore, in order to ascertain whether changes at the transcriptional 
level were responsible for the observed differences in secretory behaviour, 
transcriptional profiling was also performed for MSCs cultured as aggregates under 
atmospheric oxygen tension, allowing a direct comparison of the expression profiles of 
aggregates cultured under both physiological and atmospheric oxygen tensions. 
Although the overall expression profiles did not demonstrate any particularly obvious 
differences at the graphical level, statistical analysis revealed that aggregates cultured 
under atmospheric oxygen tensions expressed significantly lower levels of BMP4, LIF, 
NGF, EGF, neuregulin, cystatin C, FGF2, GDNF and TNF-α, compared to aggregates 
cultured under physiological oxygen tensions. Although a subset of these soluble 
factors are expressed at low levels in aggregates cultured under physiological oxygen 
tension, they may be sufficient to exert a biological effect; decreased levels in 
aggregates cultured under atmospheric oxygen tension, conversely, may fall below a 
certain threshold required for biological activity. Thus, differences in expression of 
soluble factors/cytokines concomitant with differences in proliferation/viability are 
likely to account for the observed differences in secretory behaviour of MSCs cultured 
as aggregates under physiological and atmospheric oxygen tensions. The secretory 
activity of a range of cell types is reported to be significantly influenced by oxygen 
tension (Aleyassine, 1970; Koos, 1986; Dionne et al., 1989; Ohta et al., 1990; Raff et 
al., 1990; Dionne et al., 1993; Papas et al., 1996; Zhao et al., 2009). 
 
Limitations of targeted transcriptional profiling 
Targeted transcriptional profiling of MSCs cultured under standard conditions and as 
aggregates under physiological/atmospheric oxygen tensions revealed unique 
expression profiles for several genes encoding potentially-relevant soluble 
factors/cytokines which could account, at least in part, for the observed astrogenic 
effect of MSC aggregate-derived CM. Although targeted transcriptional profiling was 
a convenient starting point in the first instance and generated an interesting dataset, 
this approach was disadvantageous due to its reductionist nature in that the dataset was 
restricted to the subset of genes selected for investigation based on current knowledge 
within the literature. A more holistic, unbiased approach would involve global analysis 
of the complete collection of mRNAs (representing the combined outputs of 
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transcription, RNA processing and RNA turnover) in MSCs cultured under the various 
conditions, in order to define the genes which are upregulated/downregulated in 
aggregates versus standard cultures. This is known as whole transcriptome analysis 
and could easily be achieved using a DNA microarray-based approach and the total 
RNA isolated and used for the targeted transcriptional profiling experiments detailed 
above. 
 
However, despite the obvious advantages of DNA microarray-based technologies and 
whole transcriptome analysis, such an approach would be somewhat unsuitable for the 
purposes of the biological issue being addressed by this study i.e. identification of the 
biologically-active soluble factors/cytokines secreted by MSC-derived aggregates, as 
whole transcriptome analysis would yield a massive dataset ascertaining to every 
single gene whose expression profile is altered, the large majority of which are likely 
to be highly irrelevant to the biological issue being addressed. Indeed, altering the 
culture conditions of MSCs from standard (10% serum, atmospheric oxygen tension) 
to aggregate-inducing (N2 supplement, physiological oxygen tension) conditions is 
likely to promote a huge number of transcriptional changes, consequences of altered 
cell-cell interactions, varying media constituents and varying oxygen tension, all of 
which have been reported to significantly affect gene expression in various systems 
(Kanoh et al., 1991; Weaver et al., 1997; Wang et al., 1998; Bacon et al., 2003; 
Rinaudo et al., 2003; Harvey et al., 2004; Csete, 2005; Schofield and Radcliffe, 2005; 
Sullivan et al., 2006). Additionally, although many of the identified genes will be 
highly characterised, some may be orphan genes to which no biological function has 
been assigned; such genes would therefore be missed due to a lack of current 
knowledge. A final consideration is the often poor correlation between mRNA levels 
and protein levels concomitant with extensive post-translational modification of 
proteins (Abbott, 1999). Direct analysis of protein complement rather than RNA is 
therefore more likely to be representative of the biological situation. 
 
Shotgun proteomic analysis using LC-MS/MS to identify secreted factors 
Accordingly, the MSC aggregate-derived secretome was further scrutinised in this 
study using a shotgun proteomic-based approach in order to indiscriminately examine 
the protein complement of MSC aggregate-derived CM. This approach is immediately 
advantageous over transcriptional profiling in that it is performed directly on the CM, 
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in contrast to transcriptional profiling, which is performed at the cellular level; as such, 
any data generated by the shotgun proteomic approach is more specific than 
transcriptional profiling, with all identified proteins immediately presenting as 
candidate factors. As proteomic-based technologies become more accessible and 
routinely available to the everyday cell biology laboratory, the number of studies 
adopting a proteomic-based approach to CM analysis are increasing, using methods 
ranging from basic 1D SDS-PAGE to more sophisticated mass spectrometric-based 
techniques (Prowse et al., 2005; Volmer et al., 2005; Chiellini et al., 2008; Kang et al., 
2008; Sardana et al., 2008; Bendall et al., 2009). In particular, there appears to be 
significant interest in scrutinising the protein complement of CM produced by cancer 
cell lines, as novel proteins secreted from cancer cells present as potential biomarkers 
of the disease, which would be invaluable from a clinical/diagnostic perspective 
(Sardana et al., 2007; Gunawardana et al., 2009; Srisomsap et al., 2010). 
 
High transferrin levels in N2 supplement are problematic during proteomic analysis 
In terms of the proteomic analysis of MSC aggregate-derived CM, an unanticipated 
problem manifested during an initial 1D SDS-PAGE screen using concentrated CM 
samples, with all profiles being dominated by a heavy, single band located in the 59-
109 kDa range of the gel. Further analysis revealed that this band was due to high 
levels of transferrin, a key component of N2 supplement used in the serum-free culture 
of these cells. It has been well documented that high abundance serum proteins such as 
albumin, transferrin and IgG are highly problematic for proteomic analysis due to their 
masking effect over truly-secreted proteins, which are typically present at much lower 
concentrations (Lim and Bodnar, 2002; Xue et al., 2008). However, contaminating 
media constituents were not anticipated to be a problem for proteomic analysis of the 
cultures used in this study as the protocol for aggregate formation stipulated that MSCs 
be seeded out in serum-free conditions in the presence of EGF and FGF (Hermann et 
al., 2004; Hermann et al., 2006). Similarly, MSCs were washed thoroughly in PBS 
prior to seeding out for aggregate formation in order to remove high abundance serum 
proteins as far as reasonably possible and without compromising cellular integrity. 
Although the observed levels of transferrin were lower than would be expected 
following culture under standard conditions (10% serum), they were still sufficient to 
mask lower abundance proteins of interest. There were two possible solutions: 
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a) Increase the number of sample preparation steps to include a transferrin-
immunodepletion step; may result in loss of low abundant proteins of 
interest due to non-specific binding to transferrin/antibody.  
b) Use an alternative cell culture supplement that contains a lower 
concentration of transferrin. 
 
A transferrin-immunodepletion strategy would be highly advantageous in that it would 
not require any significant alterations to the current experimental setup; however, the 
latter strategy involving the use of an alternative cell culture supplement was adopted 
in this study due to the high possibility of losing candidate soluble factors/cytokines 
through non-specific protein/antibody interactions. ITS supplement, a serum-free 
media supplement commercially available from Sigma-Aldrich, presented as the most 
promising alternative to N2 supplement, containing approximately 20-fold lower levels 
of transferrin (Table 5.1). Indeed, the intensity of the transferrin band was significantly 
reduced following 1D SDS-PAGE analysis of ITS-containing CM, strongly suggesting 
that ITS-containing CM would be far more amenable to proteomic analysis than its 
N2-containing counterpart. However, a further unanticipated problem was encountered 
during the biological validation of ITS-containing CM, in that the well-characterised 
astrogenic effect of N2-containing media could not be reproduced in AHPCs, either at 
the morphological level or in terms of GFAP expression, following culture under 
analogous conditions. As the only difference between the two experimental setups was 
in terms of the basic compositions of N2 and ITS supplements, it was therefore 
reasonable to assume that a component unique to N2 and lacking in ITS supplement 
was essential during the conditioning process. In keeping with this, the original study 
describing the production and characterisation of N2 supplement, using the rat 
neuroblastoma B104 cell line as a model system, made two key observations 
(Bottenstein and Sato, 1979): 
 
 The absence of any component of N2 supplement resulted in sub-
optimal cell growth. 
 Transferrin was the most stringently-required component of N2 
supplement. 
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These two key observations suggested that either a) an absence of progesterone and 
putrescine or b) significantly reduced levels of transferrin, in ITS supplement were 
responsible for abolishing the astrogenic effect in AHPCs following 7 days culture 
with ITS-containing CM. Either scenario is as likely as the other, as all three molecules 
have been demonstrated to be essential for viable cell growth/proliferation in culture; 
progesterone and putrescine have been demonstrated to be essential for cell 
proliferation, whilst transferrin has been demonstrated to be essential for sustaining 
cell division in a range of cell types (Herbst and Snell, 1949; Ham, 1964; Pohjanpelto 
and Raina, 1972; Mather and Sato, 1977). An additional consideration is that ITS 
supplement may not be suitable for longer-term cultures due to its very simple 
composition; a review of the current literature reveals that ITS supplement is 
predominantly used to generate CM samples that are highly amenable to proteomic 
analysis and, in the majority of such studies, cells are cultured in ITS-containing 
medium for less than 24 hours (Lim et al., 2002; Volmer et al., 2005). Furthermore, 
the manufacturer’s instructions even recommend the addition of 2% serum to ITS-
containing medium for optimal cell culture conditions (www.sigma-aldrich.com).  
 
In order to investigate the importance of the individual components of N2 supplement 
and their influence on the secretory activity of MSC-derived aggregates, equivalent 
cultures were set up such that MSCs were seeded out for aggregate formation in ITS-
containing media in combination with various other additives, based on the published 
formulation of N2 supplement (Table 5.1) and allowed to condition the media 
accordingly. Interestingly, aggregates cultured in ITS-containing media supplemented 
with progesterone and putrescine (ITS+P+P) demonstrated paracrine behaviour 
analogous to that observed following culture in N2-containing media, such that 
AHPCs significantly upregulated GFAP expression following 7 days culture in the 
equivalent CM. Therefore, ITS+P+P-CM provides an ideal system in which to 
scrutinise the MSC aggregate-derived secretome, for a number of reasons: 
 
a) Levels of transferrin in ITS+P+P-CM are significantly lower than levels 
observed in N2-containing CM. 
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b) Astrogenic effect observed in AHPCs following culture in N2-containing 
CM is easily reproduced by additional supplementation of ITS-containing 
media with progesterone and putrescine. 
c) Progesterone and putrescine are unlikely to complicate proteomic analysis, 
as both are non-proteins (progesterone is a steroid hormone, putrescine is a 
diamine). 
d) Lack of biological activity of the original ITS-CM sample means that this 
can be used as a suitable control against which to compare ITS+P+P-CM 
(provides a basis for distinction between non-specific aggregate-derived 
proteins and biologically-active proteins responsible for inducing an 
astrogenic effect in AHPCs) 
 
38 putative candidate factors were identified by proteomic analysis 
Following the optimisation of aggregate culture conditions to produce CM samples 
more amenable to proteomic analysis, the final aim of this study was to scrutinise the 
aggregate-derived secretome using a shotgun proteomic-based approach in order to 
indiscriminately examine the protein complement of aggregate-derived CM and 
identify the biologically active soluble factor(s)/cytokine(s) responsible for the 
observed astrogenic effect in AHPCs. The secretome of aggregates cultured in 
ITS+P+P media (biologically active) and that of ITS media (biologically inactive) 
were examined as three biologically-independent paired samples using LC-MS/MS. 
The raw data from these analyses generated an unmanageable number of hits – 2429 in 
total – though removal of redundancy/known media contaminants and application of 
stringent selection criteria (as detailed in Section 5.2.7) helped to narrow the dataset 
down to a more manageable number of hits corresponding to those proteins 
significantly upregulated/found exclusively in ITS+P+P-CM – 38 in total (Table 5.2). 
These proteins therefore present as candidate factors. 
 
The 38 proteins demonstrated to be significantly upregulated/exclusively detected in 
biologically-active ITS+P+P-CM were organised into five broad categories 
accordingly to their reported function and/or subcellular localisation – extracellular 
matrix, metabolic proteins, cytoskeletal components, chaperones/heat shock proteins 
and soluble factors/classically secreted proteins – and the distribution of the 38 
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proteins within these categories is shown diagrammatically in Figure 5.16. These 
categories and the distribution of proteins within them demonstrate the considerable 
functional diversity of the MSC aggregate-derived secretome. Interestingly, 
cytoskeletal proteins such as actin, tubulin and filamin were the most abundantly-
represented category, accounting for 32% of total protein. This, combined with the 
high representation of metabolic proteins (23%), suggested that over half of the total 
protein complement upregulated/exclusively detected in ITS+P+P-CM was 
intracellular in origin. Although such high levels of intracellular protein in CM may 
seem somewhat paradoxical, this phenomenon is not uncommon and is frequently 
observed in proteomic-based CM studies. For example, Moore and colleagues reported 
that 36% of proteins secreted by astrocytes in culture were intracellular in origin, 
whilst a similar study by Lafon-Cazal and colleagues reported a figure of 58% (Lafon-
Cazal et al., 2003; Moore et al., 2009). Even more extreme figures are reported in CM 
studies using cancer cell lines; Kulasingam and Diamandis reported that only 34% of 
the secretome of a breast cancer cell line corresponded to bona fide 
extracellular/membranous proteins, whilst an even lower figure of 23% was reported 
by Sardana and colleagues following proteomic analysis of a prostate cell line 
(Kulasingam and Diamandis, 2007; Sardana et al., 2007).  
Distribution of protein types
Extracellular matrix
Metabolic
Cytoskeletal
Heat shock 
proteins/chaperones
Soluble 
factors/miscellaneous 
secreted proteins
 
Figure 5.16. Summary of the protein distribution and functional classifications of the 38 candidate 
proteins identified in MSC aggregate-derived conditioned media using a shotgun proteomics 
approach. For the purposes of discussion, the candidate factors identified in MSC aggregate-derived 
CM using proteomics were classified into five broad categories in keeping with their distribution and 
reported functions. Classification of certain candidates into a single category was often difficult due to 
considerable overlap between the categories and multifunctionality of many of the candidate factors.  
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One possible reason to account for the high detection rate of intracellular proteins in 
CM samples is cell lysis secondary to cell death and subsequent release of intracellular 
contents into the media (Xue et al., 2008). Cell culture in serum-free conditions, as is 
routinely performed to generate CM samples amenable to proteomic analysis, is 
characterised by particularly high levels of cell death and autolysis, with several 
independent studies reporting an optimal conditioning time of between 18-24 hours, 
after which extensive contamination with intracellular proteins is observed (Mauri et 
al., 2005; Mbeunkui et al., 2006). As the protocol adopted throughout this 
investigation utilised a conditioning time of three days, it could be anticipated that the 
high levels of intracellular proteins detected in CM were attributable to extensive cell 
death/autolysis during the conditioning period; however, no significant evidence of 
this was apparent during routine observation of cultures. Furthermore, as knowledge 
continues to improve regarding the intricate processes and pathways involved in cell 
secretion, the definition of the term secretome will have to evolve accordingly, as the 
contribution of proteins released through non-classical (endoplasmic reticulum/Golgi-
independent) secretory pathways and the secretion of exosomes are largely overlooked 
in favour of proteins secreted by classical secretory pathways e.g. growth factors, 
cytokines and extracellular matrix (Volmer et al., 2005). In particular, there is 
increasing interest in the biological role(s) of exosomes, membranous vesicles of 
approximately 40-100nm diameter which are generated within the endosomal system 
and released by most cell types following fusion of multivesicular bodies with the 
plasma membrane (Johnstone, 2006; Simons and Raposo, 2009; Simpson et al., 2009). 
Exosomes have a plethora of known biological functions, including immune response, 
antigen presentation and intra-/inter-cellular communication. Proteomic methods have 
been employed in several studies in order to scrutinise the protein composition of 
exosomes and a variety of protein types have been detected, including metabolic 
enzymes, cytoskeletal proteins, elongation factors and chaperones, with exact protein 
compositions being largely representative of host cell origin (Thery et al., 2001; van 
Niel et al., 2001; Pisitkun et al., 2004; Volmer et al., 2005; Simons and Raposo, 2009; 
Simpson et al., 2009).  
 
Additionally, it is often difficult to assign each of the 38 candidate factors to a single 
category based on their reported biological function(s)/subcellular localisation(s), as 
the functional diversity of many of the factors is such that they could be assigned to 
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multiple categories. For example, metabolic enzymes were considered to be of 
intracellular origin for the purposes of the preceding discussion. Although this is an 
accurate statement, there have been several reports of metabolic enzymes such as 
thioredoxin proteins undergoing active secretion from a range of different cell types 
(Rubartelli et al., 1993; Rubartelli et al., 1995; Bäckman et al., 2007). Further 
intracellular proteins identified as candidate factors in this study have been reported to 
be actively secreted from different cell types, including translationally controlled 
tumor protein (TCTP; or lens epithelial protein) and thioredoxin-dependent peroxide 
reductase (Söderberg et al., 2000; Amzallag et al., 2004). 
 
Therefore, one of the fundamental limitations of CM studies using proteomic-based 
techniques such as those employed in this thesis is the inherent inability to distinguish 
between truly-secreted proteins and artifactual products of cell culture. As such, a 
significant contribution of non-classical/exosome secretion cannot be discounted as 
attributing towards the high representation of intracellular cytoskeletal and metabolic 
proteins identified in this study. Numerous reports of intracellular proteins undergoing 
active secretion from cells further blurs this distinction. Therefore, the intracellular 
proteins identified in this study must be considered as putatively-secreted. 
 
However, due to the lack of data regarding the secretion of intracellular cytoskeletal 
and metabolic proteins in the CM system used in this study, the remainder of this 
discussion will focus on the more classically-secreted proteins and extracellular matrix 
proteins identified, accounting for 24% and 18% of the total complement of candidate 
factors respective, as both have been reported to significantly contribute towards the 
beneficial effects of MSC-mediated paracrine activity in the nervous system (Tremain 
et al., 2001; Chen et al., 2002; Wislet-Gendebien et al., 2004; Chen and Chopp, 2006; 
Crigler et al., 2006; Rivera et al., 2006; Chen et al., 2007; Schinkothe et al., 2008).  
 
TIMP2 
A comprehensive review of the current literature combined with gene ontology 
analysis identified a number of particularly strong candidates from within this group 
that presented as potentially-important determinants of the astrogenic effect in AHPCs. 
Of these, TIMP2 (metalloproteinase inhibitor 2) presented as a particularly strong 
candidate owing to its previously recognised role as a component of neurogenic 
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signalling pathways controlling the transition of neuroprogenitors from immature, 
proliferative entities to mature, terminally-differentiated neural cell types (Jaworski 
and Perez-Martınez, 2006). TIMP2 is one of four members of the highly conserved 
TIMP protein family – tissue inhibitor of metalloproteinases – a group of proteins of 
approximately 20-30kDa which function predominantly as natural inhibitors of matrix 
metalloproteinases (MMPs) which, in turn, are a group of endopeptidases involved in 
remodelling/degradation of the extracellular matrix. Expression profiling of TIMP2 
reveals specificity to neurons and astrocytes throughout the adult nervous system, 
strongly suggesting a functional role for TIMP2 in neural development and/or 
maintenance of neural integrity (Fager and Jaworski, 2000; Crocker et al., 2004). In 
their interesting and detailed study, Jaworski and Perez-Martinez observed significant 
upregulation of TIMP2 in four neural cell lines – PC12, Neuro-2a, N1E-115 and P19 – 
following induction of neuronal differentiation in these cultures, strongly suggesting a 
role for TIMP2 in the differentiative process (Jaworski and Perez-Martinez, 2006). The 
direct influence of TIMP2 was observed to be mediated by interactions with cell 
surface-bound integrin molecules; in particular, α3β1 integrin. This observation is in 
keeping with additional studies reporting that TIMP molecules demonstrate greater 
functionally diversity than previously anticipated and are able to directly influence 
cellular behaviour in addition to indirectly influencing cellular behaviour through their 
MMP-inhibitory role (Baker et al., 2002; Crocker et al., 2004). Therefore, a direct 
contribution of TIMP2-mediated signalling to the astrogenic effect in AHPCs cannot 
be excluded; similarly, TIMP2 may contribute to the astrogenic effect via a more 
indirect mechanism, namely its effect on MMP-mediated extracellular matrix 
remodelling. In keeping with the latter possibility, MMP2, MMP3 and MMP13 were 
detected in both ITS- and ITS+P+P-CM; therefore, upregulation of TIMP2 in 
biologically-active ITS+P+P-CM may inhibit the activity of MMP2/3/13 such that the 
extracellular matrix is not remodelled and remains permissive to astrocytic 
differentiation. Furthermore, MMPs have been reported as regulators of diverse 
cellular functions such as proliferation, migration, differentiation and neurite 
outgrowth; TIMP2 may influence these cellular processes indirectly via its interaction 
with MMP molecules (Zuo et al., 1998; Diaz-Rodriguez et al., 1999; Lee et al., 2001).  
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Glia-derived nexin (serpin E2)  
Glia-derived nexin (serpin E2) also presented as a strong putative candidate factor, 
being exclusively detected in biologically-active ITS+P+P-CM samples and previously 
being reported as a neurotrophin that is actively secreted by astrocytes (Stone et al. 
1987; Brenneman et al., 1997). This protein belongs to the serpin protein family 
(serine proteinase inhibitor family) and several studies have demonstrated that it has an 
anti-apoptotic effect in the brain, undergoing significant upregulation following 
injury/ischaemia/alterations to the blood-brain barrier (Meier et al., 1989; Hoffman et 
al., 1992; Brenneman et al., 1997; Turgeon and Houenou, 1997). The neuroprotective 
function of glia-derived nexin has been attributed to its protease inhibitory function 
(Onuma et al., 2006). Additionally, glia-derived nexin has demonstrated neurite-
inducing properties in neuroblastoma cell lines and hippocampal neurons (Meier et al., 
1989). Although a direct role in promoting differentiation in neural stem/progenitor 
cells is not known with any certainty, there is evidence to suggest a role in promoting 
neuronal differentiation (Lin et al., 2005). 
 
Gamma enolase (neuron-specific enolase) 
Gamma enolase (neuron-specific enolase, or enolase 2) is one of three enolase 
isoenzymes present in mammals and is an interesting candidate factor owing to its 
restricted expression to mature neurons and other neural cell types during the later 
stages of development; indeed, Cervello and colleagues observed a three-fold 
increased in gamma enolase levels following differentiation of the N115 
neuroblastoma cell line for 24 hours (Cervello et al., 1993). Expression of gamma 
enolase was previously thought to be restricted to neuronal cell types only; however, it 
has since been detected in astrocytes, oligodendrocytes and has even been indicated as 
a marker of prostatic neuroendocrine cells (Vinores and Rubinstein, 1985; Xu et al., 
1995; Deloulme et al., 1997; Daddi et al., 2004; Untergasser et al., 2005; Raposio et 
al., 2007). However, despite its use as a neural-specific marker in cell differentiation 
studies, gamma enolase has yet to be reported as an inducer of neural differentiation, 
though it has been reported as an actively-secreted protein (Lawton et al., 1986).  
Calumenin (crocalbin) 
Another potentially-interesting candidate factor identified in this study is calumenin 
(crocalbin) which is observed to be significantly upregulated in biologically active 
ITS+P+P-CM compared to biologically-inactive ITS-CM. Calumenin is a member of 
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the CREC protein family, a small yet rapidly-expanding protein family encoded by 
five genes in total and characterised by multiple highly-conserved EF-hand domains 
(Hansen et al., 2009; Honoré, 2009). Functionally, members of the CREC family are 
highly diverse but, at the cellular level, all localise to various stages of the secretory 
pathway; however, only calumenin has been reported to undergo active secretion from 
cells into the culture media (Vorum et al., 1999; Hansen et al., 2009). Indeed, a recent 
study observed the secretion of calumenin from astrocytic cells in culture, therefore 
presenting the possibility that calumenin could have an as-yet uncharacterised role in 
neural development (Dowell et al., 2009). Upregulation of calumenin has been 
suggested to reflect Schwann cell activation and proliferation (Jiménez et al., 2005). In 
their interesting study, Østergaard and colleagues examined the effect(s) of calumenin 
on cellular behaviour by culturing fibroblasts in its presence/absence followed by 
characterisation of the cellular response using 2D SDS-PAGE MS/MS (Østergaard et 
al., 2006). The presence of extracellular calumenin altered the organisation of the actin 
cytoskeleton and also influenced cell cycle status of the cultured fibroblasts; therefore, 
it can be envisioned the calumenin functions in an analogous manner in the culture 
system used in the present study, as both cytoskeletal rearrangement and modulation of 
cell cycle status are both key processes in neural differentiation. 
 
Translationally-controlled tumour protein (lens epithelial protein) 
Translationally-controlled tumour protein (lens epithelial protein) presents as a 
potentially interesting candidate factor as its expression is restricted exclusively to lens 
epithelial cells, where it is co-expressed with the astrocytic marker, GFAP (Hatfield et 
al., 1984). Although lens epithelial cells are of a different embryological origin to 
astrocytic cells, they share many similar phenotypic traits in terms of cellular shape, 
morphology and functionality (O’Rahilly and Meyer, 1959; Hertz, 1977; Levitt et al., 
1981).  
 
Melanoma-associated antigen MG50 
Additionally, melanoma-associated antigen MG50 is a potentially interesting candidate 
factor. Melanoma-associated antigen MG50 (interleukin 1 receptor antagonist) is 
reported to be one of the only melanoma-associated antigens that is not a 
differentiation antigen or mutated protein (Mitchell et al., 2000). Although there is 
currently no published data on MG50 and its biological relevance to the nervous 
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system, other members of the melanoma-associated antigen family have been 
implicated in neural processes; for example, necdin is expressed predominantly in 
post-mitotic neurons and has been described as a promoter of neuronal 
differentiation/survival (Pisarra et al., 1998; Kuwajima et al., 2006). 
 
Olfactomedin-3 
Olfactomedin-3 is a secreted glycoprotein observed to be upregulated in biologically-
active ITS+P+P-CM and, although the precise biological function of olfactomedin-3 is 
unknown, other members of the olfactomedin protein family – including noelin, tiarin, 
pancortin, Omf1 and gliomedin – have been significantly implicated in regulation of 
the mammalian nervous system; in particular, gliomedin is reported to be secreted by 
and incorporated into the extracellular matrix surrounding Schwann cells, whilst Omf1 
has been observed to promote neuronal differentiation in Xenopus models (Zeng et al., 
2004; Moreno and Bronner-Fraser, 2005; Eshed et al., 2007; Lee et al., 2008). 
 
Cortistatin 
Cortistatin is a neuropeptide which bears significant sequence homology to 
somatostatin – sharing 11 of its 14 amino acids – and has an important role in 
signalling throughout the nervous system (Rubinfield and Shimon, 2006). Although 
the vast majority of cortistatin studies focus on its predominant role in deep sleep and 
other related processes, cortistatin has previously been reported to induce neurite 
outgrowth in PC12 cells (Kim et al., 2007). The same study also demonstrated that 
cortistatin could induce neuronal differentiation in the same cell system in the presence 
of retinoic acid; however, retinoic acid is the gold-standard neuronal differentiation 
reagent and it is therefore likely that the differentiative effects observed were 
predominantly a consequence of retinoic acid rather than cortistatin. That said, a 
combinatory effect cannot be discounted. 
 
Extracellular matrix proteins 
Also of considerable interest were the abundant number of extracellular matrix 
proteins – including various collagens and fibronectins – that were detected either 
exclusively or significantly upregulated in biologically-active ITS+P+P-CM compared 
to biologically-inactive ITS-CM. Such molecules have previously been reported to 
play crucial roles in neural developmental processes (Jaworski and Perez-Martinez, 
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2006; Li et al., 2009). The crucial role of extracellular matrix in basic neural stem cell 
biology and maintenance of neural stem cell integrity is highlighted by the necessity to 
coat cellware with various combinations/concentrations of extracellular matrix proteins 
to provide an environment more permissive to the culture of neural cell types 
(Carbonetto and Cochard, 1987). Although this is a useful and convenient compromise 
allowing the in vitro culture of neural cell types, coating cellware with individual/basic 
combinations of extracellular matrix proteins is not truly representative of the in vivo 
niche of neural cell types, where extracellular matrix reflects a dynamic combination 
of proteins arranged purposely and present at precise concentrations. 
 
In addition to provision of structural support and organisation within the niche, 
extracellular matrix components also provide key regulatory signals that promote 
cellular processes such as proliferation, migration and differentiation (Tate et al., 2004; 
Hayashi et al., 2007; Tanentzapf et al., 2007). Such phenomena can be a consequence 
of direct interaction between extracellular matrix ligands and integrin receptors on the 
cell surface, or indirectly as a consequence of binding and presentation of growth 
factors within the niche to increase their local concentration (Watt, 1986; Ferri and 
Levitt, 1995; Conover and Notti, 2008; Ma et al., 2008). However, despite the 
undoubtedly important contribution of extracellular matrix to neural stem cell biology 
within the neural niche, the function of such components are poorly understood at 
present. Studies examining the spatial and temporal expression patterns of extracellular 
matrix components within the neural stem cell niche have revealed that extracellular 
matrix is present in abundant quantities during developmental processes such as 
differentiation, migration and neurite extension etc.; however, expression of such 
components are significantly reduced at the end of development (Letourneau et al., 
1994; Lathia et al., 2007; Ma et al., 2008). Therefore, it could be envisioned that the 
extracellular matrix lattice secreted and emplaced by MSC aggregates cultured in 
ITS+P+P-supplemented media provides a culture substratum amenable to astrocytic 
differentiation (Koslova et al., 1993). It is anticipated that extracellular matrix 
components play a particularly prominent role in the later stages of neural 
differentiation, involving processes such as neurite outgrowth and synaptogenesis etc. 
(Li et al., 2009). The lack of current understanding in how interactions between 
extracellular matrix and neural stem cells contribute to differentiative processes means 
that this would be difficult to verify. 
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Overall summary 
Neural differentiation is a complex, highly intricate and multifaceted process, and is 
regulated extensively by both spatial and temporal environmental cues in vivo; 
therefore, the astrogenic effect observed in AHPCs following culture in MSC 
aggregate-derived CM for 7 days is likely to be a consequence of extensive interplay 
between several of the candidate factors identified in this chapter, as opposed to the 
effect(s) of a single factor. Within the stem cell niche there is extensive crosstalk 
between diffusible soluble factors and extracellular matrix components and it can be 
envisioned that similar cross-mechanisms are occurring in the AHPC system used 
throughout this thesis. The major limitation of conditioned media studies to date has 
been the lack of effort to characterise the cellular secretome and identify the bioactive 
factor(s) responsible for the observed cellular effects. Traditional approaches have 
involved targeting a single factor or a handful of factors predicted to be present within 
the complex secretome based on the observed cellular effect(s) and current knowledge 
within the literature. Studies within this Chapter adopted a traditional approach in the 
first instance, involving targeted transcriptional profiling using qRT-PCR and then 
adopted a more technically-advanced approach of shotgun proteomics using LC-
MS/MS to indiscriminately examine the MSC aggregate-derived secretome. A number 
of potential candidate factors have presented as ideal candidates for further 
investigation.
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6.1  General Discussion 
Stem cells are ideal candidates for potential clinical application in regenerative 
cellular-based therapies and tissue engineering strategies against a wide range of 
clinically-important disorders. In particular, adult stem cells – such as MSCs used in 
studies throughout this investigation – are garnering significant interest as they are 
widely accessible and circumvent the considerable ethical issues surrounding the use 
of embryonic stem cells. The intrinsic ability of MSCs to differentiate into mesodermal 
derivatives such as bone and fat means that they immediately present as ideal 
candidates for cellular-based therapies targeted against osseous and adipose tissue 
defects, whilst an increasing number of studies suggest that MSCs may also be used 
for cellular-based therapies against a wider range of clinically-important disorders, 
including those of the cardiac, renal and nervous systems. It is the latter that is of 
particular significance to this thesis. 
 
However, despite the intense excitement surrounding stem cells and their potential to 
revolutionise modern regenerative medicine, translation of stem cell research from the 
laboratory bench to a clinical setting has been slower than anticipated and somewhat 
disappointing. One of the main reasons to account for this lag is the assumption made 
in the majority of studies that stem cells cultured in the artificial 2D environment of 
tissue culture plastic behave in an analogous manner to which they would when 
functioning as part of a living tissue in vivo. This is highly unlikely to be the case, 
particularly in studies involving stem cells, where the contribution of niche-specific 
signals towards stem cell function/behaviour is equally as significant as the intrinsic 
properties of the stem cells themselves (Scadden, 2006). Therefore, although culturing 
cells using traditional methods is convenient and has increased our knowledge of 
biological processes, a greater appreciation of niche-specific signals and a better 
understanding of the balance between stem cell intrinsic properties, niche-specific 
signals are required before stem cells are successfully introduced into a clinical setting. 
 
Research conducted for this study has investigated numerous facets of the stem cell 
niche and the effect(s) of such facets on various aspects of MSC 
behaviour/functionality in vitro. In the first instance, cellular viability and 
differentiative potential of MSCs cultured using traditional methods i.e. 2D tissue 
Chapter 6: General summary 
 
306 
 
culture plastic was compared to that of counterparts cultured on the novel, polystyrene 
3D scaffold, Alvetex
TM
, with the hypothesis that MSCs cultured in 3D would be 
encouraged to adopt conformations/morphologies and form cell-cell interactions more 
representative of those that occur in vivo. Indeed, MSCs cultured on the 3D scaffold 
demonstrated excellent cellular morphology concomitant with enhanced 
viability/differentiative potential compared to counterparts cultured in the traditional 
environment of 2D tissue culture plastic. At the molecular level, the enhanced 
differentiative potential of MSCs cultured on 3D was determined to be a consequence, 
at least in part, of enhanced autocrine signalling; however, differences in expression of 
soluble factors/cytokines observed at the transcriptional level were not verified at the 
protein level. The contribution of autocrine and paracrine signalling, mediated by 
cellular-derived soluble factors and cytokines, represents another facet of the stem cell 
niche that is often overlooked; in fact, soluble factors/cytokines are likely to represent 
the most significant factors within the niche involved in maintenance/regulation of 
stem cell behaviour/function. Combined, results from Chapter 3 demonstrate that 
culturing cells in 3D and encouraging the formation of conformations/geometries more 
representative of those that occur in vivo and provides a more physiologically-relevant 
system in which to study the complex cellular and molecular mechanism(s) by which 
MSCs commit to a specific fate and undergo appropriate differentiation programs. The 
ultimate aim is to exploit this knowledge in order to control stem cell behaviour in 
clinical applications, and develop new and improved reagents for cell culture. 
 
An alternative method of culturing MSCs in 3D was introduced in Chapter 4. Previous 
studies have demonstrated that MSCs form large, multicellular aggregates when 
cultured under conditions described for the propagation of neurospheres, which 
promotes structural interactions/re-establishment of mutual contacts between cells 
without the use of external scaffolds such as that used in Chapter 3 (Hermann et al., 
2004; Hermann et al., 2006; Pampaloni et al., 2007; Croft and Przyborski, 2009). Of 
particular relevance to this thesis is the latter study by Croft and Przyborski, which 
observed that MSC-derived aggregates were able to influence the cell fate decisions of 
primary embryonic neural stem cells when in a co-culture system; this effect was a 
consequence of paracrine signalling between the two cell populations (Croft and 
Przyborski, 2009). In this co-culture model, MSC-derived aggregates released a 
complement of soluble factors/cytokines that induced embryonic neural stem cells to 
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commit to and undergo a neuronal differentiation program. These observations are in 
support of many previously-published studies reporting that MSC transplantation in 
numerous models of neurological and neurodegenerative disorders results in beneficial 
effects as a consequence of the paracrine action(s) of MSC-derived soluble 
factors/cytokines on host neural stem/progenitor cells (reviewed in Chapter 1). Further 
understanding of the paracrine relationship between MSCs and NSCs is highly 
desirable from a clinical perspective, as NSCs are inaccessible and technically 
challenging to culture in vitro; therefore, if MSCs can be manipulated to release a 
complement of soluble factors/cytokines that directs the differentiation of host neural 
stem cells as required, this may provide a potential therapeutic avenue for the 
treatment of neurological and neurodegenerative disorders. Detailed dissection of the 
MSC secretome may circumvent the need for cellular delivery of these bioactive 
molecules at all, instead permitting exogenous administration of such factors. 
 
Studies in Chapter 4 aimed to investigate the paracrine effect(s) of MSC-derived 
aggregates in further detail, using a conditioned media approach and the AHPC 
system. Following 7 days culture in MSC aggregate-derived CM, AHPCs were 
induced to commit to and undergo an astrocytic differentiation program, as determined 
by expression of structural/functional astrocytic markers and upregulation of 
astrocytic-promoting transcription factors. It was originally anticipated that the effects 
observed in this study would mirror those observed by Croft and Przyborski (2009); 
however, this was not the case, with MSC aggregate-derived soluble factor/cytokines 
inducing astrogenesis at the expense of neurogenesis in this system. The reasons for 
such discrepancies are highly likely to be a consequence of the obvious differences in 
experimental system between the present study and that of Croft and Przyborski 
(2009):  
 
 The present study used the AHPC cell line, which was originally 
propagated from adult rats; the study by Croft and Przyborski (2009), 
conversely, used primary E14 neural progenitor cells. It is not 
uncommon for the same molecule to exert highly different effects in 
cells of embryonic vs. adult origin (Guillemot, 2007). 
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 The present study used a conditioned media approach, in which cellular 
communication is unidirectional; the study by Croft and Przyborski, 
conversely, used a co-culture approach, in which cellular 
communication is bidirectional. Therefore, it cannot be ascertained with 
any certainty that MSCs produce and secrete the same complement of 
soluble factors/cytokines into conditioned media that they do when 
under the influence of neural stem cell-derived soluble factors/cytokines 
in co-culture; indeed, MSCs have previously been reported to modify 
their secretome depending on the microenvironment in which they are 
cultured (Chen et al., 2002).  
 
It can therefore be envisioned that the co-culture system adopted by Croft and 
Przyborski (2009) is a more physiologically-relevant system in which to study the 
paracrine relationship between MSCs and NSCs, as cellular communication is likely to 
be multi-directional in vivo rather than unidirectional, as is the case in conditioned 
media approaches. However, a conditioned media approach was adopted in this study 
as characterisation of the MSC aggregate-derived secretome is a crucial step towards 
understanding the interactions between MSCs and NSCs and how this can be exploited 
for therapeutic applications in a clinical setting; crucially, co-culture assays do not 
allow determination of the cellular origin of proteins in the media. 
 
A combinatorial approach involving targeted transcriptional profiling using qRT-PCR 
and shotgun proteomics using LC-MS/MS was adopted in Chapter 5 in order to 
scrutinise the MSC aggregate-derived secretome in further detail, with the ultimate aim 
of identifying the bioactive factor(s) responsible for exerting the biological effects 
observed in Chapter 4. To our knowledge, this is the first large-scale study targeting 
identification of neurotrophic factors in MSC-derived conditioned media. Targeted 
transcriptional profiling identified significant upregulation of LIF, NGF and GDNF at 
the mRNA level in MSC-derived aggregates; however, these transcriptional changes 
were not verified at the protein level. Shotgun proteomic analysis of MSC aggregate-
derived CM identified further putative candidate factors encompassing a wide range of 
general cellular functions, including extracellular matrix, metabolic proteins, 
cytoskeletal components, chaperones/heat shock proteins and soluble 
factors/classically-secreted proteins. Of these, TIMP2, glia derived nexin (serpine 2) 
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and calumenin (crocalbin) presented as particularly interesting putative candidate 
factors, though a significant contribution of extracellular matrix proteins such as 
collagens and fibronectins are also likely to be important contributing factors. Such is 
the complex nature of the neural differentiation process, that extensive interplay 
between several of the candidate factors identified in Chapter 5 is likely to be causative 
of the astrogenic effect in AHPCs. 
 
Studies in this thesis have examined the bifunctionality of MSCs in terms of their 
intrinsic ability to differentiate into mesodermal derivatives such as bone and fat, and 
also their paracrine behaviour involving the release of soluble factors/cytokines that 
influence the behaviour of other stem cell types; in the case of this thesis, neural stem 
cells. Of most interest is the observation that soluble factors/cytokines produced and 
secreted by MSC-derived aggregates induce astrogenesis in AHPCs following 7 days 
culture. Until recently, astrocytes were considered to be passive cells whose main 
function was to provide structural and functional support to neurons; however, this is 
no longer considered to be the case, as studies continue to be published reporting more 
widespread roles/functions of astrocytes (Svendsen, 2002; He and Sun, 2007). These 
are discussed in Chapter 4. Renewed interest in astrocyte biology means there is high 
demand for convenient in vitro assays, as astrocytes are notoriously difficult to study 
in vitro due to technical challenges in their culture. MSC aggregate-derived CM may 
therefore provide an easy source of astrocytes from neural stem/progenitor cells from 
which to perform further in vitro studies. However, further verification of the effect(s) 
of MSC aggregate-derived CM on neural stem and progenitor cells from other sources 
would be highly beneficial. 
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6.2  Summary of key findings 
 MSCs isolated from the bone marrow of postnatal rats demonstrate an MSC-
like phenotype in terms of cell surface and intracellular marker expression and 
potential to differentiate into the mesodermal derivatives, bone and fat. 
 
 MSCs cultured on the novel, polystyrene 3D scaffold manufactured by 
Reinnervate Ltd. – AlvetexTM – demonstrate enhanced viability and 
functionality in terms of their ability to differentiate into osteogenic and 
adipogenic lineages. 
 
 Enhanced osteogenic and adipogenic differentiation of MSCs cultured on the 
scaffold is attributable, at least partially, to autocrine behaviour. 
 
 MSCs can form large, multicellular aggregates resembling neurospheres 
following culture under previously-published conditions described for the 
propagation of neurospheres. MSC-derived aggregates are positive for neural 
antigen expression. 
 
 MSC-derived aggregates secrete a complement of soluble factors/cytokines 
into their culture media that induces AHPCs to undergo astrocytic 
differentiation. 
 
 The astrogenic effect observed in AHPCs occurs independently of effects on 
cell proliferation; however, increased cell death in putative oligodendrocytic-
precursors may contribute to the astrogenic effect. 
 
 Increased cell death in putative oligodendrocytic-precursors is a direct 
consequence of activation of apoptotic pathways. 
 
 LIF, NGF, GDNF, TIMP2, glia derived nexin (serpine 2) and calumenin 
(crocalbin) all present as particularly interesting candidate factors identified 
following targeted transcriptional profiling and shotgun proteomic analysis of 
MSC aggregate-derived CM. 
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 Extracellular matrix proteins secreted by MSC-derived aggregates are also 
likely to be important contributors to the astrogenic effect. 
 
6.3  Future work 
Studies in this investigation have examined several aspects of MSC behaviour and 
function, particularly the ability of MSCs to function as paracrine mediators of neural 
differentiation, using a conditioned media approach and the AHPC system as a model 
of neural development. Although the cellular and molecular mechanisms responsible 
for the astrogenic effect in AHPCs were studied in extensive detail in this thesis, a 
major limitation of this work is that the conditioned media was characterised using 
only a single cell line. As such, further verification of the effect(s) of MSC aggregate-
derived CM on neural stem and progenitor cells from other sources would be highly 
beneficial. Preliminary results achieved following culture of the human embryonic 
neural stem cell line, REN 197VM, in MSC aggregate-derived CM for 7 days are 
shown in Figure 6.1. 
 
Figure 6.1. Expression of neural markers in REN 197VM cells following 7 days culture with MSC 
aggregate-derived CM and appropriate controls. A, B and C: expression of Tuj-1; D, E and F: 
expression of GFAP; G, H and I: expression of GalC. Treatment of REN 197VM cells with conditioned 
media results in the development of more extensive and intricate processes indicative of neuronal 
differentiation compared to control cultures. However, extensive co-expression of neural markers in the 
REN 197VM cell line makes phenotypic determination difficult. Scale bar = 100µm. 
Tuj-1 
GFAP 
GalC 
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One key feature of the above study was that the proliferation control (PC), 
unconditioned media control (UC) and conditioned media (CM) cultures all 
demonstrated significant co-expression of the neural markers Tuj-1 and GFAP, and 
poor expression of GalC (Figure 6.1). Significant co-expression of Tuj-1 and GFAP in 
undifferentiated REN 197VM cultures has previously been demonstrated in our 
laboratory (data not shown). However, morphological analysis suggested that REN 
197VM cells cultured in MSC aggregate-derived CM for 7 days were beginning to 
develop more extensive and intricate processes indicative of neuronal differentiation 
compared to control cultures (Figure 6.1C). These morphological changes were very 
subtle, but apparent, and can be observed at higher magnification in Figure 6.2. 
Although induction of neuronal differentiation in REN 197VM cells differs to the 
astrogenic effect observed in AHPCs, such an effect in this system would support the 
observations of Croft and Przyborski, who observed neuronal differentiation in 
embryonic neural stem cells following co-culture with MSC-derived aggregates (Croft 
and Przyborski, 2009). These results therefore serve to highlight the importance of 
cell-intrinsic properties in the conditioned media effect. 
 
 
Figure 6.2. Morphology of Tuj-1
+
 REN 197VM cells following 7 days culture with MSC aggregate-
derived CM. Although proliferation control (PC), unconditioned media control (UC) and conditioned 
media (CM) cultures all demonstrated significant co-expression of Tuj-1, morphological analysis 
suggested that CM cultures were beginning to develop more extensive and intricate processes indicative 
of neuronal differentiation. Magnification is X40. 
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Several additional areas of this thesis would also benefit from further verification 
work; in particular, verification of mRNA data at the protein level. Transcriptional 
profiling using qRT-PCR was used at several points in this thesis to examine 
expression of soluble factors and cytokines in MSCs cultured on the 3D scaffold 
(Chapter 3) and also in MSCs cultured as large, multicellular aggregates (Chapter 5). 
Although transcriptional profiling serves as a convenient and cost-effective starting 
point for such studies, mRNA levels are not always indicative of actual protein levels 
due to extensive post-transcriptional and post-translational processing. Having said 
that, changes at the transcriptional level are useful in themselves as indicators of 
cellular activity. In order to verify the qRT-PCR work performed throughout this 
thesis, several avenues of investigation could be performed. In the first and perhaps 
simplest instance, analysis of corresponding protein levels could be performed using 
Western blot analysis on cell lysates; however, if the protein being assayed is a truly-
secreted protein, then intracellular levels may not be truly reflective of actual protein 
levels due to active secretion into the media. Therefore, a better approach could be 
concentration of the protein content of culture media followed by Western blot 
analysis, or determination of protein concentration in the media using an ELISA-based 
assay. 
 
Results in Chapter 4 demonstrated that soluble factors/cytokines produced and secreted 
by MSC-derived aggregates were able to induce apoptosis in putative 
oligodendrocytic-precursors; however, this effect was not reproduced at a statistically-
significant level in the 33B oligodendrocytoma cell line. It would be worthwhile 
investigating whether culture conditions could be modified appropriately such that 
MSC aggregate-derived CM induced apoptosis in this cancerous cell line at a 
statistically-significant level e.g. concentration of CM may result in a more potent 
induction of apoptosis. 
 
Verification and functional testing of putative candidate factors identified in Chapter 5 
would add significant impetus to this study. Although transcriptional profiling is 
limited in that mRNA levels are not always indicative of actual protein levels, targeted 
transcriptional profiling based on current knowledge within the literature was 
considered a convenient and necessary starting point because growth factors and 
cytokines are rarely detected by proteomic methods due to their low molecular weight, 
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low abundance and low stability (Moore et al., 2009). Immunological validation of the 
targeted transcriptional profiling and shotgun proteomic data would be the next logical 
step for continuation of this study. This could be achieved directly via Western blot 
and/or ELISA-based methods on conditioned media samples. Following this, 
biological validation and functional testing of the putative candidate factor(s) could be 
performed by using either a) blocking antibodies/antagonists against the relevant 
factor(s) in order to ascertain whether the biological effect is maintained/abolished, or, 
b) recombinant proteins in order to ascertain whether the biological effect can be 
reproduced. Following successful validation and functional testing of the putative 
candidate factor(s), efforts could be made to exploit this by transfecting MSCs to 
overexpress any biologically-important factors. 
 
One final point to consider is that the identification of putative candidate factors in 
Chapter 5 focussed predominantly on proteins that were significantly 
upregulated/exclusively detected in biologically-active ITS+P+P-CM, with little 
impetus placed on proteins that were downregulated. Indeed, if such factors were 
inhibitory to neural differentiation, then it could be anticipated that downregulation of 
these factors in biologically-active ITS+P+P-CM is equally as important as 
upregulation of promoting factors in determination of an astrocytic fate in AHPCs. 
Analysis of the original dataset revealed that 13 proteins were significantly 
downregulated in ITS+P+P-CM. These are: nucleoside diphosphate kinase A, 
nucleoside diphosphate kinase B, profilin-1, cystatin C, proteasome subunit α6, 
FK506-binding protein 1A, galectin-1, S100-A4, thioredoxin, eukaryotic translation 
initiation factor 5A-1, eukaryotic translation elongation factor 1 β2, myosin and 
cytochrome C. 
 
Research conducted for this study has investigated numerous facets of MSC behaviour 
and function, including their intrinsic ability to differentiate into the mesodermal 
derivatives bone and fat, concomitant with their ability to mediate neural 
differentiation via the release of soluble factors and cytokines. Although much of the 
data generated throughout this study is promising, further verification of certain 
aspects and continued investigation, as detailed above, would add significant impetus 
to these findings and facilitate the generation of novel pharmacological products and 
cell culture reagents. 
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ANTIBODY MANUFACTURER SPECIES IN WHICH 
ANTIBODY RAISED 
ANTIBODY 
SPECIFICITY 
DILUTION 
CD9 ABCAM  
ab92726 
RABBIT RAT, HUMAN, MOUSE 1:50 
CD13 SANTA CRUZ  
sc-166105 
MOUSE RAT, HUMAN, MOUSE  1:50 
CD15 ABCAM  
ab16285 
MOUSE RAT 1:50 
CD34 SANTA CRUZ  
sc-7324 
MOUSE RAT, HUMAN 1:50 
CD44 ABCAM 
ab24504 
RABBIT RAT, HUMAN, MOUSE 1:50 
CD45 ABCAM 
ab33923 
MOUSE RAT 1:50 
CD71 ABCAM 
ab65189 
MOUSE RAT 1:50 
CD90 ABCAM 
ab225 
MOUSE RAT, GUINEA PIG, 
RABBIT 
1:50 
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CD105 SANTA CRUZ 
sc-20632 
RABBIT RAT, HUMAN, MOUSE 1:50 
CD138 ABCAM 
ab60199 
RABBIT RAT, HUMAN, MOUSE, 
HAMSTER 
1:50 
α-SMA ABCAM 
ab5694 
RABBIT RAT, HUMAN, MOUSE, 
CHICKEN, COW, PIG  
1:400 
VIMENTIN ABCAM 
ab8978 
MOUSE RAT, HUMAN, MOUSE, 
CHICKEN, COW, DOG, 
GOAT, HAMSTER, 
ZEBRAFISH 
1:400 
FIBRONECTIN ABCAM 
ab6328 
MOUSE RAT, HUMAN, 
CHICKEN, COW, DOG, 
PIG 
1:200 
β-ACTIN ABCAM 
ab8226 
MOUSE RAT, HUMAN, MOUSE, 
CHICKEN, COW, DOG, 
PIG  
1:400 
NESTIN BD BIOSCIENCES 
611658 
MOUSE RAT, HUMAN, MOUSE 1:200 
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APPENDIX A. Details of the primary antibodies used throughout this thesis. Information provided in this appendix includes antigen 
targeted by antibody, manufacturer, host species, antibody specificity and dilution used. Details of the secondary antibodies used to detect these 
primary antibodies are given in the relevant methods sections in the main body of the thesis, as the secondary antibodies used differed depending 
on cell type (MSC vs. AHPC) and application (flow cytometry vs. immunofluorescence).
TUJ-1 ABCAM 
ab7751 
MOUSE RAT, HUMAN, MOUSE, 
CHICKEN, COW, 
HAMSTER, PIG 
1:600 
GFAP ABCAM 
ab7260  
RABBIT RAT, HUMAN, MOUSE, 
ZEBRAFISH 
1:200 
GALC ABCAM 
ab83752 
RABBIT RAT, HUMAN, MOUSE, 
DOG 
1:200 
BrdU ABCAM 
ab8152 
 
MOUSE N/A 1:40 
CLEAVED 
CASPASE 3 
ABCAM 
ab52294 
RABBIT RAT, HUMAN, MOUSE 1:200 
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